| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Jun―11 |
What are the key features of an equitable global vaccine strategy for the next pandemic? A qualitative study of pandemic control experts |
Ayodamope Fawole, Beth Boyer, Minahil Shahid, Ipchita Bharali, David McAdams, Gavin Yamey |
| 2 |
[GO] |
2025―Jun―07 |
Psychometric validation of the COVID-19 vaccine hesitancy scale for primary and booster doses among university students: A cross-sectional study |
Bara’ Abdallah AlShurman, Shannon E. Majowicz, Kelly Grindrod, Joslin Goh, Zahid Ahmad Butt |
| 3 |
[GO] |
2025―Jun―06 |
A review of currently licensed mucosal COVID-19 vaccines |
Alina Tscherne, Florian Krammer |
| 4 |
[GO] |
2025―Jun―06 |
Variation of COVID-19 vaccination percentage by industry and occupation in Michigan |
K.D. Rosenman, L. Wang |
| 5 |
[GO] |
2025―Jun―06 |
Association between COVID-19 vaccination and first healthcare utilization for chronic obstructive pulmonary disease: A nationwide population-based cohort study |
Sang Hyuk Kim, Seung-Hun You, Ju Won Lee, Eunji Kim, Youlim Kim, Hyun Lee, Sun-Young Jung, Ji-Yong Moon |
| 6 |
[GO] |
2025―Jun―05 |
A real-life multicenter experience for the post-pandemic management of hypersensitivity reactions to Covid-19 vaccines |
Alessandra Arcolaci, Lucia Guidolin, Elisa Olivieri, Maria Beatrice Bilò, Patrizia Bonadonna, Maria Chiara Braschi, Maria Angiola Crivellaro, Irene Martignago, Andrea Matucci, Francesca Nalin, Paola Parronchi, Rocco Scarmozzino, Gianenrico Senna, Livio Simioni, Alessandra Vultaggio, Giovanna Zanoni |
| 7 |
[GO] |
2025―Jun―05 |
Factors associated with COVID-19 vaccine confidence among Arab, Asian, Black, Indigenous, and White individuals in Canada: Latent profile analyses |
Seyed Mohammad Mahdi Moshirian Farahi, Yan Xu, Junio Dort, Lisa Caulley, Idrissa Beogo, Rose Darly Dalexis, Jude Mary Cénat |
| 8 |
[GO] |
2025―Jun―04 |
Low-dose intradermal mRNA-1273 boosting vaccine following BBiBP-CorV vaccination during the omicron pandemics |
Warawut Chaiwong, Nuchjira Takheaw, Witida Laopajon, Chote Nisoong, Supansa Pata, Pilaiporn Duangjit, Juthamas Inchai, Chaicharn Pothirat, Chaiwat Bumroongkit, Athavudh Deesomchok, Theerakorn Theerakittikul, Atikun Limsukon, Pattraporn Tajarernmuang, Nutchanok Niyatiwatchanchai, Konlawij Trongtrakul, Watchara Kasinrerk, Chalerm Liwsrisakun |
| 9 |
[GO] |
2025―Jun―04 |
COVID-19 vaccine safety studies among special populations: A systematic review and meta-analysis of 120 observational studies and randomized clinical trials |
Sima Mohammadi, Malede Mequanent Sisay, Putri Widi Saraswati, Alhadi Khogali Osman, Nicolaas P.A. Zuithoff, Daniel Weibel, Miriam Sturkenboom, Fariba Ahmadizar |
| 10 |
[GO] |
2025―Jun―04 |
Hesitancy and confidence in pediatric COVID-19 vaccination among diverse caregivers of unvaccinated children |
Lisa M. Costello, Ellen K. Kerns, Russell J. McCulloh, James R. Roberts, Daniel B. Blatt, Susanne E. Tanski, Timothy Ryan Smith, Walter Dehority, Margaret P. Huntwork, Zain Alamarat, Melinda D. Delaney, Christine W. Hockett, Ryan S. McKee, Jonathan M. Miller, Di Chang, Songthip Ounpraseuth, Sophia R. Newcomer |
| 11 |
[GO] |
2025―Jun―04 |
COVID-19 serological survey utilizing antenatal serum samples in British Columbia |
Ana Citlali Márquez, Saina Beitari, Tahereh Valadbeigy, Hind Sbihi, James Zlosnik, Lucia Forward, Sarah Mansour, Zoey Nesbitt, Guadalein Tanunliong, Mel Krajden, Agatha Jassem, Inna Sekirov, Deborah Money, Andrea Atkinson, Arianne Albert, Elisabeth McClymont, Janice Andrade, Lori Beach, Shelly Bolotin, Isabelle Boucoiran, Jared Bullard, Carmen Charlton, Joan Crane, Shelley Dougan, Jean-Claude Forest, Greg J. German, Yves Giguère, Gabriel Girouard, Catherine Hankins, Mel Krajden, Amanda Lang, Paul Levett, Jessica Minion, Cory Neudorf, Vanessa Poliquin, Jason L. Robinson, Heather Scott, Derek R. Stein, Vanessa Tran, George Zahariadis, Hong Y. Zhou |
| 12 |
[GO] |
2025―Jun―03 |
Understanding COVID-19 vaccine hesitancy during parenthood in British Columbia |
Alex Halonen, Heidi Sze Lok Fan, Stephanie Masina, Rishma Chooniedass, Elizabeth Keys, Marie Tarrant |
| 13 |
[GO] |
2025―Jun―03 |
Timeliness and completeness of serial routine vaccinations among 8062 rural children in southwest China during the COVID-19 pandemic: A multi-stage stratified cluster sampling survey in 1094 villages |
Xin-xuan Hu, Ze-zhen Qin, Zhi-yang Mo, Rui Wang, Lin Zhao, Jun-jie Ye, Xiao-hong Ma, Xian-yan Tang |
| 14 |
[GO] |
2025―Jun―02 |
Socio-demographic and behavioral predictors of multiple-dose COVID-19 vaccine uptake among older adults in Hong Kong: A community-based cross-sectional study of the generations connect project |
He Wan Jia Aaron, Runqi Yuan, Siu Chee Sophia Chan |
| 15 |
[GO] |
2025―Mai―31 |
Covid-19 vaccine incentives' effectiveness and differential impact on high-risk groups: A prospective cohort study |
Noel T. Brewer, Emmanuel M. Rockwell, Aditi Tomar, Edwin B. Fisher, Melissa B. Gilkey, Allison J. Lazard, Joseph G. Ibrahim |
| 16 |
[GO] |
2025―Mai―31 |
Estimating COVID-19 vaccine effectiveness among children and adolescents using data from a school-based weekly COVID-19 testing program |
Paige E. Harton, Allison T. Chamberlain, Amy Moore, Grace Fletcher, Kristin N. Nelson, Natalie Dean, Benjamin Lopman, Elizabeth T. Rogawski McQuade |
| 17 |
[GO] |
2025―Mai―31 |
Childhood vaccination catch-up and recovery plans for mitigating immunity gap post the COVID-19 pandemic: A case study of selected African countries |
Abu Sadat Mohammad Sayem, Godfrey Musuka, Phionah Lynn Atuhebwe, Ibrahim Dadari, Anisur Rahman Siddique |
| 18 |
[GO] |
2025―Mai―30 |
Trends in Tdap and influenza vaccination in pregnancy relative to the coronavirus disease-19 pandemic |
Eesha Dave, Jennifer F. Culhane, Lisbet S. Lundsberg, Caitlin Partridge, Katherine S. Kohari, Anna E. Denoble |
| 19 |
[GO] |
2025―Mai―30 |
Averted mortality by COVID-19 vaccination in Belgium between 2021 and 2023 |
Veerle Stouten, Izaak Van Evercooren, Catharina Vernemmen, Toon Braeye, Lucy Catteau, Mathieu Roelants, Matthieu Billuart, Thomas Lamot, Natalia Bustos Sierra, Naïma Hammami, Elias Vermeiren, Angel Rosas, Koen Blot, Anna I. Schmelz, Léonore Nasiadka, Serge Nganda, Joris A.F. van Loenhout |
| 20 |
[GO] |
2025―Mai―29 |
COVID-19 vaccination and utility of booster dose: A community-based cross-sectional study |
Geeta Yadav, Himanshu Dandu, Hardeep Singh Malhotra, Amita Jain, Shruti Radera, Vikasendu Agrawal, Anil Kumar Verma, Ravi Prakash, Shailendra Yadav, Neeraj Kumar, John Anthony, Anuj Tripathi |
| 21 |
[GO] |
2025―Mai―28 |
Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: A multinational self-controlled case series study |
Sharifa Nasreen, Yannan Jiang, Han Lu, Arier Lee, Clare L. Cutland, Angela Gentile, Norberto Giglio, Kristine Macartney, Lucy Deng, Bette Liu, Nicole Sonneveld, Karen Bellamy, Hazel J. Clothier, Gonzalo Sepulveda Kattan, Monika Naus, Zaeema Naveed, Naveed Z. Janjua, Lena Nguyen, Anders Hviid, Eero Poukka, Jori Perälä, Tuija Leino, Lukman Ade Chandra, Jarir At Thobari, Byung-Joo Park, Nam-Kyong Choi, Na-Young Jeong, Shabir A. Madhi, Felipe Villalobos, Martín Solórzano, Carlo Alberto Bissacco, Juan José Carreras-Martínez, Elisa Correcher-Martínez, Arantxa Urchueguía-Fornes, Debabrata Roy, Alison Yeomans, Taylor Aurelius, Kathryn Morton, Gianmarco Di Mauro, Miriam CJM Sturkenboom, James J. Sejvar, Karina A. Top, Karin Batty, Luam Ghebreab, Jennifer B. Griffin, Helen Petousis-Harris, Jim Buttery, Steven Black, Jeffrey C. Kwong |
| 22 |
[GO] |
2025―Mai―24 |
Understanding the shift in COVID-19 vaccine hesitancy and its associated factors for primary and booster doses among university students: A cross-sectional study |
Bara' Abdallah AlShurman, Shannon E. Majowicz, Kelly Grindrod, Joslin Goh, Xisi Zhang, Zahid Ahmad Butt |
| 23 |
[GO] |
2025―Mai―23 |
Immunogenicity and adverse effects of pneumococcal vaccines co-administered with influenza or SARS-CoV-2 vaccines in adults: A systematic review and Meta-analysis |
Hana Khajeh Rahimi, Almas Ayad Jasim, Omid Rezahosseini, Zitta Barrella Harboe |
| 24 |
[GO] |
2025―Mai―23 |
COVID-19 pandemic: A multidimensional analysis and the strategic role played by developing countries vaccine manufacturers |
Rajinder Kumar Suri, Dominique Maugeais, Kapil Maithal |
| 25 |
[GO] |
2025―Mai―22 |
Comparative study of humoral and cellular immunity against SARS-CoV-2 induced by different COVID-19 vaccine types: Insights into protection against wildtype, Delta and JN.1 omicron strains |
Zahra Hasan, Kiran Iqbal Masood, Shama Qaiser, Akbar Kanji, Fridah Mwenda, Marta Alenquer, Junaid Iqbal, Filipe Ferreira, Yaqub Wassan, Sadaf Balouch, Maliha Yameen, Shahneel Hussain, Kehkashan Begum, Khalid Feroz, Sajid Muhammad, Ayesha Sadiqa, Mishgan Akhtar, Atif Habib, Syed Muhammad Areeb Ahmed, Afsar Ali Mian, Rabia Hussain, Maria Joao Amorim, Zulfiqar A. Bhutta |
| 26 |
[GO] |
2025―Mai―20 |
Covid-19 Vaccination During Pregnancy in France: a Descriptive Study of Uptake Using the National Healthcare data System |
Elise Quentin, Ismaïl Ahmed, Chi-Hong Duong, Pascale Tubert-Bitter, Sylvie Escolano |
| 27 |
[GO] |
2025―Mai―20 |
Impact of COVID-19 vaccination by implementation timing and coverage rate in relation to misinformation prevalence in Japan |
Yuki Furuse, Takahiro Tabuchi |
| 28 |
[GO] |
2025―Mai―20 |
Real-world effectiveness of COVID-19 XBB.1.5 monovalent mRNA vaccine: Analysis over nine months |
Eliel Nham, Joon Young Song, Jang Wook Sohn, Won Suk Choi, Seong-Heon Wie, Jacob Lee, Jin-Soo Lee, Hye Won Jeong, Joong Sik Eom, Yu Jung Choi, Jin Gu Yoon, Ji Yun Noh, Hee Jin Cheong, Woo Joo Kim |
| 29 |
[GO] |
2025―Mai―20 |
Neurological adverse events following COVID-19 vaccination among Canadians referred to the special immunization clinic network |
Tiffany Fitzpatrick, Peter Yamoah, David Summerby-Murray, Juthaporn Cowan, Manish Sadarangani, Alissa Wright, Sara Belga, Cora Constantinescu, Alex Carignan, Athena McConnell, Karina A. Top |
| 30 |
[GO] |
2025―Mai―20 |
Effect of the 2022 COVID-19 booster vaccination campaign in people aged 50 years in England: Regression discontinuity analysis in OpenSAFELY-TPP |
Andrea L. Schaffer, William J. Hulme, Elsie Horne, Edward P.K. Parker, Venexia Walker, Catherine Stables, Amir Mehrkar, Seb C.J. Bacon, Chris Bates, Ben Goldacre, Alex J. Walker, Miguel A. Hernán, Jonathan A.C. Sterne |
| 31 |
[GO] |
2025―Mai―19 |
Mental health and psychosocial factors predicting concerns about the COVID-19 vaccine among refugee background and Australian-born women |
Deborah Lupton, Tyson Whitten, Alvin Kuowei Tay, Kristen Beek, Melissa Green, Fatima Hassoun, Batool Moussa, Derrick Silove, Susan Rees |
| 32 |
[GO] |
2025―Mai―15 |
Listening to micropolitan community leaders to support pandemic response efforts |
Rebecca Bucklin, Nicole Gauthreaux, Elizabeth Faber, Natoshia Askelson |
| 33 |
[GO] |
2025―Mai―15 |
Prison Vaccination in a pandemic: Geographic disparities and policy insights |
Alexes Merritt, Shweta Bansal |
| 34 |
[GO] |
2025―Mai―14 |
Practice, beliefs and intent in influenza vaccination among Hispanic patients during the pandemic: An interventional study |
Jin Mou, Gretchen LaSalle, Chaya Pflugeisen, Jamilia Sherls-Jones, Heide Castañeda, Gerson Zaragoza, Cynthia Smith, Jessica Mays, Norma Villarreal |
| 35 |
[GO] |
2025―Mai―13 |
Factors associated with laboratory-confirmed SARS-Cov-2 infection among patients with severe respiratory illness (SRI): Findings from the COVID-19 vaccine effectiveness evaluation in Kenya and Mali, 2022-2023 |
Raphael O. Anyango, Bryan O. Nyawanda, Brian O. Onyando, Fadima C. Haidara, Collins Okello, Ian K. Orege, Sidney Ogolla, Billy Ogwel, Alex O. Awuor, Samuel Kadivane, Philip Ngere, Carolyne Nasimiyu, Eric Osoro, M. Kariuki Njenga, Victor Akelo, Amos Otedo, Shirley Lidechi, John B. Ochieng, Nancy A. Otieno, Erick M.O. Muok, Kibet Sergon, Archibald Kwame Worwui, Goitom G. Weldegebriel, Isabel Bergeri, Cohuet Sandra, Celine Gurry, J. Pekka Nuorti, Patrick Amoth, Rose Jalang'o, Jason M. Mwenda, Samba O. Sow, Richard Omore |
| 36 |
[GO] |
2025―Mai―13 |
Regional mobility and COVID-19 vaccine hesitancy: Evidence from China |
Huaxin Wang-Lu, Octasiano Miguel Valerio Mendoza, Simiao Chen, Pascal Geldsetzer, Maya Adam |
| 37 |
[GO] |
2025―Mai―09 |
New-onset anesthesia/paresthesia following the administration of COVID-19 vaccines in Q, Canada |
Isabelle Rouleau, Kode Djogo Nyazy Issa Kana, Joseline Guetsop Zafack, Yv Bonnier Viger, Gaston De Serres |
| 38 |
[GO] |
2025―Mai―08 |
Reactance as a cause of COVID-19 vaccination hesitancy |
Bradley J. Adame, Steven R. Corman, Paige A. Von Feldt, Christina M. Meneses, Holly P. O'Rourke, Anique Tahir |
| 39 |
[GO] |
2025―Mai―07 |
Impact of age and prior COVID-19 on the response to influenza a components in the 2020-2021 Fluzone vaccine |
Usama Ashraf, Alexandra Lee, Qinshan Gao, Joseph C. Gonzalez, Courtney Scallan, R. Sharon Chinthrajah, Holden T. Maecker, Mark M. Davis, Kari C. Nadeau, Saborni Chakraborty, Taia T. Wang |
| 40 |
[GO] |
2025―Mai―02 |
Impact of the COVID-19 pandemic on influenza knowledge, attitudes, and vaccination practices in at-risk groups in the Kyrgyz Republic: A comparative study |
Rakhat Akmatova, Dinara Otorbaeva, Malembe S. Ebama |
| 41 |
[GO] |
2025―Mai―01 |
Factors influencing COVID-19 vaccine uptake among pregnant women in Greater Accra Region, Ghana |
Caroline Dinam Badzi, Emefa Modey, Amos Apreku, Chris Guure, Kwasi Torpey, Berhaun Fesshaye, Jessica Schue, Rupali Limaye |
| 42 |
[GO] |
2025―Mai―01 |
Short-term side effects following COVID-19 vaccination in pregnancies complicated by autoimmune inflammatory rheumatic diseases: A prospective cohort study |
Shunya Kaneshita, Christina D. Chambers, Diana Johnson, Arthur Kavanaugh, Richard Garfein, Gretchen Bandoli |
| 43 |
[GO] |
2025―Apr―30 |
Mucosal immune responses to SARS-CoV-2 infection and COVID-19 vaccination |
Mathew J. Paul, Mohammed T. Hudda, Scott Pallett, Elisabetta Groppelli, Eugenia Boariu, Nicole Falci Finardi, Rachel Wake, Nidhi Sofat, Kathryn Biddle, Soraya Koushesh, Louis Dwyer-Hemmings, Richard Cook, Julian K-C. Ma |
| 44 |
[GO] |
2025―Apr―30 |
Evaluating the effects of a multisectoral dialogue-based COVID-19 awareness-raising intervention in a limited-resource setting: A quasi-experimental study in Senegal |
Irina Kislaya, Michelangelo Caserta, Sylvain Landry Birane Faye, Oumar Khassimou Dia, Georgette Helene Coumba Sow, Cheick Oumar Doumbia, Francesca De Vito, Delphine Bousso, Ricardo Strauss, Serigne Abdou Lakhat Ndiaye, Helene Agnes Diene, Edoardo Calizza, Malick Sarr, Jürgen May, Dewi Ismajani Puradiredja, Marco Inglessis, Daniela Fusco |
| 45 |
[GO] |
2025―Apr―29 |
Developing counter-narratives to address COVID-19 misinformation among 18-24 year olds in community and campus settings |
Rhonda C. Holliday, Asantewaa Darkwa, Gail A. Brooks, Tabia Henry Akintobi, Amy Z. Chen, Rakale C. Quarells, Michael L. Best |
| 46 |
[GO] |
2025―Apr―27 |
Did inequalities in COVID-19 vaccination resolve over time? Insights from the Canadian Community Health Survey |
Donalyne-Joy Baysac, Mireille Guay, Ruoke Chen, Ève Dubé, Shannon E. MacDonald, S. Michelle Driedger, Nicolas L. Gilbert |
| 47 |
[GO] |
2025―Apr―24 |
Understanding occupational and attitudinal factors influencing UK healthcare worker decisions for COVID-19 and influenza vaccination: A cross-sectional survey within SIREN |
Quisha Bustamante, Dominic Sparkes, Lucy Findlater, Katie Munro, Irina Lut, Jameel Khawam, Sophie Russell, Ana Atti, Sarah Foulkes, Susan Hopkins, Victoria Hall, Jasmin Islam |
| 48 |
[GO] |
2025―Apr―24 |
Optimization of the preparation method of inactivated intact virus particle vaccine for COVID-19 |
Marumi Ohno, Toshiki Sekiya, Richard Obeng-Kyeremeh, Chimuka Handabile, Minori Haruta, Naoki Nomura, Tomomi Kawakita, Masashi Shingai, Hiroshi Kida |
| 49 |
[GO] |
2025―Apr―23 |
2023-2024 COVID-19 vaccine uptake among immunocompromised individuals in two US states |
Leah J. McGrath, Farid L. Khan, Santiago M.C. Lopez, Matthew A. Brouillette, Kathleen M. Andersen, Tiange Yu, Benjamin T. Carter, Laura A. Puzniak, John M. McLaughlin |
| 50 |
[GO] |
2025―Apr―18 |
Nationwide population-based surveillance of invasive pneumococcal disease in children in Japan (2014-2022): Impact of 13-valent pneumococcal conjugate vaccine and COVID-19 pandemic |
Noriko Takeuchi, Bin Chang, Naruhiko Ishiwada, Yoshiaki Cho, Junichiro Nishi, Kenji Okada, Mikiya Fujieda, Megumi Oda, Akihiko Saitoh, Mitsuaki Hosoya, Nobuhisa Ishiguro, Kohei Takahashi, Yoshihito Ozawa, Shigeru Suga |
| 51 |
[GO] |
2025―Apr―16 |
Evaluating concurrency and gaps between self-report and vaccine card data for COVID-19 vaccination |
Marie C.D. Stoner, Jenna Michaels, Jacob B. Stocks, Noah Mancuso, Zachary Soberano, Erica Browne, C. Lily Bond, Ibrahim Yigit, Allysha C. Maragh-Bass, Audrey E. Pettifor, Kathryn E. Muessig, Maria Leonora G. Comello, Margo Adams Larsen, Lisa B. Hightow-Weidman, Henna Budhwani |
| 52 |
[GO] |
2025―Apr―16 |
Antiviral humoral immunity against SARS-CoV-2 omicron JN.1 subvariants induced by JN.1 recombinant protein vaccine |
Keiya Uriu, Yu Kaku, Minoru Kihara, Kei Sato |
| 53 |
[GO] |
2025―Apr―14 |
Hybrid, vaccine-induced and natural immunity against SARS-CoV-2 in traditional food markets in Bolivia (2020-2022): A cross-sectional analysis of a serological survey |
Christine Leyns, Elliot McClenaghan, Patricia Rodriguez, Patrick Nguipdop-Djomo, Carla Ascarrunz, Daniel Eid Rodriguez, Punam Mangtani, Javier Guitian |
| 54 |
[GO] |
2025―Apr―11 |
Development and validation of a clinical prediction tool for non-receipt of updated COVID-19 vaccines |
Katia J. Bruxvoort, Lina S. Sy, Richard Contreras, Bruno Lewin, Vennis Hong, Lei Qian, Kimberly J. Holmquist, Bing Han, Stanley Xu |
| 55 |
[GO] |
2025―Apr―11 |
Behaviors, perceptions, and impact of the COVID-19 pandemic and vaccination on oncology patients in New Mexico with substantial representation of racial minorities and rural residents |
S. Sasankan, D. Gathers, A. Bellerose, V.S. Pankratz, B. Tawfik |
| 56 |
[GO] |
2025―Apr―10 |
Regional cooperation on pandemic preparedness and vaccine equity from an economic, regulatory and legal perspective |
Mei Xuan Jessalyn Chan, Olivier J. Wouters, Hui Yun Chan, Petro Terblanche, Nakorn Premsri, Jerome H. Kim, John C.W. Lim, Wei Chuen Tan-Koi, Mark Jit |
| 57 |
[GO] |
2025―Apr―08 |
COVID-19 vaccine decision-making and the role of institutions across the pandemic in UK Black African and Black Caribbean communities |
Christina Shearn, Gianina-Ioana Postavaru, Lorna Hylton, Howard Morris, Noelle Robertson, Eva M. Krockow |
| 58 |
[GO] |
2025―Apr―08 |
“Better to die trying”: Vaccine perceptions and COVID-19 experiences in rural Namibian pastoralists |
Sean Prall, Aparicio Lopes |
| 59 |
[GO] |
2025―Apr―07 |
Reasons for COVID-19 vaccination late in the pandemic: A qualitative study |
Kimberly A. Fisher, Lydia Goldthwait, Ollie Desrochers, Melanie Zemel, Cassandra Saphirak, Jeremy Malin, Rosalie Torres Stone, Sonal Singh, Sybil Crawford, Kathleen M. Mazor |
| 60 |
[GO] |
2025―Apr―06 |
Live-attenuated pandemic H1N1 influenza vaccines expressing computationally optimized broadly reactive antigens (COBRAs) are immunogenic and protective in mice and ferrets |
Po-Ling Chen, Robert A. Richardson, Samuel Rovito, Guohua Yang, Haley N. Writt, Chet Ojha, Jennifer DeBeauchamp, Jeri Carol Crumpton, Karlie Woodard, Melissa Penaflor, Lisa Kercher, Richard J. Webby, Giuseppe A. Sautto, Ted M. Ross, Charles J. Russell |
| 61 |
[GO] |
2025―Apr―06 |
COVID-19 vaccination uptake in people experiencing homelessness during the first three years of the global COVID-19 vaccination effort: A systematic review and meta-analysis |
Laura K. McCosker, Brett Dyer, Terra Sudarmana, Holly Seale, Robert S. Ware |
| 62 |
[GO] |
2025―Apr―06 |
COVID-19 vaccination rates among pregnant women in France: A nationwide cohort study |
Clément Bernard, Jérôme Drouin, Stéphane Le Vu, Jérémie Botton, Laura Semenzato, Marion Bertrand, Marie-Joelle Jabagi, Sara Miranda, Rosemary Dray-Spira, Alain Weill, Mahmoud Zureik |
| 63 |
[GO] |
2025―Apr―06 |
A national cross-sectional study of dentists' vaccine hesitancy and intention to provide HPV vaccines following emergency COVID-19 vaccination authorization |
Priscilla M. Flynn, Cynthia Stull, Vedushi M. Jain, Michael D. Evans |
| 64 |
[GO] |
2025―Apr―05 |
Effectiveness of 2023-2024 COVID-19 vaccines against COVID-19-associated hospitalizations among adults aged ≥18 years with end stage kidney disease - United States, September 2023-April 2024 |
Amanda B. Payne, Shannon Novosad, Heng-Ming Sung, Yue Zhang, Ryan Wiegand, Carla S. Gomez Victor, Megan Wallace, Danica J. Gomes, Morgan Najdowski, Bradley Lufkin, Yoganand Chillarige, Eduardo Lacson, Lorien S. Dalrymple, Ruth Link-Gelles |
| 65 |
[GO] |
2025―Apr―04 |
Immunogenicity and safety of monovalent and bivalent SARS-CoV-2 variant adapted RBD-based protein booster vaccines in adults previously immunized with different vaccine platforms: A phase II/III, randomized clinical trial |
Gonzalo Perez Marc, Lorena M. Coria, Ana Ceballos, Juan Manuel Rodriguez, Mónica E. Lombardo, Laura Bruno, Federico Páez Córdoba, Clara G. Fascetto Cassero, Melina Salvatori, Mayra Rios Medrano, Fabiana Fulgenzi, María F. Alzogaray, Analía Mykietiuk, Ignacio Leandro Uriarte, Nicolás Itcovici, Tomás Smith Casabella, Gonzalo Corral, Miriam Bruno, Oscar Roldán, Sebastián A. Núñez, Florencia Cahn, Gustavo A. Yerino, Alejandra Bianchi, Virginia Braem, Analía Christmann, Santiago Corradetti, Martín C. Darraidou, Lucila Di Nunzio, Tatiana Estrada, Rocío López Castelo, Carla Marchionatti, Lucila Pitocco, Virgina Trias Uriarte, Cristian Wood, Romina Zadoff, Florencia Bues, Rosa M. Garrido, Emanuele Montomoli, Alessandro Manenti, Sabrina A. Del Priore, Andrés C. Hernando Insua, Ingrid G. Kaufman, Adrián Di María, Adrián Gongora, Agustin Moreno, Susana Cervellini, Martin Blasco, Fernando Toneguzzo, Agostina Demaría, Lineia Prado, Celeste Pueblas Castro, Lucas Saposnik, Jorge Geffner, Federico Montes de Oca, Julio C. Vega, Juan Fló, Pablo Bonvehí, Jorge Cassará, Karina A. Pasquevich, Juliana Cassataro |
| 66 |
[GO] |
2025―Apr―04 |
Immunogenicity and safety of a monovalent Omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine in previously unvaccinated, SARS-CoV-2 seropositive participants: Primary day-28 analysis of a phase 2/3 open-label study |
Katia Alves, Alex Kouassi, Joyce S. Plested, Raj Kalkeri, Katherine Smith, Muneer Kaba, Joy Nelson, Mingzhu Zhu, Shane Cloney-Clark, Zhaohui Cai, Raburn M. Mallory, Fernando Noriega |
| 67 |
[GO] |
2025―Apr―04 |
Effectiveness of BNT162b2 and Ad26.COV2.S vaccines against COVID-19-related hospitalisation amongst adult members of a private health insurance plan in South Africa during the Delta and Omicron periods: A test-negative case-control study |
Siobhan L. Johnstone, Daniel Shapiro, Nicola Chiwandire, Lundi Matoti, Carmen Whyte, Jolene Bultinck-Human, Selaelo Mametja, Craig Getz, Boldwin Moyo, Mabatlo Semenya, Sibongile Walaza, Cheryl Cohen, Michelle J. Groome |
| 68 |
[GO] |
2025―Apr―04 |
Exploring TLR agonists as adjuvants for COVID-19 oral vaccines |
Paulo Félix, Alexandra A. Melo, João Panão Costa, Mariana Colaço, Dina Pereira, Jisette Núñez, Luís Pereira de Almeida, Olga Borges |
| 69 |
[GO] |
2025―Apr―02 |
A replicon-based COVID-19 vaccine candidate delivered by tobacco mosaic virus-like particles |
Sweta Karan, Patrick Opdensteinen, Yifeng Ma, Jessica Fernanda Affonso De Oliveira, Nicole F. Steinmetz |
| 70 |
[GO] |
2025―Mrz―31 |
Estimation of trajectory of COVID-19 vaccines effectiveness against infection |
Jialiang Jiang, Kwok Fai Lam, Eric Ho Yin Lau, Guosheng Yin, Yun Lin, Benjamin John Cowling |
| 71 |
[GO] |
2025―Mrz―31 |
A rapid cycle analytics framework for vaccine safety surveillance within a real-world data network: Experience with enhanced surveillance of the Janssen COVID-19 vaccine |
E. Claire Newbern, Azza Shoaibi, Kevin Haynes, Clair Blacketer, Corinne Willame, Frank DeFalco, Gowtham A. Rao, Kourtney Davis, Luis Anaya Velarde, Nicolas Praet, Rupa Makadia, Yimei Xu, Patrick Ryan, Martijn Schuemie |
| 72 |
[GO] |
2025―Mrz―30 |
Sociodemographic and health-related predictors of COVID-19 booster uptake among fully vaccinated adults |
Yordanos M. Tiruneh, Jihye Choi, Paula M. Cuccaro, Journey Martinez, Jing Xie, Mark Owens, Jose-Miguel Yamal |
| 73 |
[GO] |
2025―Mrz―24 |
Sociodemographic differences in parental hesitancy to the COVID-19 vaccine |
Courtney K. Blackwell, Traci Bekelman, Shivani Bakre, Lisa P. Jacobson, Nissa R. Towe-Goodman, Johnnye Lewis, Debra A. MacKenzie, Qeturah Anderson, Delma-Jean Watts, Kaja Z. LeWinn |
| 74 |
[GO] |
2025―Mrz―23 |
Adverse events among early caregivers' COVID-19 vaccination correlated inversely with intention to vaccinate their children |
R.D. Goldman, R.J. Hart, J.N. Bone, M. Seiler, P.G. Olson, K. Keitel, S. Manzano, G. Gualco, D. Krupik, S. Schroter, R.M. Weigert, S. Chung, G.C. Thompson, N. Muhammad, P. Shah, N.O. Gaucher, M.M. Lunoe, M. Evers, C. Pharisa Rochat, C.E. Nelson, M. Gal, S.H. Baumer-Mouradian |
| 75 |
[GO] |
2025―Mrz―23 |
A rapid human vaccine process development map outlining lessons learnt from ChAdOx1 nCoV-19 vaccine during the COVID-19 pandemic |
Michael James Francis |
| 76 |
[GO] |
2025―Mrz―22 |
Alcohol consumption does not influence SARS-CoV-2 vaccine immunogenicity: A stop the spread Ottawa cohort analysis |
Alicia Vachon, Alexa Keeshan, Yannick Galipeau, Angela M. Crawley, Marc-André Langlois, Curtis L. Cooper |
| 77 |
[GO] |
2025―Mrz―21 |
Concordance between parent-reported and documented COVID-19 vaccination status among hospitalized children and adolescents: Implications for vaccine effectiveness estimates, May 2021-October 2023 |
Sarah Hamid, Regina M. Simeone, Margaret M. Newhams, Natasha Halasa, Katherine E. Fleming-Dutra, Amber O. Orzel-Lockwood, Michael J. Wu, Adrienne G. Randolph, Angela P. Campbell, Laura D. Zambrano |
| 78 |
[GO] |
2025―Mrz―21 |
Predicting immune protection against outcomes of infectious disease from population-level effectiveness data with application to COVID-19 |
Tianxiao Hao, Gerard E. Ryan, Michael J. Lydeamore, Deborah Cromer, James G. Wood, Jodie McVernon, James M. McCaw, Freya M. Shearer, Nick Golding |
| 79 |
[GO] |
2025―Mrz―20 |
Challenges and enablers to establishing COVID-19 vaccine effectiveness studies in the World Health Organization Africa region: A mixed-methods evaluation of the African region monitoring vaccine effectiveness (AFRO-MoVE) network |
Adam W. Crawley, Katherine Murphy, Ian D. Plumb, Grace Adjoa Ocansey, Isaac Baffoe-Nyarko, Norman Nyazema, Sibongile Walaza, Eva Leidman |
| 80 |
[GO] |
2025―Mrz―19 |
Anti-vaccine attitudes and COVID-19 vaccine status at the end of the U.S. public health emergency |
Jasmin Choi, Jonathan Feelemyer, Karen Choe, Kathleen Lynch, Courtney McKnight, Lawrence H. Yang, Don Des Jarlais, Virginia W. Chang |
| 81 |
[GO] |
2025―Mrz―19 |
Socio-demographic differences in citizen' preferences for distributing a scarce, lifesaving resource: A case study using COVID-19 vaccine distribution in Belgium |
Nele Raskin, Mickaël Hiligsmann, Jeroen Luyten, Sandy Tubeuf, Alexander Grigoriev, Roselinde Kessels |
| 82 |
[GO] |
2025―Mrz―14 |
Targeting the early life stages of SARS-CoV-2 using a multi-peptide conjugate vaccine |
Lauren Myburgh, Haiko Karsjens, Athanasios Blanas, Aafke de Ligt, Karlijn van Loon, Elisabeth J.M. Huijbers, Judy R. van Beijnum, Diederik J.M. Engbersen, Abdessalem Rekiki, Charlotte Mignon, Oxana Vratskikh, Arjan W. Griffioen |
| 83 |
[GO] |
2025―Mrz―14 |
Applying the health belief model (HBM) to understand COVID-19 vaccine uptake among youth and young adults: Findings from a 6-month follow-up study in the United States |
Jiayi Xu, Shahin Davoudpour, Gregory Phillips |
| 84 |
[GO] |
2025―Mrz―14 |
Health care institutions and their physicians are the greatest promoters of COVID-19 vaccine acceptance among health care workers |
Laetitia Ricci, Cécile Fery, Florence Tubach, Nelly Agrinier, Amandine Gagneux-Brunon |
| 85 |
[GO] |
2025―Mrz―14 |
Factors associated with influenza and COVID-19 vaccination among health workers in Lao PDR, 2023 |
Chansay Patthammavong, Natalie Wodniak, Kongxay Phounphenghack, Chankham Tengbriacheu, Bandith Soumphonphakdy, Viengkhan Phixay, Chansavang Vongkhamsao, Viengphone Khanthamaly, Jaymin C. Patel, Martha P. Montgomery, Margaret McCarron, William W. Davis, Julie Carlton, Eva S. Bazant, Ann C. Moen, Phonethipsavanh Nouanthong |
| 86 |
[GO] |
2025―Mrz―12 |
Feasibility of cohort event monitoring and assessment of reactogenicity and adverse events among a cohort of AstraZeneca and Moderna COVID-19 vaccine recipients in Nigeria, 2021 |
Omotayo Bolu, Oluwafemi D. Alo, Emem Iwara, Ashley T. Longley, Ikwe Hadley, Comfort K. Ogar, Chukwuka Ezekwe, Uchenna Elemuwa, Oluwasanmi Adedokun, Habib O. Ramadhani, Stephen Ohakanu, Nancy Ortiz, Gladys Antonza, Asmau Abubakar, Adeyelu Asekun, Bitrus Fraden, Robert Chen, Dale Nordenberg, Sylvia Adebajo, Moji Christianah Adeyeye, Kristen A. Stafford, Peter Bassi, Abisinuola Lawal, Adekemi Adepoju, Oluwagbemisola Samuel, Kenneth Onu, Fatima Jajere, Abiodun Abiola, Thomas Torkula, Angela Faniyi, Sadik Raza, Samuel Nwafor, Favour Makava, Musa Saiki |
| 87 |
[GO] |
2025―Mrz―12 |
Childhood vaccination coverages in rural Guinea-Bissau before and during the early COVID-19 pandemic, a cohort study |
Julie Odgaard Vedel, Oides Furtado, Laerte Lima Almeida, Kimberly Raisa Nehal, Line Møller Nanque, Sabine Margarete Damerow, Quique Bassat, Aksel Karl Georg Jensen, Ane Bærent Fisker |
| 88 |
[GO] |
2025―Mrz―11 |
Effectiveness of COVID-19 vaccines against laboratory-confirmed SARS-CoV-2 infection amongst health workers, Windhoek, Namibia |
Kaveto Sikuvi, Natasha Nghitukwa, Ndiitodino Kakehongo, Ismael Katjitae, Carolina Matos, Philip Oedi, Sibongile Manga Netha, Emmanuel Nepolo, Christian Winter |
| 89 |
[GO] |
2025―Mrz―10 |
A review of Canadian online resources providing information on COVID-19 vaccination for caregivers of children aged 5-11 years |
Costanza Di Chiara, Elahe Karimi-Shahrbabak, Joelle Peresin, Daniel S. Farrar, Brooke Low, Sarah Abu Fadaleh, Katie Lee, Lauren Tailor, Nikki Wong, Pierre-Philippe Piché-Renaud, Shaun K. Morris |
| 90 |
[GO] |
2025―Mrz―10 |
Second booster doses of adenoviral- and mRNA-based COVID-19 vaccines increase protection against COVID-19 hospitalization: Final analysis from the REFORCO-Brazil real-world effectiveness study during Omicron |
Wilhelmine Meeraus, Abigail Postema, Christen M. Gray, Andrew Lee, Andre Santa Maria, Bárbara Emoingt Furtado, Eduardo Conde-Sousa, Mario Ouwens, Douglas Andreas Valverde, Clóvis Arns da Cunha, Alexandre Naime Barbosa, Claudia Corte, Sylvia Taylor |
| 91 |
[GO] |
2025―Mrz―09 |
Efficacy of BCG vaccination on incidence, severity and clinical progression of COVID-19: A BCG-REVAC population analysis |
Ramon Andrade de Souza, Florisneide Rodrigues Barreto, Carla Cristina Oliveira de Jesus Lima, Marcio Santos da Natividade, Carlos Antônio de Souza Teles Santos, Maria Yury Ichihara, Marcos Pereira, Daniel Barros de Castro, Bernd Genser, Laura Cunha Rodrigues, Maurício Lima Barreto, Susan Martins Pereira |
| 92 |
[GO] |
2025―Mrz―09 |
Comparison of Streptococcus pneumoniae nasopharyngeal colonization, serotype-specific and protein-specific antibody and cytokine levels in young children prior to, during and post COVID-19 pandemic |
Naoko Fuji, Eduardo Gonzalez, Frank N. Salamone, Peter Bajorski, Ravinder Kaur, Michael Pichichero |
| 93 |
[GO] |
2025―Mrz―07 |
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeutics |
Giulia Dowgier, Agnieszka Hobbs, David Greenwood, Marianne Shawe-Taylor, Phoebe Stevenson-Leggett, James Bazire, Rebecca Penn, Ruth Harvey, Vincenzo Libri, George Kassiotis, Steve Gamblin, Nicola S. Lewis, Bryan Williams, Charles Swanton, Sonia Gandhi, David L.V. Bauer, Edward J. Carr, Emma C. Wall, Mary Y. Wu |
| 94 |
[GO] |
2025―Mrz―07 |
COVID-19 vaccination status and associated factors among patients presenting with COVID-19-like symptoms in Uganda |
Sylvia Kusemererwa, Violet Ankunda, Terry A. Ongaria, Andrew Abaasa, Ayoub Kakande, Deogratius Ssemwanga, Geofrey Kimbugwe, Bernadette Nayiga, Henry K. Bosa, Alfred Driwale, Yonas T. Woldemariam, Annet Kisakye, James Humphreys, Archibald K. Worwui, Sandra Cohuet, Jason M. Mwenda, Alison M. Elliott, Pontiano Kaleebu, Eugene Ruzagira |
| 95 |
[GO] |
2025―Mrz―07 |
mRNA-1273 vaccines adapted to JN.1 or KP.2 elicit cross-neutralizing responses against the JN.1 sublineages of SARS-CoV-2 in mice |
Diana Wing Lee, Arshan Nasir, Sayda Elbashir, Hardik Jani, Tessa Speidel, Amy Gorrie, Daniela Montes Berrueta, Philippa Martin, Swan Tan, Yixuan Jacob Hou, Kath Hardcastle, Darin Edwards, Kai Wu, Andrea Carfi, Yadunanda Budigi |
| 96 |
[GO] |
2025―Mrz―06 |
SARS-CoV-2 conjugate vaccine elicits robust immune responses that can protect against evolving variants. |
Melanie Carroll, Heather B. Fox, Anh Tran, Gowri Chellappan, Leonardo V. Rojas, Geetha Karengil, Fataneh Karandish, John W. Langston, Brent M. Fall, Mary M. Whalen, Michael J. McCluskie, Yves Durocher, Anup Datta, Subhash V. Kapre, Ivan A. Olave |
| 97 |
[GO] |
2025―Mrz―06 |
Development of broadly protective coronavirus vaccines: A joint NIAID-CEPI workshop report. |
Jennifer L. Gordon, Erin L. Boespflug, Amanda Coleman, Kimberly Taylor, Nadia Cohen, In-Kyu Yoon, M. Cristina Cassetti |
| 98 |
[GO] |
2025―Mrz―06 |
Effectiveness of COVID-19 vaccine against SARS-CoV-2 infection among symptomatic COVID-19 patients in Uganda |
Andrew M. Abaasa, Sylvia Kusemererwa, Violet Ankunda, Terry A. Ongaria, Bernadette Nayiga, Ayoub Kakande, Deogratius Ssemwanga, Geofrey Kimbugwe, Henry K. Bosa, Yonas T. Woldemariam, Annet Kisakye, James Humphreys, Archibald K. Worwui, Sandra Cohuet, Jason M. Mwenda, Alison M. Elliott, Pontiano Kaleebu, Eugene Ruzagira |
| 99 |
[GO] |
2025―Mrz―05 |
Durability of COVID-19 vaccine and infection induced immunity: A systematic review and meta-regression analysis |
Mia Moore, Larissa Anderson, Joshua T. Schiffer, Laura Matrajt, Dobromir Dimitrov |
| 100 |
[GO] |
2025―Mrz―03 |
Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Results of a randomized vaccine-controlled phase I ADAPTCOV trial in Brazil |
Érique José Farias Peixoto de Miranda, Rodrigo T. Calado, Fernanda Castro Boulos, José Alfredo de Sousa Moreira, Fabiane Fernandes Machado, Maria Aparecida Alves Leite Dos Santos Almeida, Marcia Cristina Oliveira Da Rocha, Vanessa Infante, Laina D. Mercer, Richard Hjorth, Rami Scharf, Jessica White, Christina Polyak, Rama Raghunandan, Adolfo García-Sastre, Weina Sun, Peter Palese, Florian Krammer, Bruce Innis, Cristiano Gonçalves Pereira, Esper Georges Kallas |
| 101 |
[GO] |
2025―Mrz―03 |
Enhanced sulfate pseudo-affinity chromatography using monolith-like particle architecture for purifying SARS-CoV-2 |
Kenji Kadoi, Junya Toba, Ayana Uehara, Norikazu Isoda, Yoshihiro Sakoda, Eri Iwamoto |
| 102 |
[GO] |
2025―Mrz―03 |
Global spatio-temporal distribution of coronavirus disease 2019 vaccine hesitancy between 2020 and 2022: A meta-analysis |
Tianshuo Zhao, Qingsong Xu, Xianming Cai, Mingting Wang, Le Ao, Tingting Wei, Han Yang, Sihui Zhang, Xiyu Zhang, Shifeng Jin, Xinyu Wang, Xin Feng, Jiayi Zhao, Yifei Wu, Jieru Yang, Fuqiang Cui |
| 103 |
[GO] |
2025―Mrz―03 |
Comparative analysis of fourteen COVID-19 vaccine injury compensation systems and claim approval rates |
Chao-Fang Chu, Tzu-Hao Chang, Jen-Ji Ho |
| 104 |
[GO] |
2025―Mrz―02 |
Increasing confidence for pediatric COVID-19 and influenza vaccines using messages affirming parental autonomy: A randomized online experiment |
Lynne M. Cotter, Molecula Hopkins-Sheets, Sijia Yang, Susan R. Passmore, Mahima Bhattar, Emma Henning, Dan Schultz, Emily Latham, Malia Jones |
| 105 |
[GO] |
2025―Mrz―01 |
Factors associated with mortality among patients aged 12 years and above requiring hospitalization for severe respiratory illness (SRI): Findings from the COVID-19 vaccine effectiveness evaluation in Kenya and Mali, 2022-2023 |
Brian O. Onyando, Bryan O. Nyawanda, Daniel Onguru, Fadima C. Haidara, Collins Okello, Raphael O. Anyango, Ian K. Orege, Sidney Ogolla, Billy Ogwel, Alex O. Awuor, Samuel Kadivane, Philip Ngere, Carolyne Nasimiyu, Eric Osoro, M. Kariuki Njenga, Victor Akelo, Amos Otedo, Shirley Lidechi, John B. Ochieng, Nancy A. Otieno, Erick M.O. Muok, Kibet Sergon, Archibald Kwame Worwui, Goitom G. Weldegebriel, Isabel Bergeri, Cohuet Sandra, Celine Gurry, J. Pekka Nuorti, Patrick Amoth, Rose Jalang'o, Jason M. Mwenda, Richard Omore, Samba O. Sow |
| 106 |
[GO] |
2025―Mrz―01 |
Cost-effectiveness of routine COVID-19 adult vaccination programmes in England |
Matt J. Keeling, Edward M. Hill, Stavros Petrou, Phuong Bich Tran, May Ee Png, Sophie Staniszewska, Corinna Clark, Katie Hassel, Julia Stowe, Nick Andrews |
| 107 |
[GO] |
2025―Feb―26 |
COVID-19 vaccination integration, innovations and key populations: Results from a global survey |
Ishani Mathur, Anika Ruisch, Maeve Conlin, Ibironke Oyatoye, Ulla Griffiths, Damian G. Walker, Christian Suharlim |
| 108 |
[GO] |
2025―Feb―26 |
Assessing the risks of current COVID-19 challenge trials systematically |
Nir Eyal, David Wendler |
| 109 |
[GO] |
2025―Feb―26 |
COVID-19 and influenza hospitalizations and the role of COVID-19 vaccination in the post-pandemic period: A cross-sectional study from Saudi Arabia |
Haytham A. Sheerah, Ahmed H. Al-Jedai, Nawfal A. Al-Jerian, Maram A. Al-Otaiby, Ahad F. Al-Seraihi, Saad A. Al-Huzami, Sara A. Al-Qahtani, Ezzedine S. Zaatari |
| 110 |
[GO] |
2025―Feb―24 |
A phase 2/3 trial to investigate the safety and immunogenicity of monovalent Omicron JN.1-adapted BNT162b2 COVID-19 vaccine in adults ≥18 years old |
Oyeniyi Diya, Juleen Gayed, Francine S. Lowry, Hua Ma, Vishva Bangad, Federico Mensa, Jing Zou, Xuping Xie, Yanping Hu, Mark Cutler, Todd Belanger, David Cooper, Xia Xu, Kenneth Koury, Özlem Türeci, Uǧur Şahin, Kena A. Swanson, Kayvon Modjarrad, Annaliesa S. Anderson, Alejandra Gurtman, Nicholas Kitchin |
| 111 |
[GO] |
2025―Feb―22 |
Global perspectives on COVID-19 vaccination: Impacts on well-being and inequality |
David Leblang, Michael D. Smith, Dennis Wesselbaum |
| 112 |
[GO] |
2025―Feb―21 |
Correction to “Recombinant Spike protein vaccines coupled with adjuvants that have different modes of action induce protective immunity against SARS-CoV-2” [Vaccine 2023 Sep 22 41(41) 6025-6035. Doi: 10.1016/j.vaccine.2023.08.054] |
Shiho Chiba, Peter J. Halfmann, Shun Iida, Yuichiro Hirata, Yuko Sato, Makoto Kuroda, Tammy Armbrust, Samuel Spyra, Tadaki Suzuki, Yoshihiro Kawaoka |
| 113 |
[GO] |
2025―Feb―21 |
Attitudes of California school personnel on potential COVID-19 vaccine mandates and state law SB277 to remove nonmedical vaccine exemptions |
Matthew Z. Dudley, Alexander J. Zapf, Paul Delamater, Tina M. Proveaux, Holly B. Schuh, Alison M. Buttenheim, Jason L. Schwartz, Nicola P. Klein, Kristin Goddard, Kavin M. Patel, Saad B. Omer, Daniel A. Salmon |
| 114 |
[GO] |
2025―Feb―20 |
What three years of COVID-19 vaccine administration reveals about the incidence of shoulder injury related to vaccine administration (SIRVA). |
Laura Jane Mackenzie, Jaquelin Anne Bousie, Phillip Newman, John Cunningham, Andrew P. Woodward, Joshua Silk-Jones, Cassandra Nguyen, Mary-Jessimine Ann Bushell |
| 115 |
[GO] |
2025―Feb―20 |
A counterfactual analysis quantifying the COVID-19 vaccination impact in Sweden |
Fanny Bergström, Felix Günther, Tom Britton |
| 116 |
[GO] |
2025―Feb―20 |
SARS-CoV-2 seroreversion and all-cause mortality in nursing home residents and staff post-primary course vaccination in Belgium between February and December 2021 |
Eline Meyers, Liselore De Rop, Ellen Deschepper, Els Duysburgh, Tine De Burghgraeve, Pauline Van Ngoc, Marina Digregorio, Anja Coen, Nele De Clercq, Steven Wallaert, Laëtitia Buret, Samuel Coenen, An De Sutter, Beatrice Scholtes, Jan Y. Verbakel, Piet Cools, Stefan Heytens |
| 117 |
[GO] |
2025―Feb―20 |
Estimating neutralising antibody responses against emerging SARS-CoV-2 variants utilising convalescent sera before the roll-out of XBB-lineage vaccines |
Ana Atti, Anna England, Julia Sung, Sarah Foulkes, Jasmin Islam, Ashley Otter, Kelly Thomas, Bassam Hallis, Susan Hopkins, Sue Charlton, Victoria Hall |
| 118 |
[GO] |
2025―Feb―18 |
Global production capacity of seasonal and pandemic influenza vaccines in 2023 |
Jessica Taaffe, Shoshanna Goldin, Philipp Lambach, Erin Sparrow |
| 119 |
[GO] |
2025―Feb―18 |
COVID-19 vaccine initiation in pregnancy and risk for adverse neonatal outcomes among United States military service members, January-December 2021 |
Clinton Hall, Jackielyn Lanning, Celeste J. Romano, Anna T. Bukowinski, Gia R. Gumbs, Ava Marie S. Conlin |
| 120 |
[GO] |
2025―Feb―15 |
Cost-effectiveness models assessing COVID-19 booster vaccines across eight countries: A review of methods and data inputs |
Darvin S. Smith, Maarten Postma, David Fisman, Joaquin Mould-Quevedo |
| 121 |
[GO] |
2025―Feb―12 |
Shielding the immunocompromised: COVID-19 prevention strategies for patients with primary and secondary immunodeficiencies |
Giulio Olivieri, Donato Amodio, Emma Concetta Manno, Veronica Santilli, Nicola Cotugno, Paolo Palma |
| 122 |
[GO] |
2025―Feb―11 |
Impact in the humoral and cellular immune response to SARS-CoV-2 variants after primary vaccination with AZD1222/COVISHIELD protocol in healthy adults |
Artur Capão, Mia Ferreira Araújo, Luis Fernando Lopez Tort, Thais Stelzer Toledo, Any Caroline Alves Oliveira, Braulia Costa Caetano, Paola Cristina Resende, Olindo Assis Martins-Filho, Marcelo Ribeiro-Alves, Alba Grifoni, Daniela Weiskopf, Alessandro Sette, Marilda Mendonça Siqueira, Fernanda Heloise Côrtes, Cristiana Couto Garcia |
| 123 |
[GO] |
2025―Feb―11 |
Intention to receive new vaccines post-COVID-19 pandemic among adults and health workers in Lusaka, Zambia |
Anjali Sharma, Andrew D. Kerkhoff, Mwiza Haambokoma, Bertha Shamoya, Kombatende Sikombe, Sandra S. Simbeza, Nelly Zulu, Elvin H. Geng, Ingrid Eshun-Wilsonova, Noelle Le Tourneau, Jake M. Pry |
| 124 |
[GO] |
2025―Feb―10 |
Effectiveness and coverage of COVID-19 vaccination among the infection-naive population: A community-based retrospective cohort study in China |
Yaqun Fu, Zhihu Xu, Quan Wang, Jiawei Zhang, Peien Han, Zhijie Nie, Zheng Zhu, Yiyang Tan, Jingyu Zhao, Qingbo Wang, Qing Liu, Xia Wei, Zhiyuan Hou, Jing Guo, Li Yang |
| 125 |
[GO] |
2025―Feb―10 |
SARS-CoV-2 spike antibody levels in lung transplantation recipients versus the spectrum in non-immunocompromised persons |
Michael Y. Shino, F. Javier Ibarrondo, Otto O. Yang |
| 126 |
[GO] |
2025―Feb―07 |
Co-administration of seasonal quadrivalent influenza and COVID-19 vaccines leads to enhanced immune responses to influenza virus and reduced immune responses to SARS-CoV-2 in naive mice |
Anass Abbad, Joshua Yueh, Temima Yellin, Gagandeep Singh, Juan Manuel Carreño, Jordan J. Clark, Hiromi Muramatsu, Sachchidanand Tiwari, Disha Bhavsar, Garazi Peña Alzua, Norbert Pardi, Viviana Simon, Florian Krammer |
| 127 |
[GO] |
2025―Feb―06 |
Impacts of vaccination, school attendance, and nutrition on SARS-CoV-2 antibody titer in a prospective birth cohort in Brazil. |
Moin S Vahora, Otávio Leão, Mariângela Freitas da Silveira, Marlos Rodrigues Domingues, Pedro C Hallal, Alicia N.M. Kraay |
| 128 |
[GO] |
2025―Feb―06 |
Pregnant women's experiences of and attitudes toward COVID-19 vaccination: A qualitative descriptive study |
Hee Sun Kang, So Youn Kim, Jennie C. De Gagne, Sun-Mi Chae |
| 129 |
[GO] |
2025―Feb―05 |
Leveraging COVID-19 vaccine allergy evaluations with coincident drug allergy delabelling: Effectiveness and impact on quality of life |
Andy K.C. Kan, Hugo W.F. Mak, Valerie Chiang, Jackie S.H. Yim, Weihong Shi, Philip H. Li |
| 130 |
[GO] |
2025―Feb―05 |
Immunogenicity and safety study of a single dose of SpikoGen® vaccine as a heterologous or homologous intramuscular booster following a primary course of mRNA, adenoviral vector or recombinant protein COVID-19 vaccine in ambulatory adults |
Yoshikazu Honda-Okubo, Dimitar Sajkov, Bruce Wauchope, Joseph V. Turner, Brendan Vote, Anna Antipov, Greiciely André, Yuri Lebedin, Nikolai Petrovsky |
| 131 |
[GO] |
2025―Jan―31 |
Efficacy, immunogenicity, and safety of the Novavax COVID-19 vaccine in immunocompromised patients: A targeted literature review |
Manuela H. Gschwend, Anthony M. Marchese, Dirk Poelaert, Brandy Warren, Matthew D. Rousculp, Freddy Caldera |
| 132 |
[GO] |
2025―Jan―31 |
A phase I/II study of CpG/alum-adjuvanted mammalian-derived quadruple antigen carrying virus-like particle COVID-19 vaccine |
Ismail Cem Yilmaz, Emre Mert Ipekoglu, Berfu Saraydar Golcuklu, Tugce Bildik, Aslı Gulce Bartan Aksoy, Irem Evcili, Nilsu Turay, Naz Surucu, Artun Bulbul, Nese Guvencli, Muzaffer Yildirim, Tugce Canavar Yildirim, Yagmur Aydin Atalay, Irem Abras, Yasemin Ceylan, Yasemin Ozsurekci, Elif Tukenmez Tigen, Volkan Korten, Mayda Gursel, Ihsan Gursel |
| 133 |
[GO] |
2025―Jan―31 |
Implementing behavioural science-informed letter interventions to increase COVID-19 vaccination uptake in London residents. A difference-in-difference study in London, United Kingdom |
Kate Grailey, Roberto Fernandez Crespo, Lena Woldmann, Matthew Chisambi, Kirstie Black, Bahram Hassanpourfard, Joe Nguyen, Bob Klaber, Ara Darzi, Sarah Huf |
| 134 |
[GO] |
2025―Jan―31 |
COVID-19 in Canada: The Canadian COVID-19 experiences project and beyond |
Helena C. Maltezou |
| 135 |
[GO] |
2025―Jan―31 |
How to accelerate the supply of vaccines to all populations worldwide? Part III: Reflections after the pandemic |
Mic McGoldrick, Tran Ba Quang Truong, Cristiana Campa, Murtuza Ali, Antonio Guzzi, Mark Van Ooij, Cecile Feuillet, Jennifer Eck |
| 136 |
[GO] |
2025―Jan―30 |
Impact of the COVID-19 pandemic on routine immunization coverage of children and teenagers in Ontario, Canada |
Catherine Ji, Arrani Senthinathan, Jemisha Apajee, Vinita Dubey, Milena Forte, Jeffrey C. Kwong, Shaun K. Morris, Pierre-Philippe Piche-Renaud, Sarah E. Wilson, Karen Tu |
| 137 |
[GO] |
2025―Jan―30 |
Estimating COVID-19 associated hospitalizations, ICU admissions, and in-hospital deaths averted in the United States by 2023-2024 COVID-19 vaccination: A conditional probability, causal inference, and multiplier-based approach |
Ryan E. Wiegand, Owen Devine, Megan Wallace, Ismael R. Ortega-Sanchez, Huong T. Pham, Diba Khan, Danielle L. Moulia, Lauren E. Roper, Imelda Trejo, Katherine E. Fleming-Dutra, Fiona P. Havers, Christopher A. Taylor |
| 138 |
[GO] |
2025―Jan―30 |
COVID-19 and influenza vaccine Hesitancy among adults hospitalized in the United States, 2019-2022 |
Akram Khan, Yuwei Zhu, Hilary M. Babcock, Laurence W. Busse, Abhijit Duggal, Matthew C. Exline, Manjusha Gaglani, Kevin W. Gibbs, Michelle N. Gong, Adit A. Ginde, David N. Hager, Aluko A. Hope, Jessica Hyde, Nicholas J. Johnson, Jennie H. Kwon, Nicholas M. Mohr, Mary O'Rourke, Ithan D. Peltan, Christopher Mallow, Nida Qadir, Raju Reddy, Basmah Safdar, Nathan I. Shapiro, Ine Sohn, Jay S. Steingrub, Jennifer G. Wilson, Adrienne Baughman, Kelsey N. Womack, Jillian P. Rhoads, Wesley H. Self, William B. Stubblefield |
| 139 |
[GO] |
2025―Jan―28 |
Safety comparison between Pfizer BNT162b2, Moderna mRNA-1273, and AstraZeneca AZD1222 in a Nationwide prospective cohort survey at the beginning of the severe acute respiratory syndrome coronavirus 2 vaccination in Japan |
Suminobu Ito, Nao Tsuchida, Susumu Kusunoki, Yoshihiro Kaneko, Toshio Naito, Satoshi Hori, Morikuni Tobita |
| 140 |
[GO] |
2025―Jan―22 |
A cross-country network analysis of disease infodemics: Looking through the lens of the COVID-19 pandemic |
Peter Adu, Tosin Popoola, Naved Iqbal, Anja Roemer, Oleg N. Medvedev, Colin R. Simpson |
| 141 |
[GO] |
2025―Jan―21 |
The cost-effectiveness of vaccination against COVID-19 illness during the initial year of vaccination |
Lisa A. Prosser, Janamarie Perroud, Grace S. Chung, Acham Gebremariam, Cara B. Janusz, Kerra Mercon, Angela M. Rose, Anton L.V. Avanceña, Ellen Kim DeLuca, David W. Hutton |
| 142 |
[GO] |
2025―Jan―18 |
Impairment of the T cell memory response in chronic lymphocytic leukemia patients after SARS-CoV-2 vaccination |
Davide Raineri, Camilla Barbero Mazzucca, Riccardo Moia, Riccardo Bruna, Natasa Kustrimovic, Giuseppe Cappellano, Mattia Bellan, Mattia Perazzi, Gianluca Gaidano, Annalisa Chiocchetti |
| 143 |
[GO] |
2025―Jan―17 |
Promoting aged care COVID-19 and influenza vaccination through education of Australian residential aged care staff: A mixed methods project evaluation |
Isaac Tranter, Deborah Judd, Mark Stickley, Bhakti Vasant, Gayle Pollard, Courtney Swindells, Satyamurthy Anuradha |
| 144 |
[GO] |
2025―Jan―16 |
The impact of vaccination on the length of stay of hospitalized COVID-19 patients in Brazil |
Cleber Vinicius Brito dos Santos, Lara Esteves Coelho, Tatiana Guimarães de Noronha, Guilherme Tegoni Goedert, Daniel Csillag, Paula Mendes Luz, Guilherme Loureiro Werneck, Daniel Antunes Maciel Villela, Claudio José Struchiner |
| 145 |
[GO] |
2025―Jan―16 |
Childhood opportunity index and vaccine uptake in pediatric COVID-19 hospitalizations |
Rohan M. Shah, Simon Parzen-Johnson, Shan Sun, Sameer J. Patel |
| 146 |
[GO] |
2025―Jan―14 |
Impact of SARS-CoV-2 inactivated vaccine on symptoms following omicron variant breakthrough infection |
Yuqi Zhang, Xinjie Li, Yingxiang Yang, Yue Yin, Yan Zhong, Qiang Xu, Jing Tu, Juan Deng, Hua Liang, Tao Shen |
| 147 |
[GO] |
2025―Jan―13 |
Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial |
Júlia Corominas, Carme Garriga, Antoni Prenafeta, Alexandra Moros, Manuel Cañete, Antonio Barreiro, Luis González-González, Laia Madrenas, Irina Güell, Bonaventura Clotet, Nuria Izquierdo-Useros, Dàlia Raïch-Regué, Marçal Gallemí, Julià Blanco, Edwards Pradenas, Benjamin Trinité, Julia G. Prado, Raúl Pérez-Caballero, Laia Bernad, Montserrat Plana, Ignasi Esteban, Elena Aurrecoechea, Rachel Abu Taleb, Paula McSkimming, Alex Soriano, Jocelyn Nava, Jesse Omar Anagua, Rafel Ramos, Ruth Martí Lluch, Aida Corpes Comes, Susana Otero Romero, Xavier Martínez-Gómez, Lina Camacho-Arteaga, Jose Molto, Susana Benet, Lucía Bailón, Jose R. Arribas, Alberto M. Borobia, Javier Queiruga Parada, Jorge Navarro-Pérez, Maria José Forner Giner, Rafael Ortí Lucas, María del Mar Vázquez Jiménez, María Jesús López Fernández, Melchor Alvarez-Mon, Daniel Troncoso, Eunate Arana-Arri, Susana Meijide, Natale Imaz-Ayo, Patricia Muñoz García, Sofía de la Villa, Sara Rodríguez Fernández, Teresa Prat, Èlia Torroella, Laura Ferrer |
| 148 |
[GO] |
2025―Jan―08 |
COVID-19 pediatric vaccine Hesitancy: Themes and interactions with verified twitter accounts |
Nicolette Le, Tiana J. McMann, Christine Wenzel, Zhuoran Li, Qing Xu, Raphael E. Cuomo, Joshua Yang, Tim K. Mackey |
| 149 |
[GO] |
2025―Jan―08 |
Post-COVID symptoms after SARS-CoV-2 omicron infection and the effect of booster vaccination: A population-based cohort study |
Ida Henriette Caspersen, Siri N. Skodvin, Kristine Blix, Anna Hayman Robertson, Ida Laake, Berit Feiring, Per Magnus, Siri Mjaaland, Lill Trogstad |
| 150 |
[GO] |
2025―Jan―05 |
Association between underlying conditions, multimorbidity, and COVID-19 vaccination status of adults aged ≥80 years old in Beijing, China |
Yuping Duan, Luodan Suo, Xiaomei Li, Chengxu Bai, Mingyu Xu, Jiang Wu, Zheng Xu, Qing Wang, Binshan Jiang, Mingyue Jiang, Yanlin Cao, Yanxia Sun, Weizhong Yang, Juan Li, Luzhao Feng |
| 151 |
[GO] |
2024―Dez―31 |
Letter to the editor: SARS-CoV-2 vaccination in children and adolescents with neurodevelopmental or psychiatric disorders |
Arnaud Fernandez, Florence Askenazy, Susanne Thümmler |
| 152 |
[GO] |
2024―Dez―30 |
Mucosal vaccination against SARS-CoV-2 using recombinant influenza viruses delivering self-assembling nanoparticles |
Devaki Pilapitiya, Wen Shi Lee, Mai N. Vu, Andrew Kelly, Rosela H. Webster, Marios Koutsakos, Stephen J. Kent, Jennifer A. Juno, Hyon-Xhi Tan, Adam K. Wheatley |
| 153 |
[GO] |
2024―Dez―28 |
Corrigendum to The risk of pregnancy-related adverse outcomes after COVID-19 vaccination: propensity score-matched analysis with influenza vaccination |
Yu Jung Choi, Jaehun Jung, Minsun Kang, Min Joo Choi, Won Suk Choi, Yu Bin Seo, Hak-Jun Hyun, Yoonsun Yoon, Young June Choe, Geum Joon Cho, Young-Eun Kim, Dong Wook Kim, Hye Seong, Eliel Nham, Jin Gu Yoon, Ji Yun Noh, Joon Young Song, Woo Joo Kim, Hee Jin Cheong |
| 154 |
[GO] |
2024―Dez―25 |
Relative effectiveness of the second booster COVID-19 vaccines against laboratory confirmed SARS-CoV-2 infection in healthcare workers: VEBIS HCW VE cohort study (1 October 2022-2 May 2023) |
Camelia Savulescu, Albert Prats-Uribe, Kim Brolin, Anneli Uusküla, Colm Bergin, Catherine Fleming, Viesturs Zvirbulis, Dace Zavadska, Konstanty Szułdrzyński, Vânia Gaio, Corneliu Petru Popescu, Mihai Craiu, Maria Cisneros, Miriam Latorre-Millán, Liis Lohur, Jonathan McGrath, Lauren Ferguson, Ilze Abolina, Dagne Gravele, Ausenda Machado, Simin Aysel Florescu, Mihaela Lazar, Pilar Subirats, Laura Clusa Cuesta, Jacklyn Sui, Claire Kenny, Dainis Krievins, Elza Anna Barzdina, Aryse Melo, Alma Gabriela Kosa, Victor Daniel Miron, Carmen Muñoz-Almagro, Ana María Milagro, Sabrina Bacci, Piotr Kramarz, Anthony Nardone |
| 155 |
[GO] |
2024―Dez―25 |
Tortured confessions? Potentially erroneous statistical inferences may underpin misleading claims of harms in reanalyses of COVID-19 and HPV vaccines |
David Robert Grimes |
| 156 |
[GO] |
2024―Dez―24 |
“They need to speak a language everyone can understand”: Accessibility of COVID-19 vaccine information for Canadian adults with intellectual and developmental disabilities |
Sabrina Campanella, Tiziana Volpe, Yousef Safar, Yona Lunsky |
| 157 |
[GO] |
2024―Dez―24 |
Trust in government vaccine recommendations during the Covid-19 pandemic in Singapore: A longitudinal survey study |
Anita Sheldenkar, Tng Pei Ling, Peter Johannes Schulz, Mark I-Cheng Chen, May Oo Lwin |
| 158 |
[GO] |
2024―Dez―20 |
Corrigendum to Assessment of the Bnt162b2 covid-19 vaccine immune response in Brazilian indigenous adolescents. Vaccine Volume 43, Part 1, 1 January 2025, 126494 |
Laís Albuquerque de Oliveira, Isa Rita Brito de Morais, Silvana Beutinger Marchioro, Gabriel Barroso de Almeida, Gleyce Hellen de Almeida de Souza, Tiago da Silva Ferreira, Regina Rossoni, Dyjaene de Oliveira Barbosa, Vinicius João Navarini, Julio Croda, Alex José Leite Torres, Simone Simionatto |
| 159 |
[GO] |
2024―Dez―20 |
The Safety and Efficacy of inactivated COVID-19 vaccination in couples undergoing assisted reproductive technology: A prospective cohort study |
Juan Yang, Ying-Ling Yao, Xing-Yu Lv, Li-Hong Geng, Yue Wang, Enoch Appiah Adu-Gyamfi, Xue-Jiao Wang, Yue Qian, Ming-Xing Chen, Zhao-Hui Zhong, Ren-Yan Li, Qi Wan, Yu-Bin Ding |
| 160 |
[GO] |
2024―Dez―18 |
Timing of rejection events preceded by Covid-19 mRNA vaccination in recipients of solid organ transplants |
Quentin Perrier, Johan Noble, Agnès Bonadona, Caroline Augier, Thomas Jouve, Aude Boignard, Loïc Falque, Salomé Gallet, Pierrick Bedouch, Lionel Rostaing, Olivier Epaulard |
| 161 |
[GO] |
2024―Dez―18 |
Describing COVID-19 immunizations for First Nations people on-reserve in Alberta using real-time integration of point of care and provincial data |
Dean T. Eurich, Olivia Weaver, Cathleen McDermott, Allison Soprovich, Lisa A. Wozniak, Beth Woytas, Chris Sarin, Lauren Bilinsky, Parminder Thiara, Celine O'Brien, Lea Bill, Lynden Crowshoe, Ambikaipakan Senthilselvan, Salim Samanani |
| 162 |
[GO] |
2024―Dez―18 |
Risk of adverse events after Omicron XBB-adapted BNT162b2 COVID-19 vaccination in the United States |
Jenny W. Sun, Laura E. Dodge, Eric J. Kim, Li Zhou, Susan Mather, Henry Goebe, Nicola Charpentier, Kirsten Nespithal, Kofi Asomaning, Florence T. Wang |
| 163 |
[GO] |
2024―Dez―18 |
Evidence on trends in uptake of childhood vaccines and association with COVID-19 vaccination rates |
Ali Moghtaderi, Timothy Callaghan, Qian Luo, Matt Motta, Tina Q. Tan, Laura Hillard, Avi Dor, Allison Portnoy, Amy Winter, Bernard Black |
| 164 |
[GO] |
2024―Dez―14 |
Everyone, everywhere, all the time: Ten lessons yet to be learned from the SARS-CoV-2 pandemic |
Gregory A. Poland |
| 165 |
[GO] |
2024―Dez―14 |
Predictors of severity of SARS-CoV-2 infections in Brazil: Post hoc analyses of a randomised controlled trial |
Kerry Conlin, Daniel Jenkin, Philip de Whalley, Lily Yin Weckx, Pedro M. Folegatti, Sagida Bibi, Teresa Lambe, Parvinder K. Aley, Andrew J. Pollard, Merryn Voysey, Sue Ann Costa Clemens |
| 166 |
[GO] |
2024―Dez―12 |
Mental illness and antibody responses after COVID-19 vaccination in a prospective population-based study in Catalonia |
Marianna Karachaliou, Ana Espinosa, Xavier Farré, Natalia Blay, Gemma Castaño-Vinyals, Susana Iraola-Guzmán, Rocio Rubio, Marta Vidal, Alfons Jiménez, Marc Bañuls, Ruth Aguilar, Judith Garcia-Aymerich, Carlota Dobaño, Manolis Kogevinas, Gemma Moncunill, Rafael de Cid |
| 167 |
[GO] |
2024―Dez―07 |
Comprehensive humoral and cellular immune responses to COVID-19 vaccination in adults with cancer |
Amy Body, Luxi Lal, Sriganesh Srihari, C. Raina MacIntyre, Jim Buttery, Elizabeth Stephanie Ahern, Stephen Opat, Michael Francis Leahy, Nada Hamad, Vivienne Milch, Stuart Turville, Corey Smith, Katie Lineburg, Zin Naing, William Rawlinson, Eva Segelov |
| 168 |
[GO] |
2024―Dez―07 |
Predictors of HPV vaccination coverage among adolescents in Tennessee during the COVID-19 pandemic: A cross-sectional study |
J. Cunningham-Erves, M. Sanderson, S.W. Jin, J. Davis, H.M. Brandt |
| 169 |
[GO] |
2024―Dez―06 |
Vaccine safety surveillance in South Africa through COVID-19: A journey to systems strengthening |
Chenoa Sankar, Johanna C. Meyer, Marione Schönfeldt, Hannah Gunter, Halima Dawood, Victoria Sekiti, Naseera Pickard, Lawrence Mubaiwa, Dini Mawela, Sipho Dlamini, Jonny Peter, David Spencer, Clive Gray, Vinod Patel, Lesley Bamford, Tohlang Sehloho, Kerrigan McCarthy |
| 170 |
[GO] |
2024―Dez―05 |
The trend in national childhood immunization program coverage throughout Serbian communities in Kosovo and Metohija from 2003 to 2022: pre-COVID-19 period vs. COVID-19 pandemic |
Jelena Filimonovic, Maja Stosic, Tatjana Gazibara, Jelena Dotlic, Bojan Joksimovic, Aleksandar Subaric, Jasmina Stevanovic, Aleksandra Radulovic, Biljana Mijovic, Ljiljana Subaric, Milica Kovacevic, Jana Radulovic, Aleksandar Antonijevic, Marija Milic |
| 171 |
[GO] |
2024―Dez―05 |
Local and systemic reactogenicity after mRNA and protein-based COVID-19 vaccines compared to meningococcal vaccine (MenACWY) in a UK blinded, randomized phase 2 trial (COV-BOOST) |
Anthony M. Marchese, Hadi Beyhaghi, Matthew D. Rousculp, Vivian Huang, Xinxue Liu, Seth Toback, Saul N. Faust |
| 172 |
[GO] |
2024―Nov―30 |
COVID-19 vaccine effectiveness against severe omicron-related outcomes in children aged 5 to 11 years in Ontario: A Canadian immunization research network (CIRN) study |
Pierre-Philippe Piché-Renaud, Samantha S.M. Drover, Peter C. Austin, Shaun K. Morris, Sarah A. Buchan, Sharifa Nasreen, Kevin L. Schwartz, Mina Tadrous, Nisha Thampi, Sarah E. Wilson, Kumanan Wilson, Astrid Guttmann, Jeffrey C. Kwong |
| 173 |
[GO] |
2024―Nov―30 |
The effectiveness of vaccines against COVID-19 in Mexico: A time series approach |
D. Flores, E.M. Luna |
| 174 |
[GO] |
2024―Nov―29 |
COVID-19 vaccine responses are influenced by distinct risk factors in naive and SARS-CoV-2 experienced hemodialysis recipients |
Nicolas Gemander, Delphine Kemlin, Stéphanie Depickère, Natasha S. Kelkar, Shilpee Sharma, Pieter Pannus, Alexandra Waegemans, Véronique Olislagers, Daphnée Georges, Emilie Dhondt, Margarida Braga, Leo Heyndrickx, Johan Michiels, Anaïs Thiriard, Anne Lemy, Thomas Baudoux, Marylène Vandevenne, Maria E. Goossens, André Matagne, Isabelle Desombere, Kevin K. Ariën, Margaret E. Ackerman, Alain Le Moine, Arnaud Marchant |
| 175 |
[GO] |
2024―Nov―29 |
Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: A randomised, comparator-controlled, phase 2 trial |
Vu Dinh Thiem, Dang Duc Anh, Vu Hai Ha, Nguyen Van Thom, Tran Cong Thang, Jose Mateus, Juan Manuel Carreño, Rama Raghunandan, Nguyen Mai Huong, Laina D. Mercer, Jorge Flores, E. Alexandar Escarrega, Ariel Raskin, Duong Huu Thai, Le Van Be, Alessandro Sette, Bruce L. Innis, Florian Krammer, Daniela Weiskopf |
| 176 |
[GO] |
2024―Nov―27 |
Determinants of COVID-19 and non-COVID-19 vaccine confidence in low- and middle-income countries: A systematic review of qualitative evidence and thematic synthesis |
Alice Blukacz, Alexandra Obach, Paola Vásquez, Carla Campaña, Catalina Huerta, Yanara Bernal, Báltica Cabieses |
| 177 |
[GO] |
2024―Nov―26 |
Effectiveness of BNT162b2 and CoronaVac against COVID-19-related severe outcomes among children and adolescents: A Brazilian nationwide cohort study |
Eliandra da Silveira de Lima, Marcos Otávio Brum Antunes, Jesuely Spieckert de Souza, Marcus H. Jones, Renato T. Stein, Leonardo A. Pinto, Frederico Friedrich, Marcelo Comerlato Scotta |
| 178 |
[GO] |
2024―Nov―25 |
The risk of pregnancy-related adverse outcomes after COVID-19 vaccination: Propensity score-matched analysis with influenza vaccination |
Yu Jung Choi, Jaehun Jung, Minsun Kang, Min Joo Choi, Won Suk Choi, Yu Bin Seo, Hak-Jun Hyun, Yoonsun Yoon, Young June Choe, Geum Joon Cho, Young-Eun Kim, Dong Wook Kim, Hye Seong, Eliel Nham, Jin Gu Yoon, Ji Yun Noh, Joon Young Song, Woo Joo Kim, Hee Jin Cheong |
| 179 |
[GO] |
2024―Nov―22 |
COVID-19 vaccine acceptance and 5C psychological antecedents amid the omicron surge in South Korea and China |
Minjung Lee, Chenyuan Qin, Yubin Lee, Jie Deng, Myoungsoon You, Jue Liu |
| 180 |
[GO] |
2024―Nov―20 |
Assessment of the BNT162B2 COVID-19 vaccine immune response in Brazilian indigenous adolescents |
Laís Albuquerque de Oliveira, Isa Rita Brito de Morais, Silvana Beutinger Marchioro, Gabriel Barroso de Almeida, Gleyce Hllen de Almeida de Souza, Tiago da Silva Ferreira, Regina Rossoni, Dyjaene de Oliveira Barbosa, Vinicius João Navarini, Julio Croda, Alex José Leite Torres, Simone Simionatto |
| 181 |
[GO] |
2024―Nov―18 |
How text message reminders increase COVID-19 booster vaccine uptake: Two randomized controlled trials |
Arne Meeldijk, Lisa Vandeberg, Reinier Akkermans, Jeannine Hautvast |
| 182 |
[GO] |
2024―Nov―11 |
Exposure to objective/sensationalist information moderates associations between psychological factors and COVID-19 anti-vaccination attitudes: An experimental study |
Aldo Aguirre-Camacho, Beatriz Hidalgo, Joshua A. Rash |
| 183 |
[GO] |
2024―Nov―10 |
Modification and validation of a vaccine hesitancy scale for adolescent COVID-19 vaccination |
Annette K. Regan, Marie-Claude Couture, Timothy Callaghan, Brianna Agnew, Jillian Baker, Onyebuchi A. Arah |
| 184 |
[GO] |
2024―Nov―10 |
Phase II study on the safety and immunogenicity of single-dose intramuscular or intranasal administration of the AVX/COVID-12 “Patria” recombinant Newcastle disease virus vaccine as a heterologous booster against COVID-19 in Mexico |
Constantino López-Macías, Martha Torres, Brenda Armenta-Copca, Niels H. Wacher, Laura Castro-Castrezana, Andrea Alicia Colli-Domínguez, Tania Rivera-Hernández, Alejandro Torres-Flores, Matilde Damián-Hernández, Luis Ramírez-Martínez, Georgina Paz-De la Rosa, Oscar Rojas-Martínez, Alejandro Suárez-Martínez, Gustavo Peralta-Sánchez, Claudia Carranza, Esmeralda Juárez, Horacio Zamudio-Meza, Laura E. Carreto-Binaghi, Mercedes Viettri, Damaris Romero-Rodríguez, Andrea Palencia, Edgar Reyna-Rosas, José E. Márquez-García, David Sarfati-Mizrahi, Weina Sun, Héctor Elías Chagoya-Cortés, Felipa Castro-Peralta, Peter Palese, Florian Krammer, Adolfo García-Sastre, Bernardo Lozano-Dubernard |
| 185 |
[GO] |
2024―Nov―09 |
Relative effectiveness of homologous NVX-CoV2373 and BNT162b2 COVID-19 vaccinations in South Korea |
Eunseon Gwak, Seung-Ah Choe, Erdenetuya Bolormaa, Young June Choe, Chengbin Wang, Jonathan Fix, Muruga Vadivale, Matthew D. Rousculp |
| 186 |
[GO] |
2024―Nov―08 |
Proteomic signatures of vaccine-induced and breakthrough infection-induced host responses to SARS-CoV-2 |
Erin Williams, Felipe Echeverri Tribin, Juan Manuel Carreño, Florian Krammer, Michael Hoffer, Suresh Pallikkuth, Savita Pahwa |
| 187 |
[GO] |
2024―Nov―08 |
The association between service experience in vaccination centers and expectation confirmation as a driver of future vaccination intentions: Results from a survey among users of a Swiss mass COVID-19 vaccination center |
Franziska Mattes, Julia Dratva, Sarah Schmelzer, Aylin Wagner, Florian Liberatore |
| 188 |
[GO] |
2024―Nov―07 |
Australian parents' experiences with adolescent age-based vaccinations during the COVID-19 pandemic |
Maryke S. Steffens, Katarzyna T. Bolsewicz, Catherine King, Bianca Bullivant, Ikram Abdi, Frank Beard |
| 189 |
[GO] |
2024―Nov―07 |
Assessment and mitigation of bias in influenza and COVID-19 vaccine effectiveness analyses - IVY Network, September 1, 2022-March 30, 2023 |
Nathaniel M. Lewis, Elizabeth J. Harker, Aleda Leis, Yuwei Zhu, H. Keipp Talbot, Carlos G. Grijalva, Natasha Halasa, James D. Chappell, Cassandra A. Johnson, Todd W. Rice, Jonathan D. Casey, Adam S. Lauring, Manjusha Gaglani, Shekhar Ghamande, Cristie Columbus, Jay S. Steingrub, Nathan I. Shapiro, Abhijit Duggal, Jamie Felzer, Matthew E. Prekker, Ithan D. Peltan, Samuel M. Brown, David N. Hager, Michelle N. Gong, Amira Mohamed, Matthew C. Exline, Akram Khan, Jennifer G. Wilson, Jarrod Mosier, Nida Qadir, Steven Y. Chang, Adit A. Ginde, Nicholas M. Mohr, Christopher Mallow, Estelle S. Harris, Nicholas J. Johnson, Vasisht Srinivasan, Kevin W. Gibbs, Jennie H. Kwon, Ivana A. Vaughn, Mayur Ramesh, Basmah Safdar, Jennifer DeCuir, Diya Surie, Fatimah S. Dawood, Sascha Ellington, Wesley H. Self, Emily T. Martin |
| 190 |
[GO] |
2024―Nov―07 |
Variation in the time to complete the primary COVID-19 vaccine series by race, ethnicity, and geography among older US adults |
Yalin Deng, Kaleen N. Hayes, Yifan Zhao, Preeti Chachlani, Andrew R. Zullo, Djeneba Audrey Djibo, Cheryl N. McMahill-Walraven, Vincent Mor, Daniel A. Harris |
| 191 |
[GO] |
2024―Nov―07 |
Pandemic-related resilience in HPV vaccination programmes - Perspectives from selected countries in Africa on what it will take to vaccinate 90 % of girls by 2030 |
Kouakou Séraphin Kouassi, Eric Chisupa, Adolphus Clarke, Innocent Massenon, Christine Miano, Faith Mutuku, Sarah Wanyoike, Mutale Mumba, Raabi Diouf, Christopher Morgan, Mary Carol Jennings |
| 192 |
[GO] |
2024―Nov―05 |
Effect of COVID-19 vaccination on the risk of developing post-COVID conditions: The VENUS study |
Sung-a Kim, Megumi Maeda, Fumiko Murata, Haruhisa Fukuda |
| 193 |
[GO] |
2024―Nov―05 |
Unraveling COVID-19 vaccine hesitancy in Europeans 50 and older through a lens of preventive practices |
K. Delaruelle, E. Lermytte, M. Bockstal, P. Vuolanto, P. Bracke |
| 194 |
[GO] |
2024―Nov―02 |
Parental decisions regarding the vaccination of children and adolescents against SARS-CoV-2 from 2020 to 2023: A descriptive longitudinal study of parents and children in Montreal, Canada |
Katia Charland, Caroline Quach, Jesse Papenburg, Laura Pierce, Cat Tuong Nguyen, Adrien Saucier, Margot Barbosa Da Torre, Marie-Ève Hamelin, Julie Carbonneau, Guy Boivin, Kate Zinszer |
| 195 |
[GO] |
2024―Okt―31 |
Emerging global patterns of COVID-19 vaccine information fatigue in 23 countries in 2023 |
Trenton M. White, Jeffrey V. Lazarus, Kenneth H. Rabin, Scott C. Ratzan, Ayman El-Mohandes |
| 196 |
[GO] |
2024―Okt―31 |
On-time childhood vaccination before and during the COVID-19 pandemic in seven communities: Findings from the New Vaccine Surveillance Network |
Annika M. Hofstetter, Eileen J. Klein, Bonnie Strelitz, Rangaraj Selvarangan, Jennifer E. Schuster, Julie A. Boom, Leila C. Sahni, Natasha B. Halasa, Laura S. Stewart, Mary Allen Staat, Chelsea Rohlfs, Peter G. Szilagyi, Geoffrey A. Weinberg, John V. Williams, Marian G. Michaels, Heidi Moline, Sara A. Mirza, Christopher J. Harrison, Janet A. Englund |
| 197 |
[GO] |
2024―Okt―31 |
SARS-CoV-2 spike-based virus-like particles incorporate influenza H1/N1 antigens and induce dual immunity in mice |
Zalma V. Sanchez-Martinez, Sergio P. Alpuche-Lazcano, Matthew Stuible, Bassel Akache, Tyler M. Renner, Lise Deschatelets, Renu Dudani, Blair A. Harrison, Michael J. McCluskie, Sabahudin Hrapovic, Julie Blouin, Xinyu Wang, Matthew Schuller, Kai Cui, Jae-Young Cho, Yves Durocher |
| 198 |
[GO] |
2024―Okt―30 |
Comparing COVID-19 booster vaccine acceptance in the United Kingdom, Germany, Austria, and Jordan: The role of protection motivation theory, conspiracy beliefs, social media use and religiosity |
Judith Eberhardt, Walid Al-Qerem, Jonathan Ling |
| 199 |
[GO] |
2024―Okt―30 |
Exploring risk factors for Raynaud's phenomenon post COVID-19 vaccination |
Tzu-Chuan Ho, Shih-Chang Chuang, Kuo-Chen Hung, Chin-Chuan Chang, Kuo-Pin Chuang, Cheng-Hui Yuan, Ming-Hui Yang, Yu-Chang Tyan |
| 200 |
[GO] |
2024―Okt―30 |
The SARS-CoV-2 neutralising antibody profile of New Zealand adults in 2023: Impact of vaccination and infection. |
Reuben McGregor, Aimee Paterson, Brittany Lavender, Caitlin Hooker, Chris Frampton, Kjesten Wiig, Graham Le Gros, James E. Ussher, Maia Brewerton, Nicole J. Moreland |
| 201 |
[GO] |
2024―Okt―24 |
Acute autoimmune hepatitis following COVID-19 mRNA vaccination: A population-based study using electronic health records in Singapore |
Amelia Jing Jing Ng, Desmond Chun Hwee Teo, Sreemanee Raaj Dorajoo, Aaron Jun Yi Yap, Wan Cheng Chow, Nicholas Kai Ming Ng, Sally Bee Leng Soh |
| 202 |
[GO] |
2024―Okt―23 |
Safety of mRNA COVID-19 vaccines among persons 15- years and above in Ghana: A cohort event monitoring study |
Delese Mimi Darko, Seth Kwaku Seaneke, Eric Karikari-Boateng, Edwin Nkansah, Kwame Amponsa-Achiano, Naziru Tanko Mohamed, Harriet Affran Bonful, Richard Osei Buabeng, Adela Ashie, Abena Asamoa-Amoakohene, Jeremiah Ewudzie-Sampson, Alexander Mwinteru Derizie, Adjabui D. Neimatu, Agongo A. Wilfred, Comfort Ogar, Aida Hagos, George Tsey Sabblah |
| 203 |
[GO] |
2024―Okt―23 |
Risk of major adverse cerebro-cardiovascular events following BNT162b2, CoronaVac, and ChAdOx1 vaccination and SARS-CoV-2 infection: A self-controlled case-series study |
Norazida Ab Rahman, Teck Long King, Kalaiarasu M. Peariasamy, Sheamini Sivasampu |
| 204 |
[GO] |
2024―Okt―22 |
Incidence of ischemic stroke after COVID-19 bivalent booster vaccination in an integrated health system |
Katie A. Sharff, Thomas K. Tandy, Paul F. Lewis, Eric S. Johnson |
| 205 |
[GO] |
2024―Okt―18 |
The risk of postherpetic neuralgia in COVID-19 vaccination-associated herpes zoster: A retrospective cohort study using TriNetX |
Sheng-Hsiang Ma, Tai-Li Chen, Wei-Fan Ou, Wen-Cheng Chao, Hsin-Hua Chen, Chen-Yi Wu |
| 206 |
[GO] |
2024―Okt―17 |
Factors associated with COVID-19 vaccination or intent to be vaccinated across three U.S. states |
Robert Cockerill, Jennifer A. Horney, Samantha C. Penta, Amber Silver, Lauren Clay |
| 207 |
[GO] |
2024―Okt―17 |
Pediatric COVID-19 vaccine hesitancy among pregnant and post-partum women: A mixed-method study |
Tasmiah Nuzhath, Brian Colwell, Timothy Callaghan, Peter Hotez, Sabrina Mousum, Ummul Wara Masud, Annette K. Regan |
| 208 |
[GO] |
2024―Okt―17 |
Longitudinal safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in children aged 4-11 years with juvenile-onset autoimmune inflammatory rheumatic diseases: A prospective multicenter study |
Tali Eviatar, Amit Ziv, Amir Oved, Adi Miller-Barmak, Adi Pappo, Ruth Livny, Gil Amarilyo, Yonatan Butbul Aviel, Rinat Naor, Sara Pel, Victoria Furer, Ori Elkayam, Yosef Uziel, Merav Heshin-Bekenstein |
| 209 |
[GO] |
2024―Okt―16 |
Gender differences in adverse effects following the second dose of AstraZeneca COVID-19 vaccine: a cross-sectional study among healthcare workers |
Masoud Sedaghat, Badriyeh Karami, Farid Najafi, Fatemeh Khosravi Shadmani, Shahab Rezaeian |
| 210 |
[GO] |
2024―Okt―16 |
Intranasal booster with SARS-CoV-2 RBD protein fused to E. coli enterotoxin a subunit after primary mRNA vaccination in mice |
He-Chin Hsieh, Chung-Chu Chen, Wen-Chun Liu, Suh-Chin Wu |
| 211 |
[GO] |
2024―Okt―13 |
Corrigendum to “A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases” [Vaccine 42 (12) (2024) 3039-3048] |
Anna Schultze, Ivonne Martin, Davide Messina, Sophie Bots, Svetlana Belitser, Juan José Carreras-Martínez, Elisa Correcher-Martinez, Arantxa Urchueguía-Fornes, Mar Martín-Pérez, Patricia García-Poza, Felipe Villalobos, Meritxell Pallejà-Millán, Carlo Alberto Bissacco, Elena Segundo, Patrick Souverein, Fabio Riefolo, Carlos E. Durán, Rosa Gini, Miriam Sturkenboom, Olaf Klungel, Ian Douglas |
| 212 |
[GO] |
2024―Okt―09 |
Direct quantitative comparison of benefits and risks of COVID-19 vaccines used in National Immunization Technical Advisory Groups Guidance during the first two years of the pandemic |
Pamela Doyon-Plourde, Ruth Farley, Ramya Krishnan, Matthew Tunis, Megan Wallace, Joseline Zafack |
| 213 |
[GO] |
2024―Okt―05 |
Effective integration of COVID-19 vaccination with routine immunization: A case study from Kinshasa, DRC |
Guillaume Mwamba, Emily Margaret Gibson, Carla Toko, Christelle Tunda, Yves Rolland Kouabenan, Joseph Musenga, Benedicte Waula, Freddy Nkosi, Mireille Mutuale Ciabu Nkima, Jean Mupenda, Emily Lawrence, Mariam Zameer, Patou Musumari |
| 214 |
[GO] |
2024―Okt―04 |
Factors that shape COVID-19 pediatric vaccine decision-making in rural agricultural communities: A qualitative study |
Kelley M. Pascoe, Sonia Bishop, Xuehan Ci, Magaly Ramirez, Georgina Perez, Genoveva Ibarra, Lorenzo Garza, Sandra Linde, Miriana C. Duran, Hwa Young Chae, Thomas Quigley, Laurie Hassell, Michelle M. Garrison, Paul K. Drain, Parth D. Shah, Linda K. Ko |
| 215 |
[GO] |
2024―Okt―04 |
Using regression tree analysis to examine demographic and geographic characteristics of COVID-19 vaccination trends over time, United States, May 2021-April 2022, National Immunization Survey Adult COVID Module |
Morgan Earp, Lu Meng, Carla L. Black, Rosalind J. Carter, Peng-Jun Lu, James A. Singleton, Terence Chorba |
| 216 |
[GO] |
2024―Okt―04 |
SpiN-Tec: A T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern |
Natália S. Hojo-Souza, Júlia T. de Castro, Graziella G. Rivelli, Patrick O. Azevedo, Emiliano R. Oliveira, Lídia P. Faustino, Natália Salazar, Flávia F. Bagno, Alex F. Carvalho, Bruna Rattis, Karine L. Lourenço, Isabela P. Gomes, Bruna R.D. Assis, Mariela Piccin, Flávio G. Fonseca, Edison Durigon, João S. Silva, Renan P. de Souza, Gisele A.C. Goulart, Helton Santiago, Ana Paula S. Fernandes, Santuza R. Teixeira, Ricardo T. Gazzinelli |
| 217 |
[GO] |
2024―Okt―01 |
Roles and responsibilities of participants, researchers, and the media in the communication of vaccine trials: Experience from the United Kingdom's first COVID-19 vaccine trial |
Maia Patrick-Smith, Katherine Emary, Susanne H. Hodgson, Tonia M. Thomas, Rebecca te Water Naude, Arabella S.V. Stuart, John Henry, Marcus English, Maria Moore, Naomi Douglas, Andrew J. Pollard, Samantha Vanderslott |
| 218 |
[GO] |
2024―Sep―29 |
Validation of the Chinese version of the vaccine conspiracy beliefs scale during COVID-19 pandemic and its correlates |
Xiaokang Lyu, Xin Liu, Haijuan Hong |
| 219 |
[GO] |
2024―Sep―29 |
Sociodemographic determinants of COVID-19 vaccination in adolescents in Stockholm, Sweden |
Adonis Sotoodeh, Pontus Hedberg, Fredrik Granath, Tobias Alfvén, Pontus Nauclér |
| 220 |
[GO] |
2024―Sep―27 |
Corrigendum to “Immunogenicity during 6 months after SARS-CoV-2 infection is significantly different depending on previous COVID-19 vaccine regimens and a booster dose received” [Vaccine 42 (22) (2024) 126025] |
Paskorn Sritipsukho, Pakatip Sinlapamongkolkul, Araya Satdhabudha, Chanapai Chaiyakulsil, Surakameth Mahasirimongkol, Waritta Sawaengdee, Waraphorn Fukpho, Thana Khawcharoenporn |
| 221 |
[GO] |
2024―Sep―25 |
Variant-specific neutralising antibodies levels induced by the PHH-1 V SARS-CoV-2 vaccine (Bimervax®) by HIPRA |
Anna England, Julia Sung, Meritxell Deulofeu, Laura Ferrer Soler, Bassam Hallis, Kelly Thomas, Sue Charlton |
| 222 |
[GO] |
2024―Sep―23 |
Comparison of assays used to detect antibody response in COVID-19 vaccine trials: Results from of a UK multi-Centre randomised controlled trial to determine the immunogenicity responses of COVID-19 vaccines administered concomitantly with seasonal influenza vaccines (ComFluCOV) |
Rajeka Lazarus, Rosie Harris, Russell Thirard, Sarah Baos, Lucy Culliford, Rachel Todd, Bassam Hallis, Sue Charlton, Adam Finn, Matthew D. Snape, Chris A. Rogers |
| 223 |
[GO] |
2024―Sep―21 |
Preclinical evaluation in hamster model of the mRNA COVID-19 vaccine candidate AfriVac 2121 (Wuhan) produced under the WHO/MPP mRNA Technology Transfer Programme |
Ornéllie Bernadin, Maxime Cochin, Jean-Sélim Driouich, Caroline Laprie, Pia Steigler, Gerhardt Boukes, Caryn Fenner, Xavier de Lamballerie, Antoine Nougairède |
| 224 |
[GO] |
2024―Sep―21 |
The impact of coronavirus pandemic shutdowns on immunization completion in Hadeetha, Anbar, Iraq: A case-study of vaccine completion in a recovering healthcare system |
Sara Al-Dahir, Tahseen Abdul Latif Hassan, William Moss, Alaa Khalil, Gilbert Burnham, Maria Deloria Knoll, S.M. Moazzem Hossain, Kawsar Talaat |
| 225 |
[GO] |
2024―Sep―20 |
Detailed review of mortality reported following COVID-19 vaccination in Victoria, Australia: 2021-2023 |
Ingrid Laemmle-Ruff, Jesse J. Fryk, Priya Shenton, Hazel J. Clothier, Sarah Parsons, Linda Iles, Clare White, Michael Murray, Jim Buttery, Nigel W. Crawford |
| 226 |
[GO] |
2024―Sep―19 |
Impact of the 2023/24 autumn-winter COVID-19 seasonal booster campaign in preventing severe COVID-19 cases in Italy (October 2023-March 2024) |
E.A. Fotakis, E. Picasso, C. Sacco, D. Petrone, M. Del Manso, A. Bella, F. Riccardo, A. Odone, A. Cannone, M. Tallon, L. De Angelis, A. Sciurti, D. Cescutti, P. Pezzotti, M. Fabiani, A. Mateo-Urdiales |
| 227 |
[GO] |
2024―Sep―18 |
Risk of death and cardiovascular events following COVID-19 vaccination or positive SARS-CoV-2 test amongst adult Singaporeans during omicron transmission |
Liang En Wee, Muhammad Ismail Bin Abdul Malek, Janice Tan, Calvin Chiew, Vernon Lee, Derrick Heng, Benjamin Ong, David Chien Lye, Kelvin Bryan Tan |
| 228 |
[GO] |
2024―Sep―17 |
Defining long COVID using a population-based SARS-CoV-2 survey in California |
Jake M. Pry, Kalyani McCullough, Kristina Wen-Jeh Lai, Esther Lim, Megha L. Mehrotra, Katherine Lamba, Seema Jain |
| 229 |
[GO] |
2024―Sep―11 |
COVID-19 vaccine uptake in a predominantly minoritized cohort hospitalized during the early pandemic in New York City |
Jennifer Y. Chang, Michelle Chang, Simian Huang, Joan Bosco, Meredith McNairy, Sade Tukuru, Yi Hao Wu, Jonathan Kunkel-Jure, Jessica Weidler, Tawni Goodman, Carlie Dorr, Renée Roberts, Brett Gray, Jason Zucker, Magdalena E. Sobieszczyk, Delivette Castor |
| 230 |
[GO] |
2024―Sep―10 |
Delivery of SARS-CoV-2 spike and membrane genes in a single Baculoviral vector enhance the immune breadth against SARS-CoV-2 variants of concern |
Jungmin Chun, Doyoung Yoon, Aleksandra Nowakowska, Hyeon Dong Lee, Chanyeong Lee, Jinha Kim, Sehyun Kim, Heewon Bang, Hee-Jung Lee, Young Bong Kim |
| 231 |
[GO] |
2024―Sep―09 |
Risk factors and correlates of protection against XBB SARS-CoV-2 infection among health care workers |
Michal Canetti, Noam Barda, Yaniv Lustig, Yael Weiss-Ottolenghi, Victoria Indenbaum, Yovel Peretz, Neta Zuckerman, Keren Asraf, Sharon Amit, Yitshak Kreiss, Gili Regev-Yochay |
| 232 |
[GO] |
2024―Sep―07 |
Association of SARS-CoV-2 immunoserology and vaccination status with myocardial infarction severity and outcome |
Ana Blasco, Ana Royuela, Sergio García-Gómez, Natalia Gómez-Lozano, Alberto Sánchez-Arjona, Jorge de la Fuente, Jorge Anel, Icíar Sánchez-Galarraga, Marina Pérez-Redondo, Elisa González, Lorenzo Silva |
| 233 |
[GO] |
2024―Sep―05 |
Disparities in COVID-19 vaccination receipt by race, ethnicity, and social determinants of health among a large patient population in a network of community-based healthcare centers |
Holly C. Groom, Frances M. Biel, Bradley Crane, Evelyn Sun, Joanna P. Georgescu, Eric S. Weintraub, Michael M. McNeil, Amelia Jazwa, Ning Smith, Constance Owens-Jasey, Allison L. Naleway, Teresa Schmidt |
| 234 |
[GO] |
2024―Sep―05 |
Insights from an observational translational research program during the COVID-19 pandemic: Four years of experience |
Marjorie Rowe, Ai-ris Yonekura Collier, Dan H. Barouch |
| 235 |
[GO] |
2024―Sep―03 |
Jurisdiction-level costs of the initial phase of the COVID-19 vaccination program in the United States, December 20, 2020-May 31, 2021 |
Christine Kim, Christopher Dunphy, Christopher Duggar, Jamison Pike |
| 236 |
[GO] |
2024―Sep―03 |
Using health literacy principles to improve understanding of evolving evidence in health emergencies: Optimisation and evaluation of a COVID-19 vaccination risk-benefit calculator |
Carissa Bonner, Melody Taba, Michael Anthony Fajardo, Carys Batcup, Ben R. Newell, Amy X. Li, Helen J. Mayfield, Colleen L. Lau, John C.B. Litt |
| 237 |
[GO] |
2024―Sep―02 |
mRNA-based COVID-19 vaccination of lung transplant recipients with prior SARS-CoV-2 infection induces durable SARS-CoV-2-specific antibodies and T cells |
Siqi Liu, Laura L.A. van Dijk, Yvette den Hartog, Rogier Hoek, Erik Verschuuren, Corine H. Geurtsvankessel, Rory D. de Vries, Debbie Van Baarle, Coretta Van Leer Buter |
| 238 |
[GO] |
2024―Sep―02 |
Risk of heavy menstrual bleeding following COVID-19 vaccination: A nationwide case-control study |
Jérémie Botton, Marion Bertrand, Marie-Joëlle Jabagi, Lise Duranteau, Kim Bouillon, Jérôme Drouin, Laura Semenzato, Stéphane Le Vu, Alain Weill, Mahmoud Zureik, Rosemary Dray-Spira |
| 239 |
[GO] |
2024―Sep―02 |
Canadian health care providers' and education workers' hesitance to receive original and bivalent COVID-19 vaccines |
Brenda L. Coleman, Iris Gutmanis, Susan J. Bondy, Robyn Harrison, Joanne Langley, Kailey Fischer, Curtis Cooper, Louis Valiquette, Matthew P. Muller, Jeff Powis, Dawn Bowdish, Kevin Katz, Mark Loeb, Marek Smieja, Shelly A. McNeil, Samira Mubareka, Jeya Nadarajah, Saranya Arnoldo, Allison McGeer |
| 240 |
[GO] |
2024―Aug―31 |
Confidence and barriers: Analysis of factors associated with timely routine childhood vaccination in Canada during the COVID-19 pandemic |
Harry MacKay, Jeremy D. Gretton, Sandra Chyderiotis, Stephanie Elliott, Ana Howarth, Catherine Guo, Angela Mastroianni, Christine Kormos, Jessica Leifer, Lauryn Conway, Mark D. Morrissey |
| 241 |
[GO] |
2024―Aug―30 |
Predictors of the willingness to accept a free COVID-19 vaccine among households in Nigeria |
Oghenowede Eyawo, Uchechukwu Chidiebere Ugoji, Shenyi Pan, Patrick Oyibo, Amtull Rehman, Mishel Mahboob, Olapeju Adefunke Esimai |
| 242 |
[GO] |
2024―Aug―28 |
Lessons from a longitudinal community-based investigation of adherence to guidelines and intent to vaccinate during the COVID-19 pandemic |
Maria M. Llabre, Kiara R. Timpano, Hannah C. Broos, Rafael O. Leite, Patrice G. Saab |
| 243 |
[GO] |
2024―Aug―27 |
A Brighton Collaboration standardized template with key considerations for a benefit-risk assessment for the Comirnaty COVID-19 mRNA vaccine |
Shanti Pather, Nicola Charpentier, Frank van den Ouweland, Ruben Rizzi, Andrew Finlayson, Nadine Salisch, Alexander Muik, Claudia Lindemann, Ruzwana Khanim, Sultan Abduljawad, Emily R. Smith, Marc Gurwith, Robert T. Chen |
| 244 |
[GO] |
2024―Aug―27 |
COVID-19 vaccine hesitancy: Meaning relations between responses in an epidemiological study and twitter messages |
Sofia Natalia Ferreira-Silva, Maria Eduarda Muniz Soares, Ricardo Vasconcelos, Carolina Barbieri, Luiz Fujita Junior, Tainah Medeiros, Camila Carvalho de Souza Amorim Matos, Marcia Thereza Couto, Vivian I. Avelino-Silva |
| 245 |
[GO] |
2024―Aug―26 |
Editorial: ML-driven vaccine against COVID-19: Developmental challenges and foresight |
Dilbag Singh, Robertas Damaševičius, Vijay Kumar, Fabio Bagnoli, Simone Pecetta, Rino Rappuoli |
| 246 |
[GO] |
2024―Aug―24 |
Delayed peak antibody titers after the second dose of SARS-CoV-2 vaccine in solid organ transplant recipients: Prospective cohort study |
Kohei Unagami, Mikiko Yoshikawa, Hiroto Egawa, Satoko Ohfuji, Yoichiro Natori, Rikako Oki, Tomomi Mori, Hidetoshi Hattori, Ayumi Ishiwatari, Taichi Kanzawa, Tomokazu Shimizu, Kazuya Omoto, Masashi Inui, Yuuki Masano, Takashi Ito, Daisuke Nakajima, Tetsuya Babazono, Toshio Takagi, Shinichi Nunoda, Yoshito Tomimaru, Ryoichi Imamura, Shigeru Miyagawa, Koichi Toda, Etsuro Hatano, Hiroshi Date, Miyaji Kyakuno, Shiro Takahara, Kenji Yuzawa, Naoki Tanimine, Hideki Ohdan, Hideki Ishida, Yoshio Hirota |
| 247 |
[GO] |
2024―Aug―24 |
Identification of gene and protein signatures associated with long-term effects of COVID-19 on the immune system after patient recovery by analyzing single-cell multi-omics data using a machine learning approach |
JingXin Ren, Qian Gao, XianChao Zhou, Lei Chen, Wei Guo, KaiYan Feng, Jerry Hu, Tao Huang, Yu-Dong Cai |
| 248 |
[GO] |
2024―Aug―24 |
Patterns and predictors of COVID-19 vaccination among young adults at 44 US sites: Secondary analysis of a randomized, controlled, open-label trial, March - December 2021 |
Nadja A. Vielot, Nicole K. Kelly, Christina Ludema, Molly Rosenberg, Elizabeth R. Brown, Holly E. Janes, James G. Kublin, Kathryn E. Stephenson, Jasmine R. Marcelin, Audrey Pettifor |
| 249 |
[GO] |
2024―Aug―23 |
Patient-reported outcomes of adverse events after COVID-19 vaccination in Nigeria: A mixed methods study |
Comfort K. Ogar, Hannah N. Gilbert, Lourens T. Bloem, Christine Leopold, Peter U. Bassi, Yahaya M. Katagum, Adeline I. Osakwe, Abimbola O. Opadeyi, Ibrahim Oreagba, Danjuma N.D. Mbo, Aukje K. Mantel-Teeuwisse, Marie L. De Bruin |
| 250 |
[GO] |
2024―Aug―22 |
Co-administration of recombinant BCG and SARS-CoV-2 proteins leads to robust antiviral immunity |
Mario A. Ramírez, Ricardo A. Loaiza, Yohana Martínez-Balboa, Nicole Bruneau, Eugenio Ramírez, Pablo A. González, Susan M. Bueno, Alexis M. Kalergis |
| 251 |
[GO] |
2024―Aug―22 |
Effectiveness of inactivated influenza vaccine in children during the 2023/24 season: The first season after relaxation of intensive COVID-19 measures |
Masayoshi Shinjoh, Mizuki Yaginuma, Yoshio Yamaguchi, Kazuyo Tamura, Munehiro Furuichi, Yuki Tsumura, Ryo Itaki, Asef Iqbal, Naonori Maeda, Atsushi Narabayashi, Akinobu Kamei, Akimichi Shibata, Go Yamada, Mitsuhiro Nishida, Tsunematsu Kenichiro, Michiko Chiga, Motoko Shimoyamada, Makoto Yoshida, Naoya Fukushima, Yuji Nakata, Hiroyuki Fukushima, Chiharu Kawakami, Satoshi Narumi, Norio Sugaya |
| 252 |
[GO] |
2024―Aug―22 |
Seroprevalence of B. pertussis infection and the changes of specific antibody levels in health care workers during the first two years of COVID-19 in Wuhu, China |
Qinghong Meng, Bingsong Wang, Qianqian Du, Xianlai Zhang, Zhen Li, Fang He, Fei Ying, Linyan Cong, Juanjuan Ding, Kaihu Yao |
| 253 |
[GO] |
2024―Aug―17 |
“REAl LIfe” observational study on the effectiveness of Evusheld prophylaxis against SARS-CoV-2 omicron variants in vaccine non-responder immunocompromised patients (REALISE) |
Giuliana Lucia Esposito, Federico Fassio, Daniela Girardi, Erica Picasso, Federica Meloni, Simone Montini, Veronica Codullo, Eleonora Francesca Pattonieri, Irene Defrancesco, Antonio Bianchessi, Monica Calvi, Elena Maria Seminari, Fausto Baldanti, Daniele Lilleri, Viola Novelli, Carlo Marena |
| 254 |
[GO] |
2024―Aug―16 |
Associations of mental health with vaccination readiness in informal caregivers and the vaccination status of their care recipients during the Covid-19 pandemic - A cross sectional analysis |
Linda Sanftenberg, Felix Bader, Marietta Rottenkolber, Maria Sebastiao, Thomas Kühlein, Christine Eidenschink, Ildikó Gágyor, Domenika Wildgruber, Anita Hausen, Christian Janke, Michael Hoelscher, Daniel Teupser, Tobias Dreischulte, Jochen Gensichen |
| 255 |
[GO] |
2024―Aug―15 |
Efficacy and safety of Abdala COVID-19 subunit vaccine in children and adolescents: An open-label, single-arm, phase 2 trial (MEÑIQUE) |
Francisco Hernández-Bernal, Enrique Noa-Romero, Joel Quintana-Guerra, Cristina O. Chávez-Chong, Yenima Martín-Bauta, Laura Alvaré-Alvaré, Alena Salvato-Dueñas, Danusia Felipe-Mallea, Mairalys Porta-Díaz, Otto Cruz-Sui, Karen Urrutia-Pérez, Klaudia Urrutia-Pérez, José L. Rodríguez-Reinoso, Marel Alonso-Valdés, Zurina Cinza-Estévez, Aylin Rodríguez-Triana, Yolanda Cruz-Gómez, Miladys Limonta-Fernández, Mireida Rodríguez-Acosta, Marta Ayala-Ávila, Verena L. Muzio-González |
| 256 |
[GO] |
2024―Aug―13 |
Uptake of COVID-19 vaccines and association with hospitalisation due to COVID-19 in pregnancy: Retrospective cohort study |
Gloria Ihenetu, Paul Aylin, Vesselin Novov, Helen Skirrow, Sonia Saxena, Azeem Majeed, Thomas Woodcock |
| 257 |
[GO] |
2024―Aug―09 |
Influenza vaccine uptake among youth with sickle cell disease who are seen in clinic before and after the COVID-19 pandemic |
Joseph Walden, Joseph R. Stanek, Jennifer Young, Megan M. Griffith, Leena Nahata, Susan E. Creary |
| 258 |
[GO] |
2024―Aug―08 |
Pre- and post-Ad26.COV2·S booster dose antibody levels predict COVID-19 disease risk |
Sanne Roels, Matthias Bruckner, Jerald Sadoff, Vicky Cárdenas, Chan Tang, Stefan Hagedoorn, Dirk Heerwegh, Daniel J. Stieh, Mathieu Le Gars |
| 259 |
[GO] |
2024―Aug―08 |
Understanding structural inequities in Covid-19 vaccine access and uptake among disability, transgender and gender-diverse communities in India |
Sharin D'souza, Bhakti Ghatole, Harikeerthan Raghuram, Shreyus Sukhija, Satendra Singh, Aqsa Shaikh, Sunita Sheel Bandewar, Anant Bhan |
| 260 |
[GO] |
2024―Aug―08 |
Antibody response to non-mRNA SARS-CoV-2 vaccine in kidney transplant recipients |
Divya Bajpai, Sreyashi Bose, Nikhil Saxena, Bhagyashree Kulkarni, Kruteesh Kumar, Nikhil Rao, Sayali Thakare, Vijaya Torane, Gita Nataraj, Tukaram Jamale |
| 261 |
[GO] |
2024―Aug―08 |
The impact of the COVID-19 pandemic on childhood vaccination rates and the role of sociodemographic factors: A cohort study |
Inés Gómez-Acebo, Ana Barquín-Ruiz, Sandra Llorente, Jéssica Alonso-Molero, Javier Llorca, María J. Cabero-Perez, Trinidad Dierssen-Sotos |
| 262 |
[GO] |
2024―Aug―06 |
Factors associated with COVID-19 vaccine uptake among south African health care workers |
Gavin George, Michael Strauss, Emma Lansdell, Phiwe Nota, Remco P.H. Peters, Petra Brysiewicz, Nisha Nadesan-Reddy, Douglas Wassenaar |
| 263 |
[GO] |
2024―Aug―05 |
Identifying psychological predictors of SARS-CoV-2 vaccination: A machine learning study |
Michael V. Bronstein, Erich Kummerfeld, Angus MacDonald, Sophia Vinogradov |
| 264 |
[GO] |
2024―Aug―03 |
Should SARS-CoV-2 serological testing be used in the decision to deliver a COVID-19 vaccine booster? A pro-con assessment |
Matteo Augello, Isabell Wagenhäuser, Manuel Krone, Nicolas Dauby, Pietro Ferrara, Michela Sabbatucci, Simona Ruta, Omid Rezahosseini, Petar Velikov, Effrossyni Gkrania-Klotsas, Jose Montes, Carlos Franco-Paredes, Anna L. Goodman, Sertaç Küçükkaya, Jose Tuells, Zitta Barrella Harboe, Olivier Epaulard |
| 265 |
[GO] |
2024―Aug―01 |
A health equity science approach to assessing drivers of COVID-19 vaccination coverage disparities over the course of the COVID-19 pandemic, United States, December 2020-December 2022 |
Makhabele Nolana Woolfork, Kambria Haire, Oluyemi Farinu, Jasmine Ruffin, Jennifer M. Nelson, Fatima Coronado, Benjamin J. Silk, LaTreace Harris, Chastity Walker, Brian J. Manns |
| 266 |
[GO] |
2024―Aug―01 |
Immunization-related stress and stress-related responses of mucosal versus intramuscular COVID-19 vaccination among adults in China |
Minghuan Jiang, Haijun Zhang, Xuelin Yao, Yang Wang, Xiaozhen Lai, Hai Fang |
| 267 |
[GO] |
2024―Jul―31 |
Kinetics of SARS-CoV-2 antibody titers after booster vaccinations during an Omicron surge in Japan |
Naomi Matsumoto, Ayako Sasaki, Tomoka Kadowaki, Toshiharu Mitsuhashi, Soshi Takao, Takashi Yorifuji |
| 268 |
[GO] |
2024―Jul―30 |
COVID-19 and influenza vaccine uptake in women with criminal-legal system involvement |
Olabimpe Asupoto, Xinyang Li, Jordana L. Hemberg, Amanda Emerson, Dominique Black, Mugur V. Geana, Joi Wickliffe, Jason Glenn, Megha Ramaswamy, Alysse G. Wurcel |
| 269 |
[GO] |
2024―Jul―30 |
Genetic and epigenetic analyses of IFN-γ gene proximal promoter region underlying positive correlation between persistently high anti-SARS-CoV-2 IgG and IFN-γ among COVID-19 vaccinated Bangladeshi adults |
Anika Tahsin, Piyash Bhattacharjee, Abdullah Al Saba, Tahirah Yasmin, A.H.M. Nurun Nabi |
| 270 |
[GO] |
2024―Jul―30 |
Individual and familial factors associated with mRNA COVID-19 vaccine uptake in pregnancy: A large-scale registry-based linkage study |
Jovan Elyass, Anteneh Desalegn, Nhung T.H. Trinh, Saima Orangzeb, Mahmoud Zidan, Hedvig Nordeng, Angela Lupattelli |
| 271 |
[GO] |
2024―Jul―27 |
COVID-19 vaccination reluctance across Europe: Lessons for the future |
Abdul Suleman, Paula Vicente |
| 272 |
[GO] |
2024―Jul―26 |
Implementation and adherence to regular asymptomatic testing in a COVID-19 vaccine trial |
Lucy R. Williams, Katherine R.W. Emary, Daniel J. Phillips, Jodie Hay, Jessica P.J. Larwood, Maheshi N. Ramasamy, Andrew J. Pollard, Nicholas C. Grassly, Merryn Voysey |
| 273 |
[GO] |
2024―Jul―26 |
Weighing the risks and benefits: Parental perspectives on COVID-19 vaccines for 5- to 11-year-old children |
Anushka Ataullahjan, Pierre-Philippe Piche-Renaud, Elahe Karimi Shahrbabak, Sarah Abu Fadaleh, Costanza Di Chiara, David Avelar Rodriguez, Joelle Peresin, Shaun K. Morris |
| 274 |
[GO] |
2024―Jul―26 |
Impact of vaccination on SARS-CoV-2 evolution and immune escape variants |
Deepak Jena, Arup Ghosh, Atimukta Jha, Punit Prasad, Sunil Kumar Raghav |
| 275 |
[GO] |
2024―Jul―24 |
Impact of the emergence of severe acute respiratory syndrome coronavirus 2 omicron variants on routine childhood immunization in japan |
Yuta Aizawa, Isamu Sato, Yuki Abe, Fujio Sasagawa, Akihiko Saitoh |
| 276 |
[GO] |
2024―Jul―20 |
Heterologous and homologous COVID-19 mRNA vaccination schemes for induction of basic immunity show similar immunogenicity regarding long-term spike-specific cellular immunity in healthcare workers |
Isabell Wagenhäuser, Giovanni Almanzar, Franziska Bernhardine Förg, Astrid Stein, Isabella Eiter, Julia Reusch, Juliane Mees, Anna Herzog, Ulrich Vogel, Anna Frey, Thiên-Trí Lâm, Alexandra Schubert-Unkmeir, Lars Dölken, Oliver Kurzai, Stefan Frantz, Alexander Gabel, Nils Petri, Martina Prelog, Manuel Krone |
| 277 |
[GO] |
2024―Jul―20 |
Aluminum hydroxide and immunostimulatory glycolipid adjuvant combination for enhanced COVID-19 subunit vaccine immunogenicity |
Guo-Qing Zou, Ke Li, Cheng Yan, Ya-Qian Li, Mao-Ying Xian, Xing Hu, Rui Luo, Zheng Liu |
| 278 |
[GO] |
2024―Jul―17 |
Parental hesitancy about COVID-19, influenza, HPV, and other childhood vaccines |
Tammy A. Santibanez, Carla L. Black, Tianyi Zhou, Anup Srivastav, James A. Singleton |
| 279 |
[GO] |
2024―Jul―17 |
Duration of vaccine protection against breakthrough infections during five COVID-19 waves among healthcare workers primarily vaccinated with CoronaVac |
Alessandra Luna-Muschi, Igor Carmo Borges, Antonio dos Santos Barboza, Elizabeth de Faria, Marina Farrel Cortês, Roseli B. Santos, Bianca Costa Silva, Camila Alves Maia da Silva, Esmenia Coelho Rocha, Valquíria Reis de Souza, Raissa H. de Araujo Eliodoro, Franciane Mendes de Oliveira, Ana Carolina Mamana, Amanda Miyuki Hidifira, Marli Nishikawara, Victor Bertollo Gomes Porto, Ana Paula B. Barboza, Vanderson Sampaio, Carolina S. Lazari, Aluisio C. Segurado, Esper G. Kallas, Ana Marli C. Sartori, Anna S. Levin, Ester Cerdeira Sabino, Silvia Figueiredo Costa |
| 280 |
[GO] |
2024―Jul―16 |
Effectiveness of COVID-19 bivalent vaccination against SARS-CoV-2 infection among residents of US nursing homes, November 2022 - March 2023 |
Kelly Hatfield, Ryan Wiegand, Sujan Reddy, Arshiya Patel, James Baggs, Thomas Franceschini, Amber Gensheimer, Ruth Link-Gelles, John Jernigan, Megan Wallace |
| 281 |
[GO] |
2024―Jul―16 |
Efficiency of indirect protection of COVID-19 vaccination and interactions between indirect and direct protection on household transmission |
Yuki Takahashi, Hideo Tanaka, Chie Taniguchi, Tsuyoshi Ogata |
| 282 |
[GO] |
2024―Jul―16 |
Humoral immune response against SARS-CoV-2 after adapted COVID-19 vaccine schedules in healthy adults: The IMCOVAS randomized clinical trial |
Katie Steenackers, Nikita Hanning, Liesbeth Bruckers, Isabelle Desombere, Arnaud Marchant, Kevin K. Ariën, Daphnée Georges, Patrick Soentjens, Valentino D’Onofrio, Maya Hites, Nicole Berens-Riha, Ilse De Coster, Pierre Van Damme |
| 283 |
[GO] |
2024―Jul―14 |
GP consultations for menstrual disorders after COVID-19 vaccination - A self-controlled cohort study based on routine healthcare data from the Netherlands |
R. Jajou, T. Lieber, E.P. van Puijenbroek, E. Mulder, J. Overbeek, K. Hek, F.P.A.M. van Hunsel, A. Kant |
| 284 |
[GO] |
2024―Jul―14 |
Mass COVID-19 vaccination center: Optimizing the vaccination pathway during a 12 month timeframe |
Aurélie Le Bagousse-Bernard, Claude Dussart, Philippe Pin, Karim Tazarourte, Jihane Fattoum |
| 285 |
[GO] |
2024―Jul―14 |
COVID-19 vaccination-induced antibody responses and waning by age and comorbidity status in a large population-based prospective cohort study |
C.E. Hoeve, A.J. Huiberts, B. de Gier, S.P. Andeweg, G. den Hartog, H.E. de Melker, S.J.M. Hahne, J.H.H.M. van de Wijgert, S. van den Hof, M.J. Knol |
| 286 |
[GO] |
2024―Jul―14 |
Case-cohort design as an efficient approach to evaluating COVID-19 vaccine effectiveness, waning, heterologous immune effect and optimal dosing interval |
David N. Fisman, Alison E. Simmons, Ashleigh R. Tuite |
| 287 |
[GO] |
2024―Jul―12 |
Short- and long-term outcomes of cardiac adverse events following COVID-19 immunization managed in a Canadian pediatric center |
Anne Pham-Huy, Jennifer Bowes, Katherine Russell, Ali Amira, Lillian Lai |
| 288 |
[GO] |
2024―Jul―12 |
Identifying the intersection of parental HPV and COVID-19 vaccine hesitancy to inform health messaging interventions in community-based settings |
Samantha Garcia, Michelle Shin, Morgan Gill, Zehui He, Emily Dang, W. Martin Kast, Jennifer B. Unger, Lourdes Baezconde-Garbanati, Jennifer Tsui |
| 289 |
[GO] |
2024―Jul―11 |
Child COVID-19 vaccine uptake among participants of the 2015 Pelotas (Brazil) Birth Cohort Study |
Ana Lucia Sartori, Romina Buffarini, Aline Machado da Silva, Otávio Amaral de Andrade Leão, Thaynã Ramos Flores, Andréa Dâmaso Bertoldi, Pedro Curi Hallal, Mariângela Freitas da Silveira |
| 290 |
[GO] |
2024―Jul―09 |
Maternal-infant transfer of SARS-CoV-2 antibodies following vaccination in pregnancy: A prospective cohort study |
I. Korchinski, C. Marquez, E. McClymont, G. Av-Gay, J. Andrade, C. Elwood, A. Jassem, M. Krajden, M. Morshed, M. Sadarangani, G. Tanunliong, I. Sekirov, D. Money |
| 291 |
[GO] |
2024―Jul―08 |
Corrigendum to “Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: results from the VEBIS primary care test-negative design study, September 2023-January 2024” [Vaccine 42(19) (2024)] |
Charlotte Laniece Delaunay, Aryse Melo, Marine Maurel, Clara Mazagatos, Luise Goerlitz, Joan O’Donnell, Beatrix Oroszi, Noémie Sève, Ana Paula Rodrigues, Iván Martínez-Baz, Adam Meijer, Ivan Mlinarić, Neus Latorre-Margalef, Mihaela Lazăr, Gloria Pérez-Gimeno, Ralf Dürrwald, Charlene Bennett, Gergő Túri, Marie-Anne Rameix-Welti, Raquel Guiomar, Jesús Castilla, Mariëtte Hooiveld, Sanja Kurečić Filipović, Tove Samuelsson Hagey, Frederika Dijkstra, Vitor Borges, Violeta Ramos Marín, Sabrina Bacci, Marlena Kaczmarek, Esther Kissling |
| 292 |
[GO] |
2024―Jul―08 |
Mammalian cell expressed recombinant trimeric spike protein is a potent vaccine antigen and confers near-complete protection against SARS-CoV-2 infection in Hamster |
B. Vikram Kumar, Sneha Singh, Geetika Verma, Reetesh Kumar, Pranaya M. Mishra, Sahil Kumar, Santhosh K. Nagaraj, Joydeep Nag, Christy M. Joy, Bhushan Nikam, Dharmendra Singh, Nidhi Kalidas, Shubham Singh, Ashwani K. Bhardwaj, Dhananjay S. Mankotia, Rajesh P. Ringe, Nimesh Gupta, Shashank Tripathi, Ravi P.N. Mishra |
| 293 |
[GO] |
2024―Jul―06 |
Analyzing the 7C psychological antecedents of vaccine acceptance throughout the COVID-19 pandemic among healthcare sector workers in France: A repeated cross-sectional study (CappVac-Cov) |
Lucia Araujo-Chaveron, Cyril Olivier, Gérard Pellissier, Elisabeth Bouvet, Judith E. Mueller |
| 294 |
[GO] |
2024―Jun―29 |
Intradermal fractional dose vaccination as a method to vaccinate individuals with suspected allergy to mRNA COVID-19 vaccines |
Geert V.T. Roozen, Alexandra Granger, Rob S. van Binnendijk, Gerco den Hartog, Meta Roestenberg, Leo G. Visser, Anna H.E. Roukens |
| 295 |
[GO] |
2024―Jun―28 |
COVID-19 vaccine immunogenicity and safety surrounding fourth and subsequent vaccine doses in patients with hematologic malignancies |
Sita Bhella, Allison M. Wilkin, Katrina Hueniken, Abi Vijenthira, Michael Sebag, Peng Wang, Lisa K. Hicks, Annette E. Hay, Sarit Assouline, Graeme Fraser, Amaris Balitsky, Joy Mangel, Carolyn Owen, Anthony Reiman, Laurie Sehn, Heather Sutherland, Tinghua Zhang, Corey Arnold, Tamara Leite, Erinn McCarthy, Curtis Cooper, Marc-Andre Langlois, C. Arianne Buchan |
| 296 |
[GO] |
2024―Jun―27 |
Factors predicting primary and booster COVID-19 vaccination in a community sample of African American men and women in the United States Midwest |
Jeffrey A. Kelly, Jennifer L. Walsh, Katherine Quinn, Yuri A. Amirkhanian, Monique Plears |
| 297 |
[GO] |
2024―Jun―25 |
Safety, reactogenicity, and immunogenicity of Ad26.COV2.S as homologous or heterologous COVID-19 booster vaccination: Results of a randomized, double-blind, phase 2 trial |
Mathieu Le Gars, Jerald Sadoff, Vicky Cárdenas, Dirk Heerwegh, Fisseha Tesfaye, Griet Van Roey, Colleen Spicer, Samantha Santoro Matias, Olivia Crayne, Tobias Kamphuis, Frank Struyf, Hanneke Schuitemaker, Macaya Douoguih |
| 298 |
[GO] |
2024―Jun―22 |
Revaccination outcomes among adolescents and adults with suspected hypersensitivity reactions following COVID-19 vaccination: A Canadian immunization research network study |
Tiffany Fitzpatrick, Peter Yamoah, Gina Lacuesta, Manish Sadarangani, Victoria Cook, Persia Pourshahnazari, Chrystyna Kalicinsky, Julia E.M. Upton, Scott B. Cameron, Karver Zaborniak, Amin Kanani, Godfrey Lam, Catherine Burton, Cora Constantinescu, Jeffrey M. Pernica, Zainab Abdurrahman, Stephen Betschel, Jean-Philippe Drolet, Gaston De Serres, Caroline Quach, Anne Des Roches, Hugo Chapdelaine, Marina I. Salvadori, Alex Carignan, Athena McConnell, Anne Pham-Huy, C. Arianne Buchan, Juthaporn Cowan, Kyla Hildebrand, Karina A. Top |
| 299 |
[GO] |
2024―Jun―22 |
Factors, motivations and barriers associated with eagerness to volunteer in COVID-19 vaccine clinical trials in France: A mixed-method study |
Aloïs Helary, Elisabeth Botelho-Nevers, Marion Bonneton, Léa Khennouf, Jessica Sambourg, Odile Launay, Amandine Gagneux-Brunon |
| 300 |
[GO] |
2024―Jun―20 |
Watchful, skeptics, and system distrusters: Characteristics associated with different types of COVID-19 vaccine hesitancy among U.S. working-age adults |
Xue Zhang, Shannon M. Monnat |
| 301 |
[GO] |
2024―Jun―18 |
Guillain-Barré syndrome temporally associated with COVID-19 vaccines - Progress over time |
Ingrid Laemmle-Ruff, Hannah J Morgan, Adele Harris, Veronica Abruzzo, Hazel J Clothier, Joshua Osowicki, Jim P Buttery, Lynette Kiers, Nigel W Crawford |
| 302 |
[GO] |
2024―Jun―16 |
Relationship between parental acceptance of the COVID-19 vaccine and attitudes towards measles vaccination for children: A cross-sectional study |
Xiaoting Jiang, Jingxuan Wang, Conglu Li, Eng Kiong Yeoh, Zihao Guo, Guozhang Lin, Yuchen Wei, Ka Chun Chong |
| 303 |
[GO] |
2024―Jun―16 |
Comparing the consequences of COVID-19 vaccination between central nervous system (CNS) demyelinating diseases and other neurological disorders |
Mohammad Yazdan Panah, Saeed Vaheb, Yousef Mokary, Alireza Afshari-Safavi, Aysa Shaygannejad, Narges Ebrahimi, Vahid Shaygannejad, Omid Mirmosayyeb |
| 304 |
[GO] |
2024―Jun―15 |
Leveraging a clinical emergency department dataset to estimate two-dose COVID-19 vaccine effectiveness and duration of protection in Canada |
Daniel K. Ting, Rhonda J. Rosychuk, Jeffrey P. Hau, Christiaan H. Righolt, Jeffrey C. Kwong, Danuta M. Skowronski, Corinne M. Hohl |
| 305 |
[GO] |
2024―Jun―14 |
Investigating the predictors of COVID-19 vaccine decision-making among parents of children aged 5-11 in the UK |
Stephanie A. Davey, Claire Hampson, Michaela E. Christodoulaki, Daniel Gaffiero |
| 306 |
[GO] |
2024―Jun―13 |
The impact of COVID-19 childhood and adolescent vaccination on mortality in Argentina |
Rodrigo Quiroga, Sofía Gastellu, Braian Fernández, Romina Ottaviani, Johanna Romina Zuccoli, Pablo Daniel Vallecorsa, Jorge Aliaga, Lorena Barberia |
| 307 |
[GO] |
2024―Jun―12 |
Gender differences in COVID-19 preventative measures and vaccination rates in the United States: A longitudinal survey analysis |
Sahan Jayawardana, Mikaela Esquivel, Tin Orešković, Elias Mossialos |
| 308 |
[GO] |
2024―Jun―12 |
Immunogenicity during 6 months after SARS-CoV-2 infection is significantly different depending on previous COVID-19 vaccine regimens and a booster dose received |
Paskorn Sritipsukho, Phakatip Sinlapamongkolkul, Araya Satdhabudha, Chanapai Chaiyakulsil, Surakameth Mahasirimongkol, Waritta Sawaengdee, Waraphorn Fukpho, Thana Khawcharoenporn |
| 309 |
[GO] |
2024―Jun―12 |
Heterologous SARS-CoV-2 booster vaccine for individuals with hematological malignancies after a primary SARS-CoV-2 mRNA vaccine series |
Amy C. Sherman, Simon D. van Haren, Ella Borberg, Zoe Swank, Muneerah Aleissa, Alexandra Tong, Rebecca Rooks, Urwah Kanwal, Hannah Levine, Bridget Yates, Natalie Izaguirre, Kevin Ryff, Sanya Thomas, Lindsey Parisi, Xiaofang Li, David R. Walt, Ofer Levy, Stephen R. Walsh, Nicolas C. Issa, Lindsey R. Baden |
| 310 |
[GO] |
2024―Jun―12 |
Striving for equitable vaccination coverage: Leveraging rapid coverage and community assessments during the COVID-19 pandemic to reach missed populations in Cambodia |
Raveesha R. Mugali, Hedy Ip, Amos Zikusooka, Lenin Vong, Savy Bou, Sarath Kros, Or Vandine |
| 311 |
[GO] |
2024―Jun―12 |
Engaging Trusted Messengers to Increase COVID-19 Pediatric Vaccine Uptake in Philadelphia: Lessons from the VaxUpPhillyFamilies program |
Sarah Badlis, Haolong Yu, Heather Klusaritz, Andy S.L. Tan, Teresa Dooley, Helaine Heggs, Sophia Collins, Gabriela Raczka, Naomi DeRoche-Brown, Rachel Feuerstein-Simon, José A. Bauermeister, Antonia M. Villarruel, Stephen Bonett, Karen Glanz, Terri Lipman |
| 312 |
[GO] |
2024―Jun―11 |
COVID-19 vaccine hesitancy, trust, and communication in Sarlahi District, Nepal |
Porcia Manandhar, Joanne Katz, Tsering Pema Lama, Subarna K. Khatry, William J. Moss, Daniel J. Erchick |
| 313 |
[GO] |
2024―Jun―08 |
Dynamics of multisystem inflammatory syndrome in children associated to COVID-19 in Chile: Epidemiologic trends during pandemic, before and after children vaccination |
R. Villena, G. Izquierdo, J. Wilhelm, C. García, M. Acuña, P. Riquelme, S. Alvarado, J.P. Torres |
| 314 |
[GO] |
2024―Jun―05 |
Comparable antibody levels in heterologous and homologous mRNA COVID-19 vaccination, with superior neutralizing and IgA antibody responses in mRNA homologous boosting |
Salma Younes, Eleonora Nicolai, Nadin Younes, Massimo Pieri, Sergio Bernardini, Parveen B. Nizamuddin, Duaa W. Al-Sadeq, Hanin I. Daas, Ahmed Ismail, Hadi M. Yassine, Laith J. Abu-Raddad, Gheyath K. Nasrallah |
| 315 |
[GO] |
2024―Jun―04 |
Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023-January 2024 |
Charlotte Laniece Delaunay, Aryse Melo, Marine Maurel, Clara Mazagatos, Luise Goerlitz, Joan O’Donnell, Beatrix Oroszi, Noémie Sève, Ana Paula Rodrigues, Iván Martínez-Baz, Adam Meijer, Ivan Mlinarić, Neus Latorre-Margalef, Mihaela Lazăr, Gloria Pérez-Gimeno, Ralf Dürrwald, Charlene Bennett, Gergő Túri, Marie-Anne Rameix-Welti, Raquel Guiomar, Jesús Castilla, Mariëtte Hooiveld, Sanja Kurečić Filipović, Tove Samuelsson Hagey, Frederika Dijkstra, Vitor Borges, Violeta Ramos Marín, Sabrina Bacci, Marlena Kaczmarek, Esther Kissling |
| 316 |
[GO] |
2024―Jun―03 |
Effectiveness against severe COVID-19 of a seasonal booster dose of bivalent (original/Omicron BA.4-5) mRNA vaccines in persons aged ≥60 years: Estimates over calendar time and by time since administration during prevalent circulation of different Omicron subvariants, Italy, 2022-2023 |
Massimo Fabiani, Alberto Mateo-Urdiales, Chiara Sacco, Emmanouil Alexandros Fotakis, Serena Battilomo, Daniele Petrone, Martina Del Manso, Antonino Bella, Flavia Riccardo, Paola Stefanelli, Anna Teresa Palamara, Patrizio Pezzotti |
| 317 |
[GO] |
2024―Jun―01 |
High vaccine effectiveness against severe COVID-19 outcomes and population preventable fraction during the Omicron era in Luxembourg: A nationwide retrospective risk factor analysis |
Dritan Bejko, Corinna Ernst, Anne Vergison, Saverio Stranges, Maurice P. Zeegers, Joël Mossong |
| 318 |
[GO] |
2024―Mai―31 |
A cost-effectiveness analysis of South Africa’s COVID-19 vaccination programme |
Ijeoma Edoka, Sheetal Silal, Lise Jamieson, Gesine Meyer-Rath |
| 319 |
[GO] |
2024―Mai―27 |
Cultural and social attitudes towards COVID-19 vaccination and factors associated with vaccine acceptance in adults across the globe: A systematic review |
Tasniah Begum, Nikolaos Efstathiou, Cara Bailey, Ping Guo |
| 320 |
[GO] |
2024―Mai―27 |
Humoral response superiority of the monovalent XBB.1.5 over the bivalent BA.1 and BA.5 mRNA COVID-19 vaccines |
Yaniv Lustig, Noam Barda, Yael Weiss-Ottolenghi, Victoria Indenbaum, Ili Margalit, Keren Asraf, Ram Doolman, Spyros Chalkias, Rituparna Das, Gamal Elfatarany, Dror Harats, Yitshak Kreiss, Gili Regev-Yochay |
| 321 |
[GO] |
2024―Mai―25 |
Deployment of COVID-19 vaccine in the WHO Eastern Mediterranean Region 2021-23: How do we switch to a life course approach? |
JeongEun Bak, Quamrul Hasan, John Kissa, Mohammed Osama Mere, Dalia Samhouri, Amaya Gillespie, Tara Rose Aynsley, Abdinasir Abubakar, Rana Hajjeh, Yvan J. Hutin |
| 322 |
[GO] |
2024―Mai―25 |
Bordetella pertussis infection following relaxation of COVID-19 non-pharmaceutical interventions in 2021-2023 in Vancouver metropolitan area, British Columbia, Canada |
Frederic Reicherz, Sirui Li, Allison A. Watts, David M. Goldfarb, Pascal M. Lavoie, Bahaa Abu-Raya |
| 323 |
[GO] |
2024―Mai―25 |
Impact of the COVID-19 pandemic on routine childhood vaccination in 9 U.S. jurisdictions |
Ashley Treharne, Bhavini Patel Murthy, Elizabeth R. Zell, Nkenge Jones-Jack, Ona Loper, Arundhati Bakshi, Abhinav Nalla, Sydney Kuramoto, Iris Cheng, Allison Dykstra, Steve G. Robison, Emily H. Youngers, Stephanie Schauer, Lynn Gibbs Scharf, LaTreace Harris |
| 324 |
[GO] |
2024―Mai―24 |
Changes in vaccination uptake against pneumococcal disease, influenza, and coronavirus disease 2019 (COVID-19) before and after a Head and Neck cancer diagnosis |
Mads Frederik Eiberg, Omid Rezahosseini, Katrine Brandt Bukan, Bodil Charlotte Arp, Vivian Bui Le, Faiza Ahmad, Michael Howitz, Maria Lendorf, Jeppe Friborg, Birgitte Lindegaard, Zitta Barrella Harboe |
| 325 |
[GO] |
2024―Mai―23 |
Hybrid immunity after BNT162b2 Covid-19 vaccine administration in children aged 5 to 11 years |
Anne Tsampalieros, Roger Zemek, Nick Barrowman, Marc-André Langlois, Corey Arnold, Candice McGahern, Amy C. Plint, Anne Pham-Huy, Maala Bhatt |
| 326 |
[GO] |
2024―Mai―20 |
COVID-19 vaccine acceptance and uptake among caregivers of children aged 5-11 years in Ontario, Canada: A cross-sectional survey |
Elahe Karimi-Shahrbabak, Costanza Di Chiara, Daniel S. Farrar, Sarah M. Abu Fadaleh, Joelle Peresin, Brooke Low, David Avelar-Rodriguez, Julia Orkin, Michelle Science, Pierre-Philippe Piché-Renaud, Shaun K. Morris |
| 327 |
[GO] |
2024―Mai―19 |
Efficacy of a stable broadly protective subunit vaccine platform against SARS-CoV-2 variants of concern |
Ravendra Garg, Qiang Liu, Jill Van Kessel, Akarin Asavajaru, Eva-Maria Uhlemann, Morgane Joessel, Glenn Hamonic, Zahed Khatooni, Andrea Kroeker, Jocelyne Lew, Erin Scruten, Paul Pennington, William Deck, Tracy Prysliak, Michaela Nickol, Falko Apel, Thomas Courant, Alyson A. Kelvin, Andrew Van Kessel, Nicolas Collin, Volker Gerdts, Wolfgang Köster, Darryl Falzarano, Trina Racine, Arinjay Banerjee |
| 328 |
[GO] |
2024―Mai―17 |
Interchangeability of different COVID-19 vaccine platforms as booster doses: A phase 3 study mimicking real-world practice |
Sue Ann Costa Clemens, Lily Weckx, Eveline P. Milan, Igor Smolenov, Ralf Clemens |
| 329 |
[GO] |
2024―Mai―17 |
Effectiveness of mRNA booster doses in preventing infections and hospitalizations due to SARS-CoV-2 and its dominant variant over time in Valencian healthcare workers, Spain |
Natali Jiménez-Sepúlveda, Paula Gras-Valentí, Pablo Chico-Sánchez, José Miguel Castro-García, Elena Ronda-Pérez, Hermelinda Vanaclocha, Salvador Peiró, Javier S. Burgos, David Navarro, José Sánchez-Payá |
| 330 |
[GO] |
2024―Mai―15 |
Vaccine effectiveness in reducing COVID-19-related hospitalization after a risk-age-based mass vaccination program in a Chilean municipality: A comparison of observational study designs |
Cinthya Urquidi, Alejandro Sepúlveda-Peñaloza, María T. Valenzuela, Alexander Ponce, Verónica Menares, Claudia P. Cortes, Rosana Benítez, Emilio Santelices, Renato Anfossi, Andrea Moller, María E. Santolaya |
| 331 |
[GO] |
2024―Mai―13 |
Heterologous Ad26.COV2.S booster after primary BBIBP-CorV vaccination against SARS-CoV-2 infection: 1-year follow-up of a phase 1/2 open-label trial |
Sant Muangnoicharoen, Rakpong Wiangcharoen, Saranath Lawpoolsri, Sira Nanthapisal, Anan Jongkaewwattana, Chatnapa Duangdee, Supitcha Kamolratanakul, Viravarn Luvira, Narumon Thanthamnu, Narisara Chantratita, Arunee Thitithanyanont, T. Anh Wartel, Jean-Louis Excler, Martin F. Ryser, Chloe Leong, Tippi K. Mak, Punnee Pitisuttithum |
| 332 |
[GO] |
2024―Mai―10 |
A SARS-CoV-2 recombinant spike protein vaccine (S-268019-b) for COVID-19 prevention during the Omicron-dominant period: A phase 3, randomised, placebo-controlled clinical trial |
Vu Dinh Thiem, Pham Thi Van Anh, Chu Van Men, Do Thai Hung, Andrew J. Pollard, Akari Kamitani, Yukio Tada, Hidenori Fukuyama, Yuka Iwasaki, Mari Ariyasu, Takuhiro Sonoyama |
| 333 |
[GO] |
2024―Mai―09 |
Effectiveness of COVID-19 booster vaccination, morbidity and absenteeism among healthcare personnel during the 2022-2023 season dominated by Omicron BA.5 and BA.2 subvariants |
Helena C. Maltezou, Maria N. Gamaletsou, Theodoros V. Giannouchos, Dimitra-Maria Koukou, Flora Sourri, Amalia Karapanou, Nikolaos Lemonakis, Kyriakos Souliotis, Athanasia Lourida, Periklis Panagopoulos, Dimitrios Hatzigeorgiou, Nikolaos V. Sipsas |
| 334 |
[GO] |
2024―Mai―09 |
Persistent differences in the immunogenicity of the two COVID-19 primary vaccines series, modulated by booster mRNA vaccination and breakthrough infection |
Keon Young Lee, Kyoung-Ho Song, Kyoung Hwa Lee, Jin Yang Baek, Eu Suk Kim, Young Goo Song, Yong Chan Kim, Yoon Soo Park, Jin Young Ahn, Jun Yong Choi, Won Suk Choi, Seongman Bae, Shin-Woo Kim, Ki Tae Kwon, Eun-Suk Kang, Kyong Ran Peck, Sung-Han Kim, Hye Won Jeong, Jae-Hoon Ko |
| 335 |
[GO] |
2024―Mai―07 |
Strategies to strengthen COVID-19 vaccine uptake and improve vaccine equity in U.S. Territories and Freely Associated States during the first six months of vaccine rollout |
Ashley Tippins, Jeniffer Concepción Acevedo, Francisco S. Palomeque, Kelsey C. Coy, Phillippa Chadd, Daniel Stowell, Oluwatomiloba Ademokun, Carter Apaisam, Merlyn Basilius, Richard Brostrom, Ivan O. Garcia Collazo, Justa Encarnacion, Iris Cardona Gerena, Thane Hancock, Tai Hunte-Ceasar, Peter Judicpa, Michele Leon-Guerrero, Milton Martinez, Yolanda Masunu, Heather Pangelinan, Emman Parian, Daisy Pedro |
| 336 |
[GO] |
2024―Mai―06 |
mRNA COVID-19 vaccine safety among older adults from the Canadian National Vaccine Safety Network |
Phyumar Soe, Hubert Wong, Monika Naus, Matthew P. Muller, Otto G. Vanderkooi, James D. Kellner, Karina A. Top, Manish Sadarangani, Jennifer E. Isenor, Kimberly Marty, Gaston De Serres, Louis Valiquette, Allison McGeer, Julie A. Bettinger |
| 337 |
[GO] |
2024―Mai―06 |
Trust in governments, public health institutions, and other information sources as determinants of COVID-19 vaccine uptake behavior in Japan |
Alton Cao, Mami Ueta, Manae Uchibori, Michio Murakami, Hiroyuki Kunishima, Rauniyar Santosh Kumar, Prapichaya Prommas, Hana Tomoi, Stuart Gilmour, Haruka Sakamoto, Masahiro Hashizume, Wataru Naito, Tetsuo Yasutaka, Keiko Maruyama-Sakurai, Hiroaki Miyata, Shuhei Nomura |
| 338 |
[GO] |
2024―Mai―06 |
Low neutralization of SARS-CoV-2 Omicron BA.5.2.48 and XBB.1 sub-variants in response to breakthrough infection by booster |
Jianhua Li, Liming Gong, Jiaxuan Li, Zhenyu Gong, Xiaoxiao Wang, Hao Yan, Yanjun Zhang, Haiyan Mao, Keda Chen |
| 339 |
[GO] |
2024―Mai―06 |
Intranasal immunization with the bivalent SARS-CoV-2 vaccine effectively protects mice from nasal infection and completely inhibits disease development |
Tuksin Jearanaiwitayakul, Panya Sunintaboon, Anuwat Kittiayuwat, Jitra Limthongkul, Jidapar Wathanaphol, Yada Janhirun, Hatairat Lerdsamran, Witthawat Wiriyarat, Sukathida Ubol |
| 340 |
[GO] |
2024―Mai―03 |
The correlation between conspiracy mentality and vaccine intentions is moderated by social events: Evidence from longitudinal data during COVID-19 pandemic in the UK |
Indro Adinugroho, Tom Stafford, Richard P. Bentall |
| 341 |
[GO] |
2024―Mai―03 |
The impact of COVID-19 vaccination campaign on pediatric vaccine uptake based on parents’ attitudes towards mandatory and recommended vaccination in Southern Italy |
Francesco Baglivo, Luigi De Angelis, Mariano Magrì, Ingrid De Nicola, Erica De Vita, Pietro Luigi Lopalco, Caterina Rizzo, Alberto Fedele |
| 342 |
[GO] |
2024―Mai―03 |
Immunogenicity and safety of a recombinant Omicron BA.4/5-Delta COVID-19 vaccine ZF2202-A in Chinese adults |
Hua Hu, Fangli Ma, Lihui Gong, Yaqin Wang, Maodi Xu, Hua Sun, Qianqian Hu, Ping Wang, Lu Han, Haitang Xie |
| 343 |
[GO] |
2024―Apr―30 |
Effects of parental childhood cultural health environment on children’s influenza and COVID-19 vaccination status |
Sasha A. Fleary, Zachary Shahn, Chloe A. Teasdale |
| 344 |
[GO] |
2024―Apr―29 |
Vaccine effectiveness against COVID-19 related hospital admission in the Netherlands by medical risk condition: A test-negative case-control study |
F.A. Niessen, P.C.J.L. Bruijning-Verhagen, M.J.M. Bonten, V. Peters, H.S.M. Ammerlaan, C.E. Delsing, N.G. Dijkstra, P. Bresser, H. Kramer, D. Rusch, E.A. bij de Vaate, P. Veen, A. Dofferhoff, M. Bruns, L.C. Terpstra, W. Thijs, R. Hassing, D.H. Huijbens, E. Jong, M.J. Knol |
| 345 |
[GO] |
2024―Apr―27 |
Collective good and individual choice: Perceptions on COVID-19 vaccine mandate among COVID-19 vaccinated individuals |
Kaivalya Gudooru, Kimberly Nguyen, Kathy Le, Vyas Sarabu, Meredith Hosek, Anna Phan, Michelle Garza, Bertha E. Flores, Armida Flores, Amelie Ramirez, Luz M. Garcini |
| 346 |
[GO] |
2024―Apr―26 |
COVID-19 booster vaccine uptake and reduced risks for long-COVID: A cross-sectional study of a U.S. adult population |
Zhigang Xie, Sericea Stallings-Smith, Shraddha Patel, Stuart Case, Young-Rock Hong |
| 347 |
[GO] |
2024―Apr―25 |
Authors’ reply: Excess mortality in Cyprus during the COVID-19 vaccination campaign |
Theodore Lytras, Maria Athanasiadou, Anna Demetriou, Despina Stylianou, Alexandros Heraclides, Olga Kalakouta |
| 348 |
[GO] |
2024―Apr―25 |
A programmatic update on COVID-19 vaccination in rural communities in the United States |
Alexandra M. Piasecki, Diane M. Hall, Julie Zajac, Scott A. Miller, Jane R. Nilson |
| 349 |
[GO] |
2024―Apr―24 |
The role of religion and COVID-19 vaccine uptake in England |
Martin Ejnar Hansen, Steven David Pickering |
| 350 |
[GO] |
2024―Apr―23 |
Non-specific effects of the inactivated influenza vaccine. A test-negative study: The inactivated influenza vaccine and SARS-CoV-2 infections |
Anne Jasmijn Sellies, Mirjam J. Knol, Hester E. de Melker, Patricia C.J.L. Bruijning-Verhagen, Annemarijn R. de Boer |
| 351 |
[GO] |
2024―Apr―22 |
Who is getting COVID-19 boosters? A latent class analysis in a nationally representative sample of Mexican adults 60 years and over |
Martha Carnalla, Dalia Stern, M. Arantxa Colchero, Karla Rangel-Moreno, Ana Basto-Abreu, Celia M. Alpuche-Aranda, Sergio Bautista-Arredondo, Tonatiuh Barrientos-Gutiérrez |
| 352 |
[GO] |
2024―Apr―21 |
BBIBP-CorV vaccine effectiveness against COVID-19 in patients aged 60 years and older during the Delta-dominant period in the Federation of Bosnia and Herzegovina, a test-negative case-control study |
Sanjin Musa, Lore Merdrignac, Sinisa Skocibusic, Rozalija Nedic, Seila Cilovic-Lagarija, Esther Kissling |
| 353 |
[GO] |
2024―Apr―19 |
Are the 7C psychological antecedents associated with COVID-19 vaccine behaviours beyond intentions? A cross-sectional study on at-least-one-dose and up-to-date vaccination status, and uptake speed among adults in France |
Gaëlle Lièvre, Jonathan Sicsic, Simon Galmiche, Tiffany Charmet, Arnaud Fontanet, Judith E. Mueller |
| 354 |
[GO] |
2024―Apr―18 |
Predictors of willingness to receive updated 2023-2024 COVID-19 booster vaccines among a convenience sample in Minnesota |
I.J. Ricke, A.B. Spaulding, N.N. Rajtar, E.M. Benton, I.G. Anderson, L. Lundberg, A. Mussiel, R.H.N. Nguyen |
| 355 |
[GO] |
2024―Apr―18 |
COVID-19 vaccine uptake among children and adolescents in Norway: A comprehensive registry-based cohort study of over 800,000 individuals |
Saima Orangzeb, Anteneh Desalegn, Nhung T.H. Trinh, Jing Zhao, Hedvig Nordeng, Angela Lupattelli |
| 356 |
[GO] |
2024―Apr―17 |
Exploring COVID-19 vaccine uptake and hesitancy among vulnerable populations in inner city Vancouver, Canada: Insights into characteristics and clinical outcomes |
Saina Beitari, Shana Yi, Shawn Sharma, Rossitta Yung, Brian Conway |
| 357 |
[GO] |
2024―Apr―17 |
Safe plant Hsp90 adjuvants elicit an effective immune response against SARS-CoV2-derived RBD antigen |
Victor A. Ramos-Duarte, Alejandro Orlowski, Carolina Jaquenod de Giusti, Mariana G. Corigliano, Ariel Legarralde, Luisa F. Mendoza-Morales, Agustín Atela, Manuel A. Sánchez, Valeria A. Sander, Sergio O. Angel, Marina Clemente |
| 358 |
[GO] |
2024―Apr―16 |
COVID-19 vaccination communication: Effects of vaccine conspiracy beliefs and message framing among black and white participants |
Namyeon Lee, Yoorim Hong, Ciera E. Kirkpatrick, Sisi Hu, Sungkyoung Lee, Amanda Hinnant |
| 359 |
[GO] |
2024―Apr―16 |
Overview of U.S. COVID-19 vaccine safety surveillance systems |
Julianne Gee, Tom T. Shimabukuro, John R. Su, David Shay, Margaret Ryan, Sridhar V. Basavaraju, Karen R. Broder, Matthew Clark, C. Buddy Creech, Francesca Cunningham, Kristin Goddard, Harrison Guy, Kathryn M. Edwards, Richard Forshee, Tanya Hamburger, Anne M. Hause, Nicola P. Klein, Ian Kracalik, Chris Lamer, David A. Loran, Michael M. McNeil, Jay Montgomery, Pedro Moro, Tanya R. Myers, Christine Olson, Matthew E. Oster, Andrea J. Sharma, Ryan Schupbach, Eric Weintraub, Brett Whitehead, Steven Anderson |
| 360 |
[GO] |
2024―Apr―16 |
Analysis of causal relations between vaccine hesitancy for COVID-19 vaccines and ideological orientations in Brazil |
Eanes Torres Pereira, Sylvia Iasulaitis, Bruno Cardoso Greco |
| 361 |
[GO] |
2024―Apr―16 |
Avoidable COVID-19-related deaths and hospitalizations in Brazil, 2020-2023 |
Emil Kupek |
| 362 |
[GO] |
2024―Apr―16 |
Erratum to “Immunogenicity of an adenovirus-vectored bivalent vaccine against wild type SARS-CoV-2 and Omicron variants in a murine model” [Vaccine 42(6) (2024) 1292-1299] |
Yuanyuan Ji, Xiuwen Sui, Wei Miao, Chang Wang, Qing Wang, Zhuojun Duan, Bochao Wei, Dan Wu, Menghan Wei, Juan Shao, Xiuyu Zheng, Tao Zhu |
| 363 |
[GO] |
2024―Apr―15 |
Patient concerns and physician strategies for addressing COVID-19 vaccine hesitancy |
Joy Melnikow, Andrew Padovani, Jingwen Zhang, Marykate Miller, Melissa Gosdin, Sabrina Loureiro, Brock Daniels |
| 364 |
[GO] |
2024―Apr―15 |
Assessment of the impact of the vaccine pass policy on COVID-19 vaccine hesitancy and uptake among Chinese adults in Hong Kong |
Irene O.L. Wong, Cherry Wong, Nelly Mak, Alan Dai, Jingyi Xiao, Peng Wu, Michael Y. Ni, Qiuyan Liao, Benjamin J. Cowling |
| 365 |
[GO] |
2024―Apr―14 |
Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradient |
Layan Sukik, Hiam Chemaitelly, Houssein H. Ayoub, Peter Coyle, Patrick Tang, Hadi M. Yassine, Asmaa A. Al Thani, Mohammad R. Hasan, Zaina Al-Kanaani, Einas Al-Kuwari, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F. Abdul-Rahim, Gheyath K. Nasrallah, Mohamed Ghaith Al-Kuwari, Adeel A. Butt, Hamad Eid Al-Romaihi, Mohamed H. Al-Thani, Abdullatif Al-Khal, Roberto Bertollini, Manar E. Abdel-Rahman, Laith J. Abu-Raddad |
| 366 |
[GO] |
2024―Apr―11 |
Despite mandated primary series, health care personnel still hesitant about COVID-19 vaccine and immunizing children |
Mundeep K. Kainth, Grace N. Sembajwe, Heejoon Ahn, Min Qian, Maxine Carrington, Donna Armellino, Sophia Jan |
| 367 |
[GO] |
2024―Apr―11 |
Characterization of Brighton Collaboration criteria for myocarditis and pericarditis following COVID-19 vaccine in Korean adolescents |
Jue Seong Lee, HyoSug Choi, Seung Hwan Shin, Myung-Jae Hwang, Sara Na, Jong Hee Kim, Sangshin Park, Yoonsun Yoon, Hyun Mi Kang, Bin Ahn, Kyoungsan Seo, Young June Choe |
| 368 |
[GO] |
2024―Apr―11 |
COVID-19 vaccine uptake among non-US-born populations in the United States, 2020-2022 |
Margaret B. Nolan, Ella Chrenka, Patricia Walker, Abigail Steiner, Kristine Knuti Rodrigues, Jeremy J. Michel, Katherine Yun, Colleen Payton, Janine Young, Blain Mamo, Mateo Frumholtz, Malini DeSilva |
| 369 |
[GO] |
2024―Apr―10 |
Addressing vaccine hesitancy: Learning from the successes and failures of the COVID-19 pandemic |
Peter J. Pitts, Gregory A. Poland |
| 370 |
[GO] |
2024―Apr―09 |
A comparative analysis of knowledge, attitude, and practice (KAP) towards influenza and influenza vaccination among healthcare workers in Kyrgyzstan prior to and during the COVID-19 pandemic |
Rakhat Akmatova, Malembe S. Ebama, Sanjar Temirbekov, Venera Alymkulova, Dinara Otorbaeva |
| 371 |
[GO] |
2024―Apr―09 |
A survey of state and local practices encouraging pediatric COVID-19 vaccination of children ages 6 months through 11 years |
Alaya Koneru, Katelyn Wells, Catherine Amanda Carnes, Kathryn Drumhiller, Kevin Chatham-Stephens, Mackenzie Melton, Hilary Oliphant, Stacy Hall, Cori Dennison, Michelle Fiscus, Tara Vogt |
| 372 |
[GO] |
2024―Apr―09 |
Motivation for COVID-19 Vaccination: Applying a Self-Determination Theory Perspective to a Global Health Crisis |
Helen Thai, Élodie C. Audet, Richard Koestner |
| 373 |
[GO] |
2024―Apr―05 |
A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases |
Anna Schultze, Ivonne Martin, Davide Messina, Sophie Bots, Svetlana Belitser, Juan José Carreras-Martínez, Elisa Correcher-Martinez, Arantxa Urchueguía-Fornes, Mar Martín-Pérez, Patricia García-Poza, Felipe Villalobos, Meritxell Pallejà-Millán, Carlo Alberto Bissacco, Elena Segundo, Patrick Souverein, Fabio Riefolo, Carlos E. Durán, Rosa Gini, Miriam Sturkenboom, Olaf Klungel, Ian Douglas |
| 374 |
[GO] |
2024―Apr―04 |
Detection of SARS-CoV-2-specific mucosal antibodies in saliva following concomitant COVID-19 and influenza vaccination in the ComFluCOV trial |
Holly E. Baum, Russell Thirard, Alice Halliday, Sarah Baos, Amy C. Thomas, Rosie A. Harris, Elizabeth Oliver, Lucy Culliford, Benjamin Hitchings, Rachel Todd, Kapil Gupta, Anu Goenka, Adam Finn, Chris A. Rogers, Rajeka Lazarus |
| 375 |
[GO] |
2024―Apr―04 |
Immunogenicity and safety of SARS-CoV-2 recombinant protein subunit vaccine (IndoVac) adjuvanted with alum and CpG 1018 in Indonesian adults: A phase 3, randomized, active-controlled, multicenter trial |
Asrawati Nurdin, Yetty Movieta Nency, Martira Maddeppungeng, Rini Sekartini, Rini Mulia Sari, Fikrianti Surachman, Finny Fitry Yani, Fenty Anggrainy, Al Hafiz, Rizanda Machmud, Putri Awaliyah Deza, Vovinda Rujiana, Martga Bella Rahimi, Nur Farhanah, Setyo Gundi Pramudo, Rebriarina Hapsari, Dimas Tri Anantyo, Endang Mahati, Nani Maharani, Sidrah Darma, Andi Husni Esa Darussalam, Sharifah Shakinah, Muhammad Nasrum Massi |
| 376 |
[GO] |
2024―Mrz―30 |
Effectiveness of COVID-19 vaccination against school absenteeism in children and adolescents hospitalized with COVID-19 |
Helena C. Maltezou, Stavroula Kontogianni, Elisavet Michailidou, Eleni Vergadi, Theodoros V. Giannouchos, Evangelia Steletou, Nikolaos V. Sipsas, Emmanouil Galanakis, George A. Syrogiannopoulos, Emmanuel Roilides |
| 377 |
[GO] |
2024―Mrz―30 |
Self-reported determinants of COVID-19 vaccine acceptance among persons with and without autoimmune disease |
Jenny D. Gong, Emma Barnboym, Megan O'Mara, Natalie Gurevich, Maya Mattar, Donald D. Anthony, Adam T. Perzynski, Nora G. Singer |
| 378 |
[GO] |
2024―Mrz―28 |
Testing the impact of differing behavioural science informed text message content in COVID-19 vaccination invitations on vaccine uptake: A randomised clinical trial |
Sarah W. Huf, Kate Grailey, Roberto Fernandez Crespo, Lena Woldmann, Matthew Chisambi, Helen Skirrow, Kirstie Black, Bahram Hassanpourfard, Joe Nguyen, Bob Klaber, Ara Darzi |
| 379 |
[GO] |
2024―Mrz―25 |
Leveraging seasonal influenza health worker vaccination programmes for COVID-19 vaccine Introduction: A global qualitative analysis |
Anna-Maria Volkmann, Shoshanna Goldin, Britney McMurren, Claire Gapare, Beth Anne Pratt, Laura Frost, Shalini Desai |
| 380 |
[GO] |
2024―Mrz―23 |
Global VAX: A U.S. contribution to global COVID-19 vaccination efforts, 2021-2023 |
Benjamin A. Dahl, Beth Tritter, Deena Butryn, Melissa Dahlke, Sean Browning, Richard Gelting, Monica Fleming, Nancy Ortiz, Jacqueline Labrador, Ryan Novak, David Fitter, Elizabeth Bell, Megan McGuire, Robert Rosenbaum, Robert Pulwer, Jolene Wun, Anna McCaffrey, Maisoon Chowdhury, Nida Parks, Marc Cunningham, Anthony Mounts, Dora Curry, Dominique Richardson, Gavin Grant |
| 381 |
[GO] |
2024―Mrz―23 |
COVID-19 vaccine reactogenicity among participants enrolled in the GENCOV study |
Gregory Morgan, Selina Casalino, Sunakshi Chowdhary, Erika Frangione, Chun Yiu Jordan Fung, Elisa Lapadula, Saranya Arnoldo, Erin Bearss, Alexandra Binnie, Bjug Borgundvaag, Laurent Briollais, Marc Dagher, Luke Devine, Steven M Friedman, Zeeshan Khan, Chloe Mighton, Konika Nirmalanathan, David Richardson, Seth Stern, Ahmed Taher, Dawit Wolday, Jordan Lerner-Ellis, Jennifer Taher |
| 382 |
[GO] |
2024―Mrz―22 |
Exploring associations between the Big Five personality traits and cognitive ability with COVID-19 vaccination hesitancy and uptake among mothers and offspring in a UK prospective cohort study |
Jennifer Condie, Kate Northstone, Daniel Major-Smith, Isaac Halstead |
| 383 |
[GO] |
2024―Mrz―22 |
High COVID-19 vaccine uptake following initial hesitancy among people in Australia who inject drugs |
Olivia Price, Paul Dietze, Lisa Maher, Gregory J. Dore, Rachel Sutherland, Caroline Salom, Raimondo Bruno, Sione Crawford, Louisa Degenhardt, Sarah Larney, Amy Peacock |
| 384 |
[GO] |
2024―Mrz―20 |
Differences in social media use by COVID-19 vaccination status |
Kenneth W. Moffett, Kate Seserman, Katherine A. Margolis, Elissa C. Kranzler, Michael C. Marshall, Heather Dahlen, Jae-Eun C. Kim, Benjamin Denison, Blake Hoffman, Daphney Dupervil, Kathleen Yu, Leah Hoffman |
| 385 |
[GO] |
2024―Mrz―20 |
Mucosal immunization with dual influenza/COVID-19 single-replication virus vector protects hamsters from SARS-CoV-2 challenge |
Lindsay Hill-Batorski, Richard Bowen, Helle Bielefeldt-Ohmann, Michael J. Moser, Sarah M. Matejka, David Marshall, Yoshihiro Kawaoka, Gabriele Neumann, Pamuk Bilsel |
| 386 |
[GO] |
2024―Mrz―20 |
Humoral and cellular immunity to SARS-CoV-2 following vaccination with non-mRNA vaccines in adolescent/young adults with cancer: A prospective cohort study |
Archana Sasi, Jyotsna Dandotiya, Jyotsana Kaushal, Shuvadeep Ganguly, Akshay Binayke, K.M. Ambika, Akshi Shree, Farhana Jahan, Priyanka Sharma, Tejas Menon Suri, Amit Awasthi, Sameer Bakhshi |
| 387 |
[GO] |
2024―Mrz―19 |
Transformative vaccination: A pentavalent shield against COVID-19 and influenza with betulin-based adjuvant for enhanced immunity |
Igor Krasilnikov, Artur Isaev, Milana Djonovic, Alexander Ivanov, Ekaterina Romanovskaya-Romanko, Marina Stukova, Vitaly Zverev |
| 388 |
[GO] |
2024―Mrz―17 |
COVID-19 vaccination in cancer patients: Immune responses one year after the third dose |
Roberta Campagna, Federica Dominelli, Maria Antonella Zingaropoli, Fabio Ciurluini, Giorgia Grilli, Alessandra Amoroso, Angelo De Domenico, Donatella Amatore, Maria Stella Lia, Enrico Cortesi, Vincenzo Picone, Claudio Maria Mastroianni, Maria Rosa Ciardi, Riccardo De Santis, Florigio Lista, Guido Antonelli, Ombretta Turriziani |
| 389 |
[GO] |
2024―Mrz―16 |
Benefit-risk assessment for the Novavax COVID-19 vaccine (NVX-CoV2373) |
Jonathan Fix, T. Christopher Mast, Katherine Smith, Nicole Baker |
| 390 |
[GO] |
2024―Mrz―14 |
The effect of SARS-COV-2 variant on non-respiratory features and mortality among vaccinated and non-fully vaccinated patients |
Shannon A. Cotton, Ajan Subramanian, Thomas D. Hughes, Yong Huang, Carmen Josefa Sierra, Alex K. Pearce, Atul Malhotra, Amir M. Rahmani, Charles A. Downs, Melissa D. Pinto |
| 391 |
[GO] |
2024―Mrz―14 |
Identifying trusted local sources and predicting behavior change pathways according to COVID-19 vaccination status: Results of a 2022 statewide survey of Alaskan adults |
Drew B. Cameron, Laura Grage, Rebecca Van Wyck, Alexandra Edwards, Joy Chavez Mapaye, Ann Cheng, Gabriel Garcia |
| 392 |
[GO] |
2024―Mrz―13 |
Predicting intention to vaccinate against COVID-19 in older Syrian refugees in Lebanon: Findings from a multi-wave study |
Noura El Salibi, Sawsan Abdulrahim, Maria El Haddad, Berthe Abi Zeid, Marwan F. Alawieh, Zeinab Ramadan, Hala Ghattas, Stephen J. McCall |
| 393 |
[GO] |
2024―Mrz―13 |
The effect of a financial incentive on COVID-19 vaccination uptake, and predictors of uptake, in people experiencing homelessness: A randomized controlled trial |
Laura K. McCosker, Robert S. Ware, Holly Seale, Dona Hooshmand, Ryan O'Leary, Martin J. Downes |
| 394 |
[GO] |
2024―Mrz―12 |
Sociodemographic and Occupational Characteristics Associated with Early and Continued COVID-19 Vaccine Uptake Among Healthcare Personnel: Monroe County, NY |
Savanah Russ, Christopher Myers, Erin Licherdell, Acacia Bowden, Ellen Chinchilli, Runda Dahhan, Edwin Van Wijngaarden, Ian D. Plumb, Ghinwa Dumyati |
| 395 |
[GO] |
2024―Mrz―11 |
Safety monitoring of bivalent mRNA COVID-19 vaccine among pregnant persons in the vaccine adverse event reporting System - United States, September 1, 2022 - March 31, 2023 |
Pedro L. Moro, Grace Carlock, Nimita Fifadara, Tei Habenicht, Bicheng Zhang, Penelope Strid, Paige Marquez |
| 396 |
[GO] |
2024―Mrz―11 |
Partisan divide and Racial/Ethnic disparities in COVID-19 vaccine hesitancy among Parents/Guardians and vaccine uptake among children in the U.S. |
Alice Shijia Yan, Neil Jay Sehgal |
| 397 |
[GO] |
2024―Mrz―11 |
Pandemic antecedents - Exploring predictivity and relationships between COVID-19 vaccine uptake and influenza, shingles, and HPV vaccination |
Monique Luisi, Mugur V. Geana, Jun Pei |
| 398 |
[GO] |
2024―Mrz―08 |
Safety and immunogenicity of heterologous boosting with a bivalent SARS-CoV-2 mRNA vaccine (XBB.1.5/BQ.1) in Chinese participants aged 18 years or more: A randomised, double-blinded, active-controlled phase 1 trial |
Yu-Wen Su, Yuan-Zheng Qiu, Yuan-Hui Wang, Yan Xu, Chao-Chao Huang, Qing Zhang, Chang Su, Jun-Heng Ma, Wen Liu, Yan Liu, Mao-Sheng Zhao, Han-Yu Yang, Chun-Lei Li, Xiang Lu |
| 399 |
[GO] |
2024―Mrz―07 |
Neutralization of SARS-CoV-2 Omicron subvariant BA.2.87.1 |
Ninaad Lasrado, Annika Rössler, Marjorie Rowe, Ai-ris Y. Collier, Dan H. Barouch |
| 400 |
[GO] |
2024―Mrz―07 |
Effectiveness of inactivated COVID-19 vaccine CoronaVac in children aged less than 3 years old during Omicron wave in Hong Kong |
W.H.S. Wong, D.L. Leung, K.M. Yip, H.K. So, J.S. Rosa Duque, Y.L. Lau |
| 401 |
[GO] |
2024―Mrz―07 |
Social and demographic factors associated with receipt of a COVID-19 vaccine initial booster dose and with interval between primary series completion and initial booster dose uptake among persons aged ≥ 12 years, United States, August 2021-October 2022 |
Lu Meng, LaTreace Harris, Lauren Shaw, Hoody Lymon, Hannah Reses, Jeneita Bell, Peng-Jun Lu, Lynn Gibbs-Scharf, Terence Chorba |
| 402 |
[GO] |
2024―Mrz―06 |
“COVID is a huge jigsaw puzzle that I am trying to make sense of myself”: Exploring the perceptions towards the COVID-19 vaccine communication strategy in Australia amongst unvaccinated Australian adults |
Joshua Karras, Mia Harrison, Maryke Steffens, Ikram Abdi, Holly Seale |
| 403 |
[GO] |
2024―Mrz―06 |
Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study |
Monika Raethke, Florence van Hunsel, Nicoletta Luxi, Thomas Lieber, Chiara Bellitto, Erik Mulder, Francesco Ciccimarra, Fabio Riefolo, Nicolas H. Thurin, Debabrata Roy, Kathryn Morton, Felipe Villalobos, Francisco Batel Marques, Andreea Farcas, Simona Sonderlichová, Svetlana Belitser, Olaf Klungel, Gianluca Trifirò, Miriam C. Sturkenboom |
| 404 |
[GO] |
2024―Mrz―05 |
Association of COVID-19 vaccination with duration of hospitalization in older adults in Hong Kong |
Dongxuan Chen, Benjamin J. Cowling, Kylie E.C. Ainslie, Yun Lin, Jessica Y. Wong, Eric H.Y. Lau, Peng Wu, Joshua Nealon |
| 405 |
[GO] |
2024―Mrz―02 |
Developing a novel screening tool to address pediatric COVID-19 vaccine hesitancy at point of care |
Sarah G. Yashar-Gershman, Alix T. Rosenberg, Muskaan Sawhney, Maria Fernanda Machicao, Howard R. Moskowitz, Henry H. Bernstein |
| 406 |
[GO] |
2024―Feb―29 |
Projections of the incidence of COVID-19 in Japan and the potential impact of a Fall 2023 COVID-19 vaccine |
Michele Kohli, Michael Maschio, Amy Lee, Ataru Igarashi |
| 407 |
[GO] |
2024―Feb―29 |
An overview of the COVID-19 pediatric vaccine program - The U.S. experience vaccinating children ages 6 months through 17 years |
Kevin Chatham-Stephens, Rosalind J. Carter, Chris Duggar, Kate R. Woodworth, Catherine Amanda Carnes, Achal Bhatt, Christina Ottis, Chris Voegeli, Shannon Stokley, Tara Vogt |
| 408 |
[GO] |
2024―Feb―29 |
Planning for the future of maternal immunization: Building on lessons learned from the COVID-19 pandemic |
Dana Meaney-Delman, Sarah Carroll, Kara Polen, Tara C. Jatlaoui, Sarah Meyer, Sara Oliver, Julianne Gee, Tom Shimabukuro, Hilda Razzaghi, Laura Riley, Romeo R. Galang, Van Tong, Suzanne Gilboa, Sascha Ellington, Amanda Cohn |
| 409 |
[GO] |
2024―Feb―29 |
Impact evaluation of a youth led intervention to increase COVID-19 vaccine uptake in Kwazulu-Natal, South Africa |
Edmore Marinda, Qaqambile Mathentamo, Nancy Coulson, Saahier Parker, Patrick DMC Katoto, Gregory Houston, Mmakotsedi Magampa, Nirvana Pillay, Mercy Ngungu, Charles S. Wiysonge, Heidi van Rooyen |
| 410 |
[GO] |
2024―Feb―28 |
Intensification of integrated immunization services to recover routine vaccination coverage and bring COVID-19 vaccine to the population of Iraq in 2022 |
Firas Jabbar, Kamal A Kadhim, Riyadh A Alhilfi, Abdulaal Chitheer, Alaa Rahi, David B Hipgrave |
| 411 |
[GO] |
2024―Feb―26 |
Socio-demographic determinants of COVID-19 vaccine uptake in Ontario: Exploring differences across the Health Region model |
Ariel Mundo Ortiz, Bouchra Nasri |
| 412 |
[GO] |
2024―Feb―22 |
Mortality risk after COVID-19 vaccination: A self-controlled case series study |
Stanley Xu, Lina S. Sy, Vennis Hong, Paddy Farrington, Sungching C. Glenn, Denison S. Ryan, Abraelle M. Shirley, Bruno J. Lewin, Hung-Fu Tseng, Gabriela Vazquez-Benitez, Jason M. Glanz, Bruce Fireman, David L. McClure, Laura P. Hurley, Onchee Yu, Michael Wernecke, Ning Smith, Eric S. Weintraub, Lei Qian |
| 413 |
[GO] |
2024―Feb―22 |
Audiovestibular adverse events following COVID-19 vaccinations |
Aishwarya N. Shetty, Hannah J. Morgan, Linny K. Phuong, John Mallard, Diana Vlasenko, Christopher Pearce, Nigel W. Crawford, Jim P. Buttery, Hazel J. Clothier |
| 414 |
[GO] |
2024―Feb―16 |
Risk of SARS-CoV-2 breakthrough infection following NVX-CoV2373 and BNT162b2 vaccinations in Korean Adults: A population-based observational study |
Hee Kyoung Kim, Seon Kyeong Park, Seung Ah Choe, Eun Sun Gwak, Benjamin John Cowling, Young-Man Kim, Kil Hun Lee, Sang Won Lee, Geun-Yong Kwon, Eun Jung Jang, Ryu Kyung Kim, Young June Choe, Donghyok Kwon |
| 415 |
[GO] |
2024―Feb―15 |
U.S. COVID-19 vaccine distribution strategies, systems, performance, and lessons learned, December 2020 - May 2023 |
Christopher Duggar, Jeanne M. Santoli, Cameron Noblit, Lori B. Moore, Roua El Kalach, Carolyn B. Bridges |
| 416 |
[GO] |
2024―Feb―15 |
COVID-19 vaccine perspectives and uptake among university students three years into the pandemic |
Barbara J. Kuter, Kate Brien, Susannah Anderson, Sarah Bauerle Bass, Linda Gutierrez, Stella Winters, Breanna Eichenlaub, Carmelita Whitfield, Walter Faig |
| 417 |
[GO] |
2024―Feb―15 |
Vaccine effectiveness against COVID-19: A test negative case-control study in Tunisia, August 2021 |
Emna Mziou, Aicha Hchaichi, Hejer Letaief, Sonia Dhaouadi, Mouna Safer, Khouloud Talmoudi, Rim Mhadhbi, Nawel Elmili, Leila Bouabid, Sondes Derouiche, Souha Bougatef, Hedia Bellali, Nissaf Bouafif ép Ben Alaya |
| 418 |
[GO] |
2024―Feb―15 |
Immunogenicity and safety of a SARS-CoV-2 mRNA vaccine (SYS6006) in healthy Chinese participants: A randomized, observer-blinded, placebo-controlled phase 2 clinical trial |
Fei Jin, Yuanzheng Qiu, Zhiwei Wu, Yuan-Hui Wang, Chengye Cai, Liangcai Fu, Wenbin Jiao, Huixian Wang, Ming Gao, Chang Su, Jun-Heng Ma, Yan Xu, Chao-Chao Huang, Qing Zhang, Shaonan Ni, Maosheng Zhao, Lixian Guo, Li Ji, Hanyu Yang, Yuliang Zhao, Chunlei Li, Xiang Lu, Yu-Wen Su, Qi Li |
| 419 |
[GO] |
2024―Feb―14 |
Did the COVID-19 experience change U.S. parents’ attitudes towards HPV vaccination? Results from a national survey |
Ann C. Klassen, Giyoung Lee, Shawn Chiang, Regan Murray, Mengfei Guan, Wen-Juo Lo, Larry Hill, Amy E. Leader, Jennifer Manganello, Philip M. Massey |
| 420 |
[GO] |
2024―Feb―14 |
The impact of time since SARS-Cov-2 vaccination, age, sex and comorbidities on COVID-19 outcome in hospitalized patients with SARS-CoV-2 infection |
Francesco Donato, Andrea Pilotto, Emanuele Focà, Marco Tresoldi, Alessio Tonoli, Cristiano Perani, Davide Minisci, Massimo Salvetti, Matteo Filippini, Michela Bezzi, Gianluca EM Boari, Stefano Gipponi, Claudia Stegher, Matteo Nardin, Arnaldo Caruso, Marco Metra, Alessandro Padovani, Camillo Rossi, Francesco Castelli |
| 421 |
[GO] |
2024―Feb―13 |
Food insecurity and COVID-19 vaccine hesitancy among adults in the United States (US) |
Elizabeth B. Hearn, Ganiat Kehinde, Usha Sambamoorthi |
| 422 |
[GO] |
2024―Feb―12 |
Acute disseminated encephalomyelitis and transverse myelitis following COVID-19 vaccination - A self-controlled case series analysis |
Hannah J. Morgan, Hazel J. Clothier, Gonzalo Sepulveda Kattan, James H. Boyd, Jim P. Buttery |
| 423 |
[GO] |
2024―Feb―12 |
COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals |
K. Faksova, D. Walsh, Y. Jiang, J. Griffin, A. Phillips, A. Gentile, J.C. Kwong, K. Macartney, M. Naus, Z. Grange, S. Escolano, G. Sepulveda, A. Shetty, A. Pillsbury, C. Sullivan, Z. Naveed, N.Z. Janjua, N. Giglio, J. Perälä, S. Nasreen, H. Gidding, P. Hovi, T. Vo, F. Cui, L. Deng, L. Cullen, M. Artama, E. Weintraub, H. Lu, H.J. Clothier, K. Batty, J. Paynter, H. Petousis-Harris, J. Buttery, S. Black, A. Hviid |
| 424 |
[GO] |
2024―Feb―10 |
SARS-CoV-2 specific antibody response after an mRNA vaccine as the third dose: Homologous versus heterologous boost |
Olivera Lijeskić, Neda Bauman, Miloš Marković, Jelena Srbljanović, Branko Bobić, Đorđe Zlatković, Tijana Štajner |
| 425 |
[GO] |
2024―Feb―09 |
COVID-19 Vaccine Safety Technical (VaST) Work Group: Enhancing vaccine safety monitoring during the pandemic |
Lauri E. Markowitz, Robert H. Hopkins, Karen R. Broder, Grace M. Lee, Kathryn M. Edwards, Matthew F. Daley, Lisa A. Jackson, Jennifer C. Nelson, Laura E. Riley, Veronica V. McNally, Robert Schechter, Patricia N. Whitley-Williams, Francesca Cunningham, Matthew Clark, Margaret Ryan, Karen M. Farizo, Hui-Lee Wong, Jeffery Kelman, Tatiana Beresnev, Valerie Marshall, David K. Shay, Julianne Gee, Jared Woo, Michael M. McNeil, John R. Su, Tom T. Shimabukuro, Melinda Wharton, H. Keipp Talbot |
| 426 |
[GO] |
2024―Feb―09 |
Safe in pregnancy: A global living systematic review and meta-analysis of COVID-19 vaccines in pregnancy |
Pierre Buekens, Mabel Berrueta, Agustín Ciapponi, Ariel Bardach, Agustina Mazzoni, Federico Rodriguez-Cairoli, Sami L. Gottlieb, Beate Kampmann, Edward P.K. Parker, Xu Xiong, Sabra Zaraa, Andy Stergachis |
| 427 |
[GO] |
2024―Feb―09 |
Leveraging the immunoinformatics approach for designing the SARS-CoV-2 omicron-specific antigenic cassette of mRNA vaccine |
Rucha Wadapurkar, Sanjay Singh, Ajay Singh |
| 428 |
[GO] |
2024―Feb―06 |
Public opinion on global COVID-19 vaccine procurement and distribution policies: A nationally representative survey in Aotearoa New Zealand 2022 |
Komathi Kolandai, Barry Milne, Martin von Randow, Chris Bullen, Samantha Marsh, John A. Crump |
| 429 |
[GO] |
2024―Feb―05 |
The age-specific impact of COVID-19 vaccination on medical expenditures and hospitalization duration after breakthrough infection: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) Study |
Megumi Maeda, Fumiko Murata, Haruhisa Fukuda |
| 430 |
[GO] |
2024―Feb―02 |
The impact of Covid-19 vaccination in Aotearoa New Zealand: A modelling study |
Samik Datta, Giorgia Vattiato, Oliver J. Maclaren, Ning Hua, Andrew Sporle, Michael J. Plank |
| 431 |
[GO] |
2024―Feb―02 |
Infection-mediated immune response in SARS-CoV-2 breakthrough infection and implications for next-generation COVID-19 vaccine development |
Sho Miyamoto, Tadaki Suzuki |
| 432 |
[GO] |
2024―Feb―02 |
Longitudinal parental perception of COVID-19 vaccines for children in a multi-site, cohort study |
Patrick Rivers, Cynthia Porter, Lindsay B. LeClair, Zuha Jeddy, Ashley L. Fowlkes, Julie Mayo Lamberte, Katherine Herder, Madeleine Smith, Ramona Rai, Lauren Grant, Kurt T. Hegmann, Krystal Jovel, Molly Vaughan, Clare Mathenge, Andrew L. Phillips, Sana Khan, Amadea Britton, Tamara Pilishvili, Jefferey L. Burgess, Gabriella Newes-Adeyi, Manjusha Gaglani, Alberto Caban-Martinez, Sarang Yoon, Karen Lutrick |
| 433 |
[GO] |
2024―Feb―02 |
Utilizing a university testing program to estimate relative effectiveness of monovalent COVID-19 mRNA booster vaccine versus two-dose primary series against symptomatic SARS-CoV-2 infection |
Julia C. Bennett, Kyle G. Luiten, Jessica O'Hanlon, Peter D. Han, Devon McDonald, Tessa Wright, Caitlin R. Wolf, Natalie K. Lo, Zack Acker, Lani Regelbrugge, Kathryn M. McCaffrey, Brian Pfau, Jeremey Stone, Kristen Schwabe-Fry, Christina M. Lockwood, Brandon L. Guthrie, Geoffrey S. Gottlieb, Janet A. Englund, Timothy M. Uyeki, Marco Carone, Lea M. Starita, Ana A. Weil, Helen Y. Chu |
| 434 |
[GO] |
2024―Feb―02 |
Advancing public health informatics during the COVID-19 pandemic: Lessons learned from a public-private partnership with pharmacies |
Nkenge Jones-Jack, Roua El Kalach, Diana Yassanye, Ruth Link-Gelles, Abdulhakeem Olorukooba, Amee Khamar deMartino, Mattie Elam, Doug Romerhausen, Marley Vazquez, Chris Duggar, Christine Kim, Anita Patel, Angela Guo, Radhika Gharpure, Ashley Tippins, Lori Moore |
| 435 |
[GO] |
2024―Feb―01 |
Strong immunogenicity & protection in mice with PlaCCine: A COVID-19 DNA vaccine formulated with a functional polymer |
Subeena Sood, Majed M. Matar, Jessica Kim, Meredyth Kinsella, Kempaiah Rayavara, Olivia Signer, John Henderson, Joseph Rogers, Bhavna Chawla, Brandon Narvaez, Alex Van Ry, Swagata Kar, Austin Arnold, Jennifer S. Rice, Alanna M. Smith, Daishui Su, Jeff Sparks, Corinne Le Goff, Jean D. Boyer, Khursheed Anwer |
| 436 |
[GO] |
2024―Jan―30 |
Flu-COVID combo recombinant protein vaccines elicited protective immune responses against both influenza and SARS-CoV-2 viruses infection |
Ying Huang, Hua Shi, David Forgacs, Ted M. Ross |
| 437 |
[GO] |
2024―Jan―30 |
Immunogenicity of an adenovirus-vectored bivalent vaccine against wild type SARS-CoV-2 and Omicron variants in a murine model |
Yuanyuan Ji, Xiuwen Sui, Wei Miao, Chang Wang, Qing Wang, Zhuojun Duan, Bochao Wei, Dan Wu, Menghan Wei, Juan Shao, Xiuyu Zheng, Tao Zhu |
| 438 |
[GO] |
2024―Jan―28 |
Impact of the 'Health on Wheels' (HoW) strategy on COVID-19 vaccination coverage in hard-to-reach communities in Alta Verapaz, Guatemala, 2022 |
Evelyn Balsells, Manolo Vicente, Sharon Reyes, Marlon Figueroa, Keyla Sum, Maria Antonieta López Lacán, Azucena Escalante, Diego Campos, Mirna Montenegro, Grethel Alvarado, Luis Fernando Quezada, Claudia Jarquin, Edwin Montufar, Marc Rondy |
| 439 |
[GO] |
2024―Jan―27 |
Are COVID-19 vaccination mandates for healthcare workers effective? A systematic review of the impact of mandates on increasing vaccination, alleviating staff shortages and decreasing staff illness |
Arnold I. Okpani, Prince Adu, Tyler Paetkau, Karen Lockhart, Annalee Yassi |
| 440 |
[GO] |
2024―Jan―27 |
Antibodies against SARS-CoV-2 non-structural protein 3 cross-react with human muscle cells and neuroglial cells |
Xin-Yue Yang, Ting Liu, Si-Cong Jiang, Zhong-Wei Zhang, Yu-Fan Fu, Zi-Lin Li, Jing Hu, Shu Yuan |
| 441 |
[GO] |
2024―Jan―27 |
Short term safety of BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine among children aged 5-11 years, a nationwide parental survey |
Shirley Shapiro Ben David, Sharon Baruch Gez, Limor Adler, Rada Kovatch, Daniella Rahamim-Cohen, Na'ama Shamir-Stein, Arnon Shahar, Miri Mizrhi-Reuveni |
| 442 |
[GO] |
2024―Jan―26 |
The U.S. COVID-19 vaccination program: A look back and future directions |
Elisha Hall, Barbara E. Mahon, Georgina Peacock |
| 443 |
[GO] |
2024―Jan―25 |
Determinants of SARS-CoV-2 IgG response and decay in Canadian healthcare workers: A prospective cohort study |
Nicola Cherry, Anil Adisesh, Igor Burstyn, Carmen Charlton, Yan Chen, Quentin Durand-Moreau, France Labrèche, Shannon Ruzycki, LeeAnn Turnbull, Tanis Zadunayski, Yutaka Yasui |
| 444 |
[GO] |
2024―Jan―24 |
Influence of Community Determinants on Barriers and Facilitators to COVID-19 Vaccine Uptake: Regional Stakeholders’ Perspectives |
Savanah Russ, Nancy Bennett, Edwin van Wijngaarden, Elaine Hill, Yu Liu |
| 445 |
[GO] |
2024―Jan―23 |
Strengthening COVID-19 vaccine confidence & demand during the US COVID-19 emergency response |
Neetu Abad, Kimberly E. Bonner, Jessica Kolis, Kathryn A. Brookmeyer, Chris Voegeli, James T. Lee, James A. Singleton, Richard Quartarone, Carla Black, Daiva Yee, Aparna Ramakrishnan, Leslie Rodriguez, Kelly Clay, Sarah Hummer, Kathleen Holmes, Brian J. Manns, John Donovan, Tiffany Humbert-Rico, Stephen A. Flores, Stephanie Griswold, Sarah Meyer, Amanda Cohn |
| 446 |
[GO] |
2024―Jan―23 |
Lessons learned: COVID-19 vaccinations and people with disabilities |
Karyl Rattay, JoAnn M. Thierry, Marshalyn Yeargin-Allsopp, Shannon Griffin-Blake, Catherine E. Rice, Kevin Chatham-Stephens, Karen Remley |
| 447 |
[GO] |
2024―Jan―22 |
Humoral and cellular immunogenicity, effectiveness and safety of COVID-19 mRNA vaccination in patients with pediatric rheumatic diseases: A prospective cohort study |
Mohamad Hamad Saied, Joeri W. van Straalen, Sytze de Roock, Frans M. Verduyn Lunel, Jelle de Wit, Lia G.H. de Rond, Erika Van Nieuwenhove, Bas J. Vastert, Joris M. van Montfrans, Annet van Royen-Kerkhof, Gerrie C.J. de Joode-Smink, Joost F. Swart, Nico M. Wulffraat, Marc H.A. Jansen |
| 448 |
[GO] |
2024―Jan―22 |
Study of immunogenicity and efficacy against Omicron BA.5 of recombinant protein-based COVID-19 vaccine delivered by intramuscular and mucosal routes in nonhuman primates |
Ranajit Pal, Maria Grazia Ferrari, Yoshikazu Honda-Okubo, Lauren Wattay, Jesica Caple, Jennifer Navarrete, Hanne Andersen, Nikolai Petrovsky |
| 449 |
[GO] |
2024―Jan―21 |
Influence of the COVID-19 pandemic on caregiver beliefs and experiences of routine childhood immunisation in Indonesia |
Madeleine Randell, Meru Sheel, Michelle Dynes, Mu Li, Margie Danchin, Fitriyani Sukesmi, Lintang Dian Saraswati, Adeline Tinessia, Kylie Jenkins, Lulu Ariyantheny Dewi, Sartini Saman, Prima Yosephine, Julie Leask, Tri Yunis Miko Wahyono |
| 450 |
[GO] |
2024―Jan―21 |
The role of funded partnerships in working towards decreasing COVID-19 vaccination disparities, United States, March 2021-December 2022 |
Amy Parker Fiebelkorn, Sara Adelsberg, Rishelle Anthony, Samrawit Ashenafi, Amimah F. Asif, Maria Azzarelli, Theresa Bailey, Timothy Tee Boddie, Alaina P. Boyer, Nicole Williams Bungum, Helen Burstin, Jacqueline L. Burton, David M. Casey, Cammie Chaumont Menendez, Brigette Courtot, Kelly Cronin, Cherrie Dowdell, Laura H. Downey, Megan Fields, Tom Fitzsimmons, Alexa Frank, Emily Gustafson, Margaret Gutierrez-Nkomo, Benita L. Harris, Joanna Hill, Kathleen Holmes, Laura Huerta Migus, Joanna Jacob Kuttothara, Natalie Johns, Jennifer Johnson, Alice Kelsey, Lucy Kingangi, Cynthia M. Landrum, James T. Lee, Pedro D. Martinez, Gisela Medina Martínez, Richard Nicholls, Jane R. Nilson, Nma Ohiaeri, Laura Pegram, Claire Perkins, Alexandra M. Piasecki, Talia Pindyck, Sarah Price, Michelle S. Rodgers, Heather Roney, Ellen M. Schultz, Elizabeth Sobczyk, JoAnn M. Thierry, Chelsea Toledo, Nancy E. Weiss, Amy Wiatr-Rodriguez, Lauren Williams, Chenmua Yang, Andrea Yao, Julie Zajac |
| 451 |
[GO] |
2024―Jan―21 |
Social network risk factors and COVID-19 vaccination: A cross-sectional survey study |
Ally Memedovich, Taylor Orr, Aidan Hollis, Charleen Salmon, Jia Hu, Kate Zinszer, Tyler Williamson, Reed F. Beall |
| 452 |
[GO] |
2024―Jan―21 |
SARS-CoV-2 vaccination willingness and humoral vaccination response in radiation oncology patients |
Hans Geinitz, Elisabeth Silberberger, Kurt Spiegl, Johann Feichtinger, Helga Wagner, Philipp Hermann, Elisabeth Bräutigam, Christine Track, Eva Maria Weis, Clemens Venhoda, Roswitha Huppert, Barbara Spindelbalker-Renner, Georgine Zauner-Babor, Dalma Viktoria Nyiri, Nicola Karasek, Mercedesz Erdei, Ruben Gheju, Georg Gruber, Margot Egger, Benjamin Dieplinger |
| 453 |
[GO] |
2024―Jan―20 |
Examining changes in sense of purpose before, during, and after COVID-19 vaccination |
Patrick L. Hill, Talia Morstead, Gabrielle N. Pfund, Anthony L. Burrow, Anita DeLongis, Nancy L. Sin |
| 454 |
[GO] |
2024―Jan―20 |
Mixed-methods examination of attitudes and behaviors related to COVID-19 vaccines among parents of children with autism and autistic adults |
Melissa M. Mitchell, Adriana Klott, Jared Scholtes, B. Blair Braden, Christopher J. Smith, Nicole L. Matthews |
| 455 |
[GO] |
2024―Jan―17 |
Restricted Omicron-specific cross-variant memory B-cell immunity after a 3rd dose/booster of monovalent Wuhan-Hu-1-containing COVID-19 mRNA vaccine |
Iana H. Haralambieva, Jonathon M. Monroe, Inna G. Ovsyannikova, Nathaniel D. Warner, Diane E. Grill, Gregory A. Poland, Richard B. Kennedy |
| 456 |
[GO] |
2024―Jan―15 |
How manufacturing won or lost the COVID-19 vaccine race |
Michael L. King |
| 457 |
[GO] |
2024―Jan―14 |
COVID-19 vaccination among young people who use drugs in Vancouver, Canada |
Erica McAdam, Kanna Hayashi, Brittany Barker, Hudson Reddon, JinCheol Choi, Thomas Kerr, Kora DeBeck |
| 458 |
[GO] |
2024―Jan―11 |
Assessing the relationship between existing childhood, adolescent and adult immunization programmes and national COVID-19 vaccination capacities in 2021 |
Shoshanna Goldin, Ann Moen, William J. Moss, Jennifer Nuzzo |
| 459 |
[GO] |
2024―Jan―09 |
Mixed methods approach to understanding COVID-19 vaccine hesitancy among immigrants in the Chicago |
MaryGrace Sharp, Paula Lozano, Alia Southworth, Aven Peters, Helen Lam, Fornessa T. Randal, Michael Quinn, Karen E. Kim |
| 460 |
[GO] |
2024―Jan―09 |
The mental health symptoms of individuals with sensory disabilities and the reasons that lead to COVID-19 vaccine refusal and hesitancy |
Amanda M. Hinson-Enslin, Luis Enrique Espinoza |
| 461 |
[GO] |
2024―Jan―09 |
Characterizing predictors of COVID-19 vaccine refusal in an urban southern California jail population |
Nazia S. Qureshi, Loren G. Miller, Stephen P. Judge, Ngoc Dung T. Tran, Sean O. Henderson |
| 462 |
[GO] |
2024―Jan―06 |
Exploring preventive care practices among unvaccinated individuals in the United States during the COVID-19 pandemic |
Dejan K. Filipas, Muhieddien Labban, Edoardo Beatrici, Benjamin V. Stone, Zhiyu Qian, Vincent D́Andrea, Tim A. Ludwig, Leonardo O. Reis, Alexander P. Cole, Quoc-Dien Trinh |
| 463 |
[GO] |
2024―Jan―06 |
Parental concerns and vaccine hesitancy against COVID-19 vaccination for children in Greece: A cross-sectional survey |
E. Steletou, T. Giannouchos, G. Dimitriou, A. Karatza, X. Sinopidis, H.C. Maltezou, K. Souliotis, D. Gkentzi |
| 464 |
[GO] |
2024―Jan―05 |
Challenges and opportunities during the COVID-19 vaccination efforts in long-term care |
Nimalie D. Stone, Amy Parker Fiebelkorn, Angela Guo, Elizabeth Mothershed, Lauren Moccia, Jeneita Bell, Diana Yassanye, Elisha Hall, Chris Duggar, Arjun Srinivasan, Sarah A. Meyer, Ruth Link-Gelles |
| 465 |
[GO] |
2024―Jan―05 |
Racial and ethnic differences in COVID-19 vaccine readiness among adults in the United States, January 2021-April 2023 |
Elissa C. Kranzler, Timothy O. Ihongbe, Michael C. Marshall, Benjamin Denison, Heather Dahlen, Blake Hoffman, Kate Seserman, Jingyuan Xie, Leah Hoffman |
| 466 |
[GO] |
2024―Jan―04 |
Public's perspective on COVID-19 adenovirus vector vaccines after thrombosis with thrombocytopenia syndrome (TTS) reports and associated regulatory actions - A cross-sectional study in six EU member states |
Caroline Buhl, Ramune Jacobsen, Anna Birna Almarsdóttir, Shahab Abtahi, Armin Andersen, Elena Deligianni, Foteini Dermiki-Gkana, Christos Kontogiorgis, Chara Oikonomou, Mirdza Kursite, Elita Poplavska, Ingrid Hegger, Marloes van der Goot, Paula Barão Sousa Ferreira, Inês Ribeiro-Vaz, Ana Marta Silva, Mitja Kos, Nanča Čebron Lipovec, Ella van Vliet, Teresa Leonardo Alves |
| 467 |
[GO] |
2024―Jan―04 |
Massachusetts companion program bolsters COVID-19 vaccine rates among seniors |
Marie-Laure Charpignon, Shagun Gupta, Maimuna Shahnaz Majumder |
| 468 |
[GO] |
2023―Dez―29 |
Development of COVID-19 vaccine policy - United States, 2020-2023 |
Sara E. Oliver, Megan Wallace, Evelyn Twentyman, Danielle L. Moulia, Monica Godfrey, Ruth Link-Gelles, Sarah Meyer, Katherine E. Fleming-Dutra, Elisha Hall, JoEllen Wolicki, Jessica MacNeil, Beth P. Bell, Grace M. Lee, Matthew F. Daley, Amanda Cohn, Melinda Wharton |
| 469 |
[GO] |
2023―Dez―28 |
mRNA vaccines for COVID-19 are safe and clinically effective in patients with cardiac amyloidosis |
Gina Barzen, Finn Rieber, Karl Stangl, Katrin Hahn, Sebastian Spethmann |
| 470 |
[GO] |
2023―Dez―27 |
CDC COVID-19 vaccination program: Healthcare provider compliance with COVID-19 vaccine requirements and recommendations |
Tamara C. Surtees, Charleigh J. Granade, Christopher Wells, Michelle Banks, Paul Lucas, Samuel B. Graitcer |
| 471 |
[GO] |
2023―Dez―27 |
Long term follow up and outcomes of Covid-19 vaccine associated myocarditis in Victoria, Australia: A clinical surveillance study |
Priya Shenton, Silja Schrader, Julia Smith, Annette Alafaci, Nicholas Cox, Andrew Taylor, James Hare, Bryn Jones, Nigel W. Crawford, Jim P Buttery, Daryl R. Cheng |
| 472 |
[GO] |
2023―Dez―23 |
Covid-19 and influenza vaccine effectiveness against associated hospital admission and death among individuals over 65 years in Norway: A population-based cohort study, 3 October 2022 to 20 June 2023 |
Elina Seppälä, Jesper Dahl, Lamprini Veneti, Kjersti Margrethe Rydland, Birgitte Klüwer, Andreas Rohringer, Hinta Meijerink |
| 473 |
[GO] |
2023―Dez―23 |
Comparison of adult hesitancy towards COVID-19 vaccines and vaccines in general in the USA |
Kimberly H. Nguyen, Kelsey C. Coy, Carla L. Black, Paul Scanlon, James A. Singleton |
| 474 |
[GO] |
2023―Dez―23 |
Vaccine-associated respiratory pathology correlates with viral clearance and protective immunity after immunization with self-amplifying RNA expressing the spike (S) protein of SARS-CoV-2 in mouse models |
Alla Kachko, Prabhuanand Selvaraj, Shufeng Liu, Jaekwan Kim, David Rotstein, Charles B. Stauft, Sylvie Chabot, Naveen Rajasagi, Yangqing Zhao, Tony Wang, Marian Major |
| 475 |
[GO] |
2023―Dez―22 |
Neighborhood-level vaccine impact on COVID-19 infection and hospital admission in Q, Canada, during the Delta and early Omicron periods |
Ernest Lo, Nicholas Brousseau, Fannie Defay, Élise Fortin, Marilou Kiely |
| 476 |
[GO] |
2023―Dez―21 |
Immunogenicity and safety of a second heterologous booster dose of NVX-CoV2373 (TAK-019) in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: Interim analysis report of a phase 3 open-label trial |
Kenji Kuriyama, Kyoko Murakami, Kenkichi Sugiura, Sho Sakui, Ron P. Schuring, Mitsuhiro Mori |
| 477 |
[GO] |
2023―Dez―20 |
Building the U.S. COVID-19 vaccine effectiveness program: Past successes and future directions |
Ruth Link-Gelles, Amadea Britton, Katherine E. Fleming-Dutra |
| 478 |
[GO] |
2023―Dez―20 |
Humoral immune response in people living with HIV after administration of SARS-CoV-2 vaccine CoronaVac or BNT162b2 or CoronaVac/BNT162b2 booster sequence: A cross-sectional study |
Marcelo Wolff, Paulo Charpentier, Andrea Canals, Cecilia Vial, Juan Hormazábal, Jimena Cortés, Macarena Silva |
| 479 |
[GO] |
2023―Dez―19 |
COVID-19 vaccine effectiveness against severe COVID-19 requiring oxygen therapy, invasive mechanical ventilation, and death in Japan: A multicenter case-control study (MOTIVATE study) |
Takeshi Arashiro, Maki Miwa, Hidenori Nakagawa, Junpei Takamatsu, Kunihiro Oba, Satoshi Fujimi, Hitoshi Kikuchi, Takamasa Iwasawa, Fumiko Kanbe, Keisuke Oyama, Masayuki Kanai, Yoshitaka Ogata, Takanori Asakura, Takahiro Asami, Keiko Mizuno, Manabu Sugita, Torahiko Jinta, Yusuke Nishida, Hideaki Kato, Kazuaki Atagi, Taiki Higaki, Yoshio Nakano, Takeya Tsutsumi, Kent Doi, Shu Okugawa, Akihiro Ueda, Akira Nakamura, Toru Yoshida, Kaoru Shimada-Sammori, Keiki Shimizu, Yasuo Fujita, Yasumi Okochi, Kentaro Tochitani, Asuka Nakanishi, Hiroshi Rinka, Daisuke Taniyama, Asase Yamaguchi, Toshio Uchikura, Maiko Matsunaga, Hiromi Aono, Masanari Hamaguchi, Kentaro Motoda, Sohei Nakayama, Kei Yamamoto, Hideaki Oka, Katsushi Tanaka, Takeshi Inoue, Mieko Kobayashi, Shigeki Fujitani, Maki Tsukahara, Saki Takeda, Ashley Stucky, Tadaki Suzuki, Chris Smith, Martin Hibberd, Koya Ariyoshi, Yuji Fujino, Yuzo Arima, Shinhiro Takeda, Satoru Hashimoto, Motoi Suzuki |
| 480 |
[GO] |
2023―Dez―18 |
9-Month observational Dia-Vacc study of vaccine type influence on SARS-CoV-2 immunity in dialysis and kidney transplant patients |
Julian Stumpf, Leona Anders, Torsten Siepmann, Jörg Schwöbel, Claudia Karger, Tom Lindner, Robert Faulhaber-Walter, Torsten Langer, Katja Escher, Kirsten Anding-Rost, Harald Seidel, Jan Hüther, Frank Pistrosch, Heike Martin, Jens Schewe, Thomas Stehr, Frank Meistring, Alexander Paliege, Daniel Schneider, Ingolf Bast, Anne Steglich, Florian Gembardt, Friederike Kessel, Hannah Kröger, Patrick Arndt, Jan Sradnick, Kerstin Frank, Sarah Skrzypczyk, Moritz Anft, Anna Klimova, René Mauer, Ingo Roeder, Torsten Tonn, Nina Babel, Christian Hugo |
| 481 |
[GO] |
2023―Dez―16 |
A multifaceted approach for identification, validation, and immunogenicity of naturally processed and in silico-predicted highly conserved SARS-CoV-2 peptides |
Tamar Ratishvili, Huy Quang Quach, Iana H. Haralambieva, Yogesh R. Suryawanshi, Inna G. Ovsyannikova, Richard B. Kennedy, Gregory A. Poland |
| 482 |
[GO] |
2023―Dez―15 |
Observations of COVID-19 vaccine coverage and vaccine hesitancy on COVID-19 outbreak: An American ecological study |
Deewan Bajracharya, Rick J. Jansen |
| 483 |
[GO] |
2023―Dez―15 |
Characterization of SARS-CoV-2-specific humoral immunity and associated factors in the healthy population post-vaccination |
Xiao-Yong Zhan, Yun Chen, Xiaoying Zhang, Qipeng Shi, Kaiyin Chen, Changchun Zeng, Yi Zhang, Yuhong Liang, Wenxia Li, Manli Li, Qin Peng, Changfei Qin, Taoli Liu, Haifeng Xu, Dasen Yuan, Ziheng Ye, Ling Yan, Shuming Cheng, Ying Zhang, Yunsheng Xu, Youpeng Chen, Ming Chen, Ke Li, Changneng Ke, Yunxiao Zhu, Bihui Huang |
| 484 |
[GO] |
2023―Dez―14 |
Factors associated with COVID-19 autumn 2022 booster uptake in the Netherlands among older adults aged ≥ 60 years and younger adults with chronic conditions |
Caren van Roekel, Lisanne Labuschagne, Joyce Pijpers, Annika van Roon, Bente Smagge, José A. Ferreira, Susan Hahné, Hester de Melker |
| 485 |
[GO] |
2023―Dez―14 |
Intranasal immunization with the recombinant measles virus encoding the spike protein of SARS-CoV-2 confers protective immunity against COVID-19 in hamsters |
Sang-In Park, Sohyun Park, Kunse Lee, Hye Won Kwak, Yong Kwan Kim, Hyeong-Jun Park, Yoo-Jin Bang, Jae-Yong Kim, Daegeun Kim, Ki-Weon Seo, Su Jeen Lee, Hun Kim, Yeonhwa Kim, Do-Hyung Kim, Hyo-Jung Park, Seo-Yeon Jung, Eulhae Ga, Jaehyun Hwang, Woonsung Na, So-Hee Hong, Sang-Myeong Lee, Jae-Hwan Nam |
| 486 |
[GO] |
2023―Dez―14 |
Impact of the COVID-19 pandemic on routine vaccination coverage under varying prevalence Conditions: A cohort study in Beijing, China |
Zhiqiang Cao, Rui Yu, Qianli Yuan, Wenyan Ji, Xiaomei Li, Pei Gao, Liang Miao, Xiaojing Wen, Luodan Suo |
| 487 |
[GO] |
2023―Dez―14 |
Monitoring and reporting the US COVID-19 vaccination effort |
Lynn Gibbs Scharf, Kafayat Adeniyi, Emily Augustini, Deborah Boyd, Laura Corvin, Roua El Kalach, Hannah Fast, Janet Fath, LaTreace Harris, Danielle Henderson, Jan Hicks-Thomson, Nkenge Jones-Jack, Amanda Kellerman, Agha (Nabeel) Khan, Sunanda (Shu) McGarvey, Jennifer E. McGehee, Christine E. Miner, Lori B. Moore, Bhavini Patel Murthy, Stuart Myerburg, Elizabeth Neuhaus, Kimvy Nguyen, Melody Parker, Susan Pierce-Richards, David Samchok, Lauren K. Shaw, Samantha Spoto, Arunkumar Srinivasan, Carla Stearle, Jacob Thomas, Mark Winarsky, Elizabeth Zell |
| 488 |
[GO] |
2023―Dez―13 |
Access to SARS-CoV-2 vaccination in immigrants in Italy, by geographical area of origin |
Eliana Ferroni, Nicola Gennaro, Giovanni Maifredi, Olivia Leoni, Francesco Profili, Cristina Stasi, Laura Cacciani, Enrico Calandrini, Anteo di Napoli, Alessio Petrelli, Manuel Zorzi |
| 489 |
[GO] |
2023―Dez―12 |
The importance of community-specific survey data in understanding behavioral and social drivers of COVID-19 vaccination: Lessons learned from urban neighborhoods in four United States cities |
Sasigant So O'Neil, Emma L. Pendl-Robinson, Elizabeth A. Carosella, Brianna D. Sullivan, Anitha Sivasankaran |
| 490 |
[GO] |
2023―Dez―11 |
Effectiveness of COVID-19 vaccine mandates in raising vaccination rates among the elderly and general population in Europe: Controlled interrupted time series analysis |
Theodore Lytras, Abba Adema Alumasa Di Gregorio, Dimitrios Apostolopoulos, Demetris Naziris, Christina Zingerle, Alexandros Heraclides |
| 491 |
[GO] |
2023―Dez―09 |
Test negative design for vaccine effectiveness estimation in the context of the COVID-19 pandemic: A systematic methodology review |
Miceline Mésidor, Yan Liu, Denis Talbot, Danuta M. Skowronski, Gaston De Serres, Joanna Merckx, Anita Koushik, Mina Tadrous, Sara Carazo, Cong Jiang, Mireille E. Schnitzer |
| 492 |
[GO] |
2023―Dez―08 |
Stronger and durable SARS-CoV-2 immune response to mRNA vaccines in 5-11 years old children with prior COVID-19 |
Costanza Di Chiara, Anna Cantarutti, Maria Raffaella Petrara, Francesco Bonfante, Elisa Benetti, Riccardo Boracchini, Luca Bosa, Francesco Carmona, Chiara Cosma, Nicola Cotugno, Marthe Le Prevost, Giorgia Martini, Alessandra Meneghel, Matteo Pagliari, Paolo Palma, Elena Ruffoni, Annachiara Zin, Anita De Rossi, Carlo Giaquinto, Daniele Donà, Andrea Padoan |
| 493 |
[GO] |
2023―Dez―08 |
SARS-CoV-2 mucosal vaccine protects against clinical disease with sex bias in efficacy |
Yongjun Sui, Hanne Andersen, Jianping Li, Tanya Hoang, Mahnaz Minai, Bianca M. Nagata, Kevin W. Bock, Derron A. Alves, Mark G. Lewis, Jay A. Berzofsky |
| 494 |
[GO] |
2023―Dez―07 |
The intention to get COVID-19 booster vaccination and its association with cognitive and emotional factors: A survey of Chinese COVID-19 infected people in Hong Kong |
Yanqiu Yu, Xiaoying Zhang, Mason M.C. Lau, Joseph T.F. Lau |
| 495 |
[GO] |
2023―Dez―07 |
Why did Brazil fail to vaccinate children against COVID-19 during the pandemic? An assessment of attitudinal and behavioral determinants |
Wladimir Gramacho, Mathieu Turgeon, Pedro Santos Mundim, Isadora Pereira |
| 496 |
[GO] |
2023―Dez―06 |
CDC COVID-19 Vaccine Pregnancy Registry: Design, data collection, response rates, and cohort description |
Sabrina A. Madni, Andrea J. Sharma, Lauren Head Zauche, Ansley V. Waters, John F. Nahabedian, Tara Johnson, Christine K. Olson |
| 497 |
[GO] |
2023―Dez―05 |
The relative effectiveness of three and four doses of COVID-19 vaccine in Victoria, Australia: A data linkage study |
Jose T. Canevari, Allen C. Cheng, Logan Wu, Stacey L. Rowe, Dennis E. Wollersheim, Daniel West, Suman S. Majumdar, Sheena G. Sullivan |
| 498 |
[GO] |
2023―Dez―01 |
Production, purification and immunogenicity of Gag virus-like particles carrying SARS-CoV-2 components |
Anahita Bakhshizadeh Gashti, Gerard Agbayani, Sabahudin Hrapovic, Nasha Nassoury, Nathalie Coulombe, Renu Dudani, Blair A. Harrison, Bassel Akache, Rénald Gilbert, Parminder Singh Chahal |
| 499 |
[GO] |
2023―Nov―27 |
RBD class 1 and 2 antibody epitopes elicit around 70% neutralizing capacity against SARS-CoV-2 virus following boosting with inactivated virus vaccine |
Yuanyuan Wang, Yunqi Hu, Yong Ma, Pengbin Li, Siwei Zhou, Mengxin Xu, Bing He, Shuning Liu, Kexin Lv, Sizhe Liu, Yu Zhang, Na Zhou, Shifeng Chen, Feng Ye, Yao-Qing Chen |
| 500 |
[GO] |
2023―Nov―25 |
Resilience of routine childhood immunization services in two counties in Kenya in the face of the COVID-19 pandemic |
Harriet Mirieri, Carolyne Nasimiyu, Jeanette Dawa, Caroline Mburu, Rose Jalang'o, Peter Kamau, Ledor Igboh, Malembe Ebama, Daniel Wainaina, Jean Gitonga, Joseph Karanja, Emily Njenga, Jane Kariuki, Judith Machani, Pauline Oginga, Imani Baraka, Paul Wamaru, Sally Muhula, Peter Ratemo, Jorim Ayugi, M. Kariuki Njenga, Gideon O. Emukule, Eric Osoro, Nancy A. Otieno |
| 501 |
[GO] |
2023―Nov―25 |
Modeling COVID-19 vaccine booster-elicited antibody response and impact of infection history |
Takara Nishiyama, Yuichiro Miyamatsu, Hyeongki Park, Naotoshi Nakamura, Risa Yokokawa Shibata, Shingo Iwami, Yoji Nagasaki |
| 502 |
[GO] |
2023―Nov―25 |
Evaluation of the humoral response to the third dose of SARS-COV-2 vaccines in liver transplant recipients |
Nicolás Ducasa, Paula Benencio, Ezequiel Mauro, Margarita Anders, Bianca Mazzitelli, Lucía Bleichmar, Maria Florencia Quiroga, Manuel Barbero, Fernando Cairo, Adriana Alter, Patricia Etcheves, Giampaolo Scarton, Natalia Sobenko, Mirna Biglione, Manuel Mendizabal |
| 503 |
[GO] |
2023―Nov―23 |
Impact of accounting for correlation between COVID-19 and influenza vaccination in a COVID-19 vaccine effectiveness evaluation using a test-negative design |
Amanda B. Payne, Allison Avrich Ciesla, Elizabeth A.K. Rowley, Zachary A. Weber, Sarah E. Reese, Toan C. Ong, Gabriela Vazquez-Benitez, Allison L. Naleway, Nicola P Klein, Peter J. Embi, Shaun J. Grannis, Anupam B. Kharbanda, Manjusha Gaglani, Mark W. Tenforde, Ruth Link-Gelles |
| 504 |
[GO] |
2023―Nov―22 |
Breakthrough COVID-19 infections and perceived vaccine effectiveness |
Stephen R. Neely, Feng Hao |
| 505 |
[GO] |
2023―Nov―22 |
Sociodemographic factors and attitudes associated with Australian parental acceptance of paediatric COVID-19 vaccination |
Bing Wang, Joshua McDonough, Gang Chen, Jason J. Ong, Helen Marshall |
| 506 |
[GO] |
2023―Nov―22 |
Excess mortality in Cyprus during the COVID-19 vaccination campaign |
Eleftheria C. Economidou, Elpidoforos S. Soteriades |
| 507 |
[GO] |
2023―Nov―19 |
“I’d do it for my baby”: Lessons learned from qualitative research on COVID-19 vaccination among pregnant women in Côte d’Ivoire |
Danielle Naugle, Natalie Tibbels, Abdul Dosso, William Benie, Marjorie Nana |
| 508 |
[GO] |
2023―Nov―17 |
Assessing parental intention to vaccinate against COVID-19, influenza, and RSV in the United States in late 2023 |
Simon F. Haeder |
| 509 |
[GO] |
2023―Nov―17 |
Influenza vaccination in children with pulmonary disease during the COVID-19 pandemic |
Nofar Amitai, Reut Wertheimer, Dario Prais, Keren-Or Wertheimer, Gilat Livni |
| 510 |
[GO] |
2023―Nov―16 |
Who gets COVID-19 booster vaccination? Trust in public health institutions and promotion strategies post-pandemic in the Republic of Korea |
Yongjin Choi, Soohyun Park, Jinwoo Lee, Youngsung Kim, Byoung Joon Kim, Leesa Lin, Ashley M. Fox |
| 511 |
[GO] |
2023―Nov―14 |
Impact of a hypothetical COVID-19 vaccine mandate on parental likelihood to vaccinate children: Exploring school-related concerns and vaccination decision-making |
Joshua T. Sarafian, Stephanie A. Eucker, Michael Gillman, Amy M. DeLaroche, Robert M. Rodriguez, David Rayburn, Nicole L. Nadeau, Lisa A. Drago, Danielle Cullen, Emmalee M. Kugler, Sarah Dennis Meskill, Suzanne Bialeck, Brigitte M. Baumann |
| 512 |
[GO] |
2023―Nov―14 |
Effectiveness of a bivalent mRNA vaccine dose against symptomatic SARS-CoV-2 infection among U.S. Healthcare personnel, September 2022-May 2023 |
Ian D. Plumb, Melissa Briggs Hagen, Ryan Wiegand, Ghinwa Dumyati, Christopher Myers, Karisa K. Harland, Anusha Krishnadasan, Jade James Gist, Glen Abedi, Katherine E. Fleming-Dutra, Nora Chea, Jane E. Lee, Melissa Kellogg, Alexandra Edmundson, Amber Britton, Lucy E. Wilson, Sara A. Lovett, Valerie Ocampo, Tiffanie M. Markus, Howard A. Smithline, Peter C. Hou, Lilly C. Lee, William Mower, Fernand Rwamwejo, Mark T. Steele, Stephen C. Lim, Walter A. Schrading, Brian Chinnock, David G. Beiser, Brett Faine, John P. Haran, Utsav Nandi, Anne K. Chipman, Frank LoVecchio, Stephanie Eucker, Jon Femling, Matthew Fuller, Richard E. Rothman, Marcel E. Curlin, David A. Talan, Nicholas M. Mohr, Christopher Watts, Matthew McCullough, Sankan Nyanseor, Erin Licherdell, Alexander Peebles, Joelle Nadle, Helen Johnston, Monica Brackney, Scott Fridkin, Kaytlynn Marceaux-Galli, Ruth Lynfield, Rebecca Pierce, H. Keipp Talbot, Jillian Tozloski, Dean M. Hashimoto, Monica Bahamon, Elizabeth Krebs, Amy M. Stubbs, Michelle Huber, James C. Crosby, Sara Roy, Gregory Volturo, James Galbraith, Megan Fuentes, Jennifer Smith, Leslie Olivia Hopkins, Joseph Stuppy, Gaby Dashler, Mastura Wahedi |
| 513 |
[GO] |
2023―Nov―11 |
Impact of the surge of COVID-19 Omicron outbreak on the intention of seasonal influenza vaccination in Hong Kong: A cross-sectional study |
Xiaoting Jiang, Jingxuan Wang, Conglu Li, Eng Kiong Yeoh, Zihao Guo, Yuchen Wei, Ka Chun Chong |
| 514 |
[GO] |
2023―Nov―11 |
“Who is Anders Tegnell?” Unanswered questions hamper COVID-19 vaccine uptake: A qualitative study among ethnic minorities in Sweden |
Sibylle Herzig van Wees, Maria Stålgren, Nina Viberg, Bi Puranen, Anna Mia Ekström, Elin C. Larsson |
| 515 |
[GO] |
2023―Nov―11 |
Factors associated with uptake of bivalent mRNA COVID-19 vaccines in a large US health care system |
Katia J. Bruxvoort, Lina S. Sy, Vennis Hong, Bruno Lewin, Lei Qian, Xuan Huang, Kimberly J. Holmquist, Bing Han, Stanley Xu |
| 516 |
[GO] |
2023―Nov―10 |
COVID-19 vaccination attitudes, values, intentions: US parents for their children, September 2021 |
Matthew Z. Dudley, Benjamin Schwartz, Janesse Brewer, Lilly Kan, Roger Bernier, Jennifer E. Gerber, Haley Budigan Ni, Tina M. Proveaux, Rajiv N. Rimal, Daniel A. Salmon |
| 517 |
[GO] |
2023―Nov―10 |
Inactivated COVID-19 vaccines in peri-pregnancy period: Evaluation of safety for both pregnant women and neonates |
Caihua Yang, Zengyue Zheng, Ping Zheng, Juan Chen, Qianyun Huang, Yue Chen, Ying Zhou, Pingyan Chen, Yilei Li, Ying Wu |
| 518 |
[GO] |
2023―Nov―07 |
The association between antipyretic analgesics use and SARS-CoV-2 antibody titers following the second dose of the BNT162b2 mRNA vaccine: An observational study |
Yosuke Inoue, Yunfei Li, Shohei Yamamoto, Ami Fukunaga, Hironori Ishiwari, Masamichi Ishii, Kengo Miyo, Mugen Ujiie, Wataru Sugiura, Norio Ohmagari, Tetsuya Mizoue |
| 519 |
[GO] |
2023―Nov―04 |
Dimensions of equality in uptake of COVID-19 vaccination in Wales, UK: A multivariable linked data population analysis |
Gethin Jones, Malorie Perry, Rowena Bailey, Sudha Arumugam, Adrian Edwards, Alex Lench, Alison Cooper, Ashley Akbari, Brendan Collins, Caroline Harris, Gill Richardson, Mai Barry, Phillippa Harris, Richard Fry, Ronan A. Lyons, Simon Cottrell |
| 520 |
[GO] |
2023―Nov―04 |
Investigation of the SARS-CoV-2 post-vaccination antibody response in Canadian farmed mink |
Line Gram Hansen, Lars Erik Larsen, Thomas Bruun Rasmussen, Younes Miar, Ria Lassuniére, Charlotte Sværke Jørgensen, Pia Ryt-Hansen |
| 521 |
[GO] |
2023―Nov―03 |
Phase I study of a non-S2P SARS-CoV-2 mRNA vaccine LVRNA009 in Chinese adults |
Gui-Ling Chen, Xu-Ya Yu, Li-Ping Luo, Fan Zhang, Xia-Hong Dai, Nan Li, Zhen-Wei Shen, Kai-Qi Wu, Dan-Feng Lou, Cong-Gao Peng, Ting-Han Jin, Yu-Mei Huang, Xi Shao, Qi Liu, Qi Jiang, Tong Guo, Fang Cao, Jing-Rui Zhu, Xiao-Hong Wu, Rong-Juan Pei, Fei Deng, Guo-Ping Jiang, Yu-Hua Li, Hai-Nv Gao, Jian-Xing He, Yu-Cai Peng, Lan-Juan Li |
| 522 |
[GO] |
2023―Nov―01 |
Vaccines and global health: COVID-19 vaccine development, strategy, and implementation symposium - Summary of the meeting at Vagelos College of Physicians and Surgeons (February 22-26, 2021, New York) |
Wilmot G. James, Lawrence R. Stanberry, Phillip S. LaRussa, Marc D. Grodman |
| 523 |
[GO] |
2023―Okt―29 |
A single blinded, phase IV, adaptive randomised control trial to evaluate the safety of coadministration of seasonal influenza and COVID-19 vaccines (The FluVID study) |
J.A. Ramsay, M. Jones, A.M. Vande More, S.L. Hunt, P.C.M. Williams, M. Messer, N. Wood, K. Macartney, F.J. Lee, W.J. Britton, T.L. Snelling, I.D. Caterson |
| 524 |
[GO] |
2023―Okt―28 |
Understanding COVID-19 vaccine hesitancy in Canada |
Claire Corsten, Zoua M. Vang, Ian Gold, Maya J. Goldenberg, Fernanda Pérez-Gay Juarez, Daniel Weinstock, Maxwell J. Smith, Oren Krajden, Elizaveta Solomonova |
| 525 |
[GO] |
2023―Okt―28 |
Superior immunogenicity of mRNA over adenoviral vectored COVID-19 vaccines reflects B cell dynamics independent of anti-vector immunity: Implications for future pandemic vaccines |
Yi Liu, Stephany Sánchez-Ovando, Louise Carolan, Leslie Dowson, Arseniy Khvorov, A. Jessica Hadiprodjo, Yeu Yang Tseng, Catherine Delahunty, Ameneh Khatami, Marion Macnish, Sonia Dougherty, Michelle Hagenauer, Kathryn E. Riley, Ajay Jadhav, Joanne Harvey, Marti Kaiser, Suja Mathew, David Hodgson, Vivian Leung, Kanta Subbarao, Allen C. Cheng, Kristine Macartney, Archana Koirala, Helen Marshall, Julia Clark, Christopher C. Blyth, Peter Wark, Adam J. Kucharski, Sheena G. Sullivan, Annette Fox |
| 526 |
[GO] |
2023―Okt―26 |
Adverse events of acute nephrotoxicity reported to EudraVigilance and VAERS after COVID-19 vaccination |
Cleo Anastassopoulou, Fotini Boufidou, Sophia Hatziantoniou, Konstantinos Vasileiou, Nikolaos Spanakis, Athanasios Tsakris |
| 527 |
[GO] |
2023―Okt―25 |
The state of COVID-19 vaccine confidence and need in Black individuals in Canada: Understanding the role of sociodemographic factors, health literacy, conspiracy theories, traumatic stressors and racial discrimination |
Jude Mary Cénat, Seyed Mohammad Mahdi Moshirian Farahi, Cathy Broussard, Rose Darly Dalexis |
| 528 |
[GO] |
2023―Okt―25 |
Background rates for severe cutaneous reactions in the US: Contextual support for safety assessment of COVID-19 vaccines and novel biologics |
Diane Gubernot, Mikhail Menis, Barbee Whitaker |
| 529 |
[GO] |
2023―Okt―25 |
“Fighting the pandemic!” Western Australian pharmacists’ perspectives on COVID-19 vaccines: A qualitative study |
Taaiba Walliar, Basil Khan, Sophie Newstead, Ghoufran Al-Assadi, Sandra M Salter, Liza Seubert, Samantha J. Carlson, Katie Attwell |
| 530 |
[GO] |
2023―Okt―24 |
Antibodies to SARS-CoV2 induced by vaccination and infection correlate with protection against the infection |
Noelia Flor, María Inés García, Ana Molineri, Oscar Bottasso, Cristina Diez, Carolina Veaute |
| 531 |
[GO] |
2023―Okt―21 |
Neutralization escape by SARS-CoV-2 Omicron subvariant BA.2.86 |
Ninaad Lasrado, Ai-ris Y. Collier, Nicole P. Hachmann, Jessica Miller, Marjorie Rowe, Eleanor D. Schonberg, Stefanie L. Rodrigues, Austin LaPiana, Robert C. Patio, Trisha Anand, Jana Fisher, Camille R. Mazurek, Ruoran Guan, Kshitij Wagh, James Theiler, Bette T. Korber, Dan H. Barouch |
| 532 |
[GO] |
2023―Okt―20 |
Innovative method for rapid detection of falsified COVID-19 vaccines through unopened vials using handheld Spatially Offset Raman Spectroscopy (SORS) |
Sara Mosca, Qianqi Lin, Robert Stokes, Tehmina Bharucha, Bevin Gangadharan, Rebecca Clarke, Laura Gomez Fernandez, Michael Deats, John Walsby-Tickle, Benediktus Yohan Arman, Shrikrishna R. Chunekar, Kundan D. Patil, Sunil Gairola, Kerlijn Van Assche, Susanna Dunachie, Hamid A. Merchant, Rutendo Kuwana, Alexandrine Maes, James McCullagh, Céline Caillet, Nicole Zitzmann, Paul N. Newton, Pavel Matousek |
| 533 |
[GO] |
2023―Okt―19 |
Corrigendum to “Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants” [Vaccine 41(11) (2023) 1892-1901] |
Hye Won Kwak, Hyo-Jung Park, Seo-Yeon Jung, Eun Young Oh, Sang-In Park, Yeonhwa Kim, Hyeong-Jun Park, Sohyun Park, You-Jin Kim, Hae Li Ko, Jung-Ah Lee, Hyeran Won, Yun-Ho Hwang, Seo Yeon Kim, Se Eun Kim, Seong Eun Bae, Minhyuk Yoon, Jae-Ouk Kim, Manki Song, Su Jeen Lee, Ki-Weon Seo, Kunse Lee, Dokeun Kim, Hun Kim, Sang-Myeong Lee, So-Hee Hong, Jae-Hwan Nam |
| 534 |
[GO] |
2023―Okt―19 |
Advax-CpG55.2-adjuvanted monovalent or trivalent SARS-CoV-2 recombinant spike protein vaccine protects hamsters against heterologous infection with Beta or Delta variants |
Yoshikazu Honda-Okubo, Richard Bowen, Mckinzee Barker, Helle Bielefeldt-Ohmann, Nikolai Petrovsky |
| 535 |
[GO] |
2023―Okt―19 |
Reactogenicity, pregnancy outcomes, and SARS-CoV-2 infection following COVID-19 vaccination during pregnancy in Canada: A national prospective cohort study |
E. McClymont, A. Atkinson, A. Albert, G. Av-Gay, J. Andrade, J. Barrett, T. Bogler, I. Boucoiran, E. Castillo, R. D'Souza, D. El-Chaâr, S. Fadel, D.B. Fell, I. Korchinski, V. Kuret, G. Ogilvie, V. Poliquin, M. Sadarangani, H. Scott, J.W. Snelgrove, M. Tunde-Byass, D. Money |
| 536 |
[GO] |
2023―Okt―17 |
Effectiveness of homologous/heterologous booster COVID-19 vaccination schedules against severe illness in general population and clinical subgroups in three European countries |
Fabio Riefolo, Belén Castillo-Cano, Mar Martín-Pérez, Davide Messina, Roel Elbers, Dorieke Brink-Kwakkel, Felipe Villalobos, Ylenia Ingrasciotta, Patricia Garcia-Poza, Karin Swart-Polinder, Patrick Souverein, Luis Carlos Saiz, Carlo Alberto Bissacco, Leire Leache, Michele Tari, Salvatore Crisafulli, Lamiae Grimaldi, Tiago Vaz, Rosa Gini, Olaf Klungel, Elisa Martín-Merino |
| 537 |
[GO] |
2023―Okt―17 |
U.S. public support and opposition to vaccination mandates in K-12 education in light of the COVID-19 pandemic |
Simon F. Haeder |
| 538 |
[GO] |
2023―Okt―17 |
Effectiveness of inactivated COVID-19 vaccines against SARS-CoV-2 Omicron subvariant BF.7 among outpatients in Beijing, China |
Hui Yang, Zhaojian Wang, Ying Zhang, Man Xu, Yushu Wang, Yi Zhang, Zhuoling An, Zhaohui Tong |
| 539 |
[GO] |
2023―Okt―17 |
Distinct features of SARS-CoV-2 humoral immunity against Omicron breakthrough infection |
Takeyuki Goto, Yong Chong, Naoki Tani, Natsumi Susai, Tomoyo Yoshinaga, Tomoki Sasaki, Masahiro Taniguchi, Takahiro Kusakabe, Nobuyuki Shimono, Koichi Akashi, Hideyuki Ikematsu |
| 540 |
[GO] |
2023―Okt―13 |
Immune escape and waning immunity of COVID-19 monovalent mRNA vaccines against symptomatic infection with BA.1/BA.2 and BA.5 in Japan |
Takeshi Arashiro, Yuzo Arima, Jin Kuramochi, Hirokazu Muraoka, Akihiro Sato, Kumi Chubachi, Kunihiro Oba, Atsushi Yanai, Hiroko Arioka, Yuki Uehara, Genei Ihara, Yasuyuki Kato, Naoki Yanagisawa, Yoshito Nagura, Hideki Yanai, Akihiro Ueda, Akira Numata, Hideaki Kato, Hideaki Oka, Yusuke Nishida, Koji Ishii, Takao Ooki, Yuki Nidaira, Takahiro Asami, Torahiko Jinta, Akira Nakamura, Daisuke Taniyama, Kei Yamamoto, Katsushi Tanaka, Kankuro Ueshima, Tetsuji Fuwa, Ashley Stucky, Tadaki Suzuki, Chris Smith, Martin Hibberd, Koya Ariyoshi, Motoi Suzuki |
| 541 |
[GO] |
2023―Okt―09 |
Nonclinical safety assessment and immunogenicity of rVSVInd(GML)-mspSGtc vaccine for SARS-CoV-2 in rabbits |
Heeseon Park, Min Seong Jang, Jung-Ah Choi, Woojin Kim, Yong-Bum Kim, Na Hyung Kim, Eunsil Choi, Hwa-Young Son, Kang-Hyun Han |
| 542 |
[GO] |
2023―Okt―09 |
SARS-CoV-2 mRNA vaccine requires signal peptide to induce antibody responses |
Chuncong Mo, Xiao Li, Qianying Wu, Ye Fan, Donglan Liu, Yuhui Zhu, Yujie Yang, Xiaohong Liao, Zhichao Zhou, Liling Zhou, Qiuru Li, Qiong Zhang, Wenkuan Liu, Rong Zhou, Xingui Tian |
| 543 |
[GO] |
2023―Okt―09 |
Safety, immunogenicity and efficacy of Relcovax®, a dual receptor binding domain (RBD) and nucleocapsid (N) subunit protein vaccine candidate against SARS-CoV-2 virus |
Nikhil Sathe, Sameer Shaikh, Mahesh Bhavsar, Leena Parte, Anjaneyulu Gadiparthi, Satish Kad, Sayandev Sensarma, Hassan Nalband, R. Sangapillai, S. Sivashanmuganathan, Rakhi Pusalkar, Sathyavathy Anandan, Girish Masand, K. Pratapreddy, S. Harinarayana Rao, Abhiram Gokhale, G.E.C. Vidyadhar Reddy, Gopala Karanam, Abhishek Phatarphekar, Praveen Rao, Venkata Ramana, R.L. Ramnath |
| 544 |
[GO] |
2023―Okt―07 |
Thrombosis with thrombocytopenia syndrome (TTS) following adenovirus vector COVID-19 vaccination in Canada |
T.D. Procter, H. Ogasawara, S. Spruin, S. Wijayasri, N. Abraham, C. Blaser, K. Hutchings, A. Shaw, S. Ogunnaike-Cooke |
| 545 |
[GO] |
2023―Sep―27 |
Approaches to evaluate the specific immune responses to SARS-CoV-2 |
Ana Lopez-Gomez, Hector F. Pelaez-Prestel, Ignacio Juarez |
| 546 |
[GO] |
2023―Sep―27 |
25-Hydroxyvitamin D concentrations do not affect the humoral or cellular immune response following SARS-CoV-2 mRNA vaccinations |
A.H.A. Lavell, A.E. Schramade, J.J. Sikkens, K. van der Straten, K.A. van Dort, M.A. Slim, B. Appelman, L.A. van Vught, A.P.J. Vlaar, N.A. Kootstra, M.J. van Gils, Y.M. Smulders, R.T. de Jongh, M.K. Bomers, Brent Appelman, Diederik Beek van de, Marije K. Bomers, Justin Brabander de, Matthijs C. Brouwer, David T.P. Buis, Nora Chekrouni, Marit J. Gils van, Menno D. Jong de, Ayesha H.A. Lavell, Niels Mourik van, Sabine E. Olie, Edgar J.G. Peters, Tom D.Y. Reijnders, Michiel Schinkel, Alex R. Schuurman, Jonne J. Sikkens, Marleen A. Slim, Karlijn Straten van der, Yvo M. Smulders, Alexander P.J. Vlaar, Lonneke A. Vught van, W. Joost Wiersinga |
| 547 |
[GO] |
2023―Sep―26 |
Sequential heterologous immunization with COVID-19 vaccines induces broader neutralizing responses against SARS-CoV-2 variants in comparison with homologous boosters |
Xiuli Shen, Yanling Hao, Shuhui Wang, Dan Li, Li Ren, Meiling Zhu, Shuo Wang, Jing Li, Wenqi Tang, Yuyu Fu, Ran Chen, Ying Liu, Yiming Shao |
| 548 |
[GO] |
2023―Sep―25 |
Trends in COVID-19 and influenza vaccine ordering and distribution in Massachusetts jails |
Nicole Cassarino, Kathryn K. Ahnger-Pier, Alysse Wurcel |
| 549 |
[GO] |
2023―Sep―23 |
Insights to COVID-19 vaccine delivery: Results from a survey of 27 countries |
Ishani Mathur, Rachael Church, Anika Ruisch, Karina Noyes, Anna McCaffrey, Ulla Griffiths, Ibironke Oyatoye, Logan Brenzel, Damian Walker, Christian Suharlim |
| 550 |
[GO] |
2023―Sep―22 |
Acceptance of COVID-19 vaccination and vaccine confidence levels in Thailand: A cross-sectional study |
P. Ngamchaliew, N. Kaewkuea, N. Nonthasorn, T. Vonnasrichan, N. Rongsawat, L. Rattanachai, W. Chaipipattanakij, S. Kamolnawin, P. Vichitkunakorn |
| 551 |
[GO] |
2023―Sep―22 |
Effectiveness of various COVID-19 vaccine regimens among 10.4 million patients from the National COVID Cohort Collaborative during Pre-Delta to Omicron periods - United States, 11 December 2020 to 30 June 2022 |
Yuanyuan Fu, Kaipeng Wu, Zhanwei Wang, Hua Yang, Yu Chen, Lang Wu, Richard Yanagihara, Jerris R. Hedges, Hongwei Wang, Youping Deng |
| 552 |
[GO] |
2023―Sep―20 |
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Novavax COVID-19 Vaccine (NVX-CoV2373), a recombinant spike protein vaccine with Matrix-M adjuvant to prevent disease caused by SARS-CoV-2 viruses |
Bethanie Wilkinson, Kinjal S. Patel, Katherine Smith, Robert Walker, Chengbin Wang, Ann M. Greene, Gale Smith, Emily R. Smith, Marc Gurwith, Robert T. Chen |
| 553 |
[GO] |
2023―Sep―19 |
Review: Factors influencing parents’ decisions to vaccinate children against COVID-19 |
Haifa S. Alharbi |
| 554 |
[GO] |
2023―Sep―17 |
A large survey on COVID-19 vaccination in patients with Parkinson’s disease and healthy population |
Chao Han, Zhen Zhen Zhao, Piu Chan, Fang Li, Chun Ling Chi, Xin Zhang, Yan Zhao, Jing Chen, Jing Hong Ma |
| 555 |
[GO] |
2023―Sep―17 |
Preclinical evaluation of a SARS-CoV-2 variant B.1.351-based candidate DNA vaccine |
Ria Lassaunière, Charlotta Polacek, Jeanette Linnea Tingstedt, Anders Fomsgaard |
| 556 |
[GO] |
2023―Sep―16 |
Protocol for a living evidence synthesis on variants of concern and COVID-19 vaccine effectiveness |
Nicole Shaver, Melanie Katz, Gideon Darko Asamoah, Lori-Ann Linkins, Wael Abdelkader, Andrew Beck, Alexandria Bennett, Sarah E Hughes, Maureen Smith, Mpho Begin, Doug Coyle, Thomas Piggott, Benjamin M. Kagina, Vivian Welch, Caroline Colijn, David J.D. Earn, Khaled El Emam, Jane Heffernan, Sheila F. O'Brien, Kumanan Wilson, Erin Collins, Tamara Navarro, Joseph Beyene, Isabelle Boutron, Dawn Bowdish, Curtis Cooper, Andrew Costa, Janet Curran, Lauren Griffith, Amy Hsu, Jeremy Grimshaw, Marc-André Langlois, Xiaoguang Li, Anne Pham-Huy, Parminder Raina, Michele Rubini, Lehana Thabane, Hui Wang, Lan Xu, Melissa Brouwers, Tanya Horsley, John Lavis, Alfonso Iorio, Julian Little |
| 557 |
[GO] |
2023―Sep―15 |
COVID-19 vaccine effectiveness against hospitalizations in Paraguay, May 2021-April 2022: A test-negative design |
Sandra Irala, Sarah Hamid, Elena Penayo, Fabiana Michel, Paula Couto, Cynthia Vazquez, María José Ortega, Chavely Domínguez, Silvia Battaglia, Marta Von Horoch, Romeo Montoya, Guillermo Sequera, Francisco Nogareda |
| 558 |
[GO] |
2023―Sep―15 |
Evaluation of dynamics of immune responses and protective efficacy in piglets immunized with an inactivated porcine reproductive and respiratory syndrome vaccine candidate |
Megha Katare Pandey, Katherukamem Rajukumar, Dhanapal Senthilkumar, Subbiah Kombiah, Fateh Singh, Govindarajulu Venkatesh, Manoj Kumar, Sangeeta Shrivas, Deepali Shrivastava, Vijendra Pal Singh, Aniket Sanyal |
| 559 |
[GO] |
2023―Sep―12 |
COVID-19 vaccine booster doses provide increased protection against COVID-19 hospitalization compared with previously vaccinated individuals: Interim findings from the REFORCO-Brazil real-world effectiveness study during Delta and Omicron |
Wilhelmine Meeraus, Anke L. Stuurman, Ilgaz Durukal, Eduardo Conde-Sousa, Andrew Lee, André Santa Maria, Bárbara Emoingt Furtado, Mario Ouwens, Christen M. Gray, Douglas Andreas Valverde, Hugo Gomes da Silva, Sylvia Taylor |
| 560 |
[GO] |
2023―Sep―10 |
An overview of protein-based SARS-CoV-2 vaccines |
Yogesh R. Suryawanshi |
| 561 |
[GO] |
2023―Sep―09 |
When to be vaccinated? What to consider? Modelling decision-making and time preference for COVID-19 vaccine through a conjoint experiment |
Pak Hong Ricci Yue, Hi Po Bobo Lau, Siu Man Ng, Lai Wan Cecilia Chan, Samson Yuen |
| 562 |
[GO] |
2023―Sep―09 |
Comparative effectiveness and duration of protection of ChAdOx1, CoronaVac, BNT162b2, mRNA-1273, and Ad26.COV2.S COVID-19 vaccines for symptomatic and hospitalized Mu, Delta, and Omicron: A test-negative case-control study |
Angel Paternina-Caicedo, David Santiago Quevedo, Diana Sofía Ríos, Diane Moyano, Nelson Alvis-Guzmán, Nelson Rafael Alviz-Zakzuk, Fernando Salcedo, Lina Moyano, Javier Ramírez-Suarez, Adrian D. Smith, Fernando De la Hoz-Restrepo |
| 563 |
[GO] |
2023―Sep―05 |
Background rates of adverse events of special interest for COVID-19 vaccines: A multinational Global Vaccine Data Network (GVDN) analysis |
A. Phillips, Y. Jiang, D. Walsh, N. Andrews, M. Artama, H. Clothier, L. Cullen, L. Deng, S. Escolano, A. Gentile, G. Gidding, N. Giglio, T. Junker, W. Huang, N. Janjua, J. Kwong, J. Li, S. Nasreen, M. Naus, Z. Naveed, A. Pillsbury, J. Stowe, T. Vo, J. Buttery, H. Petousis-Harris, S. Black, A. Hviid |
| 564 |
[GO] |
2023―Sep―04 |
Understanding low COVID-19 booster uptake among US adults |
Elizabeth T. Jacobs, Felina M. Cordova-Marks, Leslie V. Farland, Kacey C. Ernst, Jennifer G. Andrews, Sage Vu, Kelly M. Heslin, Collin Catalfamo, Zhao Chen, Kristen Pogreba-Brown |
| 565 |
[GO] |
2023―Sep―04 |
Characteristics of epitope dominance pattern and cross-variant neutralisation in 16 SARS-CoV-2 mRNA vaccine sera |
Mayo Yasugi, Yu Nakagama, Natsuko Kaku, Yuko Nitahara, Noritoshi Hatanaka, Shinji Yamasaki, Yasutoshi Kido |
| 566 |
[GO] |
2023―Sep―01 |
Confirmed cases of COVID-19 after vaccination against COVID in health personnel in Bogotá, Colombia |
Alexandra Porras-Ramírez, Rafael Sánchez-París, Walter López-Devia, Zuly Moreno-Perilla, Roberto Jurado-Zambrano, Carlos Luna-Jaspe Caina, Carlos Sefair, Nicolás Ramos, Miguel Otero-Cadena, Rocío Lievano |
| 567 |
[GO] |
2023―Sep―01 |
Correlates of COVID-19 vaccine coverage in Arkansas: Results from a weighted random sample survey |
Don E. Willis, Ramey Moore, Jennifer A. Andersen, Ji Li, James P. Selig, Joshua C. McKinnon, Morgan Gurel-Headley, Sharon Reece, Pearl A. McElfish |
| 568 |
[GO] |
2023―Sep―01 |
Timeline kinetics of protective immunity to SARS-CoV-2 upon primary vaccination and humoral response to variants after booster dose |
Maria da Penha Gomes Gouvea, Ketty Lysie Libardi Lira Machado, Yasmin Gurtler Pinheiro de Oliveira, Isac Ribeiro Moulaz, Allan Gonçalves Henriques, Thayná Martins Gouveia, Beatriz Paoli Thompson, Karen Evelin Monlevade Lança, Sabrina de Souza Ramos, Gabriela Curto Cristianes Lacerda, João Pedro Gonçalves Lenzi, Felipe de Castro Pimentel, João Pedro Moraes Miossi, Matheus Leite Rassele, Luiz Antônio Bastos Camacho, Daniel Antunes Maciel Villela, Sheila Maria Barbosa de Lima, Adriana de Souza Azevedo, Ingrid Siciliano Horbach, Mia Ferreira de Araújo, Luis Fernando Lopez Tort, Any Caroline Alves de Oliveira, Marilda Mendonça Siqueira, Cristiana Couto Garcia, Ismael Artur da Costa-Rocha, Ana Carolina Campi-Azevedo, Vanessa Peruhype-Magalhães, Vanézia Gonçalves da Silva, Samira Tatiyama Miyamoto, Rosilene Nilo dos Santos Fantoni, Lauro Ferreira Pinto-Neto, Carla Magda Domingues, Nésio Fernandes de Medeiros Junior, Ana Paula Burian, Andréa Teixeira-Carvalho, Licia Maria Henrique Mota, José Geraldo Mill, Olindo Assis Martins-Filho, Valéria Valim |
| 569 |
[GO] |
2023―Aug―31 |
Developmental and reproductive safety of Advax-CpG55.2™ adjuvanted COVID-19 and influenza vaccines in mice |
Isaac G. Sakala, Yoshikazu Honda-Okubo, Nikolai Petrovsky |
| 570 |
[GO] |
2023―Aug―31 |
Rheumatoid arthritis and older age are associated with lower humoral and cellular immune response to primary series COVID-19 mRNA vaccine |
Holly M. Dudley, Megan O'Mara, Ann Auma, Jenny Gong, Yael Ross, Natalie Gurevich, Sarah Carbone, Alex Reihs, Ynez Nguyen, Grace A. McComsey, Yi Cao, Alejandro B. Balazs, Larraine Gordesky, Michael Payne, Nora Singer, Lenche Kostadinova, Brigid Wilson, David A. Zidar, Christopher L. King, David H. Canaday, Carey L. Shive, Maya M. Mattar, Donald D. Anthony |
| 571 |
[GO] |
2023―Aug―31 |
The impact of the COVID-19 pandemic on parental vaccine hesitancy: A cross-sectional survey |
Lily A. Grills, Abram L. Wagner |
| 572 |
[GO] |
2023―Aug―31 |
Challenges & opportunities for the epidemiological evaluation of the effects of COVID-19 vaccination on reproduction and pregnancy |
Annette K. Regan, Deshayne B. Fell, Lauren A. Wise, Gabriela Vazquez-Benitez, Siri E. Håberg, Comfort Ogar, Jennifer J. Yland, Amelia K. Wesselink, Ousseny Zerbo |
| 573 |
[GO] |
2023―Aug―30 |
Canada’s National Advisory Committee on immunization: Adaptations and challenges during the COVID-19 pandemic |
Matthew Tunis, Shelley Deeks, Robyn Harrison, Caroline Quach, Shainoor Ismail, Marina Salvadori, Bryna Warshawsky, Kelsey Young, Christine Mauviel, Erin Henry |
| 574 |
[GO] |
2023―Aug―29 |
Social network, political climate, income inequality, and Americans uptake of monovalent COVID-19 booster |
Feng Hao, Wanyun Shao |
| 575 |
[GO] |
2023―Aug―29 |
Parental attitudes, beliefs and behaviors toward childhood and COVID-19 vaccines: A countrywide survey conducted in Kazakhstan examining vaccine refusal and hesitancy |
Alua Yeskendir, Arnur Gusmanov, Baurzhan Zhussupov |
| 576 |
[GO] |
2023―Aug―27 |
COVID-19 vaccine hesitancy among older adult Thai Muslim people: A case-control study |
Farooq Phiriyasart, Natnaree Aimyong, Ann Jirapongsuwan, Norisan Roseh |
| 577 |
[GO] |
2023―Aug―27 |
Vaccine microarray patch self-administration: An innovative approach to improve pandemic and routine vaccination rates |
E. Hacker, B. Baker, T. Lake, C. Ross, M. Cox, C. Davies, S.R. Skinner, R. Booy, A. Forster |
| 578 |
[GO] |
2023―Aug―26 |
The immunogenicity of Alum+CpG adjuvant SARS-CoV-2 inactivated vaccine in mice |
Jie Yang, Boran Li, Dongsheng Yang, Jie Wu, Anna Yang, Wenhui Wang, Fengjie Lin, Xin Wan, YuWei Li, Zhuo Chen, Shiyun Lv, Deqin Pang, Wenbo Liao, Shengli Meng, Jia Lu, Jing Guo, Zejun Wang, Shuo Shen |
| 579 |
[GO] |
2023―Aug―25 |
Immune responses and safety of COVID-19 vaccination in atypical hemolytic uremic syndrome patients in Taiwan |
I.-Ru Chen, Guei-Jane Wang, Po-Ren Hsueh, Chia-Hui Chou, Long-Bin Jeng, Hui-Ju Lin, Huang-Jiun Liao, Ping-Chin Lai, Jan-Gowth Chang, Chiu-Ching Huang |
| 580 |
[GO] |
2023―Aug―25 |
The prevalence and clinical course of shoulder injury related to vaccine administration (SIRVA) after COVID-19 vaccines in Dutch hospital workers |
Esther R.C. Janssen, Astrid Z. van Montfoort, Freek Hollman, Frederik O. Lambers Heerspink |
| 581 |
[GO] |
2023―Aug―25 |
Recombinant spike protein vaccines coupled with adjuvants that have different modes of action induce protective immunity against SARS-CoV-2 |
Shiho Chiba, Peter J. Halfmann, Shun Iida, Yuichiro Hirata, Yuko Sato, Makoto Kuroda, Tammy Armbrust, Samuel Spyra, Tadaki Suzuki, Yoshihiro Kawaoka |
| 582 |
[GO] |
2023―Aug―25 |
COVID-19 vaccine decision-making among Black women: A qualitative study |
Inari S. Mohammed, Rachel Widome, Kelly M. Searle |
| 583 |
[GO] |
2023―Aug―24 |
Use of adrenaline to manage suspected anaphylaxis following COVID-19 vaccination: An Australian retrospective cohort study |
Lucy Deng, Kathryn Tapper, Deepali Thosar, Emma Goeman, Louise Baker, Stephen Adelstein, Michael Boyle, David A Brown, Louise Evans, Connie Katelaris, Frederick Lee, Jamma Li, Sanjay Swaminathan, Mark S Taylor, Melanie Wong, Nicholas Wood |
| 584 |
[GO] |
2023―Aug―22 |
Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 spike ferritin nanoparticle vaccine antigen produced from two different cell lines |
Ozan S. Kumru, Mrinmoy Sanyal, Natalia Friedland, John M. Hickey, Richa Joshi, Payton Weidenbacher, Jonathan Do, Ya-Chen Cheng, Peter S. Kim, Sangeeta B. Joshi, David B. Volkin |
| 585 |
[GO] |
2023―Aug―19 |
Simultaneous administration of mRNA COVID-19 bivalent booster and influenza vaccines |
Tat'Yana A. Kenigsberg, Kristin Goddard, Kayla E. Hanson, Ned Lewis, Nicola Klein, Stephanie A. Irving, Allison L. Naleway, Bradley Crane, Tia L. Kauffman, Stanley Xu, Matthew F. Daley, Laura P. Hurley, Robyn Kaiser, Lisa A. Jackson, Amelia Jazwa, Eric S. Weintraub |
| 586 |
[GO] |
2023―Aug―18 |
Neutralizing antibody and T-cell responses against SARS-CoV-2 variants by heterologous CoronaVac/ChAdOx-1 vaccination in elderly subjects with chronic obstructive pulmonary disease |
Warawut Chaiwong, Nuchjira Takheaw, Supansa Pata, Witida Laopajon, Pilaiporn Duangjit, Juthamas Inchai, Chaicharn Pothirat, Chaiwat Bumroongkit, Athavudh Deesomchok, Theerakorn Theerakittikul, Atikun Limsukon, Pattraporn Tajarernmuang, Nutchanok Niyatiwatchanchai, Konlawij Trongtrakul, Kantinan Chuensirikulchai, Passaworn Cheyasawan, Chalerm Liwsrisakun, Watchara Kasinrerk |
| 587 |
[GO] |
2023―Aug―17 |
Lessons learned from the COVID-19 pandemic for improved influenza control |
Abraham Palache, John-Kenneth Billingsley, Kristin MacLaren, Lyn Morgan, Steven Rockman, Paula Barbosa |
| 588 |
[GO] |
2023―Aug―17 |
Predictors of incomplete COVID-19 vaccine schedule among adults in Scotland: Two retrospective cohort analyses of the primary schedule and third dose |
Kirsty Morrison, Lucy Cullen, Allan B. James, Vera Chua, Christopher Sullivan, Chris Robertson, Jade Carruthers, Rachael Wood, Karen Jeffrey, Calum MacDonald, Syed Ahmar Shah, Igor Rudan, Colin R. Simpson, Colin McCowan, Srinivasa Vittal Katikireddi, Zoe Grange, Lewis Ritchie, Aziz Sheikh |
| 589 |
[GO] |
2023―Aug―15 |
Are intelligent people more likely to get vaccinated? The association between COVID-19 vaccine adherence and cognitive profiles |
Meital Zur, Leah Shelef, Elon Glassberg, Noam Fink, Ilan Matok, Limor Friedensohn |
| 590 |
[GO] |
2023―Aug―14 |
Immunogenicity and reactogenicity of fractional, heterologous primary COVID-19 vaccination schedules with BNT162b2 boosters in 5-11-year-old Thai children: A multicenter, prospective, double-blind, randomized control trial |
Orasri Wittawatmongkol, Pornumpa Bunjoungmanee, Pope Kosalaraksa, Kamolwish Laoprasopwattana, Sophida Boonsathorn, Napaporn Chantasrisawad, Tavitiya Sudjaritruk, Suvimol Niyomnaitham, Sansnee Senawong, Kanjana Srisutthisamphan, Zheng Quan Toh, Supattra Rungmaitree, Sira Nanthapisal, Supranee Phanthanawiboon, Puttichart Khantee, Chonnamet Techasaensiri, Nattiya Hirankarn, Sipang Pangprasertkul, Kulkanya Chokephaibulkit |
| 591 |
[GO] |
2023―Aug―14 |
DS-5670a, a novel mRNA-encapsulated lipid nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2: Results from a phase 2 clinical study |
Kaoru Toyama, Takashi Eto, Kenji Takazawa, Shinji Shimizu, Tetsuo Nakayama, Kei Furihata, Yoshitaka Sogawa, Masafumi Kumazaki, Nao Jonai, Satoko Matsunaga, Fumihiko Takeshita, Kazutaka Yoshihara, Hitoshi Ishizuka |
| 592 |
[GO] |
2023―Aug―12 |
Parental acceptability of vaccinating young children against influenza and COVID-19 |
Céline Berthélémy, Pascal Bouché, Zohra Lamiral, Jean-Marc Boivin |
| 593 |
[GO] |
2023―Aug―10 |
Impact of CoronaVac on Covid-19 outcomes of elderly adults in a large and socially unequal Brazilian city: A target trial emulation study |
Higor S. Monteiro, Antonio S. Lima Neto, Rebecca Kahn, Geziel S. Sousa, Humberto A. Carmona, José S. Andrade, Marcia C. Castro |
| 594 |
[GO] |
2023―Aug―06 |
COVID-19 vaccine behaviour among citizens of the Métis Nation of Ontario: A qualitative study |
Abigail J. Simms, Keith D. King, Noel Tsui, Sarah A. Edwards, Graham Mecredy |
| 595 |
[GO] |
2023―Aug―06 |
Individual and structural determinants of COVID-19 vaccine uptake in a marginalized community in the United States |
Jeanna Campbell, Amandeep Kaur, Danilo Gamino, Ellen Benoit, Brianna Amos, Liliane Windsor |
| 596 |
[GO] |
2023―Aug―04 |
Safety profile and SARS-CoV-2 breakthrough infections among HCWs receiving anti-SARS-CoV-2 and influenza vaccines simultaneously: an Italian observational study |
L. Moscara, V. Venerito, A. Martinelli, A. Di Lorenzo, F. Toro, F. Violante, S. Tafuri, P. Stefanizzi |
| 597 |
[GO] |
2023―Aug―04 |
Inactivated SARS-CoV-2 vaccination does not disturb the clinical course of Graves’ disease: An observational cohort study |
Shichen Xu, Huixin Yu, Xian Cheng, Jing Wu, Jiandong Bao, Li Zhang |
| 598 |
[GO] |
2023―Aug―03 |
Protection against symptomatic SARS-CoV-2 infection conferred by the Pfizer-BioNTech Original/BA.4-5 bivalent vaccine compared to the mRNA Original monovalent vaccines - A matched cohort study in France |
Vincent Auvigne, Cynthia Raissa Tamandjou Tchuem, Justine Schaeffer, Sophie Vaux, Isabelle Parent Du Chatelet |
| 599 |
[GO] |
2023―Jul―30 |
A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States |
Megan Wallace, Hannah G. Rosenblum, Danielle L. Moulia, Karen R. Broder, Tom T. Shimabukuro, Christopher A. Taylor, Fiona P. Havers, Sarah A. Meyer, Kathleen Dooling, Sara E. Oliver, Stephen C. Hadler, Julia W. Gargano |
| 600 |
[GO] |
2023―Jul―29 |
Beyond the numbers: An in-depth look at Cameroon's fifth national COVID-19 vaccination campaign through geographical and gender lenses |
Adidja Amani, Andreas Ateke Njoh, Phionah Atuhebwe, Shalom Ndoula, Raoul Nembot, Franck Mbossou, Landry Tsague, Lionel Adisso, André Arsène Bita Fouda, Elizabeth Gonese, Nadine Perrault, Phanuel Habimana, Yauba Saidu, Imran Mirza, Donatien Ntakarutimana, Thierno Balde, Richard Mihigo, Ted Chaiban, Abdou Salam Gueye |
| 601 |
[GO] |
2023―Jul―29 |
Comparative effectiveness of four COVID-19 vaccines, BNT162b2 mRNA, mRNA-1273, ChAdOx1 nCov-19 and NVX-CoV2373 against SARS-CoV-2 B.1.1.529 (Omicron) infection |
Bette Liu, Sandrine Stepien, Jiahui Qian, Heather Gidding, Katrina Nicolopoulos, Janaki Amin, Allen Cheng, Kristine Macartney |
| 602 |
[GO] |
2023―Jul―28 |
COVID-19 vaccine uptake before and after a vaccine mandate at a major academic hospital: Trends by race/ethnicity and level of patient contact |
Judith Green-McKenzie, Frances S. Shofer, Gregory Kruse, Florence Momplaisir, Patrick J. Brennan, Barbara J. Kuter |
| 603 |
[GO] |
2023―Jul―27 |
Robust immunogenicity of a third BNT162b2 vaccination against SARS-CoV-2 Omicron variant in a naïve New Zealand cohort |
Brittany Lavender, Caitlin Hooker, Chris Frampton, Michael Williams, Simon Carson, Aimee Paterson, Reuben McGregor, Nicole J. Moreland, Katie Gell, Frances H. Priddy, Kjesten Wiig, Graham Le Gros, James E. Ussher, Maia Brewerton |
| 604 |
[GO] |
2023―Jul―26 |
BNT162b2 mRNA COVID-19 against symptomatic Omicron infection following a mass vaccination campaign in southern Brazil: A prospective test-negative design study |
Regis Goulart Rosa, Maicon Falavigna, Josélia Larger Manfio, Cintia Laura Pereira de Araujo, Mírian Cohen, Gynara Rezende Gonzalez do Valle Barbosa, Ana Paula de Souza, Fernanda Kelly Romeiro Silva, Daniel Sganzerla, Mariana Motta Dias da Silva, Diogo Ferreira, Cristina de Oliveira Rodrigues, Emanuel Maltempi de Souza, Jaqueline Carvalho de Oliveira, Daniela Fiori Gradia, Ana Paula Carneiro Brandalize, Carla Adriane Royer, Rafael Messias Luiz, Gabriela Almeida Kucharski, Fernando Pedrotti, Srinivas Rao Valluri, Amit Srivastava, Viviane Wal Julião, Olga Chameh Melone, Kristen E. Allen, Moe H. Kyaw, Julia Spinardi, Graciela del Carmen Morales Castillo, John M. McLaughlin |
| 605 |
[GO] |
2023―Jul―22 |
Effectiveness of COVID-19 vaccines against infection in Japan: A test-negative study from the VENUS study |
Yudai Tamada, Kenji Takeuchi, Taro Kusama, Megumi Maeda, Fumiko Murata, Ken Osaka, Haruhisa Fukuda |
| 606 |
[GO] |
2023―Jul―20 |
Safety signal identification for COVID-19 bivalent booster vaccination using tree-based scan statistics in the Vaccine Safety Datalink |
W. Katherine Yih, Matthew F. Daley, Jonathan Duffy, Bruce Fireman, David L. McClure, Jennifer C. Nelson, Lei Qian, Ning Smith, Gabriela Vazquez-Benitez, Eric Weintraub, Joshua T.B. Williams, Stanley Xu, Judith C. Maro |
| 607 |
[GO] |
2023―Jul―20 |
Impact of a COVID-19 certificate requirement on vaccine uptake pattern and intention for future vaccination. A cross-sectional study among French adults |
Lucia Araujo-Chaveron, Jonathan Sicsic, Hadrien Moffroid, Carolina Díaz Luévano, Serge Blondel, François Langot, Judith E. Mueller |
| 608 |
[GO] |
2023―Jul―20 |
COVID-19 vaccine uptake in mental healthcare users: Czech nationwide register study |
Vojtech Pisl, Jan Vevera |
| 609 |
[GO] |
2023―Jul―16 |
Vaccine hesitancy comes in waves: Longitudinal evidence on willingness to vaccinate against COVID-19 from seven European countries |
Iryna Sabat, Sebastian Neumann-Böhme, Pedro Pita Barros, Aleksandra Torbica, Job van Exel, Werner Brouwer, Tom Stargardt, Jonas Schreyögg |
| 610 |
[GO] |
2023―Jul―16 |
Social inequalities and the early provision and dispersal of COVID-19 vaccinations in the United States: A population trends study |
Sean A.P. Clouston, Douglas W. Hanes, Bruce G. Link |
| 611 |
[GO] |
2023―Jul―16 |
Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate |
Alexandra Moros, Antoni Prenafeta, Antonio Barreiro, Eva Perozo, Alex Fernández, Manuel Cañete, Luis González, Carme Garriga, Edwards Pradenas, Silvia Marfil, Julià Blanco, Paula Cebollada Rica, Marta Sisteré-Oró, Andreas Meyerhans, Teresa Prat Cabañas, Ricard March, Laura Ferrer |
| 612 |
[GO] |
2023―Jul―13 |
COVID-19 mRNA vaccines as hypothetical epigenetic players: Results from an in silico analysis, considerations and perspectives |
Rossella Talotta |
| 613 |
[GO] |
2023―Jul―13 |
Impact of COVID vaccine and comorbidities in patients receiving casirivimab-imdevimab monoclonal antibody during SARS-CoV-2 B.1.617.2 (Delta) surge: A real-world study |
Pankaj Agrawal, Dushyant Damania, Attila Cseh, John Grab, Laura Strom, Brianna Frank, Dhruv Patel, Griffin Clyatt |
| 614 |
[GO] |
2023―Jul―07 |
Social processes, practical issues, and COVID-19 vaccination among hesitant adults |
Don E. Willis, Sharon Reece, Morgan Gurel-Headley, James P. Selig, Ji Li, Stacy Zimmerman, Lawrence E. Cornett, Pearl A. McElfish |
| 615 |
[GO] |
2023―Jul―05 |
Let's talk about COVID-19 vaccination: relevance of conversations about COVID-19 vaccination and information sources on vaccination intention in Switzerland |
Aylin Wagner, Sibylle Juvalta, Camilla Speranza, L. Suzanne Suggs, Julia Drava |
| 616 |
[GO] |
2023―Jul―03 |
Heavy bleeding and other menstrual disturbances in young women after COVID-19 vaccination |
Lill Trogstad, Ida Laake, Anna H Robertson, Siri Mjaaland, Ida H Caspersen, Lene K Juvet, Per Magnus, Kristine Blix, Berit Feiring |
| 617 |
[GO] |
2023―Jul―03 |
Barriers to COVID-19 vaccination of migrant populations: a qualitative interview study of immunisation providers in Victoria, Australia |
Jane Tuckerman, Jessica Kaufman, Isabella Overmars, Philippa Holland, Margie Danchin |
| 618 |
[GO] |
2023―Jul―03 |
Between nudges and mandates: The drivers of COVID-19 vaccination intentions and subsequent uptake in Russia |
Yana Roshchina, Ksenia Rozhkova, Sergey Roshchin |
| 619 |
[GO] |
2023―Jul―03 |
Veteran influenza vaccination acceptance rates after completion of the COVID-19 vaccination series among historical influenza vaccine refusers |
Ursula C. Patel, Thomas Schultz, Justin Schmidt |
| 620 |
[GO] |
2023―Jun―30 |
Immunogenicity and protective effects of recombinant bivalent COVID-19 vaccine in mice and rhesus macaques |
Yuying Liu, Aijing Zhang, Yan Wang, Jianguo Yang, Fei Yin, Shuming Wu, Yao Zhang, Xulin Jiang, Jiaton Zhu, Wenshuang Gao, Xiufen Yang, Hongyan Wen, Qian Guo, Xiao Chen, Hongcai Zhang, Ercui Shen, Zengmin Yang, Yakun Li, Dan Chen, Ling Li, Jiaping Guo, Xiaoli Du, Yazheng Shi, Sijia Fu, Haijiang Zhang, Yongjiang Liu |
| 621 |
[GO] |
2023―Jun―30 |
Effectiveness of inactivated influenza and COVID-19 vaccines in hospitalized children in 2022/23 season in Japan - The first season of co-circulation of influenza and COVID-19 |
Masayoshi Shinjoh, Munehiro Furuichi, Shinya Tsuzuki, Asef Iqbal, Naoya Fukushima, Sachiko Soen, Hiroyuki Fukushima, Ken Kobayashi, Go Yamada, Atsushi Narabayashi, Kenichiro Tsunematsu, Naonori Maeda, Motoko Shimoyamada, Makoto Yoshida, Yuu Kuramochi, Akimichi Shibata, Yoshio Yamaguchi, Mizuki Yaginuma, Takao Takahashi, Masahiro Ishikane, Norio Sugaya |
| 622 |
[GO] |
2023―Jun―28 |
Intranasal VLP-RBD vaccine adjuvanted with BECC470 confers immunity against Delta SARS-CoV-2 challenge in K18-hACE2-mice |
Katherine S Lee, Nathaniel A Rader, Olivia A Miller, Melissa Cooper, Ting Y Wong, Md. Shahrier Amin, Mariette Barbier, Justin R Bevere, Robert K Ernst, F. Heath Damron |
| 623 |
[GO] |
2023―Jun―27 |
Safety surveillance of the NVX-CoV2373 COVID-19 vaccine among Koreans aged 18 years and over |
Seontae Kim, Mijeong Ko, Yesul Heo, Yeon-Kyeng Lee, Yunhyung Kwon, Seok-Kyoung Choi, Eunok Bahng |
| 624 |
[GO] |
2023―Jun―24 |
Characterization of immune responses to two and three doses of the adenoviral vectored vaccine ChAdOx1 nCov-19 and the whole virion inactivated vaccine BBV152 in a mix-and-match study in India |
Anita Chaudhary, Ramya Madhavan, Sudhir Babji, Reshma Raju, Chanduni Syed, Ajith Kumar, Poornima Saravanan, Origanti Sharon Nikitha, Julian Vivek Leander Xavier, Jenita Sharon David Chelladurai, Arpitha Anbu Deborah, Anna George, Gagandeep Kang, Winsley Rose |
| 625 |
[GO] |
2023―Jun―23 |
Immediate adverse reactions following COVID-19 vaccination among 16-65-year-old Danish citizens |
K. Torp Hansen, F. Kusk Povlsen, B. Hammer Bech, S. Nygaard Hansen, C. Ulrikka Rask, P. Fink, T. Jørgensen, H. Nielsen, T. Meinertz Dantoft, S. Marie Thysen, D. Rytter |
| 626 |
[GO] |
2023―Jun―23 |
Public Perception of COVID-19 Vaccines through Analysis of Twitter Content and Users |
Sameh N. Saleh, Samuel A. McDonald, Mujeeb A. Basit, Sanat Kumar, Reuben J. Arasaratnam, Trish M. Perl, Christoph U. Lehmann, Richard J. Medford |
| 627 |
[GO] |
2023―Jun―23 |
Modifiers of COVID-19 Vaccine Efficacy: Results from Four COVID-19 Prevention Network Efficacy Trials |
Christine B. Turley, LaKesha Tables, Trevon Fuller, Lisa J. Sanders, Hyman Scott, Amaran Moodley, Amanda S. Woodward Davis, Brett Leav, Jacqueline Miller, Kathryn Schoemaker, An Vandebosch, Jerald Sadoff, Wayne Woo, Iksung Cho, Lisa M. Dunkle, Sijia Li, Lars van der Laan, Peter B. Gilbert, Dean Follmann, Holly Jaynes, James G. Kublin, Lindsey R. Baden, Paul Goepfert, Karen Kotloff, Cynthia L. Gay, Ann R. Falsey, Hana M. El Sahly, Magdalena E. Sobieszczyk, Yunda Huang, Kathleen M. Neuzil, Lawrence Corey, Beatriz Grinsztejn, Glenda Gray, Nadine Rouphael, Alex Luedtke |
| 628 |
[GO] |
2023―Jun―21 |
A cohort study reveals different dynamics of SARS-CoV-2-specific antibody formation after Comirnaty and Vaxzevria vaccination |
Adam Augustyniak, Tomasz Szymanski, Filip Porzucek, Adam Aron Mieloch, Julia Anna Semba, Katarzyna Anna Hubert, Dominika Grajek, Rafał Krela, Zuzanna Rogalska, Ewa Zalc-Budziszewska, Sławomir Wysocki, Krzysztof Sobczak, Lechosław Kuczyński, Jakub Dalibor Rybka |
| 629 |
[GO] |
2023―Jun―20 |
How to Model the Impact of Vaccines for Policymaking When the Characteristics are Uncertain: A Case Study in Thailand Prior to the Vaccine Rollout During the COVID-19 Pandemic |
Nantasit Luangasanatip, Chris Painter, Wirichada Pan-ngum, Sompob Saralamba, Tanaphum Wichaita, Lisa White, Ricardo Aguas, Hannah Clapham, Yi Wang, Wanrudee Isaranuwatchai, Yot Teerawattananon |
| 630 |
[GO] |
2023―Jun―20 |
PD-1/PD-L1 blockade restores tumor-induced COVID-19 vaccine bluntness |
Xiangyu Chen, Yao Lin, Shuai Yue, Yang Yang, Xiaofan Yang, Junjian He, Leiqiong Gao, Zhirong Li, Li Hu, Jianfang Tang, Yifei Wang, Qin Tian, Yaxing Hao, Lifan Xu, Qizhao Huang, Yingjiao Cao, Lilin Ye |
| 631 |
[GO] |
2023―Jun―19 |
Impacts of routine varicella vaccination program and COVID-19 pandemic on varicella and herpes zoster incidence and health resource use among children in Japan |
Kazuhiro Ud, Yusuke Okubo, Mitsuru Tsuge, Hirokazu Tsukahara, Isao Miyairi |
| 632 |
[GO] |
2023―Jun―19 |
Compliance, procrastination and refusal: American COVID-19 vaccination trust and value orientation |
Rueyling Tzeng, Fang-Yi Huang, Jaein Lee |
| 633 |
[GO] |
2023―Jun―19 |
An Advax-CpG55.2™ adjuvanted recombinant spike protein vaccine protects Cynomolgus macaques from a homologous SARS-CoV-2 virus challenge |
Yoshikazu Honda-Okubo, Lei Li, Greiciely André, King Ho Leong, Elizabeth W. Howerth, Anne G. Bebin-Blackwell, Ted M. Ross, Nikolai Petrovsky |
| 634 |
[GO] |
2023―Jun―16 |
Public opinion on COVID-19 vaccine prioritization in Bangladesh: Who gets the vaccine and whom do you leave out? |
Raaj Kishore Biswas, Awan Afiaz, Samin Huq, Maysha Farzana, Enamul Kabir |
| 635 |
[GO] |
2023―Jun―16 |
Licenced doses of approved COVID-19 vaccines may not be optimal: a review of the early-phase, dose-finding trials |
David T Dunn, Richard Gilson, Sheena McCormack, Laura E McCoy |
| 636 |
[GO] |
2023―Jun―15 |
Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink |
Tat'Yana A. Kenigsberg, Kayla E. Hanson, Nicola P. Klein, Ousseny Zerbo, Kristin Goddard, Stanley Xu, W. Katherine Yih, Stephanie A. Irving, Laura P. Hurley, Jason M. Glanz, Robyn Kaiser, Lisa A. Jackson, Eric S. Weintraub |
| 637 |
[GO] |
2023―Jun―15 |
Evaluation of Potential Adverse Events Following COVID-19 mRNA Vaccination Among Adults Aged 65 Years and Older: Two Self-Controlled Studies in the U.S |
Azadeh Shoaibi, Patricia C. Lloyd, Hui-Lee Wong, Tainya C. Clarke, Yoganand Chillarige, Rose Do, Mao Hu, Yixin Jiao, Andrew Kwist, Arnstein Lindaas, Kathryn Matuska, Rowan McEvoy, Michelle Ondari, Shruti Parulekar, Xiangyu Shi, Jing Wang, Yun Lu, Joyce Obidi, Cindy K. Zhou, Jeffrey A. Kelman, Richard A. Forshee, Steven A. Anderson |
| 638 |
[GO] |
2023―Jun―15 |
Intramuscular administration of recombinant Newcastle disease virus expressing SARS-CoV-2 spike protein protects hACE-2 TG mice against SARS-CoV-2 infection |
Deok-Hwan Kim, Jiho Lee, Sungsu Youk, Jei-hyun Jeong, Da-ye Lee, Hyo-seon Ju, Ha-na Youn, Jin-cheol Kim, Soo-bin Park, Ji-eun Park, Ji-yun Kim, Tae-hyeon Kim, Seung-hun Lee, Hyukchae Lee, Lah Mouhamed Abdallah Amal Abdal, Dong-Hun Lee, Pil-Gu Park, Kee-Jong Hong, Chang-Seon Song |
| 639 |
[GO] |
2023―Jun―15 |
Single Ad26.COV2.S booster dose following two doses of BBIBP-CorV vaccine against SARS-CoV-2 infection in adults: day 28 results of a phase 1/2 open-label trial |
Sant Muangnoicharoen, Rakpong Wiangcharoen, Sira Nanthapisal, Supitcha Kamolratakul, Saranath Lawpoolsri, Anan Jongkaewwattana, Arunee Thitithanyanont, Viravarn Luvira, Pailinrut Chinwangso, Narumon Thanthamnu, Narisara Chantratita, Jacqueline Kyungah Lim, T. Anh Wartel, Jean-Louis Excler, Martin F. Ryser, Chloe Leong, Tippi K. Mak, Punnee Pitisuttithum |
| 640 |
[GO] |
2023―Jun―13 |
COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn |
Flor M. Munoz, Christine M. Posavad, Barbra A. Richardson, Martina L. Badell, Katherine E. Bunge, Mark J. Mulligan, Lalitha Parameswaran, Clifton W. Kelly, Courtney Olson-Chen, Richard M. Novak, Rebecca C. Brady, Marcela F. Pasetti, Emily A. Defranco, Jeffrey S. Gerber, Ms. Mallory C. Shriver, Mehul S. Suthar, Rhea N. Coler, Bryan J. Berube, Ms. So Hee Kim, Jeanna M. Piper, Ms. Ashley M. Miller, Cristina V. Cardemil, Kathleen M. Neuzil, Richard H. Beigi |
| 641 |
[GO] |
2023―Jun―09 |
Uptake of COVID-19 vaccines among healthcare workers and the effect of nudging interventions: A mixed methods study |
Bahar Madran, İlker Kayi, Ayşe Beşer, Önder Ergönül |
| 642 |
[GO] |
2023―Jun―09 |
Cellular and humoral immune responses after a third dose of SARS-CoV-2 mRNA vaccine in lung transplant recipients in Japan |
Masahiro Ui, Takashi Hirama, Miki Akiba, Masako Honda, Toshiaki Kikuchi, Yoshinori Okada |
| 643 |
[GO] |
2023―Jun―08 |
Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021- January 2022 |
Brechje de Gier, Liselotte van Asten, Tjarda M. Boere, Annika van Roon, Caren van Roekel, Joyce Pijpers, C.H. Henri van Werkhoven, Caroline van den Ende, Susan J.M. Hahné, Hester E. de Melker, Mirjam J. Knol, Susan van den Hof |
| 644 |
[GO] |
2023―Jun―08 |
Seasonal influenza vaccination in the Americas: Progress and challenges during the COVID-19 pandemic |
Francisco Nogareda, Radhika Gharpure, Marcela Contreras, Martha Velandia, Carmelita Lucia Pacis, Ana Elena Chevez, Eduardo Azziz-Baumgartner, Daniel Salas |
| 645 |
[GO] |
2023―Jun―07 |
Re-evaluation of the risk of venous thromboembolism after COVID-19 vaccination using haematological criteria |
Rebecca J Shaw, Andrew J Doyle, Emily A Millen, Julia Stowe, Elise Tessier, Nick Andrews, Elizabeth Miller |
| 646 |
[GO] |
2023―Jun―06 |
From High Hopes to Disenchantment: A Qualitative Analysis of Editorial Cartoons on COVID-19 Vaccines in Canadian Newspapers |
Catherine Pelletier, Fabienne Labbé, Julie A. Bettinger, Janet Curran, Janice E. Graham, Devon Greyson, Noni E. MacDonald, Samantha B. Meyer, Audrey Steenbeek, Weiai Xu, Ève Dubé |
| 647 |
[GO] |
2023―Jun―06 |
Immune response enhancement with GLS-5310 DNA primary vaccine against SARS-CoV-2 followed by administration of an mRNA vaccine heterologous boost |
Woo Joo Kim, Christine C. Roberts, Joon Young Song, Jin Gu Yoon, Hye Seong, Hak-Jun Hyun, Hyojin Lee, Areum Gil, Yeeun Oh, Ji-Eun Park, Ji-Eun Lee, Bohyun Jeon, Deborah Kane, Susan Spruill, Sagar B. Kudchodkar, Kar Muthumani, Young K. Park, Ijoo Kwon, Joel N. Maslow |
| 648 |
[GO] |
2023―Jun―06 |
Protective immunity induced by an inhaled SARS-CoV-2 subunit vaccine |
Elizabeth Elder, Chandrashekar Bangalore Revanna, Catharina Johansson, Robert P.A. Wallin, Johan Sjödahl, Ola Winqvist, Ali Mirazimi |
| 649 |
[GO] |
2023―Jun―05 |
COVID-19 vaccination and menstrual cycle characteristics: A prospective cohort study |
Amelia K. Wesselink, Sharonda M. Lovett, Janice Weinberg, Ruth J. Geller, Tanran R. Wang, Annette K. Regan, Mary D. Willis, Rebecca B. Perkins, Jennifer J. Yland, Martha R. Koenig, Kenneth J. Rothman, Elizabeth E. Hatch, Lauren A. Wise |
| 650 |
[GO] |
2023―Jun―05 |
Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: Evidence for immunogenicity of PEG |
Gergely Tibor Kozma, Tamás Mészáros, Petra Berényi, Réka Facskó, Zsófia Patkó, Csaba Zs. Oláh, Adrienne Nagy, Tamás Gyula Fülöp, Kathryn Anne Glatter, Tamás Radovits, Béla Merkely, János Szebeni |
| 651 |
[GO] |
2023―Jun―05 |
Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort study |
Jennifer H. Ku, Lina S. Sy, Lei Qian, Bradley K. Ackerson, Yi Luo, Julia E. Tubert, Gina S. Lee, Ana Florea, Katia J. Bruxvoort, Fagen Xie, Sijia Qiu, Scott Chavers, Carla A. Talarico, Hung Fu Tseng |
| 652 |
[GO] |
2023―Jun―05 |
Immunological responses and adverse reactions of the heterologous second booster dose of BNT162b2 after two-dose CoronaVac for COVID-19 vaccination in healthcare workers of Faculty of Medicine, Naresuan University |
Supawadee Makanut, Apirath Wangteeraprasert, Wittawat Jitpewngam, Jatuporn Ngoenkam, Sutatip Pongcharoen |
| 653 |
[GO] |
2023―Jun―02 |
One year safety and immunogenicity of AZD1222 (ChAdOx1 nCoV-19): Final analysis of a randomized, placebo-controlled phase 1/2 trial in Japan |
Kensuke Ishikawa, Maria-Claudia Nascimento, Michiko Asano, Hajime Hirata, Yohji Itoh, Elizabeth J. Kelly, Akiko Matsui, Urban Olsson, Kathryn Shoemaker, Justin Green |
| 654 |
[GO] |
2023―Mai―29 |
Effectiveness of the booster dose of COVID-19 vaccine in the Basque Country during the sixth wave: a nationwide cohort study |
A. Arrospide, MG. Sagardui, I. Larizgoitia, A. Iturralde, A. Moreda, J. Mar J |
| 655 |
[GO] |
2023―Mai―29 |
Vaccination, Human Mobility, and COVID-19 Health Outcomes: Empirical Comparison Before and During the Outbreak of SARS-Cov-2 B.1.1.529 (Omicron) Variant |
Songhua Hu, Chenfeng Xiong, Yingrui Zhao, Xin Yuan, Xuqiu Wang |
| 656 |
[GO] |
2023―Mai―29 |
Medical outcomes of children with neurodevelopmental disorders after SARS-CoV-2 vaccination: A six-month follow-up study |
Liang-Jen Wang, Ching-Shu Tsai, Wen-Jiun Chou, Chia-Jung Lee, Sheng-Yu Lee, Yi-Jun Chen, I-Chun Lin |
| 657 |
[GO] |
2023―Mai―24 |
Spontaneously reported adverse events following COVID-19 basic and booster immunizations in The Netherlands |
Saskia C. van der Boor, Else T.J. Schmitz-de Vries, Dennis Smits, Joep H.G. Scholl, Leàn Rolfes, Florence van Hunsel |
| 658 |
[GO] |
2023―Mai―24 |
COVID-19 Vaccine Safety Inquiries to the Centers for Disease Control and Prevention Immunization Safety Office |
Elaine R. Miller, Pedro L. Moro, Tom T. Shimabukuro, Grace Carlock, Shaeyla Davis, Emma Freeborn, Amy Roberts, Julianne Gee, Allan W. Taylor, Ruth Gallego, Tiffany Suragh, John R. Su |
| 659 |
[GO] |
2023―Mai―22 |
Efficacy and safety of mRNA and AstraZeneca COVID-19 vaccines in patients with autoimmune rheumatic diseases: A systematic review |
Anwar I. Joudeh, Abdu Qaid Lutf, Salah Mahdi, Gui Tran |
| 660 |
[GO] |
2023―Mai―22 |
Incidence of myopericarditis after mRNA COVID-19 vaccination: a meta-analysis with focus on adolescents aged 12-17 years |
Bao-Qiang Guo, Hong-Bin Li, Li-Qiang Yang |
| 661 |
[GO] |
2023―Mai―22 |
Effectiveness of COVID-19 Vaccines at Preventing Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompromised Adults: An Observational Study of Real-World Data Across 10 US States from August-December 2021 |
Peter J. Embi, Matthew E. Levy, Palak Patel, Malini B. DeSilva, Manjusha Gaglani, Kristin Dascomb, Margaret M. Dunne, Nicola P. Klein, Toan C. Ong, Shaun J. Grannis, Karthik Natarajan, Duck-Hye Yang, Edward Stenehjem, Ousseny Zerbo, Charlene McEvoy, Suchitra Rao, Mark G. Thompson, Deepika Konatham, Stephanie A. Irving, Brian E. Dixon, Jungmi Han, Kristin E. Schrader, Nancy Grisel, Ned Lewis, Anupam B. Kharbanda, Michelle A. Barron, Sue Reynolds, I-Chia Liao, William F. Fadel, Elizabeth A. Rowley, Julie Arndorfer, Kristin Goddard, Kempapura Murthy, Nimish R. Valvi, Zachary A. Weber, Bruce Fireman, Sarah E. Reese, Sarah W. Ball, Allison L. Naleway |
| 662 |
[GO] |
2023―Mai―22 |
Estimating global changes in routine childhood vaccination coverage during the COVID-19 pandemic, 2020-2021 |
Cyrus Ghaznavi, Akifumi Eguchi, Kaung Suu Lwin, Daisuke Yoneoka, Yuta Tanoue, Rauniyar Santosh Kumar, Sayaka Horiuchi, Masahiro Hashizume, Shuhei Nomura |
| 663 |
[GO] |
2023―Mai―22 |
Title: A qualitative study on COVID-19 pandemic impacts on parental attitudes and intentions for routine adolescent vaccinations: the role of trust |
Katarzyna T Bolsewicz, Maryke S Steffens, Catherine King, Ikram Abdi, Bianca Bullivant, Frank Beard |
| 664 |
[GO] |
2023―Mai―22 |
Humoral and cell-mediated immune responses to BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis |
Alicandro G, Orena BS, Rosazza C, Cariani L, Russo M, Zatelli M, Badolato R, Gramegna A, Blasi F, Daccò V |
| 665 |
[GO] |
2023―Mai―17 |
Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination |
Zhao-Hua Zhou, Margaret M. Cortese, Jia-Long Fang, Robert Wood, Donna S. Hummell, Kimberly A. Risma, Allison E. Norton, Mark KuKuruga, Susan Kirshner, Ronald L. Rabin, Cyrus Agarabi, Mary A. Staat, Natasha Halasa, Russell Ware, Anna Stahl, Maureen McMahon, Peter Browning, Panagiotis Maniatis, Shanna Bolcen, Kathryn M. Edwards, John R. Su, Sai Dharmarajan, Richard Forshee, Karen R. Broder, Steven Anderson, Steven Kozlowski |
| 666 |
[GO] |
2023―Mai―17 |
Uncovering inequities in Covid-19 vaccine coverage for adults and elderly in Brazil: A multilevel study of 2021-2022 data |
Antonio Fernando Boing, Alexandra Crispim Boing, Lorena Barberia, Marcelo Eduardo Borges, SV Subramanian |
| 667 |
[GO] |
2023―Mai―15 |
Comparison of mRNA Vaccine Effectiveness against COVID-19-associated Hospitalization by Vaccination Source: Immunization Information Systems, Electronic Medical Records, and Self-Report - IVY Network, February 1*August 31, 2022 |
Diya Surie, Levi Bonnell, Jennifer DeCuir, Manjusha Gaglani, Tresa McNeal, Shekhar Ghamande, Jay S. Steingrub, Nathan I. Shapiro, Laurence W. Busse, Matthew E. Prekker, Ithan D. Peltan, Samuel M. Brown, David N. Hager, Harith Ali, Michelle N. Gong, Amira Mohamed, Akram Khan, Jennifer G. Wilson, Nida Qadir, Steven Y. Chang, Adit A. Ginde, David Huynh, Nicholas M. Mohr, Christopher Mallow, Emily T. Martin, Adam S. Lauring, Nicholas J. Johnson, Jonathan D. Casey, Kevin W. Gibbs, Jennie H. Kwon, Adrienne Baughman, James D. Chappell, Kimberly W. Hart, Carlos G. Grijalva, Jillian P. Rhoads, Sydney A. Swan, H. Keipp Talbot, Kelsey N. Womack, Yuwei Zhu, Mark W. Tenforde, Katherine Adams, Wesley H. Self, Meredith L. McMorrow |
| 668 |
[GO] |
2023―Mai―15 |
COVID-19 Vaccine Decision-making among Pregnant and Lactating Women in Bangladesh |
Rupali J. Limaye, Prachi Singh, Alicia Paul, Berhaun Fesshaye, Clarice Lee, Eleonor Zavala, Sydney Wade, Hasmot Ali, Hafizur Rahman, Shirina Akter, Ruth Karron, Towfida Jahan Siddiqua |
| 669 |
[GO] |
2023―Mai―15 |
Assessing vaccine safety during a pandemic: Recent experience and lessons learned for the future |
Steven B. Black, Rebecca E Chandler, Kathryn M. Edwards, Miriam C.J.M. Sturkenboom |
| 670 |
[GO] |
2023―Mai―11 |
Factors Associated with Receipt of mRNA-1273 Vaccine at a United States National Retail Pharmacy During the COVID-19 Pandemic |
Erin Roberts, Philip O. Buck, Renae L. Smith-Ray, Nicolas Van de Velde, Tanya Singh, James Mansi, Amy Shah, Michael Taitel |
| 671 |
[GO] |
2023―Mai―10 |
Number of COVID-19 hospitalisations averted by vaccination: Estimates for the Netherlands, January 6, 2021 through August 30, 2022 |
Senna C.J.L. van Iersel, Scott A. McDonald, Brechje de Gier, Mirjam J. Knol, Hester E. de Melker, C.H. Henri van Werkhovena, Susan J.M. Hahné |
| 672 |
[GO] |
2023―Mai―10 |
The increasing age of respiratory syncytial virus-related hospitalisation during COVID-19 pandemic in Lyon was associated with reduced hospitalisation costs |
Álvaro Roy, Stéphanie Polazzi, Dominique Ploin, Yves Gillet, Etienne Javouhey, Bruno Lina, VRS study group in Lyon, Anne-Florence Myard-Dury, Sandrine Couray-Targe, Antoine Duclos, Jean-Sébastien Casalegno |
| 673 |
[GO] |
2023―Mai―10 |
Safety of the NVX-CoV2373 COVID-19 Vaccine in Randomized Placebo-Controlled Clinical Trials |
Katherine Smith, Karim Hegazy, Miranda R. Cai, Irene McKnight, Matthew D. Rousculp, Katia Alves |
| 674 |
[GO] |
2023―Mai―10 |
Estimated vaccine effectiveness against SARS-CoV-2 Delta and Omicron infections among health care workers and the general adult population in Norway, August 2021 - January 2022 |
Petter Langlete, Martin Tesli, Lamprini Veneti, Jostein Starrfelt, Petter Elstrøm, Hinta Meijerink |
| 675 |
[GO] |
2023―Mai―09 |
Personal risk or societal benefit? Investigating adults’ support for COVID-19 childhood vaccination |
Chiara Chiavenna, Laura P. Leone, Alessia Melegaro, Tiziano Rotesi, Scott E. Bokemper, Elliott E. Paintsil, Amyn A. Malik, Gregory A. Huber, Saad B. Omer, Maria Cucciniello, Paolo Pin |
| 676 |
[GO] |
2023―Mai―08 |
Randomized Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Booster (Third Dose) of BNT162b2 COVID-19 Vaccine Coadministered With 20-Valent Pneumococcal Conjugate Vaccine in Adults ≥65 Years Old |
David Fitz-Patrick, Mariano Young, Kari Yacisin, Kathleen McElwee, Todd Belanger, Kelly Belanger, Yahong Peng, Dung-Yang Lee, William C. Gruber, Daniel A. Scott, Wendy Watson |
| 677 |
[GO] |
2023―Mai―08 |
Quantification of Sars-CoV-2 Spike Protein Expression from mRNA Vaccines Using Isotope Dilution Mass Spectrometry |
William J.H. Sutton, Paul J. Branham, Yulanda M. Williamson, Hans C. Cooper, Fabio N. Najjar, Carrie L. Pierce-Ruiz, John R. Barr, Tracie L. Williams |
| 678 |
[GO] |
2023―Mai―08 |
Anti-tumor necrosis factor therapy is associated with attenuated humoral response to SARS-COV-2 vaccines in patients with inflammatory bowel disease |
Filipa Bordalo Ferreira, Maria Ana Rafael, Lúcia Coimbra, Nazaré Boavida, Fernando Arrobas, Fábio Pereira Correia, Luísa Martins Figueiredo, Joana Carvalho e Branco, Luís Carvalho Lourenço, Liliana Santos, Ana Maria Oliveira |
| 679 |
[GO] |
2023―Mai―08 |
Immunogenicity and safety of a single booster dose of NVX-CoV2373 (TAK-019) in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: primary analysis report of a phase 3 open-label trial |
Kenji Kuriyama, Kyoko Murakami, Taisei Masuda, Kenkichi Sugiura, Sho Sakui, Ron P. Schuring, Mitsuhiro Mori |
| 680 |
[GO] |
2023―Mai―05 |
Dengue vaccine acceptability before and after the availability of COVID-19 vaccines in Puerto Rico |
Dania M. Rodriguez, Chelsea G. Major, Liliana Sánchez-González, Emma Jones, Mark J. Delorey, Claudia Alonso, Vanessa Rivera-Amill, Gabriela Paz-Bailey, Laura E. Adams |
| 681 |
[GO] |
2023―Mai―03 |
Vaccine Effectiveness of the mRNA-1273 3-dose Primary Series Against COVID-19 in an Immunocompromised Population: A Prospective Observational Cohort Study |
Jennifer H. Ku, Lina S. Sy, Lei Qian, PBradley K. Ackerson, Yi Luo, Julia E. Tubert, Gina S. Lee, Ana Florea, Katia J. Bruxvoort, Carla A. Talarico, Sijia Qiu, Yun Tian, Hung Fu Tseng |
| 682 |
[GO] |
2023―Mai―02 |
Attitudes towards COVID-19 Vaccination among Incarcerated Persons in the Federal Bureau of Prisons, June-July 2021 |
Rena Fukunaga, Zoe E. Kaplan, Tami Rodriguez, Liesl Hagan, Kathleen Aarvig, Charles Dusseau, Michael Crockett, Michael Long |
| 683 |
[GO] |
2023―Mai―01 |
COVID-19 vaccination decisions among Gypsy, Roma and Traveller communities: a qualitative study moving beyond “vaccine hesitancy” |
Charlotte Kühlbrandt, Catherine R. McGowan, Rachel Stuart, Pippa Grenfell, Sam Miles, Alicia Renedo, Cicely Marston |
| 684 |
[GO] |
2023―Mai―01 |
COVID-19 vaccination rates among adolescents (12-17 years) by immigrant background and sociodemographic factors: a nationwide registry study in Norway |
Lema Hussaini, Angela S. Labberton, Brita A. Winje, Kristian B. Kraft, Marte Karoline R. Kjøllesdal, Rebecca N. Gleditsch, Anna A. Godøy |
| 685 |
[GO] |
2023―Mai―01 |
Hematologic Adverse Events Reported After COVID-19 Vaccination in the Philippines: A National Database Study |
Flordeluna Z. Mesina, Frances Alexandra D. Sapinoso, Joy Ann V. de Castro, Preeti Prerna M. Vaswani, Charles Eryll S. Sy, Rizza Ann A. Oquendo, Mark Ryann A. Lirasan |
| 686 |
[GO] |
2023―Mai―01 |
Effectiveness of the COVID-19 Vaccines on Preventing Symptomatic SARS-CoV-2 Infections and Hospitalizations in Southwestern Alaska, January-December, 2021 |
Brian Lefferts, Dana Bruden, Ian D. Plumb, Ellen Hodges, Elizabeth Bates, Gerald January, Michael G. Bruce |
| 687 |
[GO] |
2023―Apr―27 |
Efficacy of Primary Series AZD1222 (ChAdOx1 nCoV-19) Vaccination Against SARS-CoV-2 Variants of Concern: Final Analysis of a Randomized, Placebo-controlled, Phase 1b/2 Study in South African Adults (COV005) |
Anthonet L. Koen, Alane Izu, Vicky Baillie, Gaurav Kwatra, Clare L. Cutland, Lee Fairlie, Sherman D. Padayachee, Keertan Dheda, Shaun L. Barnabas, Qasim Ebrahim Bhorat, Carmen Briner, Khatija Ahmed, Sutika Bhikha, Jinal N. Bhiman, Jeanine du Plessis, Aliasgar Esmail, Elizea Horne, Shi-Hsia Hwa, Aylin Oommen-Jose, Teresa Lambe, Matt Laubscher, Mookho Malahleha, Gabriella Benade, Shakeel McKenzie, Suzette Oelofse, Faeezah Patel, Sureshnee Pillay, Sarah Rhead, Hylton Rodel, Carol Taoushanis, Houriiyah Tegally, Asha Thombrayil, Tonya L. Villafana, Sarah Gilbert, Andrew J. Pollard, Shabir A. Madhi |
| 688 |
[GO] |
2023―Apr―26 |
Identifying Gaps in Vaccination Perception After Mandating the COVID-19 Vaccine in Saudi Arabia |
Nada Alsuhebany, Shuroug A. Alowais, Atheer Aldairem, Sumaya N. Almohareb, Khalid Bin Saleh, Khawla M. Kahtani, Lama I. Alnashwan, Saeed M. Alay, Mohammed G. Alamri, Ghaida K. Alhathlol, Ibrahim Asiri |
| 689 |
[GO] |
2023―Apr―26 |
COVID-19 Vaccine Deliberation in Individuals Directly Impacted by Incarceration |
Charlotte Kim, Jenerius A. Aminawung, Lauren Brinkley-Rubinstein, Emily A. Wang, Lisa B. Puglisi |
| 690 |
[GO] |
2023―Apr―26 |
Safety and adverse effects of the coronavirus disease 2019 vaccine among the general Japanese adult population |
Xi Lu, Shota Masuda, Hasita Horlad, Takahiko Katoh |
| 691 |
[GO] |
2023―Apr―25 |
COVID-19 adenovirus vector vaccine induces higher interferon and pro-inflammatory responses than mRNA vaccines in human PBMCs, macrophages and moDCs |
Miao Jiang, Elina Väisänen, Pekka Kolehmainen, Moona Huttunen, Seppo Ylä-Herttuala, Seppo Meri, Pamela Österlund, Ilkka Julkunen |
| 692 |
[GO] |
2023―Apr―24 |
Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers |
Clare Nugent, Yasin Abul, Elizabeth M. White, Fadi Shehadeh, Matthew Kaczynski, Lewis Oscar Felix, Narchonai Ganesan, Oladayo A. Oyebanji, Igor Vishnepolskiy, Elise M. Didion, Alexandra Paxitzis, Maegan L. Sheehan, Philip A. Chan, Walther M. Pfeifer, Evan Dickerson, Shreya Kamojjala, Brigid M. Wilson, Eleftherios Mylonakis, Christopher L. King, Alejandro B. Balazs, David H. Canaday, Stefan Gravenstein |
| 693 |
[GO] |
2023―Apr―19 |
Vaccine-induced immune thrombotic thrombocytopenia post dose 2 ChAdOx1 nCoV19 vaccination: Less severe but remains a problem |
Lisa Clarke, Timothy Brighton, Sanjeev D. Chunilal, Christine S.M. Lee, Freda Passam, Jennifer Curnow, Vivien M. Chen, Huyen A. Tran |
| 694 |
[GO] |
2023―Apr―18 |
Background incidence rates of selected adverse events of special interest (AESI) to monitor the safety of COVID-19 vaccines |
Alexis Pillsbury, Anastasia Phillips, Lucy Deng, Helen Quinn, Kristine Macartney, Heather Gidding |
| 695 |
[GO] |
2023―Apr―17 |
A tailored COVID-19 vaccination pathway for children 5 to 11 years in Victoria, Australia |
SF Gordon, J Lam, JT Vasquez, R Cercone, N Tenneti, J Hart, M Chisholm, M Heland, M Hoq, J Kaufman, M Danchin |
| 696 |
[GO] |
2023―Apr―17 |
COVID-19 vaccine distribution: A high reliability organization approach |
Claire Houtsma, Amanda M. Raines, Amy Reggio, La-Kenya Rushing, Ebony Harding, Edward Payton, Caitlin Martin-Klinger |
| 697 |
[GO] |
2023―Apr―14 |
COVID-19 mRNA BNT162b2 vaccine immunogenicity among children with a history of paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS) |
Kamila M Ludwikowska, Aneta Popiel, Agnieszka Matkowska-Kocjan, Mateusz Biela, Marta Wójcik, Filip Szenborn, Katarzyna Wielgos, Ewa Pielka-Markiewicz, Janusz Zaryczański, Miron B Kursa, Leszek Szenborn |
| 698 |
[GO] |
2023―Apr―14 |
Intranasal administration of adenoviral vaccines expressing SARS-CoV-2 spike protein improves vaccine immunity in mouse models |
Tobias L. Freitag, Riku Fagerlund, Nihay Laham Karam, Veli-Matti Leppänen, Hasan Ugurlu, Ravi Kant, Petri Mäkinen, Ahmed Tawfek, Sawan Kumar, Tomas Strandin, Katarzyna Leskinen, Jussi Hepojoki, Tapio Kesti, Lauri Kareinen, Suvi Kuivanen, Emma Koivulehto, Aino Sormunen, Svetlana Laidinen, Ayman Khattab, Päivi Saavalainen, Seppo Meri, Anja Kipar, Tarja Sironen, Olli Vapalahti, Kari Alitalo, Seppo Ylä-Herttuala, Kalle Saksela |
| 699 |
[GO] |
2023―Apr―12 |
Safety and Immunogenicity of Homologous versus Heterologous Booster Dose with AZD1222, mRNA-1273, or MVC-COV1901 SARS-CoV-2 Vaccines in Adults: An Observer-blinded, Multi-center, Phase 2 Randomized Trial |
Lila Estephan, Ying-Chin Lin, Yi-Tsung Lin, Yen-Hsu Chen, Sung-Ching Pan, Szu-Min Hsieh, Paal Fure Torkehagen, Yi-Jen Weng, Hao-Yuan Cheng, Josue Antonio Estrada, Alexander Waits, Charles Chen, Chia En Lien |
| 700 |
[GO] |
2023―Apr―10 |
Promises and challenges of mucosal COVID-19 vaccines |
Abhay P.S. Rathore, Ashley L. St. John |
| 701 |
[GO] |
2023―Apr―10 |
Subunit vaccines with a saponin-based adjuvant boost humoral and cellular immunity to MERS coronavirus |
Chi-Chieh Chang, Abdullah Algaissi, Chia-Chun Lai, Chun-Kai Chang, Jr-Shiuan Lin, Yi-Shiang Wang, Bo-Hao Chang, Yu-Chiuan Chang, Wei-Ting Chen, Yong-Qing Fan, Bi-Hung Peng, Chih-Yu Chao, Shiou-Ru Tzeng, Pi-Hui Liang, Wang-Chou Sung, Alan Yung-Chih Hu, Shin C. Chang, Ming-Fu Chang |
| 702 |
[GO] |
2023―Apr―07 |
Methodological changes implemented over time to support accurate and timely COVID-19 vaccine coverage estimates: Ontario, Canada |
J. Leigh Hobbs, Lauren A. Paul, Sarah A. Buchan, Tara Harris, Sarah E. Wilson |
| 703 |
[GO] |
2023―Apr―07 |
Factors Impacting Parental Uptake of COVID-19 Vaccination for U.S. Children ages 5-17 |
Julen N. Harris, Christine M. Mauro, Tucker L. Morgan, Ariel de Roche, Gregory D. Zimet, Susan L. Rosenthal |
| 704 |
[GO] |
2023―Apr―05 |
Evaluation of mortality risk after COVID-19 vaccination, Utah 2021 |
Jessica R. Payne, Srimoyee Bose, Rachel W. Kubiak, Leisha D. Nolen |
| 705 |
[GO] |
2023―Apr―05 |
VACCINE EFFECTIVENESS AGAINST TRANSMISSION OF ALPHA, DELTA AND OMICRON SARS-COV-2-INFECTION, BELGIAN CONTACT TRACING, 2021-2022 |
Toon Braeye, Lucy Catteau, Ruben Brondeel, Joris van Loenhout, Kristiaan Proesmans, Laura Cornelissen, Herman Van Oyen, Veerle Stouten, Pierre Hubin, Matthieu Billuart, Achille Djiena, Romain Mahieu, Naima Hammami, Dieter Van Cauteren, Chloé Wyndham-Thomas |
| 706 |
[GO] |
2023―Apr―04 |
The impact of immunomodulating treatment on the immunogenicity of COVID-19 vaccines in patients with immune-mediated inflammatory rheumatic diseases compared to healthy controls. A Swedish nationwide study (COVID19-REUMA) |
Martina Frodlund, Per Nived, Aikaterina Chatzidionysiou, Anna Södergren, Eva Klingberg, Anders Bengtsson, Monika Hansson, Sophie Olsson, Elisa Pin, Lars Klareskog, Meliha C Kapetanovic |
| 707 |
[GO] |
2023―Apr―04 |
Public discourse and debate about vaccines in the midst of the covid-19 pandemic: a qualitative content analysis of Twitter |
Enrique Prada-Gonzalez, Andrea Langbecker, Daniel Catalan-Matamoros |
| 708 |
[GO] |
2023―Apr―04 |
What Accounts for the Variation in COVID-19 Vaccine Hesitancy in Eastern, Southern and Western Europe? |
Dimiter Toshkov |
| 709 |
[GO] |
2023―Apr―03 |
The added effect of non-pharmaceutical interventions and lifestyle behaviors on vaccine effectiveness against severe COVID-19 in Chile: A matched case-double control study |
Cinthya Urquidi, Emilio Santelices, Anne J. Lagomarcino, María Teresa Valenzuela, Nicolás Larrañaga, Emilio Gonzalez, Axel Pavez, Amanda Wosiack, Marcela Maturana, Paulina Moller, Juan Pablo Torres, Sergio Muñoz, Miguel O'Ryan G |
| 710 |
[GO] |
2023―Apr―03 |
Pediatricians’ Perceptions, Practices, and Barriers Regarding COVID-19 Vaccine for Children: A Cross-Sectional Survey in Ontario, Canada |
Yamna Ali, Pierre-Philippe Piche-Renaud, Elahe Karimi-Shahrbabak, Daniel S. Farrar, Sarah Abu Fadaleh, Sharon Burey, Shaun K. Morris |
| 711 |
[GO] |
2023―Apr―01 |
Lack of association between vaccination rates and excess mortality in Cyprus during the COVID-19 pandemic |
Theodore Lytras, Maria Athanasiadou, Anna Demetriou, Despina Stylianou, Alexandros Heraclides, Olga Kalakouta |
| 712 |
[GO] |
2023―Mrz―31 |
Factors associated with COVID-19 vaccination during June-October, 2021: a multi-site prospective study |
Reva S. Datar, Lida M. Fette, Amy N. Hinkelman, E. Adrianne Hammershaimb, DeAnna J. Friedman-Klabanoff, Morgana Mongraw-Chaffin, William S. Weintraub, Naheed Ahmed, Michael S. Gibbs, Michael S. Runyon, Ian D. Plumb, William Thompson, Sharon Saydah, Sharon L. Edelstein, Andrea A. Berry |
| 713 |
[GO] |
2023―Mrz―30 |
Safety and immunogenicity of heterologous ChAdOx1-nCoV19 and BNT162b2 vaccination: a meta-analysis of the heterologous COVID-19 vaccination outcomes |
Yuxuan Hu, Yanning Wang, Taihang Shao, Wenxi Tang, Kerong Hu, Yujie Zhou, Liyun Miao, Jing Liu, Bin Wang, Wenying Yu |
| 714 |
[GO] |
2023―Mrz―29 |
Development of a COVID-19 vaccine effectiveness and safety assessment system in Japan: The VENUS Study |
Haruhisa Fukuda, Megumi Maeda, Fumiko Murata |
| 715 |
[GO] |
2023―Mrz―28 |
Real-life safety profile of mRNA vaccines for COVID-19: an analysis of VAERS database |
Greta Santi Laurini, Nicola Montanaro, Massimiliano Broccoli, Giulia Bonaldo, Domenico Motola |
| 716 |
[GO] |
2023―Mrz―28 |
Acute Reactions After a Homologous Primary COVID-19 Vaccination Series: Analysis of Taiwan V-Watch Data |
Wei-Ju Su, K Arnold Chan, Jen-Hsiang Chuang, Ting-Ann Wang, Shu-Fong Chen, Yun-Cheng Chang, Meng-Yu Chen, Chih-Ching Chang, Chin-Hui Yang |
| 717 |
[GO] |
2023―Mrz―27 |
Conspiracies, Misinformation and Resistance to Public Health Measures During COVID-19 in White Nationalist Online Communication |
Dror Walter, Yotam Ophir, Hui Ye |
| 718 |
[GO] |
2023―Mrz―27 |
Impact of vitamin D3 supplementation on COVID-19 vaccine response and immunoglobulin G antibodies in deficient women: A randomized controlled trial |
Fatih Cesur, Zeynep Atasever, Yavuz Özoran |
| 719 |
[GO] |
2023―Mrz―27 |
Determinants of COVID-19 vaccine acceptance in Mozambique: The role of institutional trust |
Bo Hu, Wei Yang, Paul Bouanchaud, Yolanda Chongo, Jennifer Wheeler, Sergio Chicumbe, Marcos Chissano |
| 720 |
[GO] |
2023―Mrz―27 |
Safety of COVID-19 vaccines during pregnancy: A systematic review and meta-analysis |
Agustín Ciapponi, Mabel Berrueta, Edward P. K. Parker, Ariel Bardach, Agustina Mazzoni, A. Steven Anderson, Fernando J. Argento, Jamile Ballivian, Karin Bok, Daniel Comandé, Erin Goucher, Beate Kampmann, Flor M. Munoz, Federico Rodriguez Cairoli, Victoria Santa María, Andy S. Stergachis, Gerald Voss, Xu Xiong, Natalia Zamora, Sabra Zaraa, Pierre M Buekens |
| 721 |
[GO] |
2023―Mrz―27 |
Comparison of culture-competent virus shedding duration of SARS-CoV-2 omicron variant in regard to vaccination status: a prospective cohort study |
Sung-Woon Kang, Heedo Park, Ji Yeun Kim, Joon-Yong Bae, Man-Seong Park, Sung-Han Kim |
| 722 |
[GO] |
2023―Mrz―27 |
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults |
Pieter Pannus, Stéphanie Depickère, Delphine Kemlin, Daphnée Georges, Sarah Houben, Véronique Olislagers, Alexandra Waegemans, Stéphane De Craeye, Antoine Francotte, Félicie Chaumont, Celien Van Oostveldt, Leo Heyndrickx, Johan Michiels, Elisabeth Willems, Emilie Dhondt, Marharyta Krauchuk, Marie-Noëlle Schmickler, Mathieu Verbrugghe, Nele Van Loon, Katelijne Dierick, André Matagne, Isabelle Desombere, Kevin K. Ariën, Arnaud Marchant, Maria E. Goossens |
| 723 |
[GO] |
2023―Mrz―27 |
First hepatitis B vaccine uptake in neonates prior to and during the COVID-19 pandemic |
Anna M. Dugovich, Toby H. Cox, Erin R. Weeda, Sandra S. Garner |
| 724 |
[GO] |
2023―Mrz―22 |
Divergent COVID-19 vaccine policies: Policy mapping of ten European countries |
Robin van Kessel, Rebecca Forman, Ricarda Milstein, Alicja Mastylak, Katarzyna Czabanowska, Thomas Czypionka, Isabelle Durand-Zaleski, Anja Hirche, Magdalena Krysinska-Pisarek, Laia Maynou, Bjelle Roberts, Aleksandra Torbica, Karsten Vrangbæk, Yuxi Wang, Olivier J. Wouters, Elias Mossialos |
| 725 |
[GO] |
2023―Mrz―21 |
Effect of adjuvanting RBD-dimer-based subunit COVID-19 vaccines with Sepivac SWETM |
Senyu Xu, Huixin Duan, Yaling An, Xiyue Jin, Minrun Duan, Patrice M Dubois, Yan Huang, Kun Xu, Heng Du, Harry Kleanthous, Lianpan Dai, George F. Gao |
| 726 |
[GO] |
2023―Mrz―21 |
Vaccine hesitancy against COVID-19 vaccine over time in Nigeria |
Ryoko Sato |
| 727 |
[GO] |
2023―Mrz―21 |
Preclinical safety evaluation of intradermal SARS-CoV-2 inactivated vaccine (Vero cells) administration in macaques |
Jinling Yang, Xinqian Huo, Qinfang Jiang, Yun Liao, Caixing Zhang, Li Yu, Qiyan Wang, Tingting Niu, Cong Li, Na Pi, Yun Li, Heng Zhao, Ying Zhang, Ying Tan, Wenping Liao, Yong Li, Shengtao Fan, Qihan Li |
| 728 |
[GO] |
2023―Mrz―21 |
Effectiveness of second booster compared to first booster and protection conferred by previous SARS-CoV-2 infection against symptomatic Omicron BA.2 and BA.4/5 in France |
Cynthia Tamandjou, Vincent Auvigne, Justine Schaeffer, Sophie Vaux, Isabelle Parent du Châtelet |
| 729 |
[GO] |
2023―Mrz―21 |
Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant |
Waranyoo Phoolcharoen, Balamurugan Shanmugaraj, Narach Khorattanakulchai, Piyanate Sunyakumthorn, Sathit Pichyangkul, Pornnarin Taepavarapruk, Wanlapa Praserthsee, Suchinda Malaivijitnond, Suwimon Manopwisedjaroen, Arunee Thitithanyanont, Kanjana Srisutthisamphan, Anan Jongkaewwattana, Mark Tomai, Christopher B. Fox, Suthira Taychakhoonavudh |
| 730 |
[GO] |
2023―Mrz―15 |
Serologic Responses to COVID-19 Vaccination in Children with History of Multisystem Inflammatory Syndrome (MIS-C) |
Maria A. Perez, Hui-Mien Hsiao, Xuemin Chen, Amber Kunkel, Nadine Baida, Laila Hussaini, Austin T. Lu, Carol M. Kao, Federico R. Laham, David A. Hunstad, Yajira Beltran, Teresa A. Hammett, Shana Godfred-Cato, Ann Chahroudi, Evan J. Anderson, Ermias Belay, Christina A. Rostad |
| 731 |
[GO] |
2023―Mrz―13 |
Immunocompromise among vaccinated versus unvaccinated COVID-19 cases admitted to critical care in Ireland, July to October 2021 |
David Kelly, Kate O'Donnell, Louise Marron, Rory Dwyer, Michael Power, Chantal Migone, Joan O'Donnell, Cathal Walsh |
| 732 |
[GO] |
2023―Mrz―13 |
Latent Class Analysis of Medical Mistrust and COVID-19 Vaccine Hesitancy Among Adults in the United States Just Prior to FDA Emergency Use Authorization |
Phoebe A. Lamuda, Ariel Azar, Bruce G. Taylor, Elizabeth Flanagan Balawajder, Harold A. Pollack, John A. Schneider |
| 733 |
[GO] |
2023―Mrz―09 |
Estimated COVID-19 Vaccine Effectiveness Against Seroconversion from SARS-CoV-2 Infection, March-October, 2021 |
Ian D. Plumb, Lida M. Fette, Ashley H. Tjaden, Leora Feldstein, Sharon Saydah, Amina Ahmed, Ruth Link-Gelles, Thomas F. Wierzba, Andrea Berry, DeAnna Friedman-Klabanoff, Moira P. Larsen, Michael S. Runyon, Lori M. Ward, Roberto P. Santos, Johnathan Ward, William S. Weintraub, Sharon Edelstein, Diane Uschner |
| 734 |
[GO] |
2023―Mrz―08 |
Antibody dependent disease enhancement (ADE) after COVID-19 vaccination and beta glucans as a safer strategy in management |
Nobunao Ikewaki, Gene Kurosawa, Gary A. Levy, Senthilkumar Preethy, Samuel J.K. Abraham |
| 735 |
[GO] |
2023―Mrz―07 |
Pharmacy-based immunization in rural USA during the COVID-19 pandemic: A survey of community pharmacists from five southeastern states |
Sura O. AlMahasis, Brent Fox, David Ha, Jingjing Qian, Chih-hsuan Wang, Salisa C. Westrick |
| 736 |
[GO] |
2023―Mrz―06 |
Factors associated with US caregivers’ uptake of pediatric COVID-19 vaccine by race and ethnicity |
Rebecca J. Hart, Shannon Baumer-Mouradian, Jeffrey N Bone, Prasra Olson, Stephanie Schroter, Rachel M. Weigert, SunHee Chung, Pareen Shah, Maren M Lunoe, Megan Evers, Courtney E Nelson, Ran D Goldman |
| 737 |
[GO] |
2023―Mrz―03 |
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Medigen COVID-19 Protein Vaccine |
Lila Estephan, Luke Tzu-Chi Liu, Chia En Lien, Emily R. Smith, Marc Gurwith, Robert T. Chen |
| 738 |
[GO] |
2023―Mrz―03 |
From COVID-19 Vaccines Candidates to Compulsory Vaccination: The Attitudes of Italian Citizens in the Key 7-month of Vaccination Campaign |
Andrea Grignolio Corsini, Roberta Martina Zagarella, Massimiliano Adamo, Cinzia Caporale |
| 739 |
[GO] |
2023―Mrz―02 |
fvWillingness to Vaccinate Children against COVID-19 Declined During the Pandemic |
RD. Goldman, RJ. Hart, JN. Bone, M. Seiler, PG. Olson, k. Keitel, S. Manzano, G. Gualco, D. Krupik, S. Schroter, RM. Weigert, S. Chung, GC. Thompson, N. Muhammad, P. Shah, NO. Gaucher, M. Hou, J. Griffiths, MM. Lunoe, M. Evers, C. Pharisa Rochat, CE. Nelson, M. Gal, SH. Baumer-Mouradian |
| 740 |
[GO] |
2023―Mrz―02 |
COVID-19 mRNA BNT162b2 vaccine safety and B-cell and T-cell reactogenicity among children with a history of paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS) - preliminary study |
Kamila M. Ludwikowska, Aneta Popiel, Agnieszka Matkowska-Kocjan, Mateusz J. Olbromski, Mateusz Biela, Marta Wójcik, Filip Szenborn, Katarzyna Wielgos, Ewa Pielka-Markiewicz, Janusz Zaryczański, Miron B. Kursa, Leszek Szenborn |
| 741 |
[GO] |
2023―Mrz―02 |
The mediating effect of health literacy on COVID-19 vaccine confidence among a diverse sample of urban adults in Boston and Chicago |
Emily E. Hurstak, Michael K Paasche-Orlow, Elizabeth A Hahn, Lori E. Henault, Michelle A. Taddeo, Patricia I. Moreno, Claire Weaver, Melissa Marquez, Eloisa Serrano, Jessica Thomas, James W. Griffith |
| 742 |
[GO] |
2023―Mrz―02 |
Placing a value on increased flexible vaccine manufacturing capacity for future pandemics |
Anthony T. Newall, Philippe Beutels, Zoltán Kis, Adrian Towse, Mark Jit |
| 743 |
[GO] |
2023―Mrz―01 |
Mediators of racial and ethnic disparities in COVID-19 vaccine uptake |
Ling Na, Sativa Banks, Peizhong Wang |
| 744 |
[GO] |
2023―Feb―27 |
Neutralization of Omicron subvariants BA.1 and BA.5 by a booster dose of COVID-19 mRNA vaccine in a Japanese nursing home cohort |
Masae Itamochi, Shunsuke Yazawa, Noriko Inasaki, Yumiko Saga, Emiko Yamazaki, Takahisa Shimada, Kosuke Tamura, Emi Maenishi, Junko Isobe, Masahiko Nakamura, Misuzu Takaoka, Hitoshi Sasajima, Chikako Kawashiri, Hideki Tani, Kazunori Oishi |
| 745 |
[GO] |
2023―Feb―27 |
Vaccine effectiveness and duration of protection of COVID-19 mRNA vaccines against Delta and Omicron BA.1 symptomatic and severe COVID-19 outcomes in adults aged 50 years and over in France |
Cynthia Raissa TAMANDJOU, Vincent AUVIGNE, Sophie VAUX, Charline MONTAGNAT, Juliette PAIREAU, Stéphanie MONNIER BESNARD, Amélie GABET, Nabil BENHAJKASSEN, Yann LE STRAT, Isabelle PARENT DU CHATELET, Daniel LEVY-BRUHL |
| 746 |
[GO] |
2023―Feb―27 |
Anaphylaxis rates following mRNA COVID-19 vaccination in children and adolescents: analysis of data reported to EudraVigilance |
Helena C. Maltezou, Sophia Hatziantoniou, Kalliopi Theodoridou, Konstantinos Vasileiou, Cleo Anastassopoulou, Athanasios Tsakris |
| 747 |
[GO] |
2023―Feb―27 |
Immunogenicity of adjuvanted plant-produced SARS-CoV-2 Beta spike VLP vaccine in New Zealand white rabbits |
Martha M O'Kennedy, Celia Abolnik, Tanja Smith, Thopisang Motlou, Kruger Goosen, Kamogelo M Sepotokele, Robyn Roth, Ilse du Preez, Alma Truyts, Hester C Stark, Martin Magwaza, Osborn Mahanjana, Jan A. Verschoor, Penny L. Moore, Yolandy Lemmer |
| 748 |
[GO] |
2023―Feb―26 |
Erratum to “Parental intentions to vaccinate children against COVID-19: Findings from a U.S. National Survey” [Vaccine 41(1) (2023) 101-108 |
Rebecca J. Guerin, Arash Naeim, Ryan Baxter-King, Andrea H. Okun, Derek Holliday, Lynn Vavreck |
| 749 |
[GO] |
2023―Feb―23 |
COVID-19 vaccine hesitancy among people living with HIV (PLHIV) in a low-resource setting: a multi-center study of prevalence, correlates and reasons |
Sahabi Kabir Sulaiman, Muhammad Sale Musa, Fatimah Isma'il Tsiga-Ahmed, Farouq Muhammad Dayyab, Abdulwahab Kabir Sulaiman, Bashir Dabo, Saidu Idris Ahmad, Salisu Abubakar Haruna, Abdullahi Abdurrahman Zubair, Aminu Hussein, Sadiya Usman, Jummai Usman Wada, Ayoola Yekeen Ayodele, Muhammed Wulgo Ali, Islam Umar Bello, Alhaji Muhammad Isa, Fatima Shettima Ali, Abubakar Garba Ismail, Bello Tijjani Makama, Abdulkadir Dalhatu Abdulkadir, Najib Jamal Abdulnasir, Bashir Zakar Gambo, Mukhtar Usman Mustapha, Mustapha Mohammed, Gambo Ibrahim, Hadiza Adamu Dogo, Fatima Ishaq Abubakar, Yakubu kurugu, Garba Auwal Yusufari, Salamatu Saleh, Abubakar Yakubu, Saeed Sulaiman, Abdulaziz Tijjani Bako |
| 750 |
[GO] |
2023―Feb―23 |
A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452 |
Eline A. Feitsma, Yester F. Janssen, Hendrikus H. Boersma, Yannick van Sleen, Debbie van Baarle, David G. Alleva, Thomas M. Lancaster, Thillainaygam Sathiyaseelan, Sylaja Murikipudi, Andrea R. Delpero, Melanie M. Scully, Ramya Ragupathy, Sravya Kotha, Jeffrey R. Haworth, Nishit J. Shah, Vidhya Rao, Shashikant Nagre, Shannon E. Ronca, Freedom M. Green, Ari Aminetzah, Frans Sollie, Schelto Kruijff, Maarten Brom, Gooitzen M. van Dam, Todd C. Zion |
| 751 |
[GO] |
2023―Feb―21 |
The time is now for committed and comprehensive action to attain more broadly protective coronavirus vaccines: The coronavirus vaccines R&D roadmap |
Margaret Hamburg, Gregory A. Poland |
| 752 |
[GO] |
2023―Feb―21 |
A Research and Development (R&D) Roadmap for Broadly Protective Coronavirus Vaccines: A Pandemic Preparedness Strategy |
Kristine A. Moore, Tabitha Leighton, Julia T. Ostrowsky, Cory J. Anderson, Richard N. Danila, Angela K. Ulrich, Eve M. Lackritz, Angela J. Mehr, Ralph S. Baric, Norman W. Baylor, Bruce G. Gellin, Jennifer L. Gordon, Florian Krammer, Stanley Perlman, Helen V. Rees, Melanie Saville, Charlotte L. Weller, Michael T. Osterholm |
| 753 |
[GO] |
2023―Feb―20 |
Erroneous Consonance. How inaccurate beliefs about physician opinion influence COVID-19 vaccine hesitancy |
Matt Motta, Timothy Callaghan, Kristin Lunz-Trujillo, Alee Lockman |
| 754 |
[GO] |
2023―Feb―17 |
Using the precaution adoption process model to understand decision-making about the COVID-19 booster vaccine in England |
Carly Meyer, Louis Goffe, Vivi Antonopoulou, Fiona Graham, Mei Yee Tang, Jan Lecouturier, Aikaterini Grimani, Paul Chadwick, Falko F Sniehotta |
| 755 |
[GO] |
2023―Feb―16 |
Trusted Messengers and Trusted Messages: The Role for Community-Based Organizations in Promoting COVID-19 and Routine Immunizations |
Angela K. Shen, Safa Browne, Tuhina Srivastava, Melanie L. Kornides, Andy S.L. Tan |
| 756 |
[GO] |
2023―Feb―16 |
Risk of COVID-19 breakthrough infection and hospitalization in individuals with comorbidities |
Peter D Smits, Samuel Gratzl, Michael Simonov, Senthil K Nachimuthu, Brianna M Goodwin Cartwright, Michael D Wang, Charlotte Baker, Patricia Rodriguez, Mackenzie Bogiages, Benjamin M. Althouse, Nicholas L Stucky |
| 757 |
[GO] |
2023―Feb―16 |
The social and socio-political embeddedness of COVID-19 vaccination decision-making: A five-country qualitative interview study from Europe |
Bettina M. Zimmermann, Katharina T. Paul, Emília R. Araújo, Alena Buyx, Sebastian Ferstl, Amelia Fiske, David Kraus, Luca Marelli, Stuart McLennan, Vittoria Porta, Barbara Prainsack, Isabella M. Radhuber, Gertrude Saxinger |
| 758 |
[GO] |
2023―Feb―13 |
The impact of side effect framing on COVID-19 booster vaccine intentions in an Australian sample |
K. Barnes, K. Faasse |
| 759 |
[GO] |
2023―Feb―13 |
Examining confidence and hesitancy towards COVID-19 vaccines: a cross-sectional survey using in-person data collection in rural Ghana |
Afreh OK, P. Angwaawie, E. Attivor, LA. Boateng, K. Brackstone, MG. Head, AK. Manyeh, GAA. Vidzro |
| 760 |
[GO] |
2023―Feb―13 |
Intent to vaccinate against SARS-CoV-2 and its determinants across six ethnic groups living in Amsterdam, the Netherlands: a cross-sectional analysis of the HELIUS study |
Sophie L. Campman, Gwen van Rossem, Anders Boyd, Liza Coyer, Janke Schinkel, Charles Agyemang, Henrike Galenkamp, Anitra D.M. Koopman, Tjalling Leenstra, Maarten Schim van der Loeff, Eric P. Moll van Charante, Bert-Jan H. van den Born, Anja Lok, Arnoud Verhoeff, Aeilko H. Zwinderman, Suzanne Jurriaans, Karien Stronks, Maria Prins |
| 761 |
[GO] |
2023―Feb―13 |
Determinants of humoral immune response to SARS-CoV-2 vaccines in solid cancer patients: A systematic review and meta-analysis |
Durgesh Wankhede, Sandeep Grover, Paul Hofman |
| 762 |
[GO] |
2023―Feb―13 |
Minority Health Social Vulnerability Index and COVID-19 vaccination coverage - The United States, December 14, 2020-January 31, 2022 |
Ryan Saelee, Neil Chandra Murthy, Bhavini Patel Murthy, Elizabeth Zell, Lauren Shaw, Lynn Gibbs-Scharf, LaTreace Harris, Kate M. Shaw |
| 763 |
[GO] |
2023―Feb―10 |
Did the temporary suspension of Vaxzveria vaccinations influence COVID-19 vaccination intentions, vaccination perceptions and trust in the vaccination campaign? A repeated survey study in the Netherlands |
Marion de Vries, Liesbeth Claassen, Mattijs S. Lambooij, Aura Timen |
| 764 |
[GO] |
2023―Feb―10 |
Six-month safety follow-up of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in adults: a phase 2/3, double-blind, randomized study |
Romana Hosain, Peter Aquino, Carmen Baccarini, Igor Smolenov, Ping Li, Haijing Qin, Carole Verhoeven, Branda Hu, Yung Huang, Pilar Rubio |
| 765 |
[GO] |
2023―Feb―09 |
Persuading the “Movable Middle”: Characteristics of Effective Messages to Promote Routine and COVID-19 Vaccinations for Adults and Children - The Impact of COVID-19 on Beliefs and Attitudes |
Angela K. Shen, Safa Browne, Tuhina Srivastava, Melanie L. Kornides, Andy S.L. Tan |
| 766 |
[GO] |
2023―Feb―09 |
Persistent SARS-COV-2 infection in vaccinated individual with three doses of COVID-19 vaccine |
Germana Silva Vasconcelos, Maria da Conceição Rodrigues Fernandes, Tamires Cardoso Matsui, Maria Claudia dos Santos Luciano, Cecilia Leite Costa, Clarissa Perdigão Mello Ferraz, Fernando Braga Stehling Dias, Fabio Miyajima, Fernanda Montenegro de Carvalho Araújo, Marcela Helena Gambim Fonseca |
| 767 |
[GO] |
2023―Feb―09 |
Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization |
Daniel R. Feikin, Melissa M. Higdon, Nick Andrews, Shirley Collie, Maria Deloria Knoll, Jeffrey C. Kwong, Ruth Link-Gelles, Tamara Pilishvili, Minal K. Patel |
| 768 |
[GO] |
2023―Feb―09 |
Immunogenicity of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in SARS-CoV-2-naïve and exposed individuals in a phase 2/3, double-blind, randomized study |
Erik Buntinx, Leonardo Brochado, Charissa Borja-Tabora, Charles Y. Yu, Edison R Alberto, May E.B. Montellano, Josefina C. Carlos, Leonardo Bautista Toloza, Maya Hites, George Siber, Ralf Clemens, Donna Ambrosino, Haijing Qin, Hui Ling Chen, Htay H. Han, Branda Hu, Ping Li, Carmen Baccarini, Igor Smolenov |
| 769 |
[GO] |
2023―Feb―08 |
Make it or break it: On-time Vaccination intent at the time of Covid-19 |
Jacques Bughin, Michele Cincera, Kelly Peters, Dorota Reykowska, Marcin Żyszkiewicz, Rafal Ohmed |
| 770 |
[GO] |
2023―Feb―08 |
Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis |
Atsuyuki Watanabe, Masao Iwagami, Jun Yasuhara, Hisato Takagi, Toshiki Kuno |
| 771 |
[GO] |
2023―Feb―07 |
Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants |
Hye Won Kwak, Hyo-Jung Park, Seo-Yeon Jung, Eun Young Oh, Sang-In Park, Yeonhwa Kim, Hyeong-Jun Park, Sohyun Park, You-Jin Kim, Hae Li Ko, Jung-Ah Lee, Hyeran Won, Yun-Ho Hwang, Seo Yeon Kim, Se Eun Kim, Seoung Eun Bae, Minhyuk Yoon, Jae-Ouk Kim, Manki Song, Su Jeen Lee, Ki-Weon Seo, Kunse Lee, Dokeun Kim, Hun Kim, Sang-Myeong Lee, So-Hee Hong, Jae-Hwan Nam |
| 772 |
[GO] |
2023―Feb―03 |
mRNA-based COVID-19 booster vaccination is highly effective and cost-effective in Australia |
Rui Li, Hanting Liu, Christopher K Fairley, Jason J Ong, Yuming Guo, Pengyi Lu, Zhuoru Zou, Li Xie, Guihua Zhuang, Yan Li, Mingwang Shen, Lei Zhang |
| 773 |
[GO] |
2023―Feb―03 |
Temporal trends and determinants of COVID-19 vaccine coverage and series initiation during pregnancy in Ontario, Canada, December 2020 to December 2021: a population-based retrospective cohort study |
Deshayne B. Fell, Eszter Török, Ann E. Sprague, Annette K. Regan, Tavleen Dhinsa, Gillian D. Alton, Sheryll Dimanlig-Cruz, Shannon E. MacDonald, Sarah A. Buchan, Jeffrey C. Kwong, Sarah E. Wilson, Siri E. Håberg, Christopher A. Gravel, Kumanan Wilson, Sandra Dunn, Prakesh S. Shah, Darine El-Chaâr, Jon Barrett, Mark C. Walker, Nannette Okun, Shelley D. Dougan |
| 774 |
[GO] |
2023―Feb―03 |
Unlocking Infodemics and Mysteries in COVID-19 Vaccine Hesitancy: Nexus of Conspiracy Beliefs, Digital Informational Support, Psychological Well-being, and Religious Fatalism |
Syed Hassan Raza, Muhammad Yousaf, Umer Zaman, Sanan Waheed Khan, Rachel Core, Aqdas Malik |
| 775 |
[GO] |
2023―Feb―02 |
Effectiveness of full (booster) COVID-19 vaccination against severe outcomes and work absenteeism in hospitalized patients with COVID-19 during the Delta and Omicron waves in Greece |
Helena C. Maltezou, Dimitrios Basoulis, Konstantinos Bonelis, Maria N. Gamaletsou, Theodoros V. Giannouchos, Eleni Karantoni, Αmalia Karapanou, Konstantinos Kounouklas, Maria Effrosyni Livanou, Maria Zotou, Vasiliki Rapti, Panagiota Stamou, Dimitrios Loulakis, Kyriakos Souliotis, Maria Chini, Periklis Panagopoulos, Garyfalia Poulakou, Konstantinos N. Syrigos, Dimitrios Hatzigeorgiou, Nikolaos V. Sipsas |
| 776 |
[GO] |
2023―Feb―01 |
Real-world uptake of COVID-19 vaccination among individuals expressing vaccine hesitancy: a registry-linkage study |
Kristin L. Andrejko, Jennifer F. Myers, Nozomi Fukui, Lauren Nelson, Rui Zhao, John Openshaw, James P. Watt, Seema Jain, Joseph A. Lewnard, Jake M. Pry |
| 777 |
[GO] |
2023―Feb―01 |
The societal value of SARS-CoV-2 booster vaccination in Indonesia |
Rob Johnson, Bimandra Djaafara, David Haw, Patrick Doohan, Giovanni Forchini, Matteo Pianella, Neil Ferguson, Peter C. Smith, Katharina D. Hauck |
| 778 |
[GO] |
2023―Jan―27 |
Ethics of age de-escalation in pediatric vaccine trials: Attending to the case of COVID-19 |
Ami Harbin, Naomi Laventhal, Mark Navin |
| 779 |
[GO] |
2023―Jan―27 |
Influenza and pneumococcal vaccine prescription for adults during COVID-19 first wave in three regions of Argentina |
María Gabriela Matta, Laura Pulido, Juan José Herrera-Paz, José M. Picco, Sebastian Wolff, Gary Tse, Sebastian Garcia-Zamora |
| 780 |
[GO] |
2023―Jan―27 |
Impact of COVID-19 vaccination in post-COVID cardiac complications |
Josefina B. Parodi, Agustín Indavere, Pamela Bobadilla Jacob, Guillermo C. Toledo, Rubén G. Micali, Gabriel Waisman, Walter Masson, Eduardo D. Epstein, Melina S. Huerin |
| 781 |
[GO] |
2023―Jan―23 |
The v-safe after vaccination health checker: Active vaccine safety monitoring during CDC’s COVID-19 pandemic response |
Tanya R. Myers, Paige L. Marquez, Julianne M. Gee, Anne M. Hause, Lakshmi Panagiotakopoulos, Bicheng Zhang, Isaac McCullum, Charles Licata, Christine K. Olson, Shakeeb Rahman, Sharon B. Kennedy, Matthew Cardozo, Chirayu R. Patel, Liza Maxwell, Joel R. Kallman, David K. Shay, Tom T. Shimabukuro |
| 782 |
[GO] |
2023―Jan―23 |
Safety and Efficacy of COVID-19 Prime-Boost Vaccinations: Homologous BBIBP-CorV versus Heterologous BNT162b2 Boosters in BBIBP-CorV-Primed Individuals |
Saad I. Mallah, Abdulla Alawadhi, Jaleela Jawad, Pearl Wasif, Basma Alsaffar, Ejlal Alalawi, Afaf Mohamed Merza, Alexandra E. Butler, Batool Alalawi, Donia Qayed, Sayed Ali Almahari, Ali Mubarak, Aalaa Mubarak, Sawsan Saeed, Ahmed Humaidan, Nitya Kumar, Stephen Atkin, Manaf Alqahtani |
| 783 |
[GO] |
2023―Jan―23 |
Psychological determinants of COVID-19 vaccine acceptance: A comparison between immigrants and the host population in Japan |
Yuanyuan Teng, Tomoya Hanibuchi, Masaki Machida, Tomoki Nakaya |
| 784 |
[GO] |
2023―Jan―23 |
Health Belief Model and parents' acceptance of the Pfizer-BioNTech and Sinopharm COVID-19 vaccine for children aged 5-18 years Old: A national survey |
Pasitpon Vatcharavongvan, Napat Boonyanitchayakul, Panpassorn Khampachuea, Isawan Sinturong, Vanida Prasert |
| 785 |
[GO] |
2023―Jan―23 |
COVID-19 Vaccine Hesitancy Scale and its Association with Actual COVID-19 Vaccine Uptake in Israel |
Ariella Grossman-Giron, Dana Tzur Bitan, Sharon Shemesh, Yael Mayer, Noga Shiffman, Yuval Bloch |
| 786 |
[GO] |
2023―Jan―23 |
Education increases COVID-19 vaccine uptake among people in Canadian federal prisons in a prospective randomized controlled trial: The EDUCATE study |
Tetiana Zolotarova, Camille Dussault, Hyejin Park, Olivia Varsaneux, Nicole E. Basta, Lorena Watson, Pennie Robert, Sarah Davis, Morag Mercer, Samantha Timmerman, Marla Bransfield, Michelle Minhas, Raphael Kempis, Nadine Kronfli |
| 787 |
[GO] |
2023―Jan―23 |
Predictors of COVID-19 vaccine uptake among people who inject drugs |
Steffanie A. Strathdee, Daniela Abramovitz, Carlos F. Vera, Irina Artamonova, Thomas L. Patterson, Davey M. Smith, Antoine Chaillon, Angela R. Bazzi |
| 788 |
[GO] |
2023―Jan―23 |
Comparative performance of between-population vaccine allocation strategies with applications for emerging pandemics |
Keya Joshi, Eva Rumpler, Lee Kennedy-Shaffer, Rafia Bosan, Marc Lipsitch |
| 789 |
[GO] |
2023―Jan―21 |
COVID-19 vaccination hesitancy and uptake: Perspectives from people released from the Federal Bureau of Prisons |
Camille Kramer, Minna Song, Carolyn B. Sufrin, Gabriel B. Eber, Leonard S. Rubenstein, Brendan Saloner |
| 790 |
[GO] |
2023―Jan―20 |
COVID-19 Vaccination among Different Types of US Healthcare Personnel |
Matthew Z. Dudley, Holly B. Schuh, Jana Shaw, Rajiv N. Rimal, Steven A. Harvey, Kristian R. Balgobin, Alexander J. Zapf, Daniel A. Salmon |
| 791 |
[GO] |
2023―Jan―20 |
COVID-19 vaccination hesitancy in people affected by diabetes and strategies to increase vaccine compliance: A systematic narrative review and meta-analysis |
Francesco Paolo Bianchi, Pasquale Stefanizzi, Andrea Martinelli, Nazario Brescia, Silvio Tafuri |
| 792 |
[GO] |
2023―Jan―20 |
SARS-CoV-2 vaccine breakthrough infections in Virginia, January 17, 2021 - June 30, 2021 |
Brandy Darby, Victoria Alexander, Julia Murphy |
| 793 |
[GO] |
2023―Jan―16 |
COVID-19 Vaccine Hesitancy among Pregnant Women and their Reported Reasons for Vaccine Refusal- A Prospective Study in Tehran, Iran |
Ashraf Moini, Maryam Rabiei, Reihaneh Pirjani, Amene Abiri, Arezoo Maleki-Hajiagha |
| 794 |
[GO] |
2023―Jan―13 |
COVID-19 booster vaccination uptake and infection breakthrough amongst health care workers in Wales: A national prospective cohort study |
Stuart Bedston, Emily Lowthian, Christopher I Jarvis, Ashley Akbari, Jillian Beggs, Declan Bradley, Simon de Lusignan, Rowena Griffiths, Laura Herbert, Richard Hobbs, Steven Kerr, Jane Lyons, William Midgley, Rhiannon K Owen, Jennifer K Quint, Ruby Tsang, Fatemeh Torabi, Aziz Sheikh, Ronan A Lyons |
| 795 |
[GO] |
2023―Jan―13 |
Association of death or illness from COVID-19 among family and friends on vaccine uptake within four months of the Emergency Use Authorization. Findings from a national survey in the United States |
Saurabh Kalra, Deepak Kalra, Irina Grafova, Julia Sass Rubin, Alan Monheit, Joel Cantor, Paul Duberstein, Soumitra S. Bhuyan |
| 796 |
[GO] |
2023―Jan―13 |
Decline in reported measles cases in Italy in the COVID-19 era, January 2020 - July 2022: the need to prevent a resurgence upon lifting non-pharmaceutical pandemic measures |
Giacomo Facchin, Antonino Bella, Martina Del Manso, Maria Cristina Rota, Antonietta Filia |
| 797 |
[GO] |
2023―Jan―13 |
Safety of primary immunization using inactivated SARS-CoV-2 vaccine (CoronaVac®) among population aged 3 years and older in a large-scale use: a multi-center open-label study in China |
Haitao Yang, Zhen Li, Ruizhi Zhang, Shicheng Guo, Binbing Wang, Xing Fang, Dongjuan Zhang, Xiaoshu Zhang, Yeqing Tong, Qing Wang, Qiuyun Deng, Zhaodan Sun, Xiaoqiang Liu, Yongjun Gao |
| 798 |
[GO] |
2023―Jan―09 |
Safety of Co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the Vaccine Adverse Event Reporting System (VAERS) during July 1, 2021 - June 30, 2022 |
Pedro L. Moro, Bicheng Zhang, Carol Ennulat, Margaret Harris, Rachel McVey, Gina Woody, Paige Marquez, Michael M. McNeil, John R. Su |
| 799 |
[GO] |
2023―Jan―09 |
School immunization coverage in adolescents during the COVID-19 pandemic: A retrospective cohort study |
Hannah Sell, Yuba Raj Paudel, Donald Voaklander, Shannon E. MacDonald |
| 800 |
[GO] |
2023―Jan―09 |
Experiences, risk perceptions, and COVID-19 vaccination outcomes among hospital workers |
Abram L. Wagner, Michelle H. Moniz, Molly J. Stout, Courtney Townsel, Sarah T. Hawley, Brian J. Zikmund-Fisher |
| 801 |
[GO] |
2023―Jan―09 |
Breastfeeding women’s attitudes towards and acceptance and rejection of COVID-19 vaccination: Implementation research |
Saifon Chawanpaiboon, Sanitra Anuwutnawin, Attapol Kanjanapongporn, Julaporn Pooliam, Vitaya Titapant |
| 802 |
[GO] |
2023―Jan―09 |
COVID-19 vaccine hesitancy in care home staff: a survey of Liverpool care homes |
John S P Tulloch, Karen Lawrenson, Adam L Gordon, Sam Ghebrehewet, Matthew Ashton, Steve Peddie, Paula Parvulescu |
| 803 |
[GO] |
2023―Jan―06 |
Baculoviral COVID-19 Delta DNA vaccine cross-protects against SARS-CoV2 variants in K18-ACE2 transgenic mice |
Yuyeon Jang, Hansam Cho, Jungmin Chun, Kihoon Park, Aleksandra Nowakowska, Jinha Kim, Hyeondong Lee, Chanyeong Lee, Yejo Han, Hee-Jung Lee, Ha-Youn Shin, Young Bong Kim |
| 804 |
[GO] |
2023―Jan―06 |
CNS demyelinating disease following inactivated or viral vector SARS-CoV-2 vaccines: a case series |
Narges Ebrahimi, Mahsa Mazdak, Vahid Shaygannejad, Omid Mirmosayyeb |
| 805 |
[GO] |
2023―Jan―05 |
Safety, Reactogenicity, and Immunogenicity of Ad26.COV2.S: Results of a Phase 1, Randomized, Double-blind, Placebo-controlled COVID-19 Vaccine Trial in Japan |
Yumi Tsuchiya, Hiroshi Tamura, Koji Fujii, Hirotaka Numaguchi, Kiichiro Toyoizumi, Tina Liu, Mathieu Le Gars, Vicky Cárdenas, Takashi Eto |
| 806 |
[GO] |
2023―Jan―03 |
COVID-19 vaccination refusal trends in Kenya over 2021 |
Ryan T Rego, Brooke Kenney, Anthony K Ngugi, Leon Espira, James Orwa, Geoffrey H Siwo, Christabel Sefa, Jasmit Shah, Eileen Weinheimer-Haus, Antonia Johanna Sophie Delius Mphil, Utz Johann Pape, Furqan B Irfan, Amina Abubakar, Reena Shah, Abram Wagner, Joseph Kolars, Matthew L Boulton, Timothy Hofer, Akbar K Waljee |
| 807 |
[GO] |
2023―Jan―02 |
Assessment of a COVID-19 Vaccination Protocol for Persons Experiencing Homelessness in the Emergency Department |
James S. Ford, Sam G. Rouleau, Jenny L. Wagner, Christopher B. Adams, Larissa S. May, Aman K. Parikh, James F. Holmes |
| 808 |
[GO] |
2023―Jan―02 |
A Longitudinal Assessment of Variability in COVID-19 Vaccine Hesitancy and Psychosocial Correlates in a National United States Sample |
Natalie J. Shook, Benjamin Oosterhoff, Barış Sevi |
| 809 |
[GO] |
2022―Dez―29 |
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants |
Sergio A. Rodriguez-Aponte, Neil C. Dalvie, Ting Y. Wong, Ryan S. Johnston, Christopher A. Naranjo, Sakshi Bajoria, Ozan S. Kumru, Kawaljit Kaur, Brynnan P. Russ, Katherine S. Lee, Holly A. Cyphert, Mariette Barbier, Harish D. Rao, Meghraj P. Rajurkar, Rakesh R. Lothe, Umesh S. Shaligram, Saurabh Batwal, Rahul Chandrasekaran, Gaurav Nagar, Harry Kleanthous, Sumi Biswas, Justin R. Bevere, Sangeeta B. Joshi, David B. Volkin, F. Heath Damron, J. Christopher Love |
| 810 |
[GO] |
2022―Dez―26 |
COVID-19 booster vaccination in rural community pharmacies |
Abigail Gamble, Tessa J. Hastings, Salisa C. Westrick, Megan Smith, Ashley N. Hannings, Jessica M. Robinson, Meagen Rosenthal, Stephanie N. Kiser, Geoffrey Curran, Delesha M. Carpenter |
| 811 |
[GO] |
2022―Dez―25 |
Effects of a booster dose of BNT162b2 on spike-binding antibodies to SARS-CoV-2 Omicron BA.2, BA.3, BA.4 and BA.5 subvariants in infection-naïve and previously-infected individuals |
Timothy G Kuzel, Jia Fu, Mark Anderson, Michael Stec, Michael Boler, Dylan Behun, Amy Gosha, Gavin Cloherty, Alan Landay, James Moy |
| 812 |
[GO] |
2022―Dez―23 |
Association of dual COVID-19 and seasonal influenza vaccination with COVID-19 infection and disease severity |
Zhigang Xie, Hanadi Y. Hamadi, Arch G. Mainous, Young-Rock Hong |
| 813 |
[GO] |
2022―Dez―23 |
Receipt of COVID-19 and seasonal influenza vaccines in California (USA) during the 2021-2022 influenza season |
Kristin L. Andrejko, Jennifer F. Myers, John Openshaw, Nozomi Fukui, Sophia Li, James P. Watt, Erin L. Murray, Cora Hoover, Joseph A. Lewnard, Seema Jain, Jake M. Pry |
| 814 |
[GO] |
2022―Dez―21 |
Cellular and Humoral Immune Response to the Fourth Pfizer-BioNTech COVID-19 Vaccine Dose in Individuals Aged 60 Years and Older |
Esther Saiag, Yifat Alcalay, Or Marudi, Avi Orr-Urtreger, David Hagin |
| 815 |
[GO] |
2022―Dez―21 |
One-year dynamics of antibody titers after three doses of SARS-CoV-2 BNT162b2 vaccine |
Ori Wand, Anna Breslavsky, Amir Bar-Shai, Chezy Levy, Shlomo Maayan, Avi Rimler, Moatasem Zwahra, Keren Cohen-Hagai, Alma Harish, Nadav Zacks, Natalya Bilenko |
| 816 |
[GO] |
2022―Dez―20 |
Effectiveness of Covid-19 vaccines against symptomatic and asymptomatic SARS-CoV-2 infections in an urgent care setting |
Madhura S. Rane, McKaylee Robertson, Sarah Kulkarni, Daniel Frogel, Chris Gainus, Denis Nash |
| 817 |
[GO] |
2022―Dez―20 |
A safety study evaluating non-COVID-19 mortality risk following COVID-19 vaccination |
Stanley Xu, Runxin Huang, Lina S. Sy, Vennis Hong, Sungching C. Glenn, Denison S. Ryan, Kerresa Morrissette, Gabriela Vazquez-Benitez, Jason M. Glanz, Nicola P. Klein, Bruce Fireman, David McClure, Elizabeth G. Liles, Eric S. Weintraub, Hung-Fu Tseng, Lei Qian |
| 818 |
[GO] |
2022―Dez―16 |
Changes in hepatitis B vaccine perception in response to the COVID-19 pandemic: Development of the Shift in Vaccine Confidence (SVC) survey tool |
Alix Boisson, Camille Morgan, Angela Stover, Patrick Ngimbi, Nana Mbonze, Sarah Ntambua, Jolie Matondo, Jonathan B. Parr, Marcel Yotebieng, Kashamuka Mwandagalirwa, Linda James, Samuel Mampunza, Peyton Thompson |
| 819 |
[GO] |
2022―Dez―16 |
Results from a preclinical study in rodents and a Phase 1/2, randomized, double-blind, placebo-controlled, parallel-group study of COVID-19 vaccine S-268019-a in Japanese adults |
Takuhiro Sonoyama, Satoshi Iwata, Masaharu Shinkai, Naoko Iwata-Yoshikawa, Nozomi Shiwa-Sudo, Takuya Hemmi, Akira Ainai, Noriyo Nagata, Nobuaki Matsunaga, Yukio Tada, Tomoyuki Homma, Shinya Omoto, Risa Yokokawa Shibata, Kenji Igarashi, Tadaki Suzuki, Hideki Hasegawa, Mari Ariyasu |
| 820 |
[GO] |
2022―Dez―16 |
A broad assessment of covid-19 vaccine safety using tree-based data-mining in the vaccine safety datalink |
W. Katherine Yih, Matthew F. Daley, Jonathan Duffy, Bruce Fireman, David McClure, Jennifer Nelson, Lei Qian, Ning Smith, Gabriela Vazquez-Benitez, Eric Weintraub, Joshua T.B. Williams, Stanley Xu, Judith C. Maro |
| 821 |
[GO] |
2022―Dez―15 |
The impact of seasonal influenza vaccination uptake on COVID-19 vaccination attitudes in a rural area in Greece |
Andria Papazachariou, Constantinos Tsioutis, Theodore Lytras, Onoufrios Malikides, Maria Stamatelatou, Nektaria Vasilaki, Athanasia Milioni, Maria Dasenaki, Nikolaos Spernovasilis |
| 822 |
[GO] |
2022―Dez―14 |
Impact of prenatal COVID-19 vaccination on delivery and neonatal outcomes: Results from a New York City cohort |
Erona Ibroci, Xiaoqin Liu, Whitney Lieb, Rebecca Jessel, Frederieke A.J. Gigase, Kyle Chung, Mara Graziani, Molly Lieber, Sophie Ohrn, Jezelle Lynch, Juliana Castro, Christina Marshall, Rushna Tubassum, Farida Mutawakil, Elianna T. Kaplowitz, Sascha Ellington, Nina Molenaar, Rhoda S. Sperling, Elizabeth A. Howell, Teresa Janevic, Siobhan M. Dolan, Joanne Stone, Lotje D. De Witte, Veerle Bergink, Anna-Sophie Rommel |
| 823 |
[GO] |
2022―Dez―14 |
Association Between Caregiver Opposition to Topical Fluoride and COVID-19 Vaccines |
Sapna J. Saini, Adam C. Carle, Anna R. Forsyth, Donald L. Chi |
| 824 |
[GO] |
2022―Dez―13 |
Transmission potential of vaccinated and unvaccinated persons infected with the SARS-CoV-2 Delta variant in a federal prison, July-August 2021 |
Phillip P. Salvatore, Christine C. Lee, Sadia Sleweon, David W. McCormick, Lavinia Nicolae, Kristen Knipe, Thomas Dixon, Robert Banta, Isaac Ogle, Cristen Young, Charles Dusseau, Shawn Salmonson, Charles Ogden, Eric Godwin, TeCora Ballom, Tara Ross, Nhien Tran Wynn, Ebenezer David, Theresa K. Bessey, Gimin Kim, Suganthi Suppiah, Azaibi Tamin, Jennifer L. Harcourt, Mili Sheth, Luis Lowe, Hannah Browne, Jacqueline E. Tate, Hannah L. Kirking, Liesl M. Hagan |
| 825 |
[GO] |
2022―Dez―13 |
Cold-adapted SARS-CoV-2 variants with different temperature sensitivity exhibit an attenuated phenotype and confer protective immunity |
Evgeny Faizuloev, Anastasiia Gracheva, Ekaterina Korchevaya, Daria Smirnova, Roman Samoilikov, Andrey Pankratov, Galina Trunova, Varvara Khokhlova, Yulia Ammour, Olga Petrusha, Artem Poromov, Irina Leneva, Oxana Svitich, Vitaly Zverev |
| 826 |
[GO] |
2022―Dez―12 |
Social cognitive predictors of vaccination status, uptake and mitigation behaviors in the Canadian COVID-19 Experiences Survey |
Peter A. Hall, Gang Meng, Christian Boudreau, Anna Hudson, Anne C.K. Quah, Thomas Agar, Geoffrey T. Fong |
| 827 |
[GO] |
2022―Dez―12 |
Patient flow time data of COVID-19 vaccination clinics in 23 sites, United States, April and May 2021 |
Bo-Hyun Cho, Heba M. Athar, Laurel G. Bates, Benjamin O. Yarnoff, LaTreace Q. Harris, Michael L. Washington, Nkenge H. Jones-Jack, Jamison J. Pike |
| 828 |
[GO] |
2022―Dez―09 |
Willingness of Brazilian caregivers in having their children and adolescents vaccinated against Covid-19 |
Marcio Fernandes Nehab, Karla Gonçalves Camacho, Adriana Teixeira Reis, Maria de Fátima Junqueira-Marinho, Dimitri Marques Abramov, Zina Maria Almeida de Azevedo, Margarida dos Santos Salú, Zilton Farias Meira de Vasconcelos, Saint Clair dos Santos Gomes Junior, Orli Carvalho da Silva Filho, Petala Tuani Candida de Oliveira Salvador, Kisna Yasmin Andrade Alves, Katiuscia Roseli Silva de Carvalho, Daniella Campelo Batalha Cox Moore |
| 829 |
[GO] |
2022―Dez―09 |
Prior Immunization Status of COVID-19 Patients and Disease Severity: A Multicenter Retrospective Cohort Study Assessing the Different Types of Immunity |
Javaria Aslam, Faisal Shehzad, Muhammad Talha Haris, Hewad Hewadmal, Maryam Khalid, Mohammad Y. Alshahrani, Qurrat-ul-ain Aslam, Irrum Aneela, Urooj Zafar |
| 830 |
[GO] |
2022―Dez―06 |
Trusted information sources in the early months of the COVID-19 pandemic predict vaccination uptake over one year later |
Carl Latkin, Lauren Dayton, Jacob Miller, Evan Eschliman, Jingyan Yang, Amelia Jamison, Xiangrong Kong |
| 831 |
[GO] |
2022―Dez―05 |
A case-crossover study of the effect of vaccination on SARS-CoV-2 transmission relevant behaviours during a period of national lockdown in England and Wales |
Aimee Serisier, Sarah Beale, Yamina Boukari, Susan Hoskins, Vincent Nguyen, Thomas Byrne, Wing Lam Erica Fong, Ellen Fragaszy, Cyril Geismar, Jana Kovar, Alexei Yavlinsky, Andrew Hayward, Robert W. Aldridge |
| 832 |
[GO] |
2022―Dez―02 |
Menstrual disturbances in 12- to 15-year-old girls after one dose of COVID-19 Comirnaty vaccine: population-based cohort study in Norway |
Ida Henriette Caspersen, Lene K Juvet, Berit Feiring, Ida Laake, Anna Hayman Robertson, Siri Mjaaland, Per Magnus, Lill Trogstad |
| 833 |
[GO] |
2022―Dez―02 |
Inequalities in infant vaccination coverage during the COVID-19 pandemic: a population-based study in Peru |
Ali Al-kassab-Córdova, Claudia Silva-Perez, Carolina Mendez-Guerra, Lucero Sangster-Carrasco, Iván Arroyave, Báltica Cabieses, Edward Mezones-Holguin |
| 834 |
[GO] |
2022―Dez―02 |
Exploring key informants’ perceptions of Covid-19 vaccine hesitancy in a disadvantaged urban community in Ireland: emergence of a ‘4Cs’ model |
Carolyn Ingram, Mark Roe, Vicky Downey, Lauren Phipps, Carla Perrotta |
| 835 |
[GO] |
2022―Dez―02 |
Effectiveness of vaccines in preventing hospitalization due to COVID-19: A multicenter hospital-based case-control study, Germany, June 2021 to January 2022 |
Anna Stoliaroff-Pepin, Caroline Peine, Tim Herath, Johannes Lachmann, Delphine Perriat, Achim Dörre, Andreas Nitsche, Janine Michel, Marica Grossegesse, Natalie Hofmann, Thomas Rinner, Claudia Kohl, Annika Brinkmann, Tanja Meyer, Brigitte G. Dorner, Daniel Stern, Fridolin Treindl, Sascha Hein, Laura Werel, Eberhard Hildt, Sven Gläser, Helmut Schühlen, Caroline Isner, Alexander Peric, Ammar Ghouzi, Annette Reichardt, Matthias Janneck, Guntram Lock, Lars Schaade, Ole Wichmann, Thomas Harder |
| 836 |
[GO] |
2022―Dez―01 |
Surveillance of COVID-19 vaccine safety among elderly persons aged 65 years and older |
Hui-Lee Wong, Ellen Tworkoski, Cindy Ke Zhou, Mao Hu, Deborah Thompson, Bradley Lufkin, Rose Do, Laurie Feinberg, Yoganand Chillarige, Rositsa Dimova, Patricia Lloyd, Thomas MaCurdy, Richard A. Forshee, Jeff Kelman, Azadeh Shoaibi, Steven A. Anderson |
| 837 |
[GO] |
2022―Nov―29 |
Education level modifies parental hesitancy about COVID-19 vaccinations for their children |
Shuning Tang, Xin Liu, Yingnan Jia, Hao Chen, Pinpin Zheng, Hua Fu, Qianyi Xiao |
| 838 |
[GO] |
2022―Nov―29 |
What Attributes Influence Rural Household’s Willingness to Get Vaccinated for COVID-19? Perspectives from Six Chinese Townships |
Yingying Sun, Shih-Kai Huang, Sudha Arlikatti, Michael K. Lindell |
| 839 |
[GO] |
2022―Nov―25 |
“I won’t be a guinea pig”: Rethinking public health communication and vaccine hesitancy in the context of COVID-19 |
S. Michelle Driedger, Gabriela Capurro, Jordan Tustin, Cindy G. Jardine |
| 840 |
[GO] |
2022―Nov―25 |
What impact does the attitude toward COVID-19 vaccination have on physicians as vaccine providers? A cross sectional study from the German outpatient sector |
Arno Stöcker, Jan Hoffmann, Laura Mause, Julia Neufeind, Tim Ohnhäuser, Nadine Scholten |
| 841 |
[GO] |
2022―Nov―25 |
Spirituality is associated with Covid-19 vaccination scepticism |
Natalia Zarzeczna, Tisa Bertlich, Bojana Većkalov, Bastiaan T. Rutjens |
| 842 |
[GO] |
2022―Nov―24 |
Tree-based data mining for safety assessment of first COVID-19 BOOSTER doses in the Vaccine Safety Datalink |
W. Katherine Yih, Matthew F. Daley, Jonathan Duffy, Bruce Fireman, David McClure, Jennifer Nelson, Lei Qian, Ning Smith, Gabriela Vazquez-Benitez, Eric Weintraub, Joshua T.B. Williams, Stanley Xu, Judith C. Maro |
| 843 |
[GO] |
2022―Nov―24 |
Effect of the third dose of BNT162b2 COVID-19 mRNA vaccine on anti-SARS-CoV-2 antibody levels in healthcare workers |
Hidenori Tanaka, Junji Mukai, Kenichi Kushibiki, Sayuri Mizushima, Kyoko Maeda, Yuko Fujimoto, Ryugo Sawada, Manabu Oda, Hiroshi Okuda, Mayumi Yamaki, Shin Hashiguchi, Ichiro Kawai, Izumi Kawaguchi, Noriyuki Masuda, Haruhiko Matsushita |
| 844 |
[GO] |
2022―Nov―24 |
The impact of the COVID-19 pandemic on parents’ perceptions and acceptance of routine childhood vaccination in Canada: A national longitudinal study |
Robin M. Humble, Shannon D. Scott, Eve Dubé, Joanne Olson, Shannon E. MacDonald |
| 845 |
[GO] |
2022―Nov―22 |
Background rates of 41 Adverse Events of Special Interest for COVID-19 vaccines in 10 European healthcare databases - An ACCESS cohort study |
C Willame, C Dodd, CE Durán, RJHJ Elbers, R Gini, C Bartolini, O Paoletti, L Wang, V Ehrenstein, J Kahlert, U Haug, T Schink, J Diez-Domingo, A Mira-Iglesias, JJ Carreras, C Vergara-Hernández, C Giaquinto, E Barbieri, L Stona, C Huerta, M Martín-Pérez, P García-Poza, A de Burgos, M Martínez-González, V Bryant, F Villalobos, M Pallejà-Millán, M Aragón, JJ Carreras, P Souverein, NH Thurin, D Weibel, OH Klungel, MCJM Sturkenboom |
| 846 |
[GO] |
2022―Nov―22 |
Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials |
Aykut Ozdarendeli, Zafer Sezer, Shaikh Terkis Islam Pavel, Ahmet Inal, Hazel Yetiskin, Busra Kaplan, Muhammet Ali Uygut, Adnan Bayram, Mumtaz Mazicioglu, Gamze Kalin Unuvar, Zeynep Ture Yuce, Gunsu Aydin, Ahmet Furkan Aslan, Refika Kamuran Kaya, Rabia Cakir Koc, Ihsan Ates, Ates Kara |
| 847 |
[GO] |
2022―Nov―21 |
Assessing the long-stand antibody response induced by COVID-19 vaccines: A study in an educational cohort in San Luis, Argentina |
Ricardo Javier Elicabe, Matías Nicolás Distel, Brenda Lucila Jofré, Marianela Leporati, Juan Eduardo Silva, José Luis Arias, Carolina Virginia Gorlino, Samanta Celeste Funes, Marisol Velazquez, Patricia Vitale, Roberto Carlos Davicino, María Silvia Di Genaro |
| 848 |
[GO] |
2022―Nov―18 |
COVID-19 vaccination coverage in patients with chronic obstructive pulmonary disease - A cross-sectional study in Hungary |
Monika Fekete, Alpar Horvath, Balazs Santa, Gabor Tomisa, Gergo Szollosi, Zoltan Ungvari, Vince Fazekas-Pongor, David Major, Stefano Tarantini, Janos Tamas Varga |
| 849 |
[GO] |
2022―Nov―18 |
SARS-CoV-2 viral shedding in vaccinated and unvaccinated persons: A case series |
David W. McCormick, Liesl M. Hagan, Phillip P. Salvatore, Reed Magleby, Christine Lee, Sadia Sleweon, Lavinia Nicolae, Tom Dixon, Robert Banta, Isaac Ogle, Cristen Young, Charles Dusseau, Charles Ogden, Hannah Browne, John Michael Metz, Min-hsin Chen, Maria I. Solano, Shannon Rogers, Alex Burgin, Mili Sheth, Bettina Bankamp, Azaibi Tamin, Jennifer L. Harcourt, Jacqueline E. Tate, Hannah L. Kirking |
| 850 |
[GO] |
2022―Nov―17 |
COVID-19 vaccine policy development in a sample of 44 countries- Key findings from a December 2021 survey of National Immunization Technical Advisory Groups (NITAGs) |
Anna-Lea Kahn, Christoph A Steffen, Louise Henaff, Noni E MacDonald, Christopher Morgan, Ruth Faden, Folake Olayinka, Shalini Desai |
| 851 |
[GO] |
2022―Nov―14 |
Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy: A retrospective matched cohort study |
Massimo Fabiani, Alberto Mateo-Urdiales, Chiara Sacco, Maria Cristina Rota, Daniele Petrone, Marco Bressi, Martina Del Manso, Andrea Siddu, Valeria Proietti, Serena Battilomo, Francesca Menniti-Ippolito, Patrizia Popoli, Antonino Bella, Flavia Riccardo, Anna Teresa Palamara, Giovanni Rezza, Silvio Brusaferro, Patrizio Pezzotti |
| 852 |
[GO] |
2022―Nov―14 |
COVID-19 vaccine coverage disparities in rural and farm children |
Jeffrey J. VanWormer, Gabriella Alicea, Bryan P. Weichelt, Richard L. Berg, Maria E. Sundaram |
| 853 |
[GO] |
2022―Nov―14 |
Misinformation and COVID-19 Vaccine Hesitancy |
Tara Zimmerman, Kristina Shiroma, Kenneth R Fleischmann, Bo Xie, Chenyan Jia, Nitin Verma, Min Kyung Lee |
| 854 |
[GO] |
2022―Nov―10 |
COVID-19 vaccine acceptance and its socio-demographic and emotional determinants: a multi-country cross-sectional study |
A. de Figueiredo, C. Simas, H.J. Larson |
| 855 |
[GO] |
2022―Nov―08 |
Background Rates of Adverse Events of Special Interest for COVID-19 Vaccine Safety Monitoring in the United States, 2019-2020 |
Keran Moll, Bradley Lufkin, Kathryn R. Fingar, Cindy Ke Zhou, Ellen Tworkoski, Chianti Shi, Shayan Hobbi, Mao Hu, Minya Sheng, Jillian McCarty, Shanlai Shangguan, Timothy Burrell, Yoganand Chillarige, Jeff Beers, Patrick Saunders-Hastings, Stella Muthuri, Kathryn Edwards, Steven Black, Jeff Kelman, Christian Reich, Kandace L. Amend, Djeneba Audrey Djibo, Daniel Beachler, Rachel P. Ogilvie, Alex Secora, Cheryl N. McMahill-Walraven, John D. Seeger, Patricia Lloyd, Deborah Thompson, Rositsa Dimova, Thomas MaCurdy, Joyce Obidi, Steve Anderson, Richard Forshee, Hui-Lee Wong, Azadeh Shoaibi |
| 856 |
[GO] |
2022―Nov―08 |
Homologous and heterologous booster vaccinations of S-268019-b, a recombinant S protein-based vaccine with a squalene-based adjuvant, enhance neutralization breadth against SARS-CoV-2 Omicron subvariants in cynomolgus macaques |
Masayuki Hashimoto, Shinpei Aoe, Yusuke Kawazu, Naomi M. Seki, Kumi Hashimoto, Ken Yoshihara, Tomoyuki Homma, Takuhiro Sonoyama, Shinya Omoto |
| 857 |
[GO] |
2022―Nov―07 |
A post-marketing safety assessment of COVID-19 mRNA vaccination for serious adverse outcomes using administrative claims data linked with vaccination registry in a city of Japan |
Yoshinori Takeuchi, Masao Iwagami, Sachiko Ono, Nobuaki Michihata, Kohei Uemura, Hideo Yasunaga |
| 858 |
[GO] |
2022―Nov―07 |
Short-term safety of COVID-19 mRNA vaccines with respect to all-cause mortality in the older population in Norway |
Paz Lopez-Doriga Ruiz, Nina Gunnes, Jon Michael Gran, Øystein Karlstad, Randi Selmer, Jesper Dahl, Håkon Bøas, Richard Aubrey White, Aurora Christine Hofman, Trine Hessevik Paulsen, Sara Viksmoen Watle, Anette Hylen Ranhoff, Geir Bukholm, Hanne Løvdal Gulseth, German Tapia |
| 859 |
[GO] |
2022―Nov―07 |
Occupation, Worker Vulnerability, and COVID-19 Vaccination Uptake: Analysis of the Virus Watch prospective cohort study |
Sarah Beale, Rachel Burns, Isobel Braithwaite, Thomas Byrne, Wing Lam Erica Fong, Ellen Fragaszy, Cyril Geismar, Susan Hoskins, Jana Kovar, Annalan M.D. Navaratnam, Vincent Nguyen, Parth Patel, Alexei Yavlinsky, Martie Van Tongeren, Robert W Aldridge, Andrew Hayward |
| 860 |
[GO] |
2022―Nov―07 |
Demographic disparities in COVID-19 vaccine hesitancy among U.S. adults: Analysis of household pulse survey data from Jul 21 to Oct 11 in 2021 |
Yan Yan Wu, Wei Zhang |
| 861 |
[GO] |
2022―Nov―07 |
Parental Intentions to Vaccinate Children against COVID-19: Findings from a U.S. National Survey |
Rebecca J. Guerin, Arash Naeim, Ryan Baxter-King, Andrea H. Okun, Derek Holliday, Lynn Vavreck |
| 862 |
[GO] |
2022―Nov―07 |
Frequency and temporal evolution of COVID-19 vaccination rate among oncological patients undergoing 18F-FDG-PET |
Stephan Skawran, Helen Schiesser, Alexander Maurer, Thomas Sartoretti, Manuel Dittli, Cäcilia Mader, Alessandra Curioni-Fontecedro, Christoph Berger, Martin W. Huellner, Michael Messerli |
| 863 |
[GO] |
2022―Nov―07 |
Guillain-Barré syndrome temporally associated with COVID-19 vaccines in Victoria, Australia |
Joshua Osowicki, Hannah J. Morgan, Adele Harris, Hazel J. Clothier, Jim P. Buttery, Lynette Kiers, Nigel W. Crawford |
| 864 |
[GO] |
2022―Nov―04 |
Perceived Threat and Coping Responses during the COVID-19 Pandemic: Prospective Associations with Vaccine Hesitancy |
Talia Morstead, Jason Zheng, Nancy L. Sin, Anita DeLongis |
| 865 |
[GO] |
2022―Nov―03 |
Reactions Following Pfizer-BioNTech COVID-19 mRNA Vaccination and Related Healthcare Encounters Among 7,077 Children Aged 5-11 Years Within an Integrated Healthcare System |
Deborah E. Malden, Julianne Gee, Sungching Glenn, Zhuoxin Li, Cheryl Mercado, Oluwaseye A Ogun, Sunhea Kim, Bruno Lewin, Bradley Ackerson, Amelia Jazwa, Eric Weintraub, Michael M. McNeil, Sara Y. Tartof |
| 866 |
[GO] |
2022―Nov―01 |
The impact of the COVID-19 pandemic on vaccine coverage in Kilifi, Kenya: a retrospective cohort study |
R.K. Lucinde, B. Karia, N. Ouma, D. Amadi, C. Nyundo, C. Mataza, A. Nyaguara, J. A. G. Scott, K.E. Gallagher, E. Kagucia |
| 867 |
[GO] |
2022―Nov―01 |
Association Between History of SARS-CoV-2 Infection and Severe Systemic Adverse Events After mRNA COVID-19 Vaccination Among U.S. Adults |
Lindsay K. Tompkins, James Baggs, Tanya R. Myers, Julianne M. Gee, Paige L. Marquez, Sharon B. Kennedy, David Peake, Dhruv Dua, Anne M. Hause, Penelope Strid, Winston Abara, Rebecca Rossetti, Tom T. Shimabukuro, David K. Shay |
| 868 |
[GO] |
2022―Nov―01 |
Preferences and Willingness of Accepting COVID-19 Vaccine Booster: Results from a Middle-Income Country |
Chang Chee Tao, Lim Xin Jie, Chew Chii Chii, Philip Rajan, Chan Huan Keat, Muhammad Radzi Abu Hassan, Asrul Akmal Shafie, Shaun Wen Huey Lee |
| 869 |
[GO] |
2022―Okt―31 |
The early evolution of COVID-19 incidence and mortality among people aged under 80 years or 80 years and above after COVID-19 vaccine implementation in the state of Bahia, Brazil |
Mariana C. Cruz, Cristiana M. Nascimento-Carvalho |
| 870 |
[GO] |
2022―Okt―31 |
Is vaccine confidence an unexpected victim of the COVID-19 pandemic? |
Alessandro Siani, Amy Tranter |
| 871 |
[GO] |
2022―Okt―31 |
“They're trying to bribe you and taking away your freedoms”: COVID-19 vaccine hesitancy in communities with traditionally low vaccination rates |
Gabriela Capurro, Ryan Maier, Jordan Tustin, Cindy G. Jardine, S. Michelle Driedger |
| 872 |
[GO] |
2022―Okt―31 |
A socio-ecological exploration to identify factors influencing the COVID-19 vaccine decision-making process among pregnant and lactating women: Findings from Kenya |
Rupali J. Limaye, Alicia Paul, Rachel Gur-Arie, Eleonor Zavala, Clarice Lee, Berhaun Fesshaye, Prachi Singh, Wincate Njagi, Paul Odila, Paul Munyao, Rosemary Njogu, Stephen Mutwiwa, Lisa Noguchi, Christopher Morgan, Ruth Karron |
| 873 |
[GO] |
2022―Okt―31 |
The role of trust in COVID-19 vaccine hesitancy and acceptance among Black and White Americans |
Amber Marie Reinhart, Yan Tian, Amanda E. Lilly |
| 874 |
[GO] |
2022―Okt―27 |
Strategic silences, eroded trust: The impact of divergent COVID-19 vaccine sentiments on healthcare workers' relations with peers and patients |
Leonardo W Heyerdahl, Stef Dielen, Hélène Dodion, Carla Van Riet, ToTran Nguyen, Clarissa Simas, Lise Boey, Tarun Kattumana, Nico Vandaele, Heidi J. Larson, Koen Peeters Grietens, Tamara Giles-Vernick, Charlotte Gryseels |
| 875 |
[GO] |
2022―Okt―26 |
The resurgence risk of COVID-19 in China in the presence of immunity waning and ADE: a mathematical modelling study |
Weike Zhou, Biao Tang, Yao Bai, Yiming Shao, Yanni Xiao, Sanyi Tang |
| 876 |
[GO] |
2022―Okt―26 |
Mandatory COVID-19 vaccination for healthcare personnel in the era of new SARS-CoV-2 variants |
Helena C. Maltezou, Caterina Ledda, Amandine Gagneux-Brunon, Elisabeth Botelho-Nevers |
| 877 |
[GO] |
2022―Okt―26 |
Association between COVID-19 vaccination status, time elapsed since the last vaccine dose, morbidity, and absenteeism among healthcare personnel: A prospective, multicenter study |
Helena C. Maltezou, Maria N. Gamaletsou, Dimitra-Maria Koukou, Theodoros V. Giannouchos, Flora Sourri, Natalia Syrimi, Amalia Karapanou, Nikolaos Lemonakis, Emmanuela Peskelidou, Konstantina Papanastasiou, Periklis Panagopoulos, Kyriakos Souliotis, Athanasia Lourida, Dimitrios Hatzigeorgiou, Nikolaos V. Sipsas |
| 878 |
[GO] |
2022―Okt―26 |
Parental Attitudes in the Pediatric Emergency Department about the COVID-19 Vaccine |
Jared Schiff, Anita R. Schmidt, Phung K. Pham, Jocelyn B. Pérez, Pia S. Pannaraj, Pradip P. Chaudhari, Danica B. Liberman |
| 879 |
[GO] |
2022―Okt―25 |
Poor immune response to coronavirus disease vaccines in decompensated cirrhosis patients and liver transplant recipients |
Anand V Kulkarni, Shashidhar Jaggaiahgari, Sowmya Iyengar, Venu Simhadri, Deepika Gujjarlapudi, Hardik Rugwani, Venkata Krishna Vemula, Baqar Ali Gora, Sameer Shaik, Mithun Sharma, Mitnal Sasikala, Nagaraja Rao Padaki, K. Rajender Reddy, Duvvur Nageshwar Reddy |
| 880 |
[GO] |
2022―Okt―24 |
Comparison of Test-Negative and Syndrome-Negative Controls in SARS-CoV-2 Vaccine Effectiveness Evaluations for Preventing COVID-19 Hospitalizations in the United States |
Caitlin Turbyfill, Katherine Adams, Mark W. Tenforde, Nancy L. Murray, Manjusha Gaglani, Adit A. Ginde, Tresa McNeal, Shekhar Ghamande, David J. Douin, H. Keipp Talbot, Jonathan D. Casey, Nicholas M. Mohr, Anne Zepeski, Nathan I. Shapiro, Kevin W. Gibbs, D. Clark Files, David N. Hager, Arber Shehu, Matthew E. Prekker, Anne E. Frosch, Matthew C. Exline, Michelle N. Gong, Amira Mohamed, Nicholas J. Johnson, Vasisht Srinivasan, Jay S. Steingrub, Ithan D. Peltan, Samuel M. Brown, Emily T. Martin, Adam S. Lauring, Akram Khan, Laurence W. Busse, Caitlin C. ten Lohuis, Abhijit Duggal, Jennifer G. Wilson, Alexandra June Gordon, Nida Qadir, Steven Y. Chang, Christopher Mallow, Carolina Rivas, Jennie H. Kwon, Natasha Halasa, James D. Chappell, Carlos G. Grijalva, Todd W. Rice, William B. Stubblefield, Adrienne Baughman, Jillian P. Rhoads, Christopher J. Lindsell, Kimberly W. Hart, Meredith McMorrow, Diya Surie, Wesley H. Self, Manish M. Patel |
| 881 |
[GO] |
2022―Okt―21 |
Negative sentiments toward novel coronavirus (COVID-19) vaccines |
Ruoyan Sun, Henna Budhwani |
| 882 |
[GO] |
2022―Okt―21 |
Identifying early adopters of COVID-19 vaccines in Latin America |
Alejandro Arrieta, Ariadna García-Prado, Juan Pablo Sarmiento, Carmen Paz Castro |
| 883 |
[GO] |
2022―Okt―21 |
The quest for more effective vaccine markets - Opportunities, challenges, and what has changed with the SARS-CoV-2 pandemic |
Tania Cernuschi, Stefano Malvolti, Shanelle Hall, Luc Debruyne, Hanne Bak Pedersen, Helen Rees, Emer Cooke |
| 884 |
[GO] |
2022―Okt―20 |
Do the unvaccinated perform more distancing, mask wearing and hand hygiene? A test of the risk compensation hypothesis in a representative sample during the COVID-19 pandemic |
Peter A. Hall, Gang Meng, Mohammad N. Sakib, Anne C. K. Quah, Thomas Agar, Geoffrey T. Fong |
| 885 |
[GO] |
2022―Okt―20 |
The decline in immunity and circulation of pertussis among Chinese population during the COVID-19 pandemic: A cross-sectional sero-epidemiological study |
Hanqing He, Yao Zhu, Mingjuan Jin, Yang Zhou, Xuewen Tang, Rui Yan, Xuan Deng, Kun Chen |
| 886 |
[GO] |
2022―Okt―20 |
Using narratives to inform the development of a digital health intervention related to COVID-19 vaccination in Black young adults in Georgia, North Carolina and Alabama |
Marie C.D. Stoner, David Tweedy, Maria G. Leonora Comello, Christina Toval, Audrey E. Pettifor, Margo Adams Larsen, Alejandro Baez, Allysha C. Maragh-Bass, Elizabeth E. Tolley, Erica N. Browne, LaRisa Anderson, Kathryn E. Muessig, Henna Budhwani, Lisa B. Hightow-Weidman |
| 887 |
[GO] |
2022―Okt―20 |
Neutralizing response elicited by homologous and heterologous prime booster vaccination against ancestral SARS-CoV-2 B.1, P.1, C.37 and B.1.617.2 variants |
Sebastián Blanco, Lorena Spinsanti, Juan Javier Aguilar, Adrián Diaz, María Elisa Rivarola, Mauricio Beranek, Elmer Fernández, Arnaldo Mangeaud, Brenda Salomé Konigheim, Sandra Verónica Gallego |
| 888 |
[GO] |
2022―Okt―20 |
Where are children ages 5-17 years receiving their COVID-19 vaccinations? Variations over time and by sociodemographic characteristics, United States |
Tammy A. Santibanez, Carla L. Black, Tara M. Vogt, Kevin Chatham-Stephens, Tianyi Zhou, Jessica P. Lendon, James A. Singleton |
| 889 |
[GO] |
2022―Okt―17 |
Identifying COVID-19 optimal vaccine dose using mathematical Immunostimulation/Immunodynamic Modelling |
Sophie Rhodes, Neal Smith, Thomas Evans, Richard White |
| 890 |
[GO] |
2022―Okt―17 |
Measuring the impact of COVID-19 vaccination and immunity waning: a modelling study for Portugal |
Constantino Caetano, Maria Luísa Morgado, Paula Patrício, Andreia Leite, Ausenda Machado, André Torres, João Freitas Pereira, Sónia Namorado, Ana Sottomayor, André Peralta-Santos, Baltazar Nunes |
| 891 |
[GO] |
2022―Okt―17 |
A Retrospective Evaluation of Side-Effects Associated with the Booster Dose of Pfizer-BioNTech/BNT162b2 COVID-19 Vaccine among females in Eastern Province, Saudi Arabia |
Yousif A. M. Hassan, Mohammad Daud Ali, Rawan Rashad Al-Eid, Fatimah Ali Al Ghuraya, Zainab Essa Alqasimi, Ayaz Ahmad, Zainab Eltrafi, Sherihan Ahmad Ghosn |
| 892 |
[GO] |
2022―Okt―17 |
Evaluating correlates of protection for mix-match vaccine against COVID-19 VOCs with potential of evading immunity |
Sih-Han Liao, Wei-Jung Chang, Chen-Yang Hsu, Amy Ming-Fang Yen, Ting-Yu Lin, Sam Li-Sheng Chen, Tony Hsiu-Hsi Chen |
| 893 |
[GO] |
2022―Okt―17 |
COVID-19 vaccine literacy and vaccine hesitancy among pregnant women and mothers of young children in Japan |
Yoko Takahashi, Kazue Ishitsuka, Makiko Sampei, Sumiyo Okawa, Yoshihiko Hosokawa, Akira Ishiguro, Takahiro Tabuchi, Naho Morisaki |
| 894 |
[GO] |
2022―Okt―13 |
Cognitive predictors of COVID-19 mitigation behaviors in vaccinated and unvaccinated general population members |
Anna Hudson, Peter A. Hall, Sara C. Hitchman, Gang Meng, Geoffrey T. Fong |
| 895 |
[GO] |
2022―Okt―05 |
COVID-19 Vaccine Perceptions & Hesitancy amongst Parents of School-aged Children during the Pediatric Vaccine Rollout |
Alexandra Byrne, Lindsay A. Thompson, Stephanie L. Filipp MPH, Kathleen Ryan |
| 896 |
[GO] |
2022―Okt―04 |
COVID-19 outbreak in an elderly care home: very low vaccine effectiveness and late impact of booster vaccination campaign |
Catharina E. van Ewijk, Elizabeth I. Hazelhorst, Susan J. M. Hahné, Mirjam J. Knol |
| 897 |
[GO] |
2022―Okt―03 |
Modelling optimal vaccination strategies against COVID-19 in a context of Gamma variant predominance in Brazil |
Leonardo Souto Ferreira, Gabriel Berg de Almeida, Marcelo Eduardo Borges, Lorena Mendes Simon, Silas Poloni, Ângela Maria Bagattini, Michelle Quarti Machado da Rosa, José Alexandre Felizola Diniz Filho, Ricardo de Souza Kuchenbecker, Suzi Alves Camey, Roberto André Kraenkel, Renato Mendes Coutinho, Cristiana Maria Toscano |
| 898 |
[GO] |
2022―Okt―03 |
Trends in HPV vaccine administration and HPV vaccine coverage in children by race/ethnicity and socioeconomic status during the COVID-19 pandemic in an integrated health care system in California |
Chun R. Chao, Lanfang Xu, Nancy Cannizzaro, David Bronstein, Yunsun Choi, Robert Riewerts, Brian Mittman, Richard K. Zimmerman, Melissa Gilkey, Beth Glenn, Ernest Shen, Chunyi Hsu, Erin E. Hahn |
| 899 |
[GO] |
2022―Okt―03 |
A queueing Network approach for capacity planning and patient Scheduling: A case study for the COVID-19 vaccination process in Colombia |
Carlos Franco, Nilson Herazo-Padilla, Jaime Andrés Castañeda |
| 900 |
[GO] |
2022―Okt―03 |
Counselling of non-communicable diseases’ patients for COVID-19 vaccine uptake in Jordan: Evaluating the intervention |
Ala'a Al-Shaikh, Refqi Ismail Mahmoud, Hala Boukerdenna, Nazeema Muthu, Chinara Aidyralieva, Saverio Bellizzi |
| 901 |
[GO] |
2022―Sep―28 |
With established safe and effective use, protein vaccines offer another choice against COVID-19 |
Anthony M. Marchese, Hadi Beyhaghi, Walter A. Orenstein |
| 902 |
[GO] |
2022―Sep―28 |
Immune response after COVID-19 vaccination among patients with chronic kidney disease and kidney transplant |
Thananda Trakarnvanich, Tanun Ngamvitchukorn, Uraporn Phumisantiphong, Kittisak Pholtawornkulchai, Krittima Phochanasomboon, Anan Manomaipiboon |
| 903 |
[GO] |
2022―Sep―28 |
Individual-level factors associated with COVID-19 vaccine acceptance among U.S. patients with cancer |
Cassandra A. Hathaway, Erin M. Siegel, Brian D. Gonzalez, Laura B. Oswald, Anita R. Peoples, Cornelia M. Ulrich, Frank J. Penedo, Shelley S. Tworoger, Jessica Y. Islam |
| 904 |
[GO] |
2022―Sep―28 |
Relative vaccine effectiveness of the booster dose of COVID-19 vaccine for preventing death in individuals with a primary regimen based on the BBIBP-CorV, ChAdOx1-S, or BNT162b2 vaccines during the Omicron wave in Peru: A nested case-control study using national population data |
Silva-Valencia Javier, Soto-Becerra Percy, Escobar-Agreda Stefan, Fernandez-Navarro Manuel, Elorreaga-Reyes Oliver Antonio, Mayta-Tristán Percy, Mezones-Holguin Edward, Solari Lely |
| 905 |
[GO] |
2022―Sep―28 |
An intersectional analysis of sociodemographic disparities in Covid-19 vaccination: a nationwide register-based study in Sweden |
M. Spetz, L. Lundberg, C. Nwaru, H. Li, A. Santosa, N. Ng, S. Leach, M. Gisslén, N. Hammar, F. Nyberg, M. Rosvall |
| 906 |
[GO] |
2022―Sep―27 |
Near Real-Time Surveillance of Safety Outcomes in US COVID-19 Vaccine Recipients aged 12 to 64 years |
Patricia C. Lloyd, Mao Hu, Hui-Lee Wong, Azadeh Shoaibi, Cindy Ke Zhou, An-Chi Lo, Kandace Amend, Daniel C. Beachler, Cheryl N. McMahill-Walraven, Elizabeth R. Smith, John Seeger, Alex Secora, Djeneba Audrey Djibo, Joyce Obidi, Yuhui Feng, Jennifer Song, Christian Reich, Charalynn Harris, Sandia Akhtar, Robin Clifford, Nandini Selvam, Jennifer L Pigoga, Yixin Jiao, Yoganand Chillarige, Thomas MaCurdy, Richard Forshee, Steven A. Anderson |
| 907 |
[GO] |
2022―Sep―27 |
Towards the development of an epitope-focused vaccine for SARS-CoV-2 |
Jacquelynne Cervantes-Torres, Sergio Rosales, Carlos Cabello, Laura Montero, Juan Hernandez-Aceves, Guillermo Granados, Arturo Calderón-Gallegos, Francisco Zúñiga-Flores, Mirna Ruiz-Rivera, Julio César Abarca-Magaña, Sandra Ortega-Francisco, Roxana Olguin-Alor, Georgina Díaz, Filipo Paczka-Garcia, Rubí Zavala-Gaytan, Ricardo Vázquez-Ramírez, Dolores Adriana Ayón-Nuñez, Julio César Carrero, Diana Rios, Mariana Jasso-Ramírez, Rebeca Vázquez-Hernández, David Venegas, Daniel Garzón, Laura Cobos, René Segura-Velázquez, Nelly Villalobos, Gabriela Meneses, Joaquín Zúñiga, Gerardo Gamba, Graciela Cárdenas, Marisela Hernández, Michael E Parkhouse, Marta C. Romano, Luis Alonso Herrera, Raúl J. Bobes, Mayra Pérez-Tapia, Leonor Huerta, Nora Fierro, Isabel Gracia, Gloria Soldevilla, Gladis Fragoso, Francisco Suárez-Güemes, Juan P. Laclette, Edda Sciutto |
| 908 |
[GO] |
2022―Sep―26 |
Characterization and immunogenicity of SARS-CoV-2 spike proteins with varied glycosylation |
Tingting Deng, Tingting Li, Gege Chen, Yuhe Zhu, Lang Xu, Yanlin Lin, Hui Sun, Hui Zhang, Qianjiao Fang, Junping Hong, Dinghui Wu, Shuangquan Gao, Shaoyong Li, Yingbin Wang, Tianying Zhang, Yixin Chen, Quan Yuan, Qingbing Zheng, Hai Yu, Qinjian Zhao, Jun Zhang, Shaowei Li, Ningshao Xia, Ying Gu |
| 909 |
[GO] |
2022―Sep―26 |
Prayer frequency and COVID-19 vaccine hesitancy among older adults in Europe |
Christian Tolstrup Wester, Lasse Lybecker Scheel-Hincke, Tine Bovil, Karen Andersen-Ranberg, Linda Juel Ahrenfeldt, Niels Christian Hvidt |
| 910 |
[GO] |
2022―Sep―23 |
Parental health beliefs, intention, and strategies about covid-19 vaccine for their children: A cross-sectional analysis from five Arab countries in the Middle East |
Ali Haider Mohammed, Bassam Abdul Rasool Hassan, Abdulrasool M. Wayyes, Ansam Qassim Gadhban, Ali Blebil, Sara Abu Alhija, Rula M. Darwish, Ahmed Talib Al-Zaabi, Gamil Othman, Ammar Ali Saleh Jaber, Betoul Ahmed Al Shouli, Juman Dujaili, Omar Abdulwahid Al-Ani, Fares Mohammed Saeed Muthanna |
| 911 |
[GO] |
2022―Sep―22 |
Misinformation about vaccine safety and uptake of COVID-19 vaccines among adults and 5-11-year-olds in the United States |
Daniel Romer, Kenneth M. Winneg, Patrick E. Jamieson, Colleen Brensinger, Kathleen H. Jamieson |
| 912 |
[GO] |
2022―Sep―21 |
Association between Social Vulnerability and COVID-19 Vaccination Hesitancy and Vaccination in Pregnant and Postpartum Individuals |
Miranda K Kiefer, Rebecca Mehl, Kara M Rood, Katherine Germann, Divya Mallampati, Tracy Manuck, Maged M Costantine, Courtney D Lynch, William A Grobman, Kartik K Venkatesh |
| 913 |
[GO] |
2022―Sep―21 |
Relative effectiveness of COVID-19 vaccination with 3 compared to 2 doses against SARS-CoV-2 B.1.1.529 (Omicron) among an Australian population with low prior rates of SARS-CoV-2 infection |
Bette Liu, Heather Gidding, Sandrine Stepien, Michelle Cretikos, Kristine Macartney |
| 914 |
[GO] |
2022―Sep―20 |
The intersection of gender and race in older adults’ decision to receive COVID-19 vaccines |
Janna R. Shapiro, Lois Privor-Dumm, Erica N. Rosser, Sean X. Leng, Sabra L. Klein, Rosemary Morgan |
| 915 |
[GO] |
2022―Sep―19 |
Protection of vaccination versus hybrid immunity against infection with COVID-19 Omicron variants among Health-Care Workers |
Fotinie Ntziora, Evangelia Georgia Kostaki, Amalia Karapanou, Maria Mylona, Ioulia Tseti, Nikolaos V. Sipsas, Dimitrios Paraskevis, Petros P. Sfikakis |
| 916 |
[GO] |
2022―Sep―14 |
COVID-19 vaccine hesitancy among Israeli adults before and after vaccines’ availability: a cross-sectional national survey |
Dvora Frankenthal, Miri Zatlawi, Ziv Karni-Efrati, Lital Keinan-Boker, Osnat Luxenburg, Michal Bromberg |
| 917 |
[GO] |
2022―Sep―13 |
Impact of the COVID-19 pandemic on uptake of immunization services in rural Gambia |
Isaac Osei, Golam Sarwar, Ilias Hossain, Kemo Sonko, Lamin Ceesay, B뫊rr Baldeh, Ebba Secka, Grant A Mackenzie |
| 918 |
[GO] |
2022―Sep―12 |
Vaccine-induced seroconversion in participants in the North Carolina COVID-19 Community Research Partnership |
DeAnna J. Friedman-Klabanoff, Ashley H. Tjaden, Michele Santacatterina, Iqra Munawar, John W. Sanders, David M. Herrington, Thomas F. Wierzba, Andrea A. Berry |
| 919 |
[GO] |
2022―Sep―12 |
Declining Influenza Vaccines in an Underserved Primary Care Center in the COVID-19 Pandemic |
Melissa E. Day, Melissa Klein, Heidi Sucharew, Mary Carol Burkhardt, Allison Reyner, Destiney Giles, Andrew F. Beck, Elizabeth Schlaudecker |
| 920 |
[GO] |
2022―Sep―12 |
The connection between COVID-19 vaccine abundance, vaccination coverage, and public trust in government across the globe |
Ida G. Monfared |
| 921 |
[GO] |
2022―Sep―12 |
The impact of COVID-19 vaccines on fertility-A systematic review and metanalysis |
D. Zaçe, E. La Gatta, L. Petrella, M.L. Di Pietro |
| 922 |
[GO] |
2022―Sep―12 |
Strategies to increase the intention to get vaccinated against COVID-19: Findings from a nationally representative survey of US adults, October 2020 to October 2021 |
Arash Naeim, Rebecca J. Guerin, Ryan Baxter-King, Andrea H. Okun, Neil Wenger, Karen Sepucha, Annette L. Stanton, Aaron Rudkin, Derek Holliday, Alexander Rossell Hayes, Lynn Vavreck |
| 923 |
[GO] |
2022―Sep―08 |
Supply, then demand? Health expenditure, political leanings, cost obstacles to care, and vaccine hesitancy predict state-level COVID-19 vaccination rates |
Joshua Teperowski Monrad, Sebastian Q꫞, Timothy Powell-Jackson |
| 924 |
[GO] |
2022―Sep―08 |
A Research and Development (R&D) Roadmap for Broadly Protective Coronavirus Vaccines: Setting a Path to Address Coronavirus Threats |
Kristine A. Moore, Michael T. Osterholm, Eve M. Lackritz, Gregory A. Poland |
| 925 |
[GO] |
2022―Sep―07 |
Covid-19 Vaccine Hesitancy and Resistance Amongst Parents of Children Under 18 Years of Age in Ireland |
Ruth Ceannt, Frederique Vallieres, Heather Burns, Jamie Murphy, Philip Hyland |
| 926 |
[GO] |
2022―Sep―06 |
How health workers can make a difference in the public COVID-19 vaccination response |
Katrine B Habersaat, Sideeka Narayan, Siff Malue Nielsen, Martha Scherzer, Cristiana Salvi, Holly Seale |
| 927 |
[GO] |
2022―Sep―06 |
SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipients |
Quentin Perrier, Julien Lupob, Théophile Gerster, Caroline Augier, Loïc Falque, Lionel Rostaing, Laurent Pelletier, Pierrick Bedouch, Myriam Blanc, Christel Saint-Raymond, Aude Boignard, Agnès Bonadona, Johan Noble, Olivier Epaulard |
| 928 |
[GO] |
2022―Sep―06 |
Hesitancy for SARS-CoV-2 vaccines and post-vaccination flares in patients with systemic lupus erythematosus |
Chi Chiu Mok, Kar Li Chan, Sau Mei Tse |
| 929 |
[GO] |
2022―Aug―31 |
Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults |
Joseph Fraiman, Juan Erviti, Mark Jones, Sander Greenland, Patrick Whelan, Robert M. Kaplan, Peter Doshi |
| 930 |
[GO] |
2022―Aug―31 |
Development and validation of a COVID-19 vaccine hesitancy scale for adults in the United States |
Matthew L. Hrin, Veronica K. Emmerich, Edward H. Ip, Steven R. Feldman |
| 931 |
[GO] |
2022―Aug―30 |
Can financial incentives and other nudges increase COVID-19 vaccinations among the vaccine hesitant? A randomized trial |
Mireille Jacobson, Tom Y. Chang, Manisha Shah, Rajiv Pramanik, Samir B. Shah |
| 932 |
[GO] |
2022―Aug―30 |
Permissive omicron breakthrough infections in individuals with binding or neutralizing antibodies to ancestral sars-cov-2 |
Erin Williams, Jordan Colson, Ranjini Valiathan, Juan Manuel Carreño, Florian Krammer, Michael Hoffer, Suresh Pallikkuth, Savita Pahwa, David Andrews |
| 933 |
[GO] |
2022―Aug―29 |
COVID-19 vaccine hesitancy among health care worker-parents (HCWP) in Puducherry, India and its implications on their children: a cross sectional descriptive study |
Pratik Sarkar, Venkatesh Chandrasekaran, Dhandapany Gunasekaran, Palanivel Chinnakali |
| 934 |
[GO] |
2022―Aug―29 |
Side effects during the week after first dose vaccination with four Covid-19 vaccines. Results of the ProVaVac Survey Study with 13,837 people in Spain |
Francisco Sánchez-Saez, Salvador Peiró, Llanos Cuenca-Gonzalez, Hermelinda Vanaclocha, Ramón Limón, Dolores Salas, Javier S. Burgos, José Sánchez-Payá, Ricard Meneu, Javier Díez, Aníbal García-Sempere, Isabel Hurtado Navarro, Clara Rodríguez-Bernal, Gabriel Sanfélix-Gimeno, David Navarro |
| 935 |
[GO] |
2022―Aug―29 |
Intranasal immunization with recombinant Vaccinia virus encoding trimeric SARS-CoV-2 spike receptor-binding domain induces neutralizing antibody |
Xiaoling Cao, Junjie Zai, Qingzhen Zhao, Lilan Xie, Yaoming Li |
| 936 |
[GO] |
2022―Aug―26 |
Strengthened belief in vaccine effectiveness predicted increased COVID-19 vaccination intention and behaviour: Results from a nationally representative longitudinal survey of U.S. adults from July 2020 to April/May 2021 |
Ava Kikut, Danielle Clark, Emma Jesch, Robert Hornik |
| 937 |
[GO] |
2022―Aug―26 |
Determinants of COVID-19 vaccine hesitancy and resistance in Russia |
Yana Roshchina, Sergey Roshchin, Ksenia Rozhkova |
| 938 |
[GO] |
2022―Aug―26 |
Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology |
Takuya Hemmi, Akira Ainai, Takao Hashiguchi, Minoru Tobiume, Takayuki Kanno, Naoko Iwata-Yoshikawa, Shun Iida, Yuko Sato, Sho Miyamoto, Akira Ueno, Kaori Sano, Shinji Saito, Nozomi Shiwa-Sudo, Noriyo Nagata, Koji Tamura, Ryosuke Suzuki, Hideki Hasegawa, Tadaki Suzuki |
| 939 |
[GO] |
2022―Aug―26 |
Antibody levels after BNT162b2 vaccine booster and SARS-CoV-2 Omicron infection |
Maria Teresa Vietri, Giovanna D'Elia, Gemma Caliendo, Luana Passariello, Luisa Albanese, Anna Maria Molinari, Italo Francesco Angelillo |
| 940 |
[GO] |
2022―Aug―25 |
Vasovagal reactions after COVID-19 vaccination in Japan |
Mai Okuyama, Saeko Morino, Kaori Tanaka, Haruna Nakamura-Miwa, Sayaka Takanashi, Satoru Arai, Masaki Ochiai, Koji Ishii, Motoi Suzuki, Akira Oka, Tomohiro Morio, Keiko Tanaka-Taya |
| 941 |
[GO] |
2022―Aug―22 |
Advanced vaccinology training globally: Update and impact of the COVID-19 crisis |
Carine Dochez, Philippe Duclos, Noni MacDonald, Christoph Steffen, Paul-Henri Lambert |
| 942 |
[GO] |
2022―Aug―22 |
The impact of a vaccine mandate and the COVID-19 pandemic on influenza vaccination uptake in Western Australian health care students |
G.A. Willis, L. Bloomfield, M. Berry, C. Bulsara, M. Bulsara, G. Chaney, H. Cooke, J. Maticevic, K. Russell, M. Zic, D.B. Mak |
| 943 |
[GO] |
2022―Aug―22 |
No Significant Increase in Guillain-Barré Syndrome after COVID-19 Vaccination in Adults: A Vaccine Adverse Event Reporting System Study |
M. Jaffry, F. Mostafa, K. Mandava, S. Rosario, Y. Jagarlamudi, K. Jaffry, J. Kornitzer, K. Jedidi, H. Khan, N. Souayah |
| 944 |
[GO] |
2022―Aug―22 |
Short-term mortality following COVID-19 vaccination in Bologna, Italy: a one-year study |
Elisa Stivanello, Chiara Beghelli, Francesco Cardoni, Chiara Giansante, Paolo Marzaroli, Muriel Assunta Musti, Vincenza Perlangeli, Renato Todeschini, Paolo Pandolfi |
| 945 |
[GO] |
2022―Aug―22 |
Views on COVID-19 vaccination of young children in Ireland, results from a cross-sectional survey of parents |
Louise Marron, Annamaria Ferenczi, Katie M O'Brien, Suzanne Cotter, Lucy Jessop, Yvonne Morrissey, Chantal Migone |
| 946 |
[GO] |
2022―Aug―22 |
Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine |
Sitthichai Kanokudom, Suvichada Assawakosri, Nungruthai Suntronwong, Jira Chansaenroj, Chompoonut Auphimai, Pornjarim Nilyanimit, Preeyaporn Vichaiwattana, Thanunrat Thongmee, Ritthideach Yorsaeng, Thaneeya Duangchinda, Warangkana Chantima, Pattarakul Pakchotanon, Donchida Srimuan, Thaksaporn Thatsanatorn, Sirapa Klinfueng, Juthathip Mongkolsapaya, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Sittisak Honsawek, Yong Poovorawan |
| 947 |
[GO] |
2022―Aug―22 |
Safety of the Fiocruz ChAdOx COVID-19 vaccine used in a mass vaccination campaign in Botucatu, Brazil |
Sue Ann Costa Clemens, Carlos Magno Castelo Branco Fortaleza, Madeleine Crowe, Andrew Pollard, Karen Ingrid Tasca, Rejane Maria Tommasini Grotto, Marcelo Roberto Martins, André Gasparini Spadaro, Pasqual Barretti, Tom Verstraeten, Ralf Clemens |
| 948 |
[GO] |
2022―Aug―22 |
Safety, immunogenicity, and immune persistence of two inactivated COVID-19 vaccines replacement vaccination in China: an observational cohort study |
Xiaoqi Wang, Yao Deng, Li Zhao, Lei Wang, Zhenwang Fu, Lin Tang, Fei Ye, Qianqian Liu, Wenling Wang, Siquan Wang, Bo Hu, Xuhua Guan, Zhuling Han, Yeqing Tong, Lance E. Rodewald, Zundong Yin, Wenjie Tan, Fuzhen Wang, Baoying Huang |
| 949 |
[GO] |
2022―Aug―22 |
Antibody titers among healthcare workers for coronavirus disease 2019 at 6 months after BNT162b2 vaccination |
Kazuyoshi Kurashima, Tsuyoshi Numano, Atsuki Yoshino, Akiko Osawa, Yotaro Takaku, Naho Kagiyama, Tsutomu Yanagisawa |
| 950 |
[GO] |
2022―Aug―22 |
Humoral response to different SARS-CoV-2 vaccines in orthotopic liver transplant recipients |
Liz Toapanta-Yanchapaxi, Erwin Chiquete, Esmeralda Ávila-Rojo, Silvia López-Yánez, Sonia Luna del Villar Velasco, Sergio Rivera Monroy, Tomás López Gómez, Juan Bruno Andrés Aguilar, Denek Francisco Balcázar Antonio, Carlos Alcaraz-Fuerte, Magdalena García Baysa, José Luis López Jiménez, Ernesto Márquez-Guillén, Mario Vilatobá, Rodrigo Cruz-Martínez, Paulina Carpinteyro-Espin, Mariana Chávez-Villa, Ricardo Daniel Romero Morelos, Daniel Torres-del Real, Luis F. Uscanga-Domínguez, Mario García-Alanis, Ramiro Tapia Sosa, Maximiliano Servín-Rojas, Raymundo David Valdez-Echeverria, Ignacio García-Juárez |
| 951 |
[GO] |
2022―Aug―19 |
Thrombosis with thrombocytopenia after AZD1222 (ChAdOx1 nCov-19) vaccination: Case characteristics and associations |
Michael A Laffan, Sue Rees, Madhavi Yadavalli, Lisa Beth Ferstenberg, Nirmal Kumar Shankar, Jennie Medin, Nadia Foskett, Matthew Arnold, Hugo Gomes da Silva, Prakash Bhuyan, Magnus Nord |
| 952 |
[GO] |
2022―Aug―19 |
Neutralizing antibody responses in healthcare personnel after three doses of mRNA BNT162b2 vaccine and association with baseline characteristics and past SARS-CoV-2 infection |
Loukia Psaridi, Helena C. Maltezou, Sofia Simonidou, Ioanna Lialliou, Despina Athanasopoulou, Zoi Haila, Areti Kyrimi, Ioanna Giannopoulou, Styliani Giannousa, Maria Pseimada, Olympia Christofilea, George Dounias, Sophocles Lanitis, Eirini Kremasmenou |
| 953 |
[GO] |
2022―Aug―18 |
Challenges, Best Practices, and Lessons Learned from Cholera Mass vaccination campaign in Urban Cameroon during COVID-19 era |
Adidja AMANI, Solange NGO BAMA, Mariette DIA, Skinner NGUEFACK LEKELEM, Abdou LINJOUOM, Hans MOSSI MAKEMBE, Andreas ATEKE NJOH, Fabrice Zobel CHEUYEM LEKEUMO, Serge EYEBE, Georges NGUEFACK-TSAGUE, Joseph KAMGNO |
| 954 |
[GO] |
2022―Aug―18 |
Stamping the vaccine passport? Public support for lifting COVID-19 related restrictions for vaccinated citizens in France, Germany, and Sweden |
Florian Stoeckel, Sabrina Stöckli, Joseph Phillips, Benjamin Lyons, Vittorio Mérola, Matthew Barnfield, Paula Szewach, Jack Thompson, Jason Reifler |
| 955 |
[GO] |
2022―Aug―15 |
People’s perspectives about COVID-19 vaccination certificate: Findings from a representative Italian sample |
Marta Caserotti, Teresa Gavaruzzi, Paolo Girardi, Roberta Sellaro, Enrico Rubaltelli, Alessandra Tasso, Lorella Lotto |
| 956 |
[GO] |
2022―Aug―15 |
Parents’ views on the acceptability of a COVID-19 vaccine for their children: A cross-sectional study in Abu Dhabi-United Arab Emirates |
Latifa Mohammad Baynouna AlKetbi, Farida Al Hosani, Shammah Al Memari, Shereena Al Mazrouei, Badreyya Al Shehhi, Noura AlShamsi, Mariam M. AlKwuiti, Hassan Nazmus Saleheen, Hanan Al Mutairi, Omniyat Mohammed Al Hajeri |
| 957 |
[GO] |
2022―Aug―15 |
A Historical Analysis of Vaccine Mandates in the United States Military and Its Application to the COVID-19 Vaccine Mandate |
Capt Brian P. Elliott, Col Steven Chambers |
| 958 |
[GO] |
2022―Aug―15 |
Reminders of existing vaccine mandates increase support for a COVID-19 vaccine mandate: Evidence from a survey experiment |
Filip Viskupič, David L. Wiltse, Abdallah Badahdah |
| 959 |
[GO] |
2022―Aug―08 |
COVID-19 vaccine hesitancy cannot fully explain disparities in vaccination coverage across the contiguous United States |
Songhua Hu, Chenfeng Xiong, Qingchen Li, Zitong Wang, Yuan Jiang |
| 960 |
[GO] |
2022―Aug―05 |
A Behavior Change Model to Address Caregiver Hesitancy around COVID-19 Vaccination in Pediatrics |
Jordan Yeo, Caitlyn Furr Gudmundsen, Sajjad Fazel, Alex Corrigan, Madison M. Fullerton, Jia Hu, Taj Jadavji, Susan Kuhn, Aliya Kassam, Cora Constantinescu |
| 961 |
[GO] |
2022―Aug―05 |
COVID-19 vaccine confidence and reasons for vaccination among health care workers and household members |
Angela K Ulrich, Grace K Pankratz, Bruno Bohn, Stephanie Yendell, Timothy J Beebe, Craig W Hedberg, Ryan T Demmer |
| 962 |
[GO] |
2022―Aug―05 |
Unravelling the drivers behind COVID-19 vaccination hesitancy and refusal among teachers: A nationwide study |
Marta Estrela, Tânia Magalhães Silva, Vítor Roque, Eva Rebelo Gomes, Adolfo Figueiras, Fátima Roque, Maria Teresa Herdeiro |
| 963 |
[GO] |
2022―Aug―03 |
Response to mRNA COVID-19 vaccination in three XLA patients |
J.D. Squire, A.Y. Joshi |
| 964 |
[GO] |
2022―Aug―03 |
Crowdfunding narratives and the valuation of vaccines for COVID-19 |
Jeremy Snyder, Maya Goldenberg, Valorie A. Crooks, Rachel Katz |
| 965 |
[GO] |
2022―Aug―02 |
COVID-19 Vaccine Uptake Among Arkansas Public K-12 School Teachers and Staff |
Michael J. Cima, Donald McCormick, Austin Porter, Namvar Zohoori, Scott Alsbrook, José R. Romero |
| 966 |
[GO] |
2022―Aug―01 |
Should COVID-19 Vaccines Be Mandated in Schools? - An International Caregiver Perspective |
Shannon H. Baumer-Mouradian, Rebecca J. Hart, Jeffrey N. Bone, Michelle Seiler, Prasra Olson, Kristina Keitel, Sergio Manzano, Gianluca Gualco, Danna Krupik, Stephanie Schroter, Rachel M. Weigert, SunHee Chung, Graham C. Thompson, Nina Muhammad, Pareen Shah, Nathalie O. Gaucher, Maren M. Lunoe, Meagan Evers, Cosette Pharisa Rochat, Courtney E. Nelson, Moran Shefler Gal, Adrianna Doucas, Ran D. Goldman |
| 967 |
[GO] |
2022―Aug―01 |
Longitudinal determination of BNT162b2 vaccine induced strongly binding SARS-CoV-2 IgG antibodies in a cohort of Romanian healthcare workers |
Mónika Korodi, István Horváth, Kinga Rákosi, Zsuzsanna Jenei, Gabriella Hudák, Melinda Kákes, Katalin Dallos-Fejér, Enikő Simai, Orsolya Páll, Natalia Staver, Violeta Briciu, Mihaela Lupșe, Mirela Flonta, Ariana Almaș, Victoria Birlutiu, Claudia Daniela Lupu, Andreea Magdalena Ghibu, Dana Pianoschi, Livia-Maria Terza, Szilard N. Fejer |
| 968 |
[GO] |
2022―Jul―30 |
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in China: a multicentre, non-inferiority, open-label, randomised, controlled, phase 4 trial |
Haiping Chen, Zhuoying Huang, Shaoying Chang, Mei Hu, Qingbin Lu, Yuntao Zhang, Hui Wang, Yanhui Xiao, Hui Wang, Yonghong Ge, Yong Zou, Fuqiang Cui, Shasha Han, Min Zhang, Shengyi Wang, Xiaoping Zhu, Biao Zhang, Zhi Li, Jia Ren, Xiao Chen, Rui Ma, Lei Zhang, Xue Guo, Linyun Luo, Xiaodong Sun, Xiaoming Yang |
| 969 |
[GO] |
2022―Jul―28 |
COVID-19 vaccinations in German pharmacies: A survey on patient and provider satisfaction |
Olaf Rose, Susanne Erzkamp, Wiebke Schöbel, Marcia Grajeda, Juliane Köberlein-Neu |
| 970 |
[GO] |
2022―Jul―26 |
Making more COVID-19 vaccines available to address global needs: Considerations and a framework for their evaluation |
Philip R Krause, Narendra Arora, William Dowling, César Muñoz-Fontela, Simon Funnell, Rogerio Gaspar, Marion F. Gruber, Adam Hacker, Ana Maria Henao-Restrepo, Stanley Plotkin, Helen V. Rees, Dean K. Smith, Soumya Swaminathan |
| 971 |
[GO] |
2022―Jul―26 |
Safety and Immunogenicity of a SARS-CoV-2 inactivated vaccine (CoronaVac) co-administered with an inactivated quadrivalent influenza vaccine: a randomized, open-label, controlled study in healthy adults aged 18 to 59 years in China |
Wang Shenyu, Duan Xiaoqian, Chen Bo, Deng Xuan, Wang Zeng, Zhang Hangjie, Zheng Qianhui, Liang Zhenzhen, Yan Chuanfu, Yang Juan, Zeng Gang, Lv Huakun |
| 972 |
[GO] |
2022―Jul―18 |
COVID-19 Vaccine Express strategy in Malawi: An effort to Reach the Un-Reach |
Ghanashyam Sethy, Mike Chisema, Lokesh Sharma, Krupal Joshi, Sanjay Singhal, Patrick Omar Nicks, Steve Macheso, Tedla Damte, Antoinette Eleonore Ba, Collins Mitambo, Mavuto Thomas, Ms Beverly Laher, John Phuka |
| 973 |
[GO] |
2022―Jul―18 |
Skin-patch delivered subunit vaccine induces broadly neutralising antibodies against SARS-CoV-2 variants of concern |
Christopher L.D. McMillan, Alberto A. Amarilla, Naphak Modhiran, Jovin J.Y. Choo, Armira Azuar, Kate Honeyman, Alexander A. Khromykh, Paul R. Young, Daniel Watterson, David A. Muller |
| 974 |
[GO] |
2022―Jul―13 |
COVID-19 vaccination intention and activation among health care system employees: A mixed methods study |
Lavanya Vasudevan, Rebecca Bruening, Anna Hung, Sandra Woolson, Adrian Brown, Susan N. Hastings, Tammy Linton, Genevieve Embree, Christopher J. Hostler, Elizabeth Mahanna, Nwora Lance Okeke, Hayden Bosworth, Nina R. Sperber |
| 975 |
[GO] |
2022―Jul―12 |
Risk of Myocarditis and Pericarditis Following BNT162b2 and mRNA-1273 COVID-19 Vaccination |
Kristin Goddard, Ned Lewis, Bruce Fireman, Eric Weintraub, Tom Shimabukuro, Ousseny Zerbo, Thomas G. Boyce, Matthew E. Oster, Kayla E. Hanson, James G. Donahue, Pat Ross, Allison Naleway, Jennifer C. Nelson, Bruno Lewin, Jason M. Glanz, Joshua T.B. Williams, Elyse O. Kharbanda, W. Katherine Yih, Nicola P. Klein |
| 976 |
[GO] |
2022―Jul―12 |
COVID-19 vaccination in pregnant women in Sweden and Norway |
Anne K. Örtqvist, Elisabeth Dahlqwist, Maria C. Magnus, Rickard Ljung, Jerker Jonsson, Bernice Aronsson, Björn Pasternak, Siri E. Håberg, Olof Stephansson |
| 977 |
[GO] |
2022―Jul―12 |
Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adults |
Frances H. Priddy, Michael Williams, Simon Carson, Brittany Lavender, Julia Mathieson, Chris Frampton, Nicole J. Moreland, Reuben McGregor, Georgia Williams, Maia Brewerton, Katie Gell, James Ussher, Graham Le Gros |
| 978 |
[GO] |
2022―Jul―11 |
Humoral and cellular responses to SARS-CoV-2 BNT162b2 vaccination in allogeneic hematopoietic stem cell transplantation recipients |
Alexis Cuffel, Sarah Maylin, Helene Le Buanec, Constance Delaugerre, Marine Minier, David Bergerat, Marine Merandet, Charles Cassius, Régis Peffault de Latour, Jérôme Le Goff, Gérard Socié, Sophie Caillat-Zucman, Marie Robin, Aliénor Xhaard |
| 979 |
[GO] |
2022―Jul―06 |
Intranasal administration of a live-attenuated recombinant newcastle disease virus expressing the SARS-CoV-2 Spike protein induces high neutralizing antibody levels and protects from experimental challenge infection in hamsters |
Rik L. de Swart, Olav S. de Leeuw, Nadia Oreshkova, Nora M. Gerhards, Irina C. Albulescu, Sandra Vreman, José L. Gonzales, Riks Maas, Frank J.M. van Kuppeveld, Peter Soema, Berend-Jan Bosch, Ben P.H. Peeters |
| 980 |
[GO] |
2022―Jul―04 |
The impact of the COVID-19 pandemic on hepatitis B virus vaccination and transmission among men who have sex with men: a mathematical modelling study |
Maria Xiridou, Philippe Adam, Annemarie Meiberg, Maartje Visser, Amy Matser, John de Wit, Eline Op de Coul |
| 981 |
[GO] |
2022―Jul―04 |
SARS-CoV-2 infection risk among vaccinated and unvaccinated household members during the Alpha variant surge - Denver, Colorado, and San Diego, California, January-April 2021 |
David W. McCormick, Stacey L. Konkle, Reed Magleby, Ayan K. Chakrabarti, Blake Cherney, Kristine Lindell, Apophia Namageyo-Funa, Susanna Visser, Raymond A. Soto, Marisa A.P. Donnelly, Ginger Stringer, Brett Austin, Mark E. Beatty, Sarah Stous, Bernadette A. Albanese, Victoria T. Chu, Meagan Chuey, Elizabeth A. Dietrich, Jan Drobeniuc, Jennifer M. Folster, Marie E. Killerby, Jennifer A. Lehman, Eric C. McDonald, Jasmine Ruffin, Noah G. Schwartz, Sarah W. Sheldon, Sadia Sleweon, Natalie J. Thornburg, Laura J. Hughes, Marla Petway, Suxiang Tong, Melissa J. Whaley, Hannah L. Kirking, Jacqueline E. Tate, Christopher H. Hsu, Almea Matanock |
| 982 |
[GO] |
2022―Jul―01 |
Women's views and experiences of accessing pertussis vaccination in pregnancy and infant vaccinations during the COVID-19 pandemic: A multi-methods study in the UK |
Helen Skirrow, Sara Barnett, Sadie Bell, Sandra Mounier-Jack, Beate Kampmann, Beth Holder |
| 983 |
[GO] |
2022―Jul―01 |
Hesitancy to receive the novel coronavirus vaccine and potential influences on vaccination among a cohort of healthcare workers in the Democratic Republic of the Congo |
Angelica Barrall, Nicole A. Hoff, Dalau Mukadi Nkamba, Kamy Musene, Nick Ida, Anna Bratcher, Camille Dzogang, Sylvia Tangney, Michael Beya, Michel Kabamba, David Kampilu, Gloire Mbaka Onya, Christophe Luhata, Adva Gadoth, Elisabeth Mukamba, Placide Mbala, Didine Kaba, Anne W. Rimoin |
| 984 |
[GO] |
2022―Jun―29 |
The effect of needle length and skin to deltoid muscle distance in adults receiving an mRNA COVID-19 vaccine |
Thomas Hills, Aimee Paterson, Rebecca Woodward, Francis Middleton, Lauren H. Carlton, Reuben McGregor, Sebastien Barfoot, Ciara Ramiah, Alana L. Whitcombe, Victor M. Zimbron, David Mahuika, Joshua Brown, Kate Palmer-Neels, Brittany Manning, Devanshi Jani, Brooke Reeves, Georgia T. Whitta, Susan Morpeth, Richard Beasley, Mark Weatherall, Anthony Jordan, Peter McIntyre, Nicole J. Moreland, S. Ali Mirjalili |
| 985 |
[GO] |
2022―Jun―27 |
The impact of personal coaching on influenza vaccination among healthcare workers before and during COVID-19 pandemic |
Shuk-Ching Wong, Veronica Wing-Man Chan, Germaine Kit-Ming Lam, Lithia Lai-Ha Yuen, Christine Ho-Yan AuYeung, Xin Li FRCPath, Jonathan Hon-Kwan Chen, Pui-Hing Chau, Kwok-Yung Yuen, Vincent Chi-Chung Cheng |
| 986 |
[GO] |
2022―Jun―27 |
Employer Requirements and COVID-19 Vaccination and Attitudes among Healthcare Personnel in the U.S.: Findings from National Immunization Survey Adult COVID Module, August - September 2021 |
James T. Lee, S. Sean Hu, Tianyi Zhou, Kim Bonner, Jennifer L. Kriss, Elisabeth Wilhelm, Rosalind J. Carter, Carissa Holmes, Marie A. de Perio, Peng-jun Lu, Kimberly H. Nguyen, Noel T. Brewer, James A. Singleton |
| 987 |
[GO] |
2022―Jun―27 |
Vaccine innovation model: A technology transfer perspective in pandemic contexts |
Maurício Z. Medeiros, Priscila F. Soares, Beatriz C. Fialho, Leandro Gauss, Fábio S. Piran, Daniel P. Lacerda |
| 988 |
[GO] |
2022―Jun―24 |
Artificial intelligence and clinical data suggest the T cell mediated SARS-CoV-2 nonstructural protein intranasal vaccines for global COVID-19 immunity |
Murat Seyran |
| 989 |
[GO] |
2022―Jun―24 |
COVID-19 Vaccine Safety monitoring in low and middle income countries - Time for a bold new approach |
Walter Straus, Harvey Rubin |
| 990 |
[GO] |
2022―Jun―24 |
Considerations for the Chemistry, Manufacturing and Controls (CMC) - quality package for COVID-19 vaccines- interim lessons learnt by the European medicines Agency (EMA) |
Ragini Shivji, Roberto Conocchia, Evdokia Korakianiti, Veronika Jekerle |
| 991 |
[GO] |
2022―Jun―23 |
COVID-19 differentiated measures for unvaccinated individuals: The need for clear goals and strong justifications |
Teck Chuan Voo, Julian Savulescu, Owen Schaefer, Abel Ho Zhi Ling, Clarence C. Tam |
| 992 |
[GO] |
2022―Jun―23 |
A national survey of COVID-19 vaccine acceptance in Nigeria |
Ahmad Ibrahim Al-Mustapha, Ochulor Okechukwu, Ademola Olayinka, Oyeniyi Rasheed Muhammed, Muftau Oyewo, Samuel A. Owoicho, Ahmed Tijani Abubakar, Abdulsalam Olabisi, Aliyu Jibril, Simon Ereh, Oluwatosin Enoch Fakayode, Oluwaseun Adeolu Ogundijo, Nusirat Elelu, Victoria Olusola Adetunji |
| 993 |
[GO] |
2022―Jun―23 |
Relationship between double covid-19 vaccine uptake and trust in effectiveness and safety of vaccination in 23 european member states: an ecological study |
Àurea Cartanyà-Hueso, Jose M Martínez-Sánchez, Juan Carlos Martín-Sánchez, Cristina Lidón-Moyano, Hipólito Pérez-Martín, Adrián González-Marrón |
| 994 |
[GO] |
2022―Jun―21 |
Relative effectiveness of booster vs. 2-dose mRNA Covid-19 vaccination in the Veterans Health Administration: Self-controlled risk interval analysis |
Caroline Korves, Hector S. Izurieta, Jeremy Smith, Gabrielle M. Zwain, Ethan I. Powell, Abirami Balajee, Kathryn M. Ryder, Yinong Young-Xu |
| 995 |
[GO] |
2022―Jun―20 |
BCG vaccine safety in COVID-19 convalescent adults: BATTLE a randomized controlled trial |
Franciele A.V. Dionato, Mehrsa Jalalizadeh, Keini Buosi, Marília B. Visacri, Luciana S.B. Dal Col, Cristiane F. Giacomelli, Patricia A.F. Leme, Cristiane L. Maia, Patricia Moriel, Leonardo O. Reis |
| 996 |
[GO] |
2022―Jun―16 |
Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil |
Patricia Mouta Nunes de Oliveira, Daniela P. Mendes-de-Almeida, Victor Bertollo Gomes Porto, Catherine Crespo Cordeiro, Gabriellen Vitiello Teixeira, Renata Saraiva Pedro, Paulo Roberto Gomes Takey, Letícia Kegele Lignani, Janaína Reis Xavier, Vitor Cardoso Doria da Gama, Luiz Amorim Filho, Bárbara Emoingt Furtado, André Santa Maria, Tiago Dahrug Barros, Livia Neves Waite Freitas, Tainá dos Santos Pereira, Debora Lima Abreu, Michael Bernardes Ramos, Caroline Gabe, James William Smith, Maria de Lourdes de Sousa Maia |
| 997 |
[GO] |
2022―Jun―15 |
Estimating the number of US children susceptible to measles resulting from COVID-19-related vaccination coverage declines |
Ashley Gambrell, Maria Sundaram, Robert A. Bednarczyk |
| 998 |
[GO] |
2022―Jun―15 |
Response to letter to the editor: Immunophenotyping of SARS-CoV-2 and vaccine design |
Rima Moghnieh, Dania Abdallah, Mohamed H. Sayegh, Abdul Rahman Bizri |
| 999 |
[GO] |
2022―Jun―15 |
Immunophenotyping of SARS-CoV-2 and vaccine design |
Nevio Cimolai |
| 1000 |
[GO] |
2022―Jun―13 |
COVID-19 vaccination coverage and intent among women aged 18-49 years by pregnancy status, United States, April-November 2021 |
Hilda Razzaghi, David Yankey, Kushagra Vashist, Peng-jun Lu, Jennifer L. Kriss, Kimberly H Nguyen, James Lee, Sascha Ellington, Kara Polen, Kimberly Bonner, Tara C. Jatlaoui, Elisabeth Wilhelm, Dana Meaney-Delman, James A. Singleton |
| 1001 |
[GO] |
2022―Jun―13 |
RelCoVax®, a two antigen subunit protein vaccine candidate against SARS-CoV-2 induces strong immune responses in mice |
Abhishek Phatarphekar, G.E.C. Vidyadhar Reddy, Abhiram Gokhale, Gopala Karanam, Pushpa Kuchroo, Ketaki Shinde, Girish Masand, Shyam Pagare, Nilesh Khadpe, Sangita S. Pai, Vijita Vijayan, R.L. Ramnath, K. Pratap Reddy, Praveen Rao, S. Harinarayana Rao, Venkata Ramana |
| 1002 |
[GO] |
2022―Jun―09 |
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273) |
Brett Leav, Walter Straus, Phil White, Alison Leav, Tashawnee Gaines, Grace Maggiacomo, Denny Kim, Emily R. Smith, Marc Gurwith, Robert T. Chen |
| 1003 |
[GO] |
2022―Jun―08 |
The effect of health literacy on COVID-19 vaccine hesitancy among community population in China: The moderating role of stress |
Huiqiao Zhang, Yue Li, Sihui Peng, Yue Jiang, Huihui Jin, Fan Zhang |
| 1004 |
[GO] |
2022―Jun―08 |
Safety and Protective Capability of an Inactivated SARS-CoV-2 Vaccine on Pregnancy, Lactation and the Growth of offspring in hACE2 Mice |
Kaili Lin, Meixuan Liu, Linlin Bao, Qi Lv, Hua Zhu, Dan Li, Yanfeng Xu, Zhiguang Xiang, Jiangning Liu, Xujian Liang, Yunlin Han, Zhe Cong, Ruixue Liu, Ran Deng, Siyuan Wang, Zhi Guo, Lu Sun, Qiang Wei, Hongwei Qiao, Shunyi Wang, Sidan Pan, Hong Gao, Chuan Qin |
| 1005 |
[GO] |
2022―Jun―08 |
Vaccine effectiveness against COVID-19 related hospital admission in the Netherlands: a test-negative case-control study |
F.A. Niessen, J. Mirjam Knol, J.M. Susan Hahné, VECTOR study group, M.J.M. Bonten, P.C.J.L. Bruijning-Verhagen |
| 1006 |
[GO] |
2022―Jun―08 |
Shoulder Injury Related to Vaccine Administration (SIRVA) After COVID-19 Vaccination |
Jessica R. Bass, Gregory A. Poland |
| 1007 |
[GO] |
2022―Jun―08 |
Corowa-kun: A messenger app chatbot delivers COVID-19 vaccine information, Japan 2021 |
Takaaki Kobayashi, Yuka Nishina, Hana Tomoi, Ko Harada, Kyuto Tanaka, Eiyu Matsumoto, Kenta Horimukai, Jun Ishihara, Shugo Sasaki, Kanako Inaba, Kyosuke Seguchi, Hiromizu Takahashi, Jorge L. Salinas, Yuji Yamada |
| 1008 |
[GO] |
2022―Jun―07 |
The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study |
Elke Wynberg, Alvin X. Han, Anders Boyd, Hugo D.G. van Willigen, Anouk Verveen, Romy Lebbink, Karlijn van der Straten, Neeltje Kootstra, Marit J. van Gils, Colin Russell, Tjalling Leenstra, Menno D. de Jong, Godelieve J. de Bree, Maria Prins |
| 1009 |
[GO] |
2022―Jun―07 |
Safety of COVID-19 vaccination and acute neurological events: a self-controlled case series in England using the OpenSAFELY platform |
Jemma L Walker, Anna Schultze, John Tazare, Arina Tamborska, Bhagteshwar Singh, Katherine Donegan, Julia Stowe, Caroline E Morton, William J Hulme, Helen J Curtis, Elizabeth J Williamson, Amir Mehrkar, Rosalind M Eggo, Christopher T Rentsch, Rohini Mathur, Sebastian Bacon, Alex J Walker, Simon Davy, David Evans, Peter Inglesby, George Hickman, Brian MacKenna, Laurie Tomlinson, Amelia CA Green, Louis Fisher, Jonathan Cockburn, John Parry, Frank Hester, Sam Harper, Christopher Bates, Stephen JW Evans, Tom Solomon, Nick J Andrews, Ian J Douglas, Ben Goldacre, Liam Smeeth, Helen I McDonald |
| 1010 |
[GO] |
2022―Jun―06 |
A socio-ecological perspective on parents’ intention to vaccinate their children against COVID-19 |
Lauren Dayton, Jacob Miller, Justin Strickland, Melissa Davey-Rothwell, Carl Latkin |
| 1011 |
[GO] |
2022―Jun―06 |
Induced humoral immunity of different types of vaccines against most common variants of SARS-CoV-2 in Egypt prior to Omicron outbreak |
Rabeh El-Shesheny, Ahmed El Taweel, Mokhtar R. Gomaa, Wael H. Roshdy, Ahmed Kandeil, Richard J. Webby, Ghazi Kayali, Mohamed A. Ali |
| 1012 |
[GO] |
2022―Jun―06 |
Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys |
Masayuki Hashimoto, Noriyo Nagata, Tomoyuki Homma, Hiroki Maeda, Keiji Dohi, Naomi M. Seki, Ken Yoshihara, Naoko Iwata-Yoshikawa, Nozomi Shiwa-Sudo, Yusuke Sakai, Masayuki Shirakura, Noriko Kishida, Tomoko Arita, Yasushi Suzuki, Shinji Watanabe, Hideki Asanuma, Takuhiro Sonoyama, Tadaki Suzuki, Shinya Omoto, Hideki Hasegawa |
| 1013 |
[GO] |
2022―Jun―06 |
Preclinical Evaluation of a Plant-derived SARS-CoV-2 Subunit Vaccine: Protective Efficacy, Immunogenicity, Safety, and Toxicity |
Balamurugan Shanmugaraj, Narach Khorattanakulchai, Chalisa Panapitakkul, Ashwini Malla, Rawiwan Im-erbsin, Manutsanun Inthawong, Piyanate Sunyakumthorn, Taweewun Hunsawong, Chonticha Klungthong, Matthew C. Reed, Taratorn Kemthong, Nutchanat Suttisan, Suchinda Malaivijitnond, Passaraporn Srimangkornkaew, Aekkarin Klinkhamhom, Suwimon Manopwisedjaroen, Arunee Thitithanyanont, Suthira Taychakhoonavudh, Waranyoo Phoolcharoen |
| 1014 |
[GO] |
2022―Jun―03 |
A “step too far” or “perfect sense”? A qualitative study of British adults’ views on mandating COVID-19 vaccination and vaccine passports |
Martine Stead, Allison Ford, Douglas Eadie, Hannah Biggs, Claire Elliott, Michael Ussher, Helen Bedford, Kathryn Angus, Kate Hunt, Anne Marie MacKintosh, Curtis Jessop, Andy MacGregor |
| 1015 |
[GO] |
2022―Mai―30 |
COVID-19 IMPACT ON ROUTINE IMMUNISATIONS FOR VACCINE-PREVENTABLE DISEASES: PROJECTING THE EFFECT OF DIFFERENT ROUTES TO RECOVERY |
Jaspreet Toor, Xiang Li, Mark Jit, L. Caroline Trotter, Susy Echeverria-Londono, Anna-Maria Hartner, Jeremy Roth, Allison Portnoy, Kaja Abbas, M. Neil Ferguson, Katy AM Gaythorpe |
| 1016 |
[GO] |
2022―Mai―30 |
COVID-19 management landscape- A need for an affordable to manufacture safe and efficacious bio-therapeutic and prophylactic for developing countries |
Vyankatesh Pidiyar, Ganesh Kumraj, Kafil Ahmed, Syed Ahmed, Sanket Shah, Bhawna Verma, Sarang Pathak, Sushmita Mukherjee |
| 1017 |
[GO] |
2022―Mai―30 |
Comparative Effectiveness of Mandates and Financial Policies Targeting COVID-19 Vaccine Hesitancy: A Randomized, Controlled Survey Experiment |
Jessica Fishman, Mandy K. Salmon, Daniel Scheitrum, K. Aleks Schaefer, Christopher T. Robertson |
| 1018 |
[GO] |
2022―Mai―30 |
Thrombocytopenia after Ad.26.COV2.S COVID-19 vaccine: reports to the Vaccine Adverse Event Reporting System |
Emily Jane Woo, Rositsa B. Dimova |
| 1019 |
[GO] |
2022―Mai―30 |
Nanomedicine to deliver biological macromolecules for treating COVID-19 |
Barnabas Wilson, Kannoth Mukundan Geetha |
| 1020 |
[GO] |
2022―Mai―30 |
Utilizing Google trends to monitor coronavirus vaccine interest and hesitancies |
Emily Merrick, Joshua P. Weissman, Sameer J. Patel |
| 1021 |
[GO] |
2022―Mai―27 |
Relationship Between the Use of Nonpharmaceutical Interventions and COVID-19 Vaccination Among U.S. Child Care Providers: A Prospective Cohort Study |
Kavin M. Patel, Mehr Shafiq, Amyn A. Malik, Ayse Cobanoglu, Madeline Klotz, John Eric Humphries, Aiden Lee, Thomas Murray, David Wilkinson, Inci Yildirim, Jad A. Elharake, Rachel Diaz, Rosalia Rojas, Anael Kuperwajs Cohen, Saad B. Omer, Walter S. Gilliam |
| 1022 |
[GO] |
2022―Mai―27 |
Benefit-Risk Evaluation of COVID-19 Vaccination in Special Population Groups of Interest |
Paul Moss, Francis Berenbaum, Giuseppe Curigliano, Ayelet Grupper, Thomas Berg, Shanti Pather |
| 1023 |
[GO] |
2022―Mai―27 |
Hypertension is associated with antibody response and breakthrough infection in health care workers following vaccination with inactivated SARS-CoV-2 |
Gatot Soegiarto, Laksmi Wulandari, Dewajani Purnomosari, Karin Dhia Fahmita, Hendra Ikhwan Gautama, Satrio Tri Hadmoko, Muhammad Edwin Prasetyo, Bagus Aulia Mahdi, Nur Arafah, Dewi Prasetyaningtyas, Pujo Prawiro Negoro, Cita Rosita Sigit Prakoeswa, Anang Endaryanto, Desak Gede Agung Suprabawati, Damayanti Tinduh, Eka Basuki Rachmad, Erwin Astha Triyono, Joni Wahyuhadi, Catur Budi Keswardiono, Feby Elyana Wardani, Fitriyah Mayorita, Nunuk Kristiani, Ari Baskoro, Deasy Fetarayani, Wita Kartika Nurani, Delvac Oceandy |
| 1024 |
[GO] |
2022―Mai―27 |
Broad neutralization against SARS-CoV-2 variants induced by ancestral and B.1.351 AS03-Adjuvanted recombinant Plant-Derived Virus-Like particle vaccines |
Charlotte Dubé, Sarah Paris-Robidas, Guadalupe Andreani, Cindy Gutzeit, Marc-André D'Aoust, Brian J. Ward, Sonia Trépanier |
| 1025 |
[GO] |
2022―Mai―27 |
COVID-19 and seasonal flu vaccination hesitancy: Links to personality and general intelligence in a large, UK cohort |
Isaac N. Halstead, Ryan T. McKay, Gary J. Lewis |
| 1026 |
[GO] |
2022―Mai―25 |
Between persuasion and compulsion: The case of COVID-19 vaccination in Canada |
Eve Dubé, Dominique Gagnon, Noni MacDonald |
| 1027 |
[GO] |
2022―Mai―25 |
Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: a Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines |
Natalia Abraham, Sarah Spruin, Tanya Rossi, Bruce Fireman, Joseline Zafack, Christine Blaser, Amanda Shaw, Kimberley Hutchings, Susanna Ogunnaike-Cooke |
| 1028 |
[GO] |
2022―Mai―20 |
A log-odds system for waning and boosting of COVID-19 vaccine effectiveness |
Joshua Szanyi, Tim Wilson, Nick Scott, Tony Blakely |
| 1029 |
[GO] |
2022―Mai―19 |
Risk-based cost-benefit analysis of alternative vaccines against COVID-19 in Brazil: Coronavac vs. Astrazeneca vs. Pfizer |
Paulo Gabriel Siqueira, Heitor Oliveira Duarte, Márcio das Chagas Moura |
| 1030 |
[GO] |
2022―Mai―19 |
Jabbing together? The complementarity between social capital, formal public health rules, and COVID-19 vaccine rates in the United States |
Byron Carson, Justin Isaacs, Tony Carilli |
| 1031 |
[GO] |
2022―Mai―17 |
Parental socioeconomic and psychological determinants of the 2009 pandemic influenza A(H1N1) vaccine uptake in children |
Krista Salo-Tuominen, Tamara Teros-Jaakkola, Laura Toivonen, Helena Ollila, Päivi Rautava, Minna Aromaa, Elina Lahti, Niina Junttila, Ville Peltola |
| 1032 |
[GO] |
2022―Mai―16 |
Experimental pre-tests of public health communications on the COVID-19 vaccine: A null finding for medical endorsement, risk and altruism |
Deirdre A. Robertson, Kieran S. Mohr, Martina Barjaková, Peter D. Lunn |
| 1033 |
[GO] |
2022―Mai―14 |
Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam |
Anh Duc Dang, Thiem Dinh Vu, Ha Hai Vu, Van Thanh Ta, Anh Thi Van Pham, Mai Thi Ngoc Dang, Be Van Le, Thai Huu Duong, Duoc Van Nguyen, Saranath Lawpoolsri, Pailinrut Chinwangso, Jason S. McLellan, Ching-Lin Hsieh, Adolfo Garcia-Sastre, Peter Palese, Weina Sun, Jose L. Martinez, Irene Gonzalez-Dominguez, Stefan Slamanig, Juan Manuel Carreño, Johnstone Tcheou, Florian Krammer, Ariel Raskin, Huong Minh Vu, Thang Cong Tran, Huong Mai Nguyen, Laina D. Mercer, Rama Raghunandan, Manjari Lal, Jessica A. White, Richard Hjorth, Bruce L. Innis, Rami Scharf |
| 1034 |
[GO] |
2022―Mai―14 |
Effects of vaccination status in the United States on willingness to undergo surgery during a pandemic: A prospective survey study |
Anna Clebone Ruskin, Stephen Rice, Michael O'Connor, Keith J. Ruskin |
| 1035 |
[GO] |
2022―Mai―13 |
Catch-up vaccination campaign in children between 6 and 8 years old during COVID-19 pandemic: The experience in a COVID hub in Milan, Italy |
Matteo Mancarella, Federica Natarelli, Caterina Bertolini, Antonino Zagari, Maria Enrica Bettinelli, Silvana Castaldi |
| 1036 |
[GO] |
2022―Mai―13 |
Phase 1/2 Clinical Trial of COVID-19 Vaccine in Japanese Participants: A Report of Interim Findings |
Satoshi Iwata, Takuhiro Sonoyama, Akari Kamitani, Risa Shibata, Tomoyuki Homma, Shinya Omoto, Kenji Igarashi, Mari Ariyasu |
| 1037 |
[GO] |
2022―Mai―13 |
COVID-19 vaccine uptake and its associated factors among Palestinian healthcare workers: Expectations beaten by reality |
Walaa Abu Alia, Beesan Maraq, Zaher Nazzal, Mahmoud Odeh, Rabee Makhalfa, Ali Nassif, Mousa Aabed |
| 1038 |
[GO] |
2022―Mai―12 |
Safety of Pfizer-BioNTech vaccine in a cohort of healthcare providers: differences between naïve and previously infected by SARS-CoV-2 |
Andrea Chong-Valbuena, Isabel De-Jesús-María, Adriana Agurto-Ramírez, Francesc Puchades-Gimeno, Mercedes Melero-García |
| 1039 |
[GO] |
2022―Mai―11 |
Acceptability of COVID-19 vaccine mandates among New York City parents, November 2021 |
Chloe A. Teasdale, Scott Ratzan, Hannah Stuart Lathan, Lauren Rauh, Spencer Kimball, Ayman El-Mohandes |
| 1040 |
[GO] |
2022―Mai―11 |
Decay of anti-Bordetella pertussis antibodies in women of childbearing age following COVID-19 non-pharmaceutical measures |
Frederic Reicherz, Liam Golding, Pascal M Lavoie, Bahaa Abu-Raya |
| 1041 |
[GO] |
2022―Mai―08 |
Impact of National Covid-19 Vaccination Campaign, South Korea |
Seonju Yi, Young June Choe, Do Sang Lim, Hye Roen Lee, Jia Kim, Yoo-Yeon Kim, Ryu Kyung Kim, Eun Jung Jang, Sangwon Lee, Eunjoo Park, Seung-Jin Kim, Young-Joon Park |
| 1042 |
[GO] |
2022―Mai―08 |
Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern |
Jeroen Pollet, Ulrich Strych, Wen-Hsiang Chen, Leroy Versteeg, Brian Keegan, Bin Zhan, Junfei Wei, Zhuyun Liu, Jungsoon Lee, Rahki Kundu, Rakesh Adhikari, Cristina Poveda, Maria Jose Villar, Syamala Rani Thimmiraju, Brianna Lopez, Portia M. Gillespie, Shannon Ronca, Jason T. Kimata, Martin Reers, Vikram Paradkar, Peter J. Hotez, Maria Elena Bottazzi |
| 1043 |
[GO] |
2022―Mai―07 |
Flu and pertussis vaccination during pregnancy in Geneva during the COVID-19 pandemic: A multicentric, prospective, survey-based study |
M. Lumbreras Areta, A. Valiton, A. Diana, M. Morales, J. Wiederrecht-Gasser, S. Jacob, A. Chilin, S. Quarta, C. Jaksic, JR. Vallarta-Robledo, B. Martinez de Tejada |
| 1044 |
[GO] |
2022―Mai―06 |
Building population and health system resilience: Using lessons learned during the COVID pandemic to implement life-course immunisation policy |
Sandra Evans, Daphné Holt, Catherine Weil-Olivier, Gary Finnegan, Vytautas Usonis |
| 1045 |
[GO] |
2022―Mai―05 |
Measuring parents’ readiness to vaccinate themselves and their children against COVID-19 |
Franziska Rees, Mattis Geiger, Lau Lilleholt, Ingo Zettler, Cornelia Betsch, Robert Böhm, Oliver Wilhelm |
| 1046 |
[GO] |
2022―Mai―05 |
COVID-19 and seasonal influenza: The potential 2021-22 “Twindemic” |
Saverio Bellizzi, Catello M. Panu Napodano, Sergio Pinto, Giuseppe Pichierri |
| 1047 |
[GO] |
2022―Mai―05 |
Prevalence and factors of influenza vaccination during the COVID-19 pandemic among university students in China |
Yanqiu Yu, Yee-ling Ma, Sitong Luo, Suhua Wang, Junfeng Zhao, Guohua Zhang, Lijuan Li, Liping Li, Joseph Tak-fai Lau |
| 1048 |
[GO] |
2022―Mai―05 |
Characteristics associated with the willingness to receive a COVID-19 vaccine and an exploration of the general public's perceptions: A mixed-methods approach |
Norina Gasteiger, Chiara Gasteiger, Kavita Vedhara, Elizabeth Broadbent |
| 1049 |
[GO] |
2022―Mai―05 |
Factors affecting COVID-19 vaccine hesitancy among healthcare providers in 23 countries |
Jeanna Parsons Leigh, Stephana J. Moss, Trenton M. White, Camila A. Picchio, Kenneth H. Rabin, Scott C. Ratzan, Katarzyna Wyka, Ayman El-Mohandes, Jeffrey V. Lazarus |
| 1050 |
[GO] |
2022―Mai―05 |
Covid-19 vaccine immunogenicity in people living with HIV-1 |
Lauriane Nault, Lorie Marchitto, Guillaume Goyette, Daniel Tremblay-Sher, Claude Fortin, Valérie Martel-Laferrière, Benoît Trottier, Jonathan Richard, Madeleine Durand, Daniel Kaufmann, Andrés Finzi, Cécile Tremblay |
| 1051 |
[GO] |
2022―Mai―03 |
Readability of COVID-19 Vaccine Information for the General Public |
Luke S. Bothun, Scott E. Feeder, Gregory A. Poland |
| 1052 |
[GO] |
2022―Mai―02 |
Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization |
Daniel R. Feikin, Laith J. Abu-Raddad, Nick Andrews, Mary-Ann Davies, Melissa M. Higdon, Walter A. Orenstein, Minal K. Patel |
| 1053 |
[GO] |
2022―Apr―28 |
Overcoming COVID-19 vaccine hesitancy among ethnic minorities: A systematic review of UK studies |
Basharat Hussain, Asam Latif, Stephen Timmons, Kennedy Nkhoma, Laura B. Nellums |
| 1054 |
[GO] |
2022―Apr―27 |
Commentary: “The vaccine Selfie” and its influence on COVID-19 vaccine acceptance |
Netana H. Markovitz, Arianna L. Strome, Payal K. Patel |
| 1055 |
[GO] |
2022―Apr―27 |
Differences in clinical outcomes of COVID-19 among vaccinated and unvaccinated kidney transplant recipients |
Erol Demir, Hamad Dheir, Seda Safak, Ayse Serra Artan, Savas Sipahi, Aydin Turkmen |
| 1056 |
[GO] |
2022―Apr―27 |
Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance |
Sharifa Nasreen, Andrew Calzavara, Sarah A. Buchan, Nisha Thampi, Caitlin Johnson, Sarah E. Wilson, Jeffrey C. Kwong |
| 1057 |
[GO] |
2022―Apr―23 |
War, pandemic and vaccination - Upcoming health problems by the refugee wave in Europe? |
Antonio Perciaccante, Victor Asensi, Andrei I. Cucu, Philippe Charlier, Simon T. Donell, Andreas G. Nerlich, Raffaella Bianucci |
| 1058 |
[GO] |
2022―Apr―22 |
Self-Reported COVID-19 Vaccination Acceptance and Hesitancy among Autistic Adults |
Lindsay L. Shea, Alec Becker, Brian K. Lee, Kaitlin Koffer Miller, Dylan Cooper, Kristy Anderson, Mark S. Salzer, David J. Vanness |
| 1059 |
[GO] |
2022―Apr―22 |
COVID-19 vaccinations in Bhutan - Mix-and-Match to Boosters: an experience |
Saran Tenzin Tamang, Thinley Dorji |
| 1060 |
[GO] |
2022―Apr―22 |
SARS-CoV-2 immunogenicity: is S protein the best target for vaccination? |
Tania Antonopoulou, Irene Athanassakis |
| 1061 |
[GO] |
2022―Apr―22 |
Predictors of hospitalisation and death due to SARS-CoV-2 infection in Finland: a population-based register study with implications to vaccinations |
Heini Salo, Toni Lehtonen, Kari Auranen, Ulrike Baum, Tuija Leino |
| 1062 |
[GO] |
2022―Apr―18 |
Delay between COVID-19 complete vaccination and SARS-CoV-2 infection among healthcare workers |
Anastasia Saade, Leo Cha, Emilie Tadié, Bruno Jurado, Alix Le Bihan, Pauline Baron-Latouche, Christine Febreau, Vincent Thibault, Ronan Garlantezec, Pierre Tattevin, Christophe Paris |
| 1063 |
[GO] |
2022―Apr―18 |
De-escalation of asymptomatic testing and potential of future COVID-19 outbreaks in U.S. nursing homes amidst rising community vaccination coverage: a modeling study |
Brajendra K. Singh, Joseph Walker, Prabasaj Paul, Sujan Reddy, Camden D. Gowler, John Jernigan, Rachel B. Slayton |
| 1064 |
[GO] |
2022―Apr―18 |
Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic |
Stanley Xu, Vennis Hong, Lina S. Sy, Sungching C. Glenn, Denison S. Ryan, Kerresa Morrissette, Jennifer C. Nelson, Simon J. Hambidge, Bradley Crane, Ousseny Zerbo, Malini B DeSilva, Jason M. Glanz, James G Donahue, Elizabeth Liles, Jonathan Duffy, Lei Qian |
| 1065 |
[GO] |
2022―Apr―18 |
Impact of COVID-19 Vaccine-Associated Side Effects on Health Care Worker Absenteeism and Future Booster Vaccination |
Ara A. Chrissian, Udochukwu E. Oyoyo, Pranjal Patel, W. Lawrence Beeson, Lawrence K. Loo, Shahriyar Tavakoli, Alex Dubov |
| 1066 |
[GO] |
2022―Apr―18 |
Immunogenicity of heterologous inactivated and adenoviral-vectored COVID-19 vaccine: real-world data |
Nasamon Wanlapakorn, Nungruthai Suntronwong, Harit Phowatthanasathian, Ritthideach Yorsaeng, Thanunrat Thongmee, Preeyaporn Vichaiwattana, Chompoonut Auphimai, Lakkhana Wongsrisang, Sirapa Klinfueng, Natthinee Sudhinaraset, Yong Poovorawan |
| 1067 |
[GO] |
2022―Apr―18 |
Covax-19/Spikogen® vaccine based on recombinant spike protein extracellular domain with Advax-CpG55.2 adjuvant provides single dose protection against SARS-CoV-2 infection in hamsters |
Lei Li, Yoshikazu Honda-Okubo, Jeremy Baldwin, Richard Bowen, Helle Bielefeldt-Ohmann, Nikolai Petrovsky |
| 1068 |
[GO] |
2022―Apr―12 |
Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the Vaccine Adverse Event Reporting System (VAERS), December 2020 - October 2021 |
Pedro L. Moro, Christine K. Olson, Elizabeth Clark, Paige Marquez, Penelope Strid, Sascha Ellington, Bicheng Zhang, Adamma Mba-Jonas, Meghna Alimchandani, Janet Cragan, Cynthia Moore |
| 1069 |
[GO] |
2022―Apr―12 |
Screening for SARS-CoV-2 antibodies to save vaccine doses |
Florence Fenollar, Laurence Thomas, Didier Raoult, Philippe Gautret |
| 1070 |
[GO] |
2022―Apr―12 |
Increased Delta variant SARS-CoV-2 infections in a highly vaccinated medical center in Japan |
Yan Yan, Toshio Naito, Yoko Tabe, Kanami Ito, Shuko Nojiri, Gautam A. Deshpande, Kuniaki Seyama, Kazuhisa Takahashi |
| 1071 |
[GO] |
2022―Apr―12 |
VACCINE EFFECTIVENESS AGAINST ONWARD TRANSMISSION OF SARS-COV2-INFECTION BY VARIANT OF CONCERN AND TIME SINCE VACCINATION, BELGIAN CONTACT TRACING, 2021 |
Toon Braeye, Lucy Catteau, Ruben Brondeel, Joris van Loenhout, Kristiaan Proesmans, Laura Cornelissen, Herman Van Oyen, Veerle Stouten, Pierre Hubin, Matthieu Billuart, Achille Djiena, Romain Mahieu, Naima Hammami, Dieter Van Cauteren, Chloé Wyndham-Thomas |
| 1072 |
[GO] |
2022―Apr―11 |
A Case Of Myocarditis And Isolated Hypopotassemia After Biontech-Pfizer Vaccine For Covid-19 |
Mehmet Emin Ceylan, Barış Önen Ünsalver, Aslıhan Dönmez, Fatma Duygu Kaya Yertutanol, Alper Evrensel, Hatice Zeynep Ceylan |
| 1073 |
[GO] |
2022―Apr―11 |
Trends in effectiveness of inactivated influenza vaccine in children by age groups in seven seasons immediately before the COVID-19 era |
Masayoshi Shinjoh, Munehiro Furuichi, Hisato Kobayashi, Yoshio Yamaguchi, Naonori Maeda, Mizuki Yaginuma, Ken Kobayashi, Taisuke Nogayama, Michiko Chiga, Mio Oshima, Yuu Kuramochi, Go Yamada, Atsushi Narabayashi, Ichiro Ookawara, Mitsuhiro Nishida, Kenichiro Tsunematsu, Isamu Kamimaki, Motoko Shimoyamada, Makoto Yoshida, Akimichi Shibata, Yuji Nakata, Nobuhiko Taguchi, Keiko Mitamura, Takao Takahashi |
| 1074 |
[GO] |
2022―Apr―11 |
Evaluation of weekly Covid-19 vaccination and case data supports negative correlation between incidence and vaccination in German federal states and cities during 4th wave |
Steffen Springer, Martin Kaatz, Michael Zieger |
| 1075 |
[GO] |
2022―Apr―11 |
Patterns and influencing factors of COVID-19 vaccination willingness among college students in China |
Xi-Mei Zhu, Wei Yan, Jie Sun, Lin Liu, Yi-Miao Zhao, Yong-Bo Zheng, Jian-Yu Que, Si-Wei Sun, Yi-Miao Gong, Na Zeng, Kai Yuan, Le Shi, Yan-Kun Sun, Sui-Huai Guo, Yu Lu, Mao-Sheng Ran, Samuel Yeung Shan Wong, Jie Shi, Zheng-Dong Jiang, Yan-Ping Bao, Lin Lu |
| 1076 |
[GO] |
2022―Apr―11 |
Need for a contingency dimension when planning vaccine development in a pandemic environment |
Paul Beninger |
| 1077 |
[GO] |
2022―Apr―11 |
Differences by region of birth in SARS-CoV-2 vaccine coverage and positive SARS-CoV-2 test among 400 000 healthcare workers and the general population in Sweden |
Rickard Ljung, Maria Feychting, Bo Burström, Jette Möller |
| 1078 |
[GO] |
2022―Apr―08 |
Impact of COVID-19 immunisation on COVID-19 incidence, hospitalisations, and deaths by age group in Germany from December 2020 to October 2021 |
Nita Perumal, Annika Steffen, Alexander Ullrich, Anette Siedler |
| 1079 |
[GO] |
2022―Apr―08 |
Designing an evidence-based Bayesian network for estimating the risk versus benefits of AstraZeneca COVID-19 vaccine |
Helen J. Mayfield, Colleen L. Lau, Jane E. Sinclair, Samuel J. Brown, Andrew Baird, John Litt, Aapeli Vuorinen, Kirsty R. Short, Michael Waller, Kerrie Mengersen |
| 1080 |
[GO] |
2022―Apr―08 |
Ask Me Anything”: Lessons learned in implementing a COVID-19 vaccine information initiative in Massachusetts jails |
Parsa Erfani, Raquel Sofia Sandoval, Katherine M. Rich, Ayotomiwa Ojo, Liz Walker MDiv, Gloria White-Hammond, Eugene Lambert, Alysse Wurce |
| 1081 |
[GO] |
2022―Apr―08 |
Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the Vaccine Safety Datalink |
Tat'Yana A. Kenigsberg, Anne M. Hause, Michael M. McNeil, Jennifer C. Nelson, Jo Ann Shoup, Kristin Goddard, Yingbo Lou, Kayla E. Hanson, Sungching C. Glenn, Eric Weintraub |
| 1082 |
[GO] |
2022―Apr―07 |
Extended Reporting Guidance for Vaccine Effectiveness Studies for Variants of Concern for COVID-19 |
Lori-Ann Linkins, Alfonso Iorio, Julian Little, John Lavis |
| 1083 |
[GO] |
2022―Apr―07 |
Factors associated with the intention to participate in COVID-19 vaccine clinical trials: A cross-sectional study in Peru |
Abraham De-Los-Rios-Pinto, Daniel Fernandez-Guzman, David R. Soriano-Moreno, Lucero Sangster-Carrasco, Noelia Morocho-Alburqueque, Antony Pinedo-Soria, Valentina Murrieta-Ruiz, Angelica Diaz-Corrales, Jorge Alave, Wendy Nieto-Gutierrez, Jose Armando Gonzales-Zamora |
| 1084 |
[GO] |
2022―Apr―05 |
Factors associated with COVID-19 vaccination intent in Singapore, Australia and Hong Kong |
Shimoni Shah, Hao Gui, Pearleen Ee Yong Chua, Jing-Yu Benjamin Tan, Lorna Kwai-ping Suen, Sally Wai-chi Chan, Junxiong Pang |
| 1085 |
[GO] |
2022―Apr―04 |
Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates |
Jewell N. Walters, Blake Schouest, Ami Patel, Emma L. Reuschel, Katherine Schultheis, Elizabeth Parzych, Igor Maricic, Ebony N. Gary, Mansi Purwar, Viviane M. Andrade, Arthur Doan, Dustin Elwood, Zeena Eblimit, Brian Nguyen, Drew Frase, Faraz I. Zaidi, Abhijeet Kulkarni, Alison Generotti, J Joseph Kim, Laurent M. Humeau, Stephanie J. Ramos, Trevor R.F. Smith, David B. Weiner, Kate E. Broderick |
| 1086 |
[GO] |
2022―Apr―01 |
Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: evidence from an outbreak in Yunnan, China, 2021 |
Chao Ma, Weiwei Sun, Tingting Tang, Manhong Jia, Yonghua Liu, Yongfang Wan, Jizhou Han, Lance Rodewald, Junhong Li, Yudan Song, Yamin Wang, Dan Wu, Fuzhen Wang, Hui Zheng, Lin Tang, George F. Gao, Zundong Yin, Zhijie An |
| 1087 |
[GO] |
2022―Apr―01 |
A self-amplifying RNA vaccine protects against SARS-CoV-2 (D614G) and Alpha variant of concern (B.1.1.7) in a transmission-challenge hamster model |
Rebecca Frise, Laury Baillon, Jie Zhou, Ruthiran Kugathasan, Thomas P. Peacock, Jonathan C. Brown, Karnyart Samnuan, Paul F. McKay, Robin J. Shattock, Wendy S. Barclay |
| 1088 |
[GO] |
2022―Apr―01 |
Comparison of the effectiveness and duration of anti-RBD SARS-CoV-2 IgG antibody response between different types of vaccines: Implications for Vaccine Strategies |
MA. Sughayer, L. Souan, MM. Abu Alhowr, D. Al Rimawi, M. Siag, S. Albadr. M. Owdeh, T. Al Atrash |
| 1089 |
[GO] |
2022―Mrz―29 |
Trends and disparities in the utilization of influenza vaccines among commercially insured US adults during the COVID-19 pandemic |
Kun Li, Tianzhou Yu, Seth A. Seabury, Avi Dor |
| 1090 |
[GO] |
2022―Mrz―29 |
Vaccine-induced humoral response against SARS-CoV-2 dramatically declined but cellular immunity possibly remained at 6 months post BNT162b2 vaccination |
Hideaki Kato, Kei Miyakawa, Norihisa Ohtake, Yutaro Yamaoka, Satoshi Yajima, Etsuko Yamazaki, Tomoko Shimada, Atsushi Goto, Hideaki Nakajima, Akihide Ryo |
| 1091 |
[GO] |
2022―Mrz―29 |
The early impact of vaccination against SARS-CoV-2 in Region Stockholm, Sweden |
Catherine Isitt, Daniel Sjöholm, Maria-Pia Hergens, Fredrik Granath, Pontus Nauclér |
| 1092 |
[GO] |
2022―Mrz―28 |
Supporting Immunization Programs to Address COVID-19 Vaccine Hesitancy: Recommendations for National and Community-Based Stakeholders |
Katelyn Wells, Kelly L. Moore, Robert Bednarczyk |
| 1093 |
[GO] |
2022―Mrz―28 |
Benefit-Risk Assessment of COVID-19 Vaccine, mRNA (Comirnaty) for Age 16-29 years |
Patrick R. Funk, Osman N. Yogurtcu, Richard A. Forshee, Steve A. Anderson, Peter W. Marks, Hong Yang |
| 1094 |
[GO] |
2022―Mrz―28 |
Erythema nodosum triggered by BNT162b2 mRNA COVID-19 vaccine |
Vanessa Juddoo, Sonia Juddoo, Bruno Mégarbane |
| 1095 |
[GO] |
2022―Mrz―25 |
Disparities in COVID-19 Vaccine Uptake Among Health Care Workers |
Wigdan Farah, Laura Breeher, Vishal Shah, Caitlin Hainy, Christopher P. Tommaso, Melanie D. Swift |
| 1096 |
[GO] |
2022―Mrz―25 |
Understanding COVID-19 Vaccine Uptake during Pregnancy:‘Hesitance’, Knowledge, and Evidence-Based Decision-Making |
Leigh Ann Simmons, Mackenzie DM Whipps, Jennifer E Phipps, Nikita S Satish, Geeta K. Swamy |
| 1097 |
[GO] |
2022―Mrz―24 |
IgA nephropathy in a pediatric patient after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine |
Derar H. Abdel-Qader, Issa Hazza Alkhatatbeh, Wail Hayajneh, Hassan Annab, Ahmad Z. Al Meslamani, Reem A. Elmusa |
| 1098 |
[GO] |
2022―Mrz―22 |
Decreasing routine vaccination rates in children in the COVID-19 era |
Helena C. Maltezou, Snezana Medic, Dimitrios C. Cassimos, Evgnosia Effraimidou, Gregory A. Poland |
| 1099 |
[GO] |
2022―Mrz―22 |
Effectiveness of the Comirnaty and the Vaxzevria vaccines in preventing SARS-CoV-2 infection among residents in Lazio region (Italy) |
Valeria Fano, Alessia Crielesi, Enzo Coviello, Massimo Fabiani, Antonio Salvatore Miglietta, Giovanni Colaiocco, Irene Moretti, Caterina Pasqua, Fabio Vivaldi, Giuseppe De Angelis, Marina Cerimele |
| 1100 |
[GO] |
2022―Mrz―21 |
SIRVA (Shoulder Injury Related to Vaccine Administration) following mRNA COVID-19 Vaccination: Case discussion and literature review |
Wen Loong Paul Yuen, Sir Young James Loh, Dehao Bryan Wang |
| 1101 |
[GO] |
2022―Mrz―21 |
Why do Hong Kong parents have low intention to vaccinate their children against COVID-19? testing health belief model and theory of planned behavior in a large-scale survey |
Jian-Bin Li, Eva Yi Hung Lau, Derwin King Chung Chan |
| 1102 |
[GO] |
2022―Mrz―18 |
The Effect of Immunization with Inactivated SARS-CoV-2 Vaccine (CoronaVac) and/or SARS-CoV-2 Infection on Antibody Levels, Plasmablasts, Long-lived-plasma-cells, and IFN-γ Release by Natural Killer Cells |
Huseyin Bilgin, Marisa Marku, Sultan Seval Yilmaz, Aysegul Karahasan Yagci, Uluhan Sili, Baris Can, Rabia Can Sarinoglu, Lutfiye Mulazimoglu Durmusoglu, Goncagul Haklar, Onder Sirikci, Emel Eksioglu Demiralp |
| 1103 |
[GO] |
2022―Mrz―17 |
Erratum to ““Cultivating” acceptance of a COVID-19 vaccination program: Lessons from Italy” [Vaccine 38(48) (2020) 7585-7586] |
Guendalina Graffigna, Lorenzo Palamenghi, Serena Barello, Stefania Boccia |
| 1104 |
[GO] |
2022―Mrz―17 |
A candidate multi-epitope vaccine against porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae induces robust humoral and cellular response in mice |
Zhisong Gao, Lingxiao Chen, Tao Song, Xuan Pan, Xiaojing Li, Guangzong Lu, Yajie Tang, Xiang Wu, Baohua Zhao, Ran Zhang |
| 1105 |
[GO] |
2022―Mrz―15 |
Hesitancy towards COVID-19 vaccines on social media in Canada |
Bobbi Rotolo, Eve Dubé, Maryline Vivion, Shannon E. MacDonald, Samantha B. Meyer |
| 1106 |
[GO] |
2022―Mrz―15 |
SARS-CoV-2 outbreak in a nursing home after vaccination with BNT162b2: a role for the quantification of circulating antibodies |
Jordi Càmara, Aida González-Díaz, Irene Barrabeig, Miguel Fernández-Huerta, Laura Calatayud, Jordi Niubó, Sara Martí, Mª Ángeles Domínguez, Carmen Ardanuy |
| 1107 |
[GO] |
2022―Mrz―14 |
Sociodemographic and psychological correlates of COVID-19 vaccine hesitancy and resistance in the young adult population in Italy |
Ughetta Moscardino, Pasquale Musso, Cristiano Inguglia, Chiara Ceccon, Diana Miconi, Cécile Rousseau |
| 1108 |
[GO] |
2022―Mrz―09 |
Healthcare Worker Perspectives on COVID-19 Vaccines: Implications for Increasing Vaccine Acceptance among Healthcare Workers and Patients |
Christine M. Thomas, Kelly Searle, Alma Galván, Amy K Liebman, Erin M. Mann, Jonathan D. Kirsch, William M. Stauffer |
| 1109 |
[GO] |
2022―Mrz―09 |
Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination? |
Lotus L. van den Hoogen, Gaby Smits, Cheyenne C.E. van Hagen, Denise Wong, Eric R.A. Vos, Michiel van Boven, Hester E. de Melker, Jeffrey van Vliet, Marjan Kuijer, Linde Woudstra, Alienke J. Wijmenga-Monsuur, Corine H. GeurtsvanKessel, Susanne P. Stoof, Daphne Reukers, Lisa A. Wijsman, Adam Meijer, Chantal B.E.M. Reusken, Nynke Y. Rots, Fiona R.M. van der Klis, Robert S. van Binnendijk, Gerco den Hartog |
| 1110 |
[GO] |
2022―Mrz―07 |
Political Attitudes and Efficacy of Health Expert Communication on the Support for COVID-19 Vaccination Program: Findings from a Survey in Hong Kong |
Vera Wing Han YUEN |
| 1111 |
[GO] |
2022―Mrz―07 |
COVID-19 vaccine preferences in India |
Prateek Bansal, Alok Raj, Dhirendra Mani Shukla, Naveen Sunder |
| 1112 |
[GO] |
2022―Mrz―03 |
COVID-19 vaccine intention among young adults: Comparative results from a cross-sectional study in Canada and France |
Pierre-julien Coulaud, Aidan Ablona, Naseeb Bolduc, Danya Fast, Karine Bertrand, Jeremy Ward, Devon Greyson, Marie Jauffret-Roustide, Rod Knight |
| 1113 |
[GO] |
2022―Mrz―03 |
Public opinion on global distribution of COVID-19 vaccines: evidence from two nationally representative surveys in Germany and the United States |
Matthias Klumpp, Ida G. Monfared, Sebastian Vollmer |
| 1114 |
[GO] |
2022―Mrz―03 |
IgG antibody production and persistence to 6 months following SARS-CoV-2 vaccination: a Northern Ireland observational study |
Louise J. Robertson, Ruth Price, Julie S. Moore, Grace Curry, John Farnan, Amy Black, Kevin Blighe, M. Andrew Nesbit, James A.D. McLaughlin, Tara Moore |
| 1115 |
[GO] |
2022―Mrz―02 |
How do COVID-19 vaccine mandates affect attitudes toward the vaccine and participation in mandate-affected activities? Evidence from the United States |
S.E. Kreps, D.L. Kriner |
| 1116 |
[GO] |
2022―Mrz―01 |
The impact of COVID-19 on routine pediatric vaccination delivery in Brazil |
Carolina Moura, Paul Truche, Lucas Sousa Salgado, Thiaro Meireles, Vitor Santana, Alexandra Buda, Aline Bentes, Fabio Botelho, David Mooney |
| 1117 |
[GO] |
2022―Feb―28 |
Aggregating human judgment probabilistic predictions of the safety, efficacy, and timing of a COVID-19 vaccine |
Thomas McAndrew, Juan Cambeiro, Tamay Besiroglu |
| 1118 |
[GO] |
2022―Feb―28 |
WHO Guidance on COVID-19 vaccine trial designs in the context of authorized COVID-19 vaccines and expanding global access: ethical considerations |
Jerome Amir Singh, Sonali Kochhar, Jonathan Wolff, Caesar Atuire, Anant Bhan, Ezekiel Emanuel, Ruth Faden, Prakash Ghimire, Dirceu Greco, Calvin Ho, Suerie Moon, Ehsan Shamsi-Gooshki, Aissatou Touré, Beatriz Thomé, Maxwell J. Smith, Ross E.G. Upshur |
| 1119 |
[GO] |
2022―Feb―28 |
Nepal Measles outbreak response immunization during COVID-19: a risk-based intervention strategy |
Anindya Sekhar Bose, Pasang Rai, Binod Prasad Gupta, Rahul Pradhan, Mona Lacoul, Sushil Shakya, Dipesh Shrestha, Abhiyan Gautam, Bharat Bhandari, Basanta Shrestha, Bhim Singh Tinkari, Runa Jha, Basudha Khanal, Pradeep Shrestha, Sushma Bhusal, Jhalak Sharma Gautam |
| 1120 |
[GO] |
2022―Feb―25 |
Immunological features that associate with the strength of antibody responses to BNT162b2 mRNA vaccine against SARS-CoV-2 |
Takahiro Kageyama, Shigeru Tanaka, Keishi Etori, Koto Hattori, Kazusa Miyachi, Tadamichi Kasuya, Taro Iwamoto, Kei Ikeda, Hidetoshi Igari, Koutaro Yokote, Hiroshi Nakajima |
| 1121 |
[GO] |
2022―Feb―22 |
Monitoring COVID-19 vaccine use in Italian Long Term Care Centers: the GeroCovid VAX Study |
Angela Marie Abbatecola, Raffaele Antonelli Incalzi, Alba Malara, Annapina Palmieri, Anna Di Lonardo, Giorgio Fedeli, Paola Stefanelli, Gilda Borselli, Marcello Russo, Marianna Noale, Stefano Fumagalli, Pietro Gareri, Enrico Mossello, Caterina Trevisan, Stefano Volpato, Fabio Monzani, Alessandra Coin, Giuseppe Bellelli, Chukwuma Okoye, Susanna Del Signore, Gianluca Zia, Elisa Bottoni, Carmine Cafariello, Graziano Onder, GeroCovid Vax |
| 1122 |
[GO] |
2022―Feb―22 |
Understanding the Influence of Political Orientation, Social Network, and Economic Recovery on COVID-19 Vaccine Uptake among Americans |
Feng Hao, Wanyun Shao |
| 1123 |
[GO] |
2022―Feb―21 |
Immunogenicity and safety of an intradermal fractional third dose of ChAdOx1 nCoV-19/AZD1222 vaccine compared with those of a standard intramuscular third dose in volunteers who previously received two doses of CoronaVac: A randomized controlled trial |
Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, Kasiruck Wittayasak, Nawarat Thonwirak, Kamonwan Soonklang, Gaidganok Sornsamdang, Chirayu Auewarakul, Nithi Mahanonda |
| 1124 |
[GO] |
2022―Feb―18 |
Couples and COVID-19 Vaccination: Frequency and Reasons for Discordance |
Karen B. Schmaling |
| 1125 |
[GO] |
2022―Feb―17 |
The correlates and dynamics of COVID-19 vaccine-specific hesitancy |
Eric Merkley, Peter John Loewen |
| 1126 |
[GO] |
2022―Feb―17 |
Localising vaccination services: Qualitative insights on public health and minority group collaborations to co-deliver coronavirus vaccines |
Ben Kasstan, Sandra Mounier-Jack, Louise Letley, Katherine M. Gaskell, Chrissy H. Roberts, Neil R.H. Stone, Sham Lal, Rosalind M. Eggo, Michael Marks, Tracey Chantler |
| 1127 |
[GO] |
2022―Feb―17 |
The effect of ChAdOx1 nCov-19 vaccine on arterial thrombosis development and platelet aggregation in female rats |
Bartlomiej Kalaska, Joanna Miklosz, Justyna Swieton, Aleksandra Jakimczuk, Dariusz Pawlak, Andrzej Mogielnicki |
| 1128 |
[GO] |
2022―Feb―16 |
Immune response to one dose of BNT162b2 mRNA Covid-19 vaccine followed by Sars-CoV-2 infection: an Italian prospective observational study |
Pasquale Stefanizzi, Angela Maria Vittoria Larocca, Andrea Martinelli, Savino Soldano, Maria Dell'Aera, Giovanni Migliore, Cinzia Annatea Germinario, Luigi Vimercati, Silvio Tafuri, Francesco Paolo Bianchi |
| 1129 |
[GO] |
2022―Feb―15 |
Influenza virus vaccine compliance among pregnant women during the COVID-19 pandemic (pre-vaccine era) in Israel and future intention to uptake BNT162b2 mRNA COVID-19 vaccine |
Ola Ali Saleh, Ofra Halperin |
| 1130 |
[GO] |
2022―Feb―15 |
A cell-based ELISA as surrogate of virus neutralization assay for RBD SARS-CoV-2 specific antibodies |
Franciscary Pi-Estopiñan, Maria Teresa Pérez, Anitza Fraga, Gretchen Bergado, Geidy D. Diaz, Ivette Orosa, Marianniz Díaz, Joaquin Antonio Solozabal, Laura Marta Rodriguez, Dagmar Garcia-Rivera, Consuelo Macias, Yanet Jerez, Ana V. Casadesús, Briandy Fernández-Marrero, Ernesto Bermudez, Claudia A. Plasencia, Belinda Sanchez, Tays Hernández |
| 1131 |
[GO] |
2022―Feb―15 |
How to accelerate the supply of vaccines to all populations worldwide? Part I: Initial industry lessons learned and practical overarching proposals leveraging the COVID-19 situation |
Mic McGoldrick, Thierry Gastineau, Diane Wilkinson, Cristiana Campa, Norbert De Clercq, Andrea Mallia-Milanes, Olivier Germay, Jyothsna Krishnan, M. Van Ooij, Michael P. Thien, Peter J. Mlynarczyk, Edward Saltus, Philippe Juvin, Didier Clenet, Ana Basso, Nora Dellepiane, Sonia Pagliusi, Monique Collaço de Moraes Stávale, Venkatraman H. Sivaramakrishnan, Samir Desai |
| 1132 |
[GO] |
2022―Feb―15 |
How to accelerate the supply of vaccines to all populations worldwide? Part II: Initial industry lessons learned and detailed technical reflections leveraging the COVID-19 situation |
Mic McGoldrick, Thierry Gastineau, Diane Wilkinson, Cristiana Campa, Norbert De Clercq, Andrea Mallia-Milanes, Olivier Germay, Jyothsna Krishnan, M Van Ooij, Michael P Thien, Peter J. Mlynarczyk, Edward Saltus, Florence Wauters, Philippe Juvin, Didier Clenet, Ana Basso, Nora Dellepiane, Sonia Pagliusi, Monique Collaço de Moraes Stávale, Venkatraman H Sivaramakrishnan, Samir Desai |
| 1133 |
[GO] |
2022―Feb―14 |
Ethics review of COVID-19 human challenge studies: a joint HRA/WHO workshop |
Eloise Williams, Kathrine Craig, Christopher Chiu, Hugh Davies, Stephanie Ellis, Claudia Emerson, Euzebiusz Jamrozik, Monica Jefford, Gagan deep Kang, Melissa Kapulu, Simon E. Kolstoe, Katherine Littler, Anthony Lockett, Elena Rey Lozano, Janet Messer, Helen McShane, Carla Saenz, Michael J. Selgelid, Seema Shah, Peter G. Smith, Naho Yamazaki |
| 1134 |
[GO] |
2022―Feb―14 |
Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine |
Shohei Yamamoto, Ami Fukunaga, Akihito Tanaka, Junko S. Takeuchi, Yosuke Inoue, Moto Kimura, Kenji Maeda, Gohzoh Ueda, Tetsuya Mizoue, Mugen Ujiie, Wataru Sugiura, Norio Ohmagari |
| 1135 |
[GO] |
2022―Feb―14 |
Promoting Immunization Equity in Latin America and the Caribbean: Case Studies, Lessons Learned and their Implication for COVID-19 Vaccine Equity |
Isabella L. Chan, Robin Mowson, Juan Pedro Alonso, Javier Roberti, Marcela Contreras, Martha Velandia-González |
| 1136 |
[GO] |
2022―Feb―14 |
Mumps to COVID-19: Vaccinated Persons Remain Vulnerable When Community Uptake Is Low |
Kristin K. Gaffney, M. Jana Broadhurst, David M. Brett-Major |
| 1137 |
[GO] |
2022―Feb―14 |
The effect of the E484K mutation of SARS-CoV-2 on the neutralizing activity of antibodies from BNT162b2 vaccinated individuals |
Yoshifumi Uwamino, Takashi Yokoyama, Takako Shimura, Tomoyasu Nishimura, Yasunori Sato, Masatoshi Wakui, Kenjiro Kosaki, Naoki Hasegawa, Mitsuru Murata |
| 1138 |
[GO] |
2022―Feb―14 |
Establishment of the first Chinese national standard for protein subunit SARS-CoV-2 vaccine |
Fan Gao, Chaoqiang An, Lianlian Bian, Yiping Wang, Jialu Zhang, Bopei Cui, Qian He, Yadi Yuan, Lifang Song, Jinghuan Yang, Xujia Yan, Kangwei Xu, Changgui Li, Shanshan Yao, Xing Wu, Qunying Mao, Zhenglun Liang, Miao Xu |
| 1139 |
[GO] |
2022―Feb―14 |
Unmet need for COVID-19 vaccination coverage in Kenya |
Samuel K. Muchiri, Rose Muthee, Hellen Kiarie, Joseph Sitienei, Ambrose Agweyu, Peter M. Atkinson, C. Edson Utazi, Andrew J. Tatem, Victor A. Alegana |
| 1140 |
[GO] |
2022―Feb―11 |
“On the last day of the last month, I will go”: A qualitative exploration of COVID-19 vaccine confidence among Ivoirian adults |
Natalie Tibbels, Abdul Dosso, Corinne Fordham, William Benie, Jeanne Aka Brou, Diarra Kamara, Zoé Hendrickson, Danielle Naugle |
| 1141 |
[GO] |
2022―Feb―11 |
Public perceptions and the willingness to get vaccinated against COVID-19: Lessons from Israel |
Oren Heller, Yung Chun, Yaniv Shlomo, Ateret Gewirtz-Meydan, Mary Acri, Saneel Kulkarni, Michal Grinstein-Weiss |
| 1142 |
[GO] |
2022―Feb―10 |
Impact of vaccination status on mortality among symptomatic COVID-19 patients during the second wave of the pandemic: a cohort study |
Kundavaram Paul Prabhakar Abhilash, Ponnivalavan Mathiyalagan, Vivek Raja K. Krishnaraj, Saravanan Selvan, Rohini Kanagarajan, Narmadha P. Reddy, Natarajan Rajendiran, Darpanarayan Hazra, Karthik Gunasekharan, Mahesh Moorthy, Sudha Jasmine, John Prasad Davis, Tina George, Krupa George, George M Varghese, Priscilla Rupali, T.J. Barney Isaac, Richa Gupta, Kishore Pichamuthu, Melvin Joy, Lakshmanan Jayaseelan, Prasad Mathews, John Victor Peter |
| 1143 |
[GO] |
2022―Feb―09 |
How frequent are acute reactions to COVID-19 vaccination and who is at risk? |
Nancy Dreyer, Matthew W Reynolds, Lisa Albert, Emma Brinkley, Tom Kwon, Christina Mack, Stephen Toovey |
| 1144 |
[GO] |
2022―Feb―09 |
Effectiveness of Covishield vaccine in preventing Covid-19 - A test-negative case-control study |
Stuti Pramod, Dhanajayan Govindan, Premkumar Ramasubramani, Sitanshu Sekhar Kar, Rakesh Aggarwal |
| 1145 |
[GO] |
2022―Feb―08 |
Impact of the COVID-19 pandemic on routine immunization coverage in children under 2 years old in Ontario, Canada: A retrospective cohort study |
Catherine Ji, Pierre-Philippe Piché-Renaud, Jemisha Apajee, Ellen Stephenson, Milena Forte, Jeremy N. Friedman, Michelle Science, Stanley Zlotkin, Shaun K. Morris, Karen Tu |
| 1146 |
[GO] |
2022―Feb―08 |
A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: safety, reactogenicity and immunogenicity |
Sonia Pérez-Rodríguez, Meiby de la Caridad Rodríguez-González, Rolando Ochoa-Azze, Yanet Climent-Ruiz, Carlos Alberto González-Delgado, Beatriz Paredes-Moreno, Carmen Valenzuela-Silva, Laura Rodríguez-Noda, Rocmira Perez-Nicado, Raúl González-Mugica, Marisel Martínez-Pérez, Belinda Sánchez-Ramírez, Tays Hernández-García, Alina Díaz-Machado, Maura Tamayo-Rodríguez, Alis Martín-Trujillo, Jorman Rubino-Moreno, Anamary Suárez-Batista, Marta Dubed-Echevarría, María Teresa Pérez-Guevara, Mayté Amoroto-Roig, Yanet Chappi-Estévez, Gretchen Bergado-Báez, Franciscary Pi-Estopiñán, Guang-Wu Chen, Yury Valdés-Balbín, Dagmar García-Rivera, Vicente Verez-Bencomo |
| 1147 |
[GO] |
2022―Feb―08 |
A phase 1/2 randomised placebo-controlled study of the COVID-19 vaccine mRNA-1273 in healthy Japanese adults: an interim report |
Taisei Masuda, Kyoko Murakami, Kenkichi Sugiura, Sho Sakui, Ron Philip Schuring, Mitsuhiro Mori |
| 1148 |
[GO] |
2022―Feb―07 |
Conspiracy theories and misinformation about COVID-19 in Nigeria: implications for vaccine demand generation communications |
Chizoba Wonodi, Chisom Obi-Jeff, Funmilayo Adewumi, Somto Chloe Keluo-Udeke, Rachel Gur-Arie, Carleigh Krubiner, Elana Felice Jaffe, Tobi Bamiduro, Ruth Karron, Ruth Faden |
| 1149 |
[GO] |
2022―Feb―07 |
The impact of COVID-19 on income and employment and willingness to become vaccinated among African Americans enrolled in a smoking cessation randomized trial |
Erica Cruvinel, Kimber Richter, Taneisha Scheuermann, Nathalia Munck Machado, Matthew S. Mayo, Alexandra Brown, Nikki Nollen |
| 1150 |
[GO] |
2022―Feb―07 |
Attitude toward a mandatory COVID-19 vaccination policy and its determinants: Evidence from serial cross-sectional surveys conducted throughout the pandemic in Germany |
Philipp Sprengholz, Lars Korn, Sarah Eitze, Lisa Felgendreff, Regina Siegers, Laura Goldhahn, Freia De Bock, Lena Huebl, Robert Böhm, Cornelia Betsch |
| 1151 |
[GO] |
2022―Feb―07 |
Myocarditis following mRNA Covid-19 vaccination: a pooled analysis |
Ioannis Bellos, Vasilios Karageorgiou, Dana Viskin |
| 1152 |
[GO] |
2022―Feb―07 |
Towards a Predictive Model of COVID-19 Vaccine Hesitancy among American Adults |
Jack Mewhirter, Mustafa Sagir, Rebecca Sanders |
| 1153 |
[GO] |
2022―Feb―07 |
Effect of the 2020/21 season influenza vaccine on SARS-CoV-2 infection in a cohort of Italian healthcare workers |
Alexander Domnich, Andrea Orsi, Laura Sticchi, Donatella Panatto, Guglielmo Dini, Allegra Ferrari, Matilde Ogliastro, Simona Boccotti, Vanessa De Pace, Valentina Ricucci, Bianca Bruzzone, Paolo Durando, Giancarlo Icardi |
| 1154 |
[GO] |
2022―Feb―07 |
Modeling Strategies for the Allocation of SARS-CoV-2 Vaccines in the United States |
Joseph Walker, Prabasaj Paul, Kathleen Dooling, Sara Oliver, Pragati Prasad, Molly Steele, Paul A. Gastañaduy, Michael A. Johansson, Matthew Biggerstaff, Rachel B. Slayton |
| 1155 |
[GO] |
2022―Feb―04 |
Exploring the attitudes, concerns, and knowledge regarding COVID-19 vaccine by the parents of children with rheumatic disease: Cross-sectional online survey |
Özlem Akgün, Gülşah Kavrul Kayaalp, Fatma Gül Demirkan, Figen Çakmak, Ayşe Tanatar, Vefa Guliyeva, Hafize Emine Sönmez, Nuray Aktay Ayaz |
| 1156 |
[GO] |
2022―Feb―04 |
Estimating the cost of COVID-19 vaccine deployment and introduction in Ghana using the CVIC Tool |
Justice Nonvignon, Richmond Owusu, Brian Asare, Alex Adjagba, Wei Aund, Yeung Karene Hoi Ting, Joycelyn Naa Korkoi Azeez, Martha Gyansa-Lutterodt, Godwin Gulbi, Kwame Amponsa-Achiano, Frederick Dadzie, George E. Armah, Logan Brenzel, Raymond Hutubessy, Stephen C. Resch |
| 1157 |
[GO] |
2022―Feb―03 |
Italy’s rollout of COVID-19 vaccinations: the crucial contribution of the first experimental mass vaccination site in Lombardy |
Francesco Oliani, Antonella Savoia, Giulia Gallo, Navpreet Tiwana, Matteo Letzgus, Flaminia Gentiloni, Alessandra Piatti, Laura Chiappa, Alberto Bisesti, Dario Laquintana, Silvana Castaldi |
| 1158 |
[GO] |
2022―Feb―01 |
COVID-19 vaccination intention and behavior in a large, diverse, U.S. refugee population |
Jana Shaw, Kathryn B. Anderson, Rachel E. Fabi, Carlie A. Thompson, Megan Harris, Nidaa Aljabbarin, Donna Bolourchi, Nicole Mozo, Daniel Lichtenstein, Christina D. Lupone, David A. Larsen, Andrea V. Shaw |
| 1159 |
[GO] |
2022―Feb―01 |
Looking Ahead: Caregivers’ COVID-19 vaccination intention for children 5 years old and younger using the health belief model |
Morgan E. Ellithorpe, Fashina Aladé, Robyn B. Adams, Glen J. Nowak |
| 1160 |
[GO] |
2022―Feb―01 |
Conditionality of COVID-19 vaccine acceptance in European countries |
Leonardo W. Heyerdahl, Muriel Vray, Benedetta Lana, Nastassia Tvardik, Nina Gobat, Marta Wanat, Sarah Tonkin-Crine, Sibyl Anthierens, Herman Goossens, Tamara Giles-Vernick |
| 1161 |
[GO] |
2022―Feb―01 |
Immunity Debt or Vaccination Crisis? A Multi-Method Evidence on Vaccine Acceptance and Media Framing for Emerging COVID-19 Variants |
Muhammad Yousaf, Syed Hassan Raza, Nasir Mahmood, Rachel Core, Umer Zaman, Aqdas Malik |
| 1162 |
[GO] |
2022―Jan―31 |
Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452 |
Yester F. Janssen, Eline A. Feitsma, Hendrikus H. Boersma, David G. Alleva, Thomas M. Lancaster, Thillainaygam Sathiyaseelan, Sylaja Murikipudi, Andrea R. Delpero, Melanie M. Scully, Ramya Ragupathy, Sravya Kotha, Jeffrey R. Haworth, Nishit J. Shah, Vidhya Rao, Shashikant Nagre, Shannon E. Ronca, Freedom M. Green, Ari Aminetzah, Frans Sollie, Schelto Kruijff, Maarten Brom, Gooitzen M. van Dam, Todd C. Zion |
| 1163 |
[GO] |
2022―Jan―26 |
Worldwide routine immunisation coverage regressed during the first year of the COVID-19 pandemic |
Beth Evans, Thibaut Jombart |
| 1164 |
[GO] |
2022―Jan―26 |
The Role of Perceived Social Norms in College Student Vaccine Hesitancy: Implications for COVID-19 Prevention Strategies |
Anna E. Jaffe, Scott Graupensperger, Jessica A. Blayney, Jennifer C. Duckworth, Cynthia A. Stappenbeck |
| 1165 |
[GO] |
2022―Jan―24 |
B-CELL CYTOPENIA AND TIME TO LAST B-CELL-DEPLETING THERAPY PREDICT RESPONSE TO SARS-COV-2 VACCINES IN PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS |
Mégane Tanguay, Marianne Boutin, Annemarie Laumaea, Matthew Salaciak, Alma Mendoza, Chantal Cassis, Lissa Ajjamada, Sarit Assouline, François Patenaude, Michael Webster Clark, Andrés Finzi, Nathalie A. Johnson |
| 1166 |
[GO] |
2022―Jan―20 |
Priming with social benefit information of vaccination to increase acceptance of COVID-19 vaccines |
Qiuyan Liao, Benjamin J Cowling, Jingyi Xiao, Jiehu Yuan, Meihong Dong, Michael Y Ni, Richard Fielding, Wendy Wing Tak Lam |
| 1167 |
[GO] |
2022―Jan―20 |
An AAV vaccine targeting the RBD of the SARS-CoV-2 S protein induces effective neutralizing antibody titers in mice and canines |
Fei Liu, Canbin Feng, Shiqi Xu, Qiang Wu, Jian Tang, Yan Chen, Ruisheng Xu, Fuliang Chen, Ni Gao, Zhengzheng Xu, Shihui Gu, Yang Lan, Haibo Zhou, Xinde Hu, Xiaojing Wang |
| 1168 |
[GO] |
2022―Jan―19 |
Reducing the Rates of Household Transmission: The Impact of COVID-19 Vaccination in Healthcare Workers with a Known Household Exposure |
Catherine L. Passaretti, Jennifer S. Priem, Tammie G. Agner, Lewis McCurdy |
| 1169 |
[GO] |
2022―Jan―19 |
Impact of Prior SARS-CoV-2 Infection on Incidence of Hospitalization and Adverse Events Following mRNA SARS-CoV-2 vaccination: A Nationwide, Retrospective Cohort Study |
Lucy Li, Chunlei Zheng, Jennifer La, Nhan Do, Paul Monach, Judith Strymish, Nathanael R. Fillmore, Westyn Branch-Elliman |
| 1170 |
[GO] |
2022―Jan―19 |
A recombinant SARS-CoV-2 receptor-binding domain expressed in an engineered fungal strain of Thermothelomyces heterothallica induces a functional immune response in mice |
Laura Lazo, Monica Bequet-Romero, Gilda Lemos, Alexis Musacchio, Ania Cabrales, Andy J. Bruno, Luis Ariel Espinosa, Markku Saloheimo, Marika Vitikainen, Amalia Hernández, Mark Emalfarb, Ronen Tchelet, Edith Suzarte, Gerardo Guillén |
| 1171 |
[GO] |
2022―Jan―19 |
Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing IgG, IgA and cellular immune responses and can boost neutralizing antibody responses primed by an injected vaccine |
Jacob Pitcovski, Nady Gruzdev, Anna Abzach, Chen Katz, Ran Ben-Adiva, Michal Brand-Shwartz, Itamar Yadid, Einav Ratzon-Ashkenazi, Ken Emquies, Hadasa Israeli, Hadar Haviv, Irena Rapoport, Itai Bloch, Roy Shadmon, Zohar Eitan, Dalia Eliahu, Talia Hilel, Morris Laster, Sigal Kremer-Tal, Tamara Byk-Tennenbaum, Ehud Shahar |
| 1172 |
[GO] |
2022―Jan―17 |
COVID-19 vaccine reactogenicity - A cohort event monitoring study in the Netherlands using patient reported outcomes |
Leàn Rolfes, Linda Härmark, Agnes Kant, Leontine van Balveren, Wil Hilgersom, Florence van Hunsel |
| 1173 |
[GO] |
2022―Jan―15 |
COVID-19 vaccine uptake, effectiveness, and waning in 82,959 health care workers: A national prospective cohort study in Wales |
Stuart Bedston, Ashley Akbari, Christopher I. Jarvis, Emily Lowthian, Fatemeh Torabi, Laura North, Jane Lyons, Malorie Perry, Lucy J. Griffiths, Rhiannon K. Owen, Jillian Beggs, Antony Chuter, Declan T. Bradley, Simon de Lusignan, Richard Fry, F.D. Richard Hobbs, Joe Hollinghurst, Srinivasa Vittal Katikireddi, Siobhán Murphy, Dermot O'Reily, Chris Robertson, Ting Shi, Ruby S.M. Tsang, Aziz Sheikh, Ronan A. Lyons |
| 1174 |
[GO] |
2022―Jan―12 |
Adolescents’ attitudes to the COVID-19 Vaccination |
W.H.S. Wong, D. Leung, G.T. Chua, J.S.R. Duque, S. Peare, H.K. So, S.M. Chan, M.Y.W. Kwan, P. Ip, Y.L. Lau |
| 1175 |
[GO] |
2022―Jan―10 |
Factors Associated with COVID-19 Vaccination Intentions among Adults in the Deep South |
Casey L. Daniel, Jacob Williams, Rachel Legg, Chelsea Green, Jesse Stutzman |
| 1176 |
[GO] |
2022―Jan―10 |
Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine |
Kah-Whye Peng, Timothy Carey, Patrycja Lech, Rianna Vandergaast, Miguel Á. Muñoz-Alía, Nandakumar Packiriswamy, Clement Gnanadurai, Karina Krotova, Mulu Tesfay, Christopher Ziegler, Michelle Haselton, Kara Sevola, Chase Lathrum, Samantha Reiter, Riya Narjari, Baskar Balakrishnan, Lukkana Suksanpaisan, Toshie Sakuma, Jordan Recker, Lianwen Zhang, Scott Waniger, Luke Russell, Christopher D. Petro, Christos A. Kyratsous, Alina Baum, Jody L. Janecek, Rachael M. Lee, Sabarinathan Ramachandran, Melanie L. Graham, Stephen J. Russell |
| 1177 |
[GO] |
2022―Jan―07 |
Young age, female sex, and presence of systemic adverse reactions are associated with high post-vaccination antibody titer after two doses of BNT162b2 mRNA SARS-CoV-2 vaccination: An observational study of 646 Japanese healthcare workers and university staff |
Yoshifumi Uwamino, Toshinobu Kurafuji, Yasunori Sato, Yukari Tomita, Ayako Shibata, Akiko Tanabe, Yoko Yatabe, Masayo Noguchi, Tomoko Arai, Akemi Ohno, Hiromitsu Yokota, Wakako Yamasawa, Shunsuke Uno, Tomoyasu Nishimura, Naoki Hasegawa, Hideyuki Saya, Masatoshi Wakui, Mitsuru Murata |
| 1178 |
[GO] |
2022―Jan―05 |
Understanding COVID-19 vaccination willingness among youth: A survey study in the Netherlands |
Saskia Euser, Floor M. Kroese, Mare Derks, Marijn de Bruin |
| 1179 |
[GO] |
2022―Jan―01 |
Impact of the COVID-19 pandemic on pediatric and adolescent vaccinations and well child visits in the United States: A database analysis |
Stephanie A. Kujawski, Lixia Yao, Echo Wang, Cristina Da Silva Carias, Ya-Ting Chen |
| 1180 |
[GO] |
2021―Dez―31 |
Modulation of immunosuppressant drug treatment to improve SARS-CoV-2 vaccine efficacy in mice |
Amy V. Paschall, Ahmet Ozdilek, Sydney L. Briner, Melinda A. Brindley, Fikri Y. Avci |
| 1181 |
[GO] |
2021―Dez―30 |
Protection against avian coronavirus conferred by oral vaccination with live bacteria secreting LTB-fused viral proteins |
Avishai Lublin, Chen Katz, Nady Gruzdev, Itamar Yadid, Itai Bloch, Yigal Farnoushi, Luba Simanov, Asaf Berkowitz, Dalia Elyahu, Jacob Pitcovski, Ehud Shahar |
| 1182 |
[GO] |
2021―Dez―30 |
Intranasal immunization with a Middle East respiratory syndrome-coronavirus antigen conjugated to the M-cell targeting ligand Co4B enhances antigen-specific mucosal and systemic immunity and protects against infection |
Ye Lin Yang, Ju Kim, Yongsu Jeong, Yong-Suk Jang |
| 1183 |
[GO] |
2021―Dez―27 |
Optimizing vaccine distribution via mobile clinics: a case study on COVID-19 vaccine distribution to long-term care facilities |
Samta Shukla, Francois Fressin, Michelle Un, Henriette Coetzer, Sreekanth K. Chaguturu |
| 1184 |
[GO] |
2021―Dez―24 |
COVID-19 and Routine Childhood and Adolescent Immunizations: Evidence from Louisiana Medicaid |
Brigham Walker, Andrew Anderson, Charles Stoecker, Yixue Shao, Thomas A. LaVeist, Kevin Callison |
| 1185 |
[GO] |
2021―Dez―24 |
Safety and Effectiveness of BNT162b2 mRNA Covid-19 Vaccine in Adolescents |
Young June Choe, Seonju Yi, Insob Hwang, Jia Kim, Young-Joon Park, Eunhee Cho, Myoungyoun Jo, Hyunju Lee, Eun Hwa Choi |
| 1186 |
[GO] |
2021―Dez―24 |
Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial |
Stephen J. Thomas, John L. Perez, Stephen P. Lockhart, Subramanian Hariharan, Nicholas Kitchin, Ruth Bailey, Katherine Liau, Eleni Lagkadinou, Özlem Türeci, Ugur Şahin, Xia Xu, Kenneth Koury, Samuel S. Dychter, Claire Lu, Teresa C. Gentile, William C. Gruber |
| 1187 |
[GO] |
2021―Dez―22 |
COVID-19 vaccine is correlated with favourable epidemiological indicators in the Auvergne-Rhône-Alpes region (France): an ecological study |
Nicolas Romain-Scelle, Christelle Elias, Philippe Vanhems |
| 1188 |
[GO] |
2021―Dez―22 |
Immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 with 12-dose vials: An interim analysis |
Anan Manomaipiboon, Uraporn Phumisantiphong, Jakravoot Maneerit, Yupin Chalearmchai, Warissara Jirawathin, Achiraya Prajongsai, Patchara Phankavong, Thananda Trakarnvanich |
| 1189 |
[GO] |
2021―Dez―21 |
COVID-19 and missed or delayed vaccination in 26 middle- and high-income countries: An observational survey |
Gilla K. Shapiro, Nisha Gottfredson, Julie Leask, Kerrie Wiley, Francine E. Ganter-Restrepo, Sarah P. Jones, Lisa Menning, Noel T. Brewer |
| 1190 |
[GO] |
2021―Dez―21 |
Did the European suspension of the AstraZeneca vaccine decrease vaccine acceptance during the COVID-19 pandemic? |
Michael Bang Petersen, Frederik Jørgensen, Marie Fly Lindholt |
| 1191 |
[GO] |
2021―Dez―20 |
Evaluation of the Gam-COVID-Vac and vaccine-induced neutralizing response against SARS-CoV-2 lineage P.1 variant in an Argentinean cohort |
Sebastián Blanco, Brenda Salomé Konigheim, Adrian Diaz, Lorena Spinsanti, Juan Javier Aguilar, María Elisa Rivarola, Mauricio Beranek, César Collino, Miguel Diaz, María Gabriela Barbás, Arnaldo Mangeaud, Sandra Verónica Gallego |
| 1192 |
[GO] |
2021―Dez―18 |
Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020 - October 2021 |
Eero Poukka, Ulrike Baum, Arto A. Palmu, Toni O. Lehtonen, Heini Salo, Hanna Nohynek, Tuija Leino |
| 1193 |
[GO] |
2021―Dez―17 |
Induction of Th1 and Th2 in the protection against SARS-CoV-2 through mucosal delivery of an adenovirus vaccine expressing an engineered spike protein |
Nai-Hsiang Chung, Ying-Chin Chen, Shiu-Ju Yang, Yu-Ching Lin, Horng-Yunn Dou, Lily Hui-Ching Wang, Ching-Len Liao, Yen-Hung Chow |
| 1194 |
[GO] |
2021―Dez―16 |
Does a major change to a COVID-19 vaccine program alter vaccine intention? A qualitative investigation |
Samantha J. Carlson, Lara McKenzie, Leah Roberts, Christopher C. Blyth, Katie Attwell |
| 1195 |
[GO] |
2021―Dez―15 |
Levels and Factors derived from the Health Action Process Approach of Behavioral Intentions to Take up COVID-19 Vaccination: a random Population-based study |
Yanqiu Yu, Wanru Jia, Mason M.C. Lau, Joseph T.F. Lau |
| 1196 |
[GO] |
2021―Dez―15 |
Towards A Population-Based Threshold of Protection for COVID-19 Vaccines |
David Goldblatt, Andrew Fiore-Gartland, Marina Johnson, Adam Hunt, Christopher Bengt, Dace Zavadska, Hilda Darta Snipe, Jeremy S Brown, Lesley Workman, Heather J Zar, David Montefiori, Xiaoying Shen, Peter Dull, Stanley Plotkin, George Siber, Donna Ambrosino |
| 1197 |
[GO] |
2021―Dez―14 |
On the rise of the new B.1.1.529 variant: Five dimensions of access to a COVID-19 vaccine |
Xiang Chen, Hui Wang |
| 1198 |
[GO] |
2021―Dez―11 |
Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines |
Jérémie Botton, Rosemary Dray-Spira, Bérangère Baricault, Jérôme Drouin, Marion Bertrand, Marie-Joëlle Jabagi, Alain Weill, Mahmoud Zureik |
| 1199 |
[GO] |
2021―Dez―11 |
Effect of the suspension of the J&J COVID-19 vaccine on vaccine hesitancy in the United States |
Yuli Lily Hsieh, Summer Rak, Gillian K SteelFisher, Sebastian Bauhoff |
| 1200 |
[GO] |
2021―Dez―11 |
COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers |
Karen Lutrick, Holly Groom, Ashley L. Fowlkes, Kimberly D Groover, Manjusha Gaglani, Patrick Rivers, Allison L. Naleway, Kimberly Nguyen, Meghan Herring, Kayan Dunnigan, Andrew Phillips, Joel Parker, Julie Mayo Lamberte, Khaila Prather, Matthew S. Thiese, Zoe Baccam, Harmony Tyner, Sarang Yoon |
| 1201 |
[GO] |
2021―Dez―11 |
Humoral response to the SARS-CoV-2 BTN161b2 mRNA vaccine: Real-world data from a large cohort of healthcare workers |
Joana Oliveira-Silva, Teresa Reis, Cristiana Lopes, Ricardo Batista-Silva, Ricardo Ribeiro, Gilberto Marques, Vânia Pacheco, Tiago Rodrigues, Alexandre Afonso, Vítor Pinheiro, Lucília Araújo, Fernando Rodrigues, Isabel Antunes |
| 1202 |
[GO] |
2021―Dez―10 |
Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI) |
Mark A. Katz, Efrat Bron Harlev, Bibiana Chazan, Michal Chowers, David Greenberg, Alon Peretz, Sagi Tshori, Joseph Levy, Mili Yacobi, Avital Hirsch, Doron Amichay, Ronit Weinberger, Anat Ben Dor, Elena Keren Taraday, Dana Reznik, Chen Barazani Chayat, Dana Sagas, Haim Ben Zvi, Rita Berdinstein, Gloria Rashid, Yonat Shemer Avni, Michal Mandelboim, Neta Zuckerman, Nir Rainy, Amichay Akriv, Noa Dagan, Eldad Kepten, Noam Barda, Ran D. Balicer |
| 1203 |
[GO] |
2021―Dez―09 |
Adverse event of Sinovac Coronavirus vaccine: Deafness |
Hai Zhao, Yongtuan Li, Zhiyuan Wang |
| 1204 |
[GO] |
2021―Dez―04 |
Prior COVID-19 infection is associated with increased Adverse Events (AEs) after the first, but not the second, dose of the BNT162b2/Pfizer vaccine |
Rachael K. Raw, Jon Rees, Clive Kelly, Caroline Wroe, David R. Chadwick |
| 1205 |
[GO] |
2021―Dez―04 |
oInfluenza vaccination uptake among Canadian adults before and during the COVID-19 pandemic: An analysis of the Canadian Longitudinal Study on Aging (CLSA) |
Giorgia Sulis, Nicole E. Basta, Christina Wolfson, Susan A. Kirkland, Jacqueline McMillan, Lauren E. Griffith, Parminder Raina |
| 1206 |
[GO] |
2021―Dez―04 |
Willingness to Vaccinate Against SARS-CoV-2: The Role of Reasoning Biases and Conspiracist Ideation |
Michael V. Bronstein, Erich Kummerfeld, Angus MacDonald, Sophia Vinogradov |
| 1207 |
[GO] |
2021―Dez―03 |
Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults |
Ritthideach Yorsaeng, Nungruthai Suntronwong, Harit Phowatthanasathian, Suvichada Assawakosri, Sitthichai Kanokudom, Thanunrat Thongmee, Preeyaporn Vichaiwattana, Chompoonut Auphimai, Lakkhana Wongsrisang, Donchida Srimuan data collection, Thaksaporn Thatsanatorn data collection, Sirapa Klinfueng, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Yong Poovorawan |
| 1208 |
[GO] |
2021―Dez―03 |
Correlation of Anti-SARS-CoV-2 S1-specific IgG antibody levels and adverse events following vaccination with BNT162b2 mRNA COVID-19 Vaccine in healthcare workers |
Marina Izak, Evgeniy Stoyanov, Keren Dezuraev, Eilat Shinar |
| 1209 |
[GO] |
2021―Dez―03 |
SARS-CoV-2-antibody response in health care workers after vaccination or natural infection in a longitudinal observational study |
Jonas Herzberg, Tanja Vollmer, Bastian Fischer, Heiko Becher, Ann-Kristin Becker, Human Honarpisheh, Salman Yousuf Guraya, Tim Strate, Cornelius Knabbe |
| 1210 |
[GO] |
2021―Dez―02 |
Pacific Eclipse - A tabletop exercise on smallpox pandemic response |
C. Raina MacIntyre, David J. Heslop, Phi Nguyen, Dillon Adam, Mallory Trent, Brian J. Gerber |
| 1211 |
[GO] |
2021―Dez―02 |
AZD1222 (ChAdOx1 nCov-19): A Single-Dose biodistribution study in mice |
Richard Stebbings, Gillian Armour, Vivian Pettis, Joanne Goodman |
| 1212 |
[GO] |
2021―Dez―01 |
COVID-19 from a polio perspective |
Robert Hill |
| 1213 |
[GO] |
2021―Dez―01 |
Individual factors influencing COVID-19 vaccine acceptance in between and during pandemic waves (July-December 2020) |
Sara Valckx, Jonas Crèvecoeur, Frederik Verelst, Maren Vranckx, Greet Hendrickx, Niel Hens, Pierre Van Damme, Koen Pepermans, Philippe Beutels, Thomas Neyens |
| 1214 |
[GO] |
2021―Nov―30 |
COVID-19 vaccine Mandates: An Australian attitudinal study |
Katie Attwell, Marco Rizzi, Lara McKenzie, Samantha J Carlson, Leah Roberts, Sian Tomkinson, Chris Blyth |
| 1215 |
[GO] |
2021―Nov―27 |
Predicting Vaccine Uptake during COVID-19 Crisis: A Motivational Approach |
Mathias Schmitz, Olivier Luminet, Olivier Klein, Sofie Morbée, Omer Van den Bergh, Pascaline Van Oost, Joachim Waterschoot, Vincent Yzerbyt, Maarten Vansteenkiste |
| 1216 |
[GO] |
2021―Nov―27 |
Mass vaccination campaign during the 2016 influenza outbreak in Panama: challenges and implications for COVID-19 vaccination efforts |
Franz Castro, Juan Miguel Pascale, Itzel Slocum Hewitt, Arlene Calvo |
| 1217 |
[GO] |
2021―Nov―27 |
Anaphylaxis rates associated with COVID-19 vaccines are comparable to those of other vaccines |
Helena C. Maltezou, Cleo Anastassopoulou, Sophia Hatziantoniou, Gregory A. Poland, Athanasios Tsakris |
| 1218 |
[GO] |
2021―Nov―22 |
A Retrospective Analysis of Social Media posts pertaining to COVID-19 vaccination side effects |
Max-Philipp Lentzen, Viola Huebenthal, Rolf Kaiser, Matthias Kreppel, Joachim E. Zoeller, Matthias Zirk |
| 1219 |
[GO] |
2021―Nov―22 |
Inactive SARS-CoV-2 vaccine generates high antibody responses in healthcare workers with and without prior infection |
Harika Oyku Dinc, Nese Saltoglu, Gunay Can, Ilker Inanc Balkan, Beyhan Budak, Dogukan Ozbey, Bilge Caglar, Rıdvan Karaali, Bilgul Mete, Yesim Tuyji Tok, Yagmur Ersoy, Mert Ahmet Kuskucu, Kenan Midilli, Sevgi Ergin, Bekir Sami Kocazeybek |
| 1220 |
[GO] |
2021―Nov―20 |
Moving the Needle on Racial Disparity: COVID-19 Vaccine Trust and Hesitancy |
Cheryl Lin, Pikuei Tu, Thomas C. Terry |
| 1221 |
[GO] |
2021―Nov―19 |
Perceived Facilitators and Barriers to Intentions of Receiving the COVID-19 Vaccines among Elderly Chinese Adults |
Tianen Chen, Minhao Dai, Shilin Xia |
| 1222 |
[GO] |
2021―Nov―19 |
Increasing acceptance of a vaccination program for coronavirus disease 2019 in france: a challenge for one of the world’s most vaccine-hesitant countries |
L. Cambon, M. Schwarzinger, F. Alla |
| 1223 |
[GO] |
2021―Nov―18 |
Inclusiveness of prisons in COVID-19 vaccination deployment: Evidence from Jordan |
Saverio Bellizzi, Chinara Aidyralieva, Ala'a Al-Shaikh, Nazeema Muthu, Anwar Al-Sadder, Jamela Al-Raiby |
| 1224 |
[GO] |
2021―Nov―18 |
Disparities in national and state estimates of COVID-19 vaccination receipt and intent to vaccinate by race/ethnicity, income, and age group among adults ≥ 18 years, United States |
Kimberly H. Nguyen, Elyssa Anneser, Alexander Toppo, Jennifer D. Allen, J. Scott Parott, Laura Corlin |
| 1225 |
[GO] |
2021―Nov―17 |
Acceptance, attitude, and factors affecting the intention to accept COVID-19 vaccine among Thai people and expatriates living in Thailand |
Amornphat Kitro, Wachiranun Sirikul, Chanodom Piankusol, Pawaruj Rirermsoonthorn, Mathuramat Seesen, Kampanat Wangsan, Pheerasak Assavanopakun, Vithawat Surawattanasakul, Apiradee Kosai, Ratana Sapbamrer |
| 1226 |
[GO] |
2021―Nov―15 |
A Meta-Analysis of Influenza Vaccination Following Correspondence: Considerations for COVID-19 |
Robert P. Murphy, Carol Taaffe, Elayne Ahern, Grace McMahon, Orla Muldoon |
| 1227 |
[GO] |
2021―Nov―15 |
Trends in COVID-19 vaccination intent and factors associated with deliberation and reluctance among adult homeless shelter residents and staff, 1 November 2020 to 28 February 2021 - King County, Washington |
Julia H. Rogers, Sarah N. Cox, James P. Hughes, Amy C. Link, Eric J. Chow, Idabelle Fosse, Margaret Lukoff, M. Mia Shim, Timothy M. Uyeki, Constance Ogokeh, Michael L. Jackson, Michael Boeckh, Janet A. Englund, Emily Mosites, Melissa A. Rolfes, Helen Y. Chu |
| 1228 |
[GO] |
2021―Nov―15 |
The seductive allure of technical language and its effect on covid-19 vaccine beliefs and intentions |
Jonathan Silas, Alexander Jones, Leonardo Weiss-Cohen, Peter Ayton |
| 1229 |
[GO] |
2021―Nov―13 |
Influence of Rapid COVID-19 Vaccine Development on Vaccine Hesitancy |
Sonny Rosenthal, Christopher L. Cummings |
| 1230 |
[GO] |
2021―Nov―11 |
A Long Shot: The Importance of Needle Length in Vaccinating Patients with Obesity Against COVID-19 |
Shradha Chhabria, Fatima Cody Stanford |
| 1231 |
[GO] |
2021―Nov―11 |
BNT162b2 mRNA COVID-19 Vaccine Reactogenicity: The Key Role of Immunity |
Pilar Vizcarra, Johannes Haemmerle, Hector Velasco, Tamara Velasco, Marina Fernández-Escribano, Alejandro Vallejo, José L. Casado |
| 1232 |
[GO] |
2021―Nov―08 |
Social inequalities in COVID-19 vaccine acceptance and uptake for children and adolescents in Montreal, Canada |
Britt McKinnon, Caroline Quach, Ève Dubé, Cat Tuong Nguyen, Kate Zinszer |
| 1233 |
[GO] |
2021―Nov―08 |
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice |
Kai Wu, Angela Choi, Matthew Koch, Sayda Elbashir, LingZhi Ma, Diana Lee, Angela Woods, Carole Henry, Charis Palandjian, Anna Hill, Hardik Jani, Julian Quinones, Naveen Nunna, Sarah O'Connell, Adrian B McDermott, Samantha Falcone, Elisabeth Narayanan, Tonya Colpitts, Hamilton Bennett, Kizzmekia S Corbett, Robert Seder, Barney S Graham, Guillaume BE Stewart-Jones, Andrea Carfi, Darin K Edwards |
| 1234 |
[GO] |
2021―Nov―06 |
SARS-CoV-2 vaccine for domestic and captive animals: An effort to counter COVID-19 pandemic at the human-animal interface |
Khan Sharun, Ruchi Tiwari, AbdulRahman A. Saied, Kuldeep Dhama |
| 1235 |
[GO] |
2021―Nov―06 |
Early Experience with COVID-19 Vaccine in a Federally-Qualified Healthcare Center for the Homeless |
Jean-Venable R. Goode, Patricia Cook, Stephanie Cuttino, Sharon B. S. Gatewood |
| 1236 |
[GO] |
2021―Nov―04 |
Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework |
Colleen L Lau, Helen J Mayfield, Jane E Sinclair, Samuel J Brown, Michael Waller, Anoop K Enjeti, Andrew Baird, Kirsty Short, Kerrie Mengersen, John Litt |
| 1237 |
[GO] |
2021―Nov―03 |
Evaluation of a prototype decontamination mobile unit (UMDEO) for COVID-19 vaccination: a cross-sectional survey in France |
Anna Ribera-Cano, Maud Dupont, Charles-Henri Houzé-Cerfon, Vanessa Houzé-Cerfon, Alexander Hart, Attila J. Hertelendy, Gregory Ciottone, Vincent Bounes |
| 1238 |
[GO] |
2021―Nov―02 |
Vaccination of healthcare personnel in the COVID-19 era: a call for actions |
Helena C. Maltezou |
| 1239 |
[GO] |
2021―Nov―01 |
Multicomponent vaccines to fight sars-cov-2 variants of concern |
Antonio Cassone, Roberto Cauda |
| 1240 |
[GO] |
2021―Okt―30 |
COVID-19 vaccination significantly reduces morbidity and absenteeism among healthcare personnel: a prospective multicenter study |
Helena C. Maltezou, Periklis Panagopoulos, Flora Sourri, Theodoros V. Giannouchos, Vasilios Raftopoulos, Maria N. Gamaletsou, Amalia Karapanou, Dimitra-Maria Koukou, Athanasia Koutsidou, Emmanuela Peskelidou, Konstantina Papanastasiou, Kyriakos Souliotis, Athanasia Lourida, Nikolaos V. Sipsas, Dimitrios Hatzigeorgiou |
| 1241 |
[GO] |
2021―Okt―30 |
COVID-19 Vaccine - Long Term Immune Decline and breakthrough infections |
Johad Khoury, Ronza Najjar Debbiny, Ayman Hanna, Adel Jabbour, Yara Abu Ahmad, Aamir Saffori, Majdolen Abu-Sene, Rashid Shakiri, Ameer Elemy, Fahed Hakim |
| 1242 |
[GO] |
2021―Okt―30 |
Development of Recombinant COVID-19 Vaccine based on CHO-produced, prefusion Spike Trimer and Alum/CpG Adjuvants |
Haitao Liu, Chenliang Zhou, Jiao An, Yujiao Song, Ping Yu, Jiadai Li, Chenjian Gu, Dongdong Hu, Yuanxiang Jiang, Lingli Zhang, Chuanqi Huang, Chao Zhang, Yunqi Yang, Qianjun Zhu, Dekui Wang, Yuqiang Liu, Chenyang Miao, Xiayao Cao, Longfei Ding, Yuanfei Zhu, Hua Zhu, Linlin Bao, Lingyun Zhou, Huan Yan, Jiang Fan, Jianqing Xu, Zhongyu Hu, Youhua Xie, Jiangning Liu, Ge Liu |
| 1243 |
[GO] |
2021―Okt―29 |
Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: A case-control study |
Miguel García-Grimshaw, Santa Elizabeth Ceballos-Liceaga, Anaclara Michel-Chávez, Mario García-Alanis, Arturo Cadena-Fernández, Javier Andrés Galnares-Olalde, Guillermo Carbajal-Sandoval, Daniel Amado Carrillo-García, Noé Hernández-Valdivia, Laura E. Hernández-Vanegas, María del Mar Saniger-Alba, Alonso Gutierrez-Romero, José Luis Díaz-Ortega, Gustavo Reyes-Terán, Hugo López-Gatell, Fernando Daniel Flores-Silva, Carlos Cantú-Brito, Erwin Chiquete, Antonio Arauz, Sergio Iván Valdés-Ferrer |
| 1244 |
[GO] |
2021―Okt―28 |
“Any idea how fast ‘It’s just a mask!’ can turn into ‘It’s just a vaccine!’”: From mask mandates to vaccine mandates during the COVID-19 pandemic |
Sam Martin, Samantha Vanderslott |
| 1245 |
[GO] |
2021―Okt―28 |
COVAX No Fault Compensation Program for COVID-19 Vaccine Injuries in 92 Low and Middle Income Countries |
Anne Mazur, Stefanie Benitez, Stéphanie Chuffart-Finsterwald, Rafael La Rotta, Lee M. Hampton |
| 1246 |
[GO] |
2021―Okt―25 |
Changes in COVID-19 Vaccine Acceptance Rate Among Recovered Critically Ill atients: A 12 Month Follow-up Study |
Titilope Olanipekun, Temidayo Abe, Valery Effoe, Gloria Westney, Richsard Snyder |
| 1247 |
[GO] |
2021―Okt―22 |
The immediate impact of the COVID-19 pandemic on polio immunization and surveillance activities |
Brent Burkholder, Zubair Wadood, Ahmed M. Kassem, Derek Ehrhardt, Delayo Zomahoun |
| 1248 |
[GO] |
2021―Okt―22 |
Would COVID-19 vaccination willingness increase if mobile technologies prohibit unvaccinated individuals from public spaces? A nationwide discrete choice experiment from China |
Jing Wang, Abram L. Wagner, Ying Chen, Etienne Jaime, Xinwen Hu, Shiqiang Wu, Yihan Lu, Yuhua Ruan, Stephen W. Pan |
| 1249 |
[GO] |
2021―Okt―22 |
Evaluation of a downstream process for the recovery and concentration of a Cell-Culture-Derived rVSV-Spike COVID-19 vaccine candidate |
Arik Makovitzki, Elad Lerer, Yaron Kafri, Yaakov Adar, Lilach Cherry, Edith Lupu, Arik Monash, Rona Levy, Ofir Israeli, Eyal Dor, Eyal Epstein, Lilach Levin, Einat Toister, Idan Hefetz, Ophir Hazan, Irit Simon, Arnon Tal, Meni Girshengorn, Hanan Tzadok, Osnat Rosen, Ziv Oren |
| 1250 |
[GO] |
2021―Okt―22 |
Covid-19 vaccine hesitancy, conspiracist beliefs, paranoid ideation and perceived ethnic discrimination in a sample of University students in Venezuela |
Gabriel Andrade |
| 1251 |
[GO] |
2021―Okt―22 |
Persuasive Messaging to Increase COVID-19 Vaccine Uptake Intentions |
Erin K. James, Scott E. Bokemper, Alan S. Gerber, Saad B. Omer, Gregory A. Huber |
| 1252 |
[GO] |
2021―Okt―22 |
Ameliorated immunity elicited by intradermal inoculation in individuals vaccinated with inactivated SARS-CoV-2 vaccine |
Shengtao Fan, Dandan Li, Heng Zhao, Li Yu, Pingfang Cui, Lichun Wang, Ying Zhang, Yun Liao, Xingli Xu, Guorun Jiang, Qihan Li |
| 1253 |
[GO] |
2021―Okt―19 |
Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system |
Johanna Chapin-Bardales, Tanya Myers, Julianne Gee, David K. Shay, Paige Marquez, James Baggs, Bicheng Zhang, Charles Licata, Tom T. Shimabukuro |
| 1254 |
[GO] |
2021―Okt―19 |
Resource Allocation for Different Types of Vaccines against COVID-19: Tradeoffs and Synergies between Efficacy and Reach |
Daniel Kim, Pelin Pekgün, İnci Yildirim, Pınar Keskinocak |
| 1255 |
[GO] |
2021―Okt―19 |
Effect of Inactivated Influenza Vaccination on Human Coronavirus Infection: Secondary Analysis of a Randomized Trial in Hutterite Colonies |
Andrew T Chen, Hannah D Stacey, Art Marzok, Pardeep Singh, Jann Ang, Matthew S Miller, Mark Loeb |
| 1256 |
[GO] |
2021―Okt―09 |
Canadian parents’ perceptions of COVID-19 vaccination and intention to vaccinate their children: results from a cross-sectional national survey |
Robin M. Humble, Hannah Sell, Eve Dubé, Noni E. MacDonald, Joan Robinson, S. Michelle Driedger, Manish Sadarangani, Samantha B. Meyer, Sarah Wilson, Karen M. Benzies, Samuel Lemaire-Paquette, Shannon E. MacDonald |
| 1257 |
[GO] |
2021―Okt―09 |
A Self-administered Virtual Reality Intervention Increases COVID-19 Vaccination Intention |
Aske Mottelson, Clara Vandeweerdt, Michael Atchapero, Tiffany Luong, Christian Holz, Robert Böhm, Guido Makransky |
| 1258 |
[GO] |
2021―Okt―09 |
Trends, patterns and psychological influences on COVID-19 vaccination intention: findings from a large prospective community cohort study in England and Wales (Virus Watch) |
Thomas Byrne, Parth Patel, Madhumita Shrotri, Sarah Beale, Susan Michie, Jabeer Butt, Nicky Hawkins, Pia Hardelid, Alison Rodger, Anna Aryee, Isobel Braithwaite, Wing Lam Erica Fong, Ellen Fragaszy, Cyril Geismar, Jana Kovar, Annalan MD Navaratnam, Vincent Nguyen, Andrew Hayward, Robert W Aldridge, Linda Wijlaar, Eleni Nastouli, Moira Spyer, Ben Killingley, Ingemar Cox, Vasileios Lampos, Rachel A McKendry, Tao Cheng, Yunzhe Liu, Anne M Johnson, Jo Gibbs, Richard Gilson |
| 1259 |
[GO] |
2021―Okt―06 |
Development of an IgG-Fc Fusion COVID-19 Subunit Vaccine, AKS-452 |
David G. Alleva, Andrea R. Delpero, Melanie M. Scully, Sylaja Murikipudi, Ramya Ragupathy, Emma K. Greaves, Thillainaygam Sathiyaseelan, Jeffrey R. Haworth, Nishit J. Shah, Vidhya Rao, Shashikant Nagre, Thomas M. Lancaster, Sarah S. Webb, Allison I. Jasa, Shannon E. Ronca, Freedom M. Green, Hanne Andersen Elyard, JoAnn Yee, Jeffrey Klein, Larry Karnes, Frans Sollie, Todd C. Zion |
| 1260 |
[GO] |
2021―Okt―06 |
A Case Series of Acute Pericarditis following COVID-19 Vaccination in the Context of Recent Reports from Europe and the United States |
George Lazaros, Cleo Anastassopoulou, Sophia Hatziantoniou, Theodoros Kalos, Stergios Soulaidopoulos, Emilia Lazarou, Charalambos Vlachopoulos, Dimitrios Vassilopoulos, Athanasios Tsakris, Costas Tsioufis |
| 1261 |
[GO] |
2021―Okt―02 |
Christian Nationalism and COVID-19 Vaccine Hesitancy and Uptake |
Katie E. Corcoran, Christopher P. Scheitle, Bernard D. DiGregorio |
| 1262 |
[GO] |
2021―Sep―29 |
History of pandemic H1N1-containing influenza vaccination and risk for spontaneous abortion and birth defects |
Celeste J. Romano, Clinton Hall, Zeina G. Khodr, Anna T. Bukowinski, Gia R. Gumbs, Ava Marie S. Conlin |
| 1263 |
[GO] |
2021―Sep―27 |
Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemic |
Natalia A Molodecky, Hamid Jafari, Rana M Safdar, Jamal A Ahmed, Abdirahman Mahamud, Ananda S Bandyopadhyay, Hemant Shukla, Arshad Quddus, Michel Zaffran, Roland W Sutter, Nicholas C Grassly, Isobel M Blake |
| 1264 |
[GO] |
2021―Sep―27 |
Parental consent for vaccination of minors against COVID-19 |
Nina Shevzov-Zebrun, Arthur Caplan |
| 1265 |
[GO] |
2021―Sep―27 |
Preferences for COVID-19 vaccination information and location: Associations with vaccine hesitancy, race and ethnicity |
Kimberly A. Fisher, Ngoc Nguyen, Sybil Crawford, Hassan Fouayzi, Sonal Singh, Kathleen M. Mazor |
| 1266 |
[GO] |
2021―Sep―27 |
Early exploration of COVID-19 vaccination safety and effectiveness during pregnancy: interim descriptive data from a prospective observational study |
Inna Bleicher, Einav Kadour-Peero, Lena Sagi-Dain, Shlomi Sagi |
| 1267 |
[GO] |
2021―Sep―27 |
Characteristics associated with COVID-19 vaccine hesitancy: A nationwide survey of 1000 patients with immune-mediated inflammatory diseases |
Rodrigo Poubel Vieira Rezende, Alessandra S. Braz, Maria Fernanda B. Guimarães, Sandra Lúcia E. Ribeiro, Rejane Maria R. Abreu Vieira, Blanca E. Bica, Vítor A. Cruz, Ketty Lysie Libardi Lira Machado, Joana S. Carvalho, Odirlei A. Monticielo, Lilian D. Valadares, Kátia Lino Baptista, Anna Carolina F.M. Gomes Tavares, Adriana M. Kakehasi, Edgard T. Neto, Ana Karla Guedes Melo, Gilda A. Ferreira, Viviane A. de Souza, Gecilmara S. Pileggi, Marcelo M. Pinheiro |
| 1268 |
[GO] |
2021―Sep―24 |
Title: Antibody Response after First and Second-dose of ChAdOx1-nCOV (CovishieldTM®) and BBV-152 (CovaxinTM®) among Health Care Workers in India: The Final Results of Cross-sectional Coronavirus Vaccine-induced Antibody Titre (COVAT) study |
Awadhesh Kumar Singh, Sanjeev Ratnakar Phatak, Ritu Singh, Kingshuk Bhattacharjee, Nagendra Kumar Singh, Arvind Gupta, Arvind Sharma |
| 1269 |
[GO] |
2021―Sep―24 |
A Phase III, Observer-blind, Randomized, Placebo-controlled Study of the Efficacy, Safety, and Immunogenicity of SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 Years: An Interim Analysis in Indonesia |
Eddy Fadlyana, Kusnandi Rusmil, Rodman Tarigan, Andri Reza Rahmadi, Susantina Prodjosoewojo, Yulia Sofiatin, Citra V Khrisna, Rini Mulia Sari, Lilis Setyaningsih, Fikrianti Surachman, Novilia Sjafri Bachtiar, Hadyana Sukandar, Imam Megantara, Chrysanti Murad, Krisna Nur A Pangesti, Vivi Setiawati, Sunarjati Sudigdoadi, Yaling Hu, Qiang Gao, Cissy B Kartasasmita |
| 1270 |
[GO] |
2021―Sep―17 |
COVID-19 diagnosis in a Senegalese company: a model for COVID-19 vaccination? |
Jean Michel MANSUY, Asséga Sylvain SAGNA, Michael LAURENT, Jacques IZOPET |
| 1271 |
[GO] |
2021―Sep―16 |
Supporting National Immunization Technical Advisory Groups in the WHO European Region in developing national COVID-19 vaccination recommendations through online communication platform |
Liudmila Mosina, Wiebe Külper-Schiek, Lisa Jacques-Carroll, Andrew Earnshaw, Thomas Harder, Federico Martinón-Torres, Annelies Wilder-Smith, Ole Wichmann, Siddhartha Sankar Datta |
| 1272 |
[GO] |
2021―Sep―08 |
Inequalities in coverage of COVID-19 vaccination: a population register based cross-sectional study in Wales, UK |
Malorie Perry, Ashley Akbari, Simon Cottrell, Michael B Gravenor, Richard Roberts, Ronan A Lyons, Stuart Bedston, Fatemah Torabi, Lucy Griffiths |
| 1273 |
[GO] |
2021―Sep―07 |
UAE Efforts in Promoting COVID-19 Vaccination and Building Vaccine Confidence |
Duaa Mohamed Suliman, Faisal A. Nawaz, Parvathy Mohanan, Mohamed Abdul Kareem Adam Modber, Muhammad Kabir Musa, Mohamed Babiker Musa, Diala El Chbib, Yasir Ahmed Mohammed Elhadi, Mohammad Yasir Essar, Mashkur Abdulhamid Isa, Don Eliseo Lucero-Prisno III, Immanuel Azaad Moonesar |
| 1274 |
[GO] |
2021―Sep―07 |
Prenatal maternal COVID-19 vaccination and pregnancy outcomes |
Tamar Wainstock, Israel Yoles, Ruslan Sergienko, Eyal Sheiner |
| 1275 |
[GO] |
2021―Sep―07 |
Predicting COVID-19 Vaccination Intention Using Protection Motivation Theory and Conspiracy Beliefs |
Judith Eberhardt, Jonathan Ling |
| 1276 |
[GO] |
2021―Sep―07 |
Racial differences in anticipated COVID-19 vaccine acceptance among religious populations in the US |
Christopher Justin Jacobi, Brandon Vaidyanathan |
| 1277 |
[GO] |
2021―Sep―07 |
Low COVID-19 Vaccine Hesitancy in Brazil |
Daniella Campelo Batalha Cox Moore, Marcio Fernandes Nehab, Karla Gonçalves Camacho, Adriana Teixeira Reis, Maria de Fátima Junqueira-Marinho, Dimitri Marques Abramov, Zina Maria Almeida de Azevedo, Livia Almeida de Menezes, Margarida dos Santos Salú, Carlos Eduardo da Silva Figueiredo, Maria Elisabeth Lopes Moreira, Zilton Farias Meira de Vasconcelos, Flavia Amendola Anisio de Carvalho, Livia de Rezende de Mello, Roberta Fernandes Correia, Saint Clair dos Santos Gomes Junior |
| 1278 |
[GO] |
2021―Sep―04 |
Myocarditis following COVID-19 vaccination - a case series |
Dan Levin, Gil Shimon, Maggie Fadlon-Derai, Liron Gershovitz, Amiram Shovali, Anat Sebbag, Shakib Bader, Noam Fink, Barak Gordon MD |
| 1279 |
[GO] |
2021―Sep―03 |
Unmethylated CpG Motif-Containing Genomic DNA Fragments of Bacillus Calmette-Guerin Improves Immune Response towards a DNA Vaccine for COVID-19 |
Zehua Zhou, Xinyu Zhang, Qianqian Li, Lili Fu, Meiyu Wang, Shuo Liu, Jiajing Wu, Jianhui Nie, Li Zhang, Chenyan Zhao, Fei Jiang, Yimeng An, Bin Yu, Haifa Zheng, Youchun Wang, Aihua Zhao, Weijin Huang |
| 1280 |
[GO] |
2021―Sep―03 |
Legal and Regulatory Processes for Japan’s COVID-19□Immunization Program |
Norihisa Yamamoto, Yuichi Takahashi, Shuichiro Hayashi |
| 1281 |
[GO] |
2021―Sep―02 |
COVID-19 vaccine uptake among healthcare workers in the fourth country to authorize BNT162b2 during the first month of rollout |
Mazin Barry, Mohamad-Hani Temsah, Fadi Aljamaan, Basema Saddik, Ayman Al-Eyadhy, Shuliweeh Alenezi, Nurah Alamro, Abdullah N Alhuzaimi, Ali Alhaboob, Khalid Alhasan, Fahad Alsohime, Ali Alaraj, Rabih Halwani, Amr Jamal, Omar Temsah, Fahad Alzamil, Ali Somily, Jaffar A. Al-Tawfiq |
| 1282 |
[GO] |
2021―Sep―02 |
Collaboration in Times of Crisis: A Study on COVID-19 Vaccine R&D Partnerships |
Louise C. Druedahl, Timo Minssen, W. Nicholson Price |
| 1283 |
[GO] |
2021―Aug―31 |
The Impact of COVID-19 Vaccination Delay: A Data-Driven Modelling Analysis for Chicago and New York City |
Vinicius V.L. Albani, Jennifer Loria, Eduardo Massad, Jorge P. Zubelli |
| 1284 |
[GO] |
2021―Aug―31 |
Association between ChAdOx1 nCoV-19 vaccination and bleeding episodes: Large population-based cohort study |
Lill Trogstad, Anna Hayman Robertson, Siri Mjaaland, Per Magnus |
| 1285 |
[GO] |
2021―Aug―30 |
Oropharyngeal shedding of herpesviruses before and after BNT162b2 mRNA vaccination against COVID-19 |
Tal Brosh-Nissimov, Nadav Sorek, Michal Yeshayahu, Irena Zherebovich, Maria Elmaliach, Amos Cahan, Sharon Amit, Erela Rotlevi |
| 1286 |
[GO] |
2021―Aug―30 |
Association of Flu specific and SARS-CoV-2 specific CD4 T cell responses in SARS-CoV-2 infected asymptomatic heath care workers |
Suresh Pallikkuth, Erin Williams, Rajendra Pahwa, Michael Hoffer, Savita Pahwa |
| 1287 |
[GO] |
2021―Aug―26 |
SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1 |
John Lok Man Law, Michael Logan, Michael A. Joyce, Abdolamir Landi, Darren Hockman, Kevin Crawford, Janelle Johnson, Gerald LaChance, Holly A. Saffran, Justin Shields, Eve Hobart, Raelynn Brassard, Elena Arutyunova, Kanti Pabbaraju, Matthew Croxen, Graham Tipples, M. Joanne Lemieux, D. Lorne Tyrrell, Michael Houghton |
| 1288 |
[GO] |
2021―Aug―25 |
A Hub-and-spoke Design for Ultra-cold COVID-19 Vaccine Distribution |
Xinglu Xu, Mark D. Rodgers, Weihong (Grace) Guo |
| 1289 |
[GO] |
2021―Aug―25 |
COVID-19 Vaccine Safety Monitoring: Might Differential Healthcare Seeking Introduce Detection Bias Into Rates of Medical Events and Cause False Safety Signals? |
Rafael Harpaz |
| 1290 |
[GO] |
2021―Aug―24 |
Making COVID-19 vaccinations accessible for people with disabilities |
Sara Rotenberg, Matthew B Downer, Jane Cooper |
| 1291 |
[GO] |
2021―Aug―19 |
Walking the Tightrope: Reevaluating Science Communication in the Era of COVID-19 Vaccines |
Matthew Z. Dudley, Roger Bernier, Janesse Brewer, Daniel A. Salmon |
| 1292 |
[GO] |
2021―Aug―19 |
Vaccine effectiveness against infection and onwards transmission of COVID-19: analysis of Belgian contact tracing data, January-June 2021 |
Toon Braeye, Laura Cornelissen, Lucy Catteau, Freek Haarhuis, Kristiaan Proesmans, Karin De Ridder, Achille Djiena, Romain Mahieu, Frances De Leeuw, Alex Dreuw, Naima Hammami, Sophie Quoilin, Herman Van Oyen, Chloé Wyndham-Thomas, Dieter Van Cauteren |
| 1293 |
[GO] |
2021―Aug―17 |
Public Attitudes toward COVID-19 Vaccines on English-language Twitter: A Sentiment Analysis |
Siru Liu, Jialin Liu |
| 1294 |
[GO] |
2021―Aug―16 |
Continuity of routine immunization programs in Canada during the COVID-19 pandemic |
Hannah Sell, Ali Assi, S. Michelle Driedger, Eve Dubé, Arnaud Gagneur, Samantha B. Meyer, Joan Robinson, Manish Sadarangani, Matthew Tunis, Shannon E. MacDonald |
| 1295 |
[GO] |
2021―Aug―16 |
Immune efficacy of a candidate porcine reproductive and respiratory syndrome vaccine rHN-NP49 administered by a Needle-free intradermal delivery system in comparison with intramuscular injection |
Yifeng Jiang, Xianbin Li, Lingxue Yu, Wu Tong, Pengfei Chen, Shuaiyong Wang, Kuan Zhao, Xiangmei Tan, Fei Gao, Hai Yu, Guoxin Li, Liwei Li, Yujiao Zhang, Erwin van den Born, Yanjun Zhou, Guangzhi Tong |
| 1296 |
[GO] |
2021―Aug―14 |
COVID-19 Vaccination in the Federal Bureau of Prisons, December 2020-April 2021 |
Liesl M. Hagan, Charles Dusseau, Michael Crockett, Tami Rodriguez, Michael J. Long |
| 1297 |
[GO] |
2021―Aug―13 |
Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review |
Agustín Ciapponi, Ariel Bardach, Agustina Mazzoni, Tomás Alconada, A. Steven Anderson, Fernando J. Argento, Jamile Ballivian, Karin Bok, Daniel Comandé, Emily Erbelding, Erin Goucher, Beate Kampmann, Ruth Karron, Flor M. Munoz, María Carolina Palermo, Edward P. K. Parker, Federico Rodriguez Cairoli, Victoria Santa María, Andy S. Stergachis, Gerald Voss, Xu Xiong, Natalia Zamora, Sabra Zaraa, Mabel Berrueta, Pierre M Buekens |
| 1298 |
[GO] |
2021―Aug―11 |
Could live attenuated vaccines better control COVID-19? |
Shinya Okamura, Hirotaka Ebina |
| 1299 |
[GO] |
2021―Aug―11 |
Kinetics of SARS-CoV-2 anti-S IgG after BNT162b2 vaccination |
Daniel Grupel, Sivan Gazit, Licita Schreiber, Varda Nadler, Tamar Wolf, Rachel Lazar, Lia Supino-Rosin, Galit Perez, Asaf Peretz, Amir Ben Tov, Miri Mizrahi-Reuveni, Gabriel Chodick, Tal Patalon |
| 1300 |
[GO] |
2021―Aug―11 |
Detection of SARS-CoV-2 antibodies formed in response to the BNT162b2 and mRNA-1237 mRNA vaccine by commercial antibody tests |
Jamil N Kanji, Ashley Bailey, Jayne Fenton, Sean H Ling, Rafael Rivera, Sabrina Plitt, Wendy I Sligl, Sean Taylor, LeeAnn Turnbull, Graham Tipples, Carmen L. Charlton |
| 1301 |
[GO] |
2021―Aug―11 |
Does BCG provide long-term protection against SARS-CoV-2 infection? A case-control study in Q, Canada |
Jacques Pépin, Annie-Claude Labbé, Alex Carignan, Marie-Elise Parent, Jennifer Yu, Cynthia Grenier, Stéphanie Beauchemin, Philippe De Wals, Louis Valiquette, Marie-Claude Rousseau |
| 1302 |
[GO] |
2021―Aug―10 |
The Next Frontier in Vaccine Safety and VAERS: Lessons from COVID-19 and Ten Recommendations for Action |
John G. Rizk, Charles E. Barr, Youssef Rizk, John C. Lewin |
| 1303 |
[GO] |
2021―Aug―08 |
From program suspension to the pandemic: A qualitative examination of Australia’s vaccine pharmacovigilance system over 10 years |
Anastasia Phillips, Samantha Carlson, Margie Danchin, Frank Beard, Kristine Macartney |
| 1304 |
[GO] |
2021―Aug―06 |
Semi-quantitative, high throughput analysis of SARS-CoV-2 neutralizing antibodies: Measuring the level and duration of immune response antibodies post infection/vaccination |
Sean C. Taylor, Beth Hurst, Ian Martiszus, Marvin S. Hausman, Samar Sarwat, Jeffrey M. Schapiro, Sarah Rowell, Alexander Lituev |
| 1305 |
[GO] |
2021―Aug―05 |
Prevalence of SARS-CoV-2 IgG antibodies and their association with clinical symptoms of COVID-19 in Estonia (KoroSero-EST-1 study) |
Piia Jõgi, Hiie Soeorg, Diana Ingerainen, Mari Soots, Freddy Lättekivi, Paul Naaber, Karolin Toompere, Pärt Peterson, Liis Haljasmägi, Eva Žusinaite, Hannes Vaas, Merit Pauskar, Arina Shablinskaja, Katrin Kaarna, Heli Paluste, Kai Kisand, Marje Oona, Riina Janno, Irja Lutsar |
| 1306 |
[GO] |
2021―Aug―05 |
Sub-cutaneous Pfizer/BioNTech COVID-19 vaccine administration results in seroconversion among young adults |
Limor Friedensohn, Meital Zur, Maxim Timofeyev, Saar Burshtein, Yossi Ben Michael, Noam Fink, Elon Glassberg |
| 1307 |
[GO] |
2021―Aug―05 |
Perceived public health threat a key factor for willingness to get the COVID-19 vaccine in Australia |
Rachael H Dodd, Kristen Pickles, Erin Cvejic, Samuel Cornell, Jennifer MJ Isautier, Tessa Copp, Brooke Nickel, Carissa Bonner, Carys Batcup, Danielle M Muscat, Julie Ayre, Kirsten J McCaffery |
| 1308 |
[GO] |
2021―Aug―03 |
Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection |
Lei Li, Yoshikazu Honda-Okubo, Ying Huang, Hyesun Jang, Michael A. Carlock, Jeremy Baldwin, Sakshi Piplani, Anne G. Bebin-Blackwell, David Forgacs, Kaori Sakamoto, Alberto Stella, Stuart Turville, Tim Chataway, Alex Colella, Jamie Triccas, Ted M Ross, Nikolai Petrovsky |
| 1309 |
[GO] |
2021―Jul―31 |
Geo-prioritization framework for COVID-19 vaccine allocation in India |
Akshay Mahajan, Jasmine Kaur, Chirag Sidana, Shashwat Shivam, Harpreet Singh |
| 1310 |
[GO] |
2021―Jul―31 |
An overview of procurement, pricing, and uptake of COVID-19 vaccines in Pakistan |
Adeel Siddiqui, Ali Ahmed, Maria Tanveer, Muhammad Saqlain, Chia Siang Kow, Syed Shahzad Hasan |
| 1311 |
[GO] |
2021―Jul―27 |
Optimal Planning of the COVID-19 Vaccine Supply Chain |
Georgios P. Georgiadis, Michael C. Georgiadis |
| 1312 |
[GO] |
2021―Jul―24 |
COVID-19 vaccination for cancer patients: evidence, priority, and practice |
Shiv Rajan, Naseem Akhtar, Sonali Sharma, Deep Chakrabarti, Vijay Kumar |
| 1313 |
[GO] |
2021―Jul―24 |
Association of total and neutralizing SARS-CoV-2 spike -Receptor Binding Domain antibodies with epidemiological and clinical characteristics after immunization with the 1st and 2nd doses of the BNT162b2 vaccine |
Athanasios Michos, Elizabeth-Barbara Tatsi, Fillipos Filippatos, Charilaos Dellis, Dimitra Koukou, Vasiliki Efthymiou, Evangelia Kastrinelli, Aimilia Mantzou, Vasiliki Syriopoulou |
| 1314 |
[GO] |
2021―Jul―24 |
Quantification of SARS-CoV-2 spike and nucleocapsid proteins using isotope dilution tandem mass spectrometry |
Carrie Pierce-Ruiz, Wanda I. Santana, William J. H. Sutton, David A. Fischler, Hans C. Cooper, Lidoshka R. Marc, John R. Barr, Tracie L. Williams |
| 1315 |
[GO] |
2021―Jul―23 |
Parental plans to vaccinate children for COVID-19 in New York City |
Chloe A. Teasdale, Luisa N. Borrell, Yanhan Shen, Spencer Kimball, Michael L. Rinke, Sasha A. Fleary, Denis Nash |
| 1316 |
[GO] |
2021―Jul―23 |
Background rates of all-cause mortality, hospitalizations, and emergency department visits among nursing home residents in Ontario, Canada to inform COVID-19 vaccine safety assessments |
Maria Sundaram, Sharifa Nasreen, Andrew Calzavara, Siyi He, Hannah Chung, Susan E. Bronskill, Sarah A. Buchan, Mina Tadrous, Peter Tanuseputro, Kumanan Wilson, Sarah Wilson, Jeffrey C. Kwong |
| 1317 |
[GO] |
2021―Jul―23 |
Enablers and barriers to COVID-19 vaccine uptake: an international study of perceptions and intentions |
Paul F. Burke, Daniel Masters, Graham Massey |
| 1318 |
[GO] |
2021―Jul―22 |
Patients with history of covid-19 had more side effects after the first dose of covid-19 vaccine |
Noémie Tissot, Anne-Sophie Brunel, Fabienne Bozon, Béatrice Rosolen, Catherine Chirouze, Kevin Bouiller |
| 1319 |
[GO] |
2021―Jul―22 |
Will COVID-19 vaccine equity be possible in India? |
Kanagavalli Mathivathanan |
| 1320 |
[GO] |
2021―Jul―20 |
Playing vaccine roulette: Why the current strategy of staking everything on Covid-19 vaccines is a high-stakes wager |
Elisabeth Paul, Garrett W. Brown, Andreas Kalk, Valéry Ridde |
| 1321 |
[GO] |
2021―Jul―16 |
An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity |
Anne-Catherine Fluckiger, Barthelemy Ontsouka, Jasminka Bozic, Abebaw Diress, Tanvir Ahmed, Tamara Berthoud, Anh Tran, Diane Duque, Mingmin Liao, Michael McCluskie, Francisco Diaz-Mitoma, David E. Anderson, Catalina Soare |
| 1322 |
[GO] |
2021―Jul―16 |
Vitamin D supplementation: an alternative to enhance the effectiveness of vaccines against SARS-CoV-2? |
Felipe Inserra, Carlos Tajer, Laura Antonietti, Javier Mariani, León Ferder, Walter Manucha |
| 1323 |
[GO] |
2021―Jul―13 |
Marketing the COVID-19 vaccine and the implications for public health |
Emmanuel Mogaji |
| 1324 |
[GO] |
2021―Jul―13 |
COVID-19 Vaccine Capacity: Challenges and Mitigation - The DCVMN perspective |
Benoit Hayman, Rajinder Suri, Sai D. Prasad |
| 1325 |
[GO] |
2021―Jul―13 |
The Novel Platform of mRNA COVID-19 Vaccines and Myocarditis: Clues into the Potential Underlying Mechanism |
George Lazaros, Allan L. Klein, Sophia Hatziantoniou, Costas Tsioufis, Athanasios Tsakris, Cleo Anastassopoulou |
| 1326 |
[GO] |
2021―Jul―10 |
Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - a risk-benefit analysis for people <60 years in Australia |
Chandini Raina MacIntyre, Benjamin Veness, David Berger, Nada Hamad, Noor Bari |
| 1327 |
[GO] |
2021―Jul―07 |
Initial impact of SARS-Cov-2 vaccination on healthcare workers in Italy- Update on the 28th of March 2021 |
Alberto Mateo-Urdiales, Martina Del Manso, Xanthi Andrianou, Matteo Spuri, Fortunato D'Ancona, Antonietta Filia, Maria Cristina Rota, Daniele Petrone, Maria Fenicia Vescio, Flavia Riccardo, Antonino Bella, Patrizio Pezzotti, Massimo Fabiani |
| 1328 |
[GO] |
2021―Jun―30 |
Henoch-Schönlein Purpura Presenting Post COVID-19 Vaccination |
Adam M. Hines, Neal Murphy, Christine Mullin, Julia Barillas, Jacqueline C. Barrientos |
| 1329 |
[GO] |
2021―Jun―29 |
Cost of vaccine delivery strategies in low- and middle-income countries during the COVID-19 pandemic |
Christina Banks, Allison Portnoy, Flavia Moi, Laura Boonstoppel, Logan Brenzel, Stephen C. Resch |
| 1330 |
[GO] |
2021―Jun―29 |
COVID-19 vaccine roll-out in middle-income countries: lessons learned from the Jordan experience |
Ala'a Al-Shaikh, Nazeema Muthu, Chinara Aidyralieva, Maria Cristina Profili, Saverio Bellizzi |
| 1331 |
[GO] |
2021―Jun―26 |
Significance of SARS-CoV-2 Specific Antibody Testing during COVID-19 Vaccine Allocation |
Akane B. Fujimoto, Inci Yildirim, Pinar Keskinocak |
| 1332 |
[GO] |
2021―Jun―26 |
Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding |
Sandra Scheiblhofer, Stephan Drothler, Werner Braun, Reinhard Braun, Maximilian Boesch, Richard Weiss |
| 1333 |
[GO] |
2021―Jun―25 |
Specialist confirmed allergic reactions to COVID-19 mRNA vaccines at a mass vaccination site |
Ian A Myles, Joshua S Vinciguerra, Robert T Premus |
| 1334 |
[GO] |
2021―Jun―23 |
Tolerance of BNT162b2 mRNA COVI-19 vaccine in patients with a medical history of COVID-19 disease : a case control study |
Aurelie Baldolli, Jocelyn Michon, Fanny Appia, Caroline Galimard, Renaud Verdon, Jean Jacques Parienti |
| 1335 |
[GO] |
2021―Jun―23 |
Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration |
Aditya P. Desai, Aryan P. Desai, Gregory J. Loomis |
| 1336 |
[GO] |
2021―Jun―23 |
Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: a comparative survey of five large cities in the United States, United Kingdom, and Australia |
Mallory Trent, Holly Seale, Abrar Ahmad Chughtai, Daniel Salmon, C. Raina MacIntyre |
| 1337 |
[GO] |
2021―Jun―23 |
One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model |
Karen E. Gooch, Trevor R.F. Smith, Francisco J. Salguero, Susan A. Fotheringham, Robert J. Watson, Mike J. Dennis, Alastair Handley, Holly E. Humphries, Stephanie Longet, Tom Tipton, Charlotte Sarfas, Laura Sibley, Gillian S. Slack, Emma Rayner, Kathryn A. Ryan, Katherine Schultheis, Stephanie J. Ramos, Andrew White, Sue Charlton, Sally A. Sharpe, Fergus Gleeson, Laurent M. Humeau, Yper Hall, Kate E. Broderick, Miles W. Carroll |
| 1338 |
[GO] |
2021―Jun―22 |
Adapting the Motors of Influenza Vaccination Acceptance Scale into the Motors of COVID-19 Vaccination Acceptance Scale: Psychometric evaluation among mainland Chinese university students |
I-Hua Chen, Daniel Kwasi Ahorsu, Nai-Ying Ko, Cheng-Fang Yen, Chung-Ying Lin, Mark D. Griffiths, Amir H. Pakpour |
| 1339 |
[GO] |
2021―Jun―22 |
Recent MMR vaccination in Health Care Workers and Covid-19: a test negative case-control study |
Lisa Lundberg, Maria Bygdell, Gustaf Stukat von Feilitzen, Susanne Woxenius, Claes Ohlsson, Jenny M Kindblom, Susannah Leach |
| 1340 |
[GO] |
2021―Jun―21 |
Should older adult pneumococcal vaccination recommendations change due to decreased vaccination in children during the pandemic? A cost-effectiveness analysis |
Kenneth J. Smith, Angela R. Wateska, Mary Patricia Nowalk, Chyongchiou J. Lin, Lee H. Harrison, William Schaffner, Richard K. Zimmerman |
| 1341 |
[GO] |
2021―Jun―17 |
Early influenza vaccination rates in children during the COVID-19 pandemic |
Benjamin Fogel, Eric W. Schaefer, Steven D. Hicks |
| 1342 |
[GO] |
2021―Jun―17 |
COVID-19 Vaccination Rates Vary By Community Vulnerability: A County-level Analysis |
Clare C. Brown, Sean G. Young, George C. Pro |
| 1343 |
[GO] |
2021―Jun―15 |
Title: Helping patients with ethical concerns about COVID-19 vaccines in light of fetal cell lines used in some COVID-19 vaccines |
Richard K Zimmerman |
| 1344 |
[GO] |
2021―Jun―14 |
The Need for Broadly Protective COVID-19 Vaccines: Beyond S-Only Approaches |
Gregory A. Poland, Inna G. Ovsyannikova, Richard B. Kennedy |
| 1345 |
[GO] |
2021―Jun―12 |
COVID-19 RELATED IMMUNIZATION DISRUPTIONS IN RAJASTHAN, INDIA: A RETROSPECTIVE OBSERVATIONAL STUDY |
Radhika Jain, Ambika Chopra, Camille Falézan, Mustufa Patel, Pascaline Dupas |
| 1346 |
[GO] |
2021―Jun―12 |
Long-term antibody persistence and exceptional vaccination response on previously SARS-CoV-2 infected subjects |
Davide Ferrari, Chiara Di Resta, Rossella Tomaiuolo, Eleonora Sabetta, Marina Pontillo, Andrea Motta, Massimo Locatelli |
| 1347 |
[GO] |
2021―Jun―10 |
Estimating the number of averted illnesses and deaths as a result of vaccination against an influenza pandemic in nine low- and middle-income countries |
Chelsea S. Lutz, Matthew Biggerstaff, Melissa A. Rolfes, Kathryn E. Lafond, Eduardo Azziz-Baumgartner, Rachael M. Porter, Carrie Reed, Joseph S. Bresee |
| 1348 |
[GO] |
2021―Jun―09 |
Twitter discourse reveals geographical and temporal variation in concerns about COVID-19 Vaccines in the United States |
Sharath Chandra Guntuku, Alison M. Buttenheim, Garrick Sherman, Raina M. Merchant |
| 1349 |
[GO] |
2021―Jun―08 |
A new group at increased risk of a SARS-CoV-2 infection emerges: The recently vaccinated |
Sebastian Hoehl, Sandra Ciesek, Jürgen Graf, Sabine Wicker |
| 1350 |
[GO] |
2021―Jun―07 |
Knowledge and attitude of Kenyan healthcare workers towards pandemic influenza disease and vaccination: 9 years after the last influenza pandemic |
Fred Andayi, Gideon O. Emukule, Eric Osoro, Linus K. Ndegwa, Fredrick Otiato, Peter Muturi, Eduardo Azziz-Baumgartner, Rosalia Kalani, Edwina Anyango, Philip M. Muthoka, Malembe S. Ebama, Joseph Bresee, Sandra S Chaves |
| 1351 |
[GO] |
2021―Jun―05 |
One size does not fit all: Lessons from Israel's Covid-19 vaccination drive and hesitancy |
Aviad Raz, Yael Keshet, Ariela Popper-Giveon, Maha Sabbah Karkabi |
| 1352 |
[GO] |
2021―Jun―04 |
Public trust on regulatory decisions: the European Medicines Agency and the AstraZeneca COVID-19 vaccine label |
Rafael Dal-Ré, Odile Launay |
| 1353 |
[GO] |
2021―Jun―01 |
Impact of the COVID-19 pandemic on the provision of routine childhood immunizations in Ontario, Canada |
Pierre-Philippe Piché-Renaud, Catherine Ji, Daniel S. Farrar, Jeremy N. Friedman, Michelle Science, Ian Kitai, Sharon Burey, Mark Feldman, Shaun K. Morris |
| 1354 |
[GO] |
2021―Jun―01 |
Evaluation of post-introduction COVID-19 Vaccine Effectiveness: Summary of interim guidance of the World Health Organization |
Minal K. Patel, Isabel Bergeri, Joseph S. Bresee, Benjamin J. Cowling, Natasha S. Crowcroft, Kamal Fahmy, Siddhivinayak Hirve, Gagandeep Kang, Mark A. Katz, Claudio F. Lanata, Maïna L'Azou Jackson, Sudhir Joshi, Marc Lipsitch, Jason M. Mwenda, Francisco Nogareda, Walter A. Orenstein, Justin R. Ortiz, Richard Pebody, Stephanie J. Schrag, Peter G. Smith, Padmini Srikantiah, Lorenzo Subissi, Marta Valenciano, David W. Vaughn, Jennifer R. Verani, Annelies Wilder-Smith, Daniel R. Feikin |
| 1355 |
[GO] |
2021―Jun―01 |
Immunogenic Potential of DNA Vaccine candidate, ZyCoV-D against SARS-CoV-2 in Animal Models |
Ayan Dey, T.M. Chozhavel Rajanathan, Harish Chandra, Hari P.R. Pericherla, Sanjeev Kumar, Huzaifa S. Choonia, Mayank Bajpai, Arun K. Singh, Anuradha Sinha, Gurwinder Saini, Parth Dalal, Sarosh Vandriwala, Mohammed A. Raheem, Rupesh D. Divate, Neelam L. Navlani, Vibhuti Sharma, Aashini Parikh, Siva Prasath, M. Sankar Rao, Kapil Maithal |
| 1356 |
[GO] |
2021―Mai―30 |
The missing season: The impacts of the COVID-19 pandemic on influenza |
Casey M. Zipfel, Vittoria Colizza, Shweta Bansal |
| 1357 |
[GO] |
2021―Mai―28 |
Myocarditis following COVID-19 mRNA vaccination |
Saif Abu Mouch, Ariel Roguin, Elias Hellou, Amorina Ishai, Uri Shoshan, Lamis Mahamid, Marwan Zoabi, Marina Aisman, Nimrod Goldshmidt, Noa Berar Yanay |
| 1358 |
[GO] |
2021―Mai―28 |
Adverse Events Following mRNA SARS-CoV-2 Vaccination among U.S. Nursing Home Residents |
Barbara H. Bardenheier, Stefan Gravenstein, Carolyn Blackman, Roee Gutman, Indra Neil Sarkar, Richard A. Feifer, Elizabeth M. White, Kevin McConeghy, Aman Nanda, Vincent Mor |
| 1359 |
[GO] |
2021―Mai―27 |
COVID-19 vaccine hesitancy: lessons from Israel |
David Gurwitz |
| 1360 |
[GO] |
2021―Mai―26 |
Willingness to get vaccinated against Covid-19 and attitudes towards vaccination in general |
Roselinde Kessels, Jeroen Luyten, Sandy Tubeuf |
| 1361 |
[GO] |
2021―Mai―24 |
A breath of humanity in the era of Covid-19 vaccine |
Philippe Vanhems |
| 1362 |
[GO] |
2021―Mai―24 |
Evidence for antibody as a protective correlate for COVID-19 vaccines |
Kristen A. Earle, Donna M. Ambrosino, Andrew Fiore-Gartland, David Goldblatt, Peter B. Gilbert, George R. Siber, Peter Dull, Stanley A. Plotkin |
| 1363 |
[GO] |
2021―Mai―21 |
Changes in Childhood Vaccination During the Coronavirus Disease 2019 Pandemic in Japan |
Yuta Aizawa, Tomohiro Katsuta, Hiroshi Sakiyama, Keiko Tanaka-Taya, Hiroyuki Moriuchi, Akihiko Saitoh |
| 1364 |
[GO] |
2021―Mai―21 |
Lessons from the 1656 Neapolitan Plague:Something to Learn for the Current Coronavirus Pandemic? |
Maurizio Bifulco, Simona Pisanti, Idamaria Fusco |
| 1365 |
[GO] |
2021―Mai―19 |
The first Chinese national standards for SARS-CoV-2 neutralizing antibody |
Lidong Guan, Yuanling Yu, Xiaohong Wu, Jianhui Nie, Jun Zhang, Zejun Wang, Na Li, Rui Shi, Hui Zhao, Hongbo Chen, Chunxia Luo, Yaling Hu, Youchun Wang, Weijin Huang, Miao Xu, Jifeng Hou |
| 1366 |
[GO] |
2021―Mai―18 |
An mRNA-based vaccine candidate against SARS-CoV-2 elicits stable immuno-response with single dose |
Kakon Nag, Juwel Chandra Baray, Maksudur Rahman Khan, Asif Mahmud, Jikrul Islam, Sanat Myti, Rostum Ali, Enamul Haq Sarker, Samir Kumar, Mobarak Hossain Chowdhury, Rony Roy, Faqrul Islam, Uttam Barman, Habiba Khan, Sourav Chakraborty, Alam Badsha, Manik Hossain, Shamim Ahammad, Mashfiqur Rahman Chowdhury, Polash Ghosh, Rayhanul Islam Shimul, Ronzu Ahmmed, Eleus Hussain Bhuiya, Bipul Kumar Biswas, Mohammad Mohiuddin, Naznin Sultana |
| 1367 |
[GO] |
2021―Mai―18 |
Prevalence and determinants of SARS-CoV-2 vaccine hesitancy in Hong Kong: a population-based survey |
Tzu Tsun LUK, Shengzhi ZHAO, Yongda WU, Janet Yuen-ha WONG, Man Ping WANG, Tai Hing LAM |
| 1368 |
[GO] |
2021―Mai―14 |
Operational research for the safe and effective design of COVID-19 mass vaccination centres |
Richard M. Wood, Ben J. Murch, Simon J. Moss, Joshua M.B. Tyler, Alexander L. Thompson, Christos Vasilakis |
| 1369 |
[GO] |
2021―Mai―14 |
U.S. Population-Based Background Incidence Rates of Medical Conditions for Use in Safety Assessment of COVID-19 Vaccines |
Diane Gubernot, Amelia Jazwa, Manette Niu, Jane Baumblatt, Julianne Gee, Pedro Moro, Jonathan Duffy, Theresa Harrington, Michael M. McNeil, Karen Broder, John Su, Satoshi Kamidani, Christine K. Olson, Lakshmi Panagiotakopoulos, Tom Shimabukuro, Richard Forshee, Steven Anderson, Sarah Bennett |
| 1370 |
[GO] |
2021―Mai―12 |
COVID-19 vaccine hesitancy among persons living in homeless shelters in France |
C Longchamps, S Ducarroz, L Crouzet, N. Vignier, L. Pourtau, C Allaire, AC Colleville, T El Aarbaoui, M Melchior |
| 1371 |
[GO] |
2021―Mai―12 |
Older Adolescents and Young Adults Willingness to Receive the COVID-19 Vaccine: Implications for Informing Public Health Strategies |
Tracie O. Afifi, Samantha Salmon, Tamara Taillieu, Ashley Stewart-Tufescu, Janique Fortier, S. Michelle Driedger |
| 1372 |
[GO] |
2021―Mai―11 |
Covid-19 vaccine trials: ethnic diversity and immunogenicity |
Hannah Jethwa, Richard Wong, Sonya Abraham |
| 1373 |
[GO] |
2021―Mai―09 |
Influenza and pneumococcal vaccinations are not associated to COVID-19 outcomes among patients admitted to a university hospital |
Roberta Pastorino, Leonardo Villani, Daniele Ignazio La Milia, Roberto Ieraci, Francesco Chini, Enrico Volpe, Alessandra Barca, Danilo Fusco, Patrizia Laurenti, Walter Ricciardi, Stefania Boccia |
| 1374 |
[GO] |
2021―Mai―06 |
Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines |
Masaharu Somiya, Sohtaro Mine, Kosuke Yasukawa, Saki Ikeda |
| 1375 |
[GO] |
2021―Apr―30 |
Strengthening and accelerating SARS-CoV-2 vaccine safety surveillance through registered pre-approval rollout after challenge tests |
Nir Eyal, Tobias Gerhard, Brian L. Strom |
| 1376 |
[GO] |
2021―Apr―30 |
Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS) |
Kerry J. Welsh, Jane Baumblatt, Wambui Chege, Ravi Goud, Narayan Nair |
| 1377 |
[GO] |
2021―Apr―27 |
Missed childhood immunizations during the COVID-19 pandemic in Brazil: analyses of routine statistics and of a national household survey |
Mariangela F Silveira, Cristian T Tonial, Ana Goretti K Maranhão, Antonia MS Teixeira, Pedro C Hallal, Ana Maria B Menezes, Bernardo L Horta, Fernando P Hartwig, Aluisio JD Barros, Cesar G Victora |
| 1378 |
[GO] |
2021―Apr―27 |
Childhood immunization during the COVID-19 pandemic in Texas |
Tasmiah Nuzhath, Kobi V. Ajayi, Qiping Fan, Peter Hotez, Brian Colwell, Timothy Callaghan, Annette K. Regan |
| 1379 |
[GO] |
2021―Apr―27 |
The impact of disruptions caused by the COVID-19 pandemic on global polio eradication |
Dominika A. Kalkowska, Arie Voorman, Mark A. Pallansch, Steven G. F. Wassilak, Stephen L. Cochi, Kamran Badizadegan, Kimberly M. Thompson |
| 1380 |
[GO] |
2021―Apr―24 |
Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia |
C Raina MacIntyre, Valentina Costantino, Mallory Trent |
| 1381 |
[GO] |
2021―Apr―24 |
Factors Influencing Covid-19 Vaccine Acceptance across Subgroups in the United States: Evidence from a Conjoint Experiment |
S.E. Kreps, D.L. Kriner |
| 1382 |
[GO] |
2021―Apr―15 |
Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: a national cross-sectional study |
Chao Wang, Bingfeng Han, Tianshuo Zhao, Hanyu Liu, Bei Liu, Linyi Chen, Mingzhu Xie, Jiang Liu, Hui Zheng, Sihui Zhang, Yu Wang, Ninghua Huang, Juan Du, Ya-Qiong Liu, Qing-Bin Lu, Fuqiang Cui |
| 1383 |
[GO] |
2021―Apr―09 |
The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59 years: a phase I randomized, double-blinded, controlled trial |
Jing Pu, Qin Yu, Zhifang Yin, Ying Zhang, Xueqi Li, Qiongzhou Yin, Hongbo Chen, Runxiang Long, Zhimei Zhao, Tangwei Mou, Heng Zhao, Shiyin Feng, Zhongping Xie, Lichun Wang, Zhanlong He, Yun Liao, Shengtao Fan, Ruiju Jiang, Jianfeng Wang, Lingli Zhang, Jing Li, Huiwen Zheng, Pingfang Cui, Guorun Jiang, Lei Guo, Mingjue Xu, Huijuan Yang, Shan Lu, Xuanyi Wang, Yang Gao, Xingli Xu, Linrui Cai, Jian Zhou, Li Yu, Zhuo Chen, Chao Hong, Dan Du, Hongling Zhao, Yan Li, Kaili Ma, Yunfei Ma, Donglan Liu, Shibao Yao, Changgui Li, Yanchun Che, Longding Liu, Qihan Li |
| 1384 |
[GO] |
2021―Apr―08 |
Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: a mathematical modelling analysis |
Alexandra B. Hogan, Peter Winskill, Oliver J. Watson, Patrick G.T. Walker, Charles Whittaker, Marc Baguelin, Nicholas F. Brazeau, Giovanni D. Charles, Katy A.M. Gaythorpe, Arran Hamlet, Edward Knock, Daniel J. Laydon, John A. Lees, Alessandra Løchen, Robert Verity, Lilith K. Whittles, Farzana Muhib, Katharina Hauck, Neil M. Ferguson, Azra C. Ghani |
| 1385 |
[GO] |
2021―Apr―06 |
Impact of Reduced Human Papillomavirus Vaccination Coverage Rates Due to COVID-19 in the United States: A Model Based Analysis |
Vincent Daniels, Kunal Saxena, Craig Roberts, Smita Kothari, Shelby Corman, Linda Niccolai |
| 1386 |
[GO] |
2021―Apr―06 |
When politics collides with public health: COVID-19 vaccine country of origin and vaccination acceptance in Brazil |
Wladimir G. Gramacho, Mathieu Turgeon |
| 1387 |
[GO] |
2021―Apr―06 |
Anaphylactic reactions to mRNA COVID-19 vaccines: A call for further study |
Sophia Hatziantoniou, Helena C. Maltezou, Athanasios Tsakris, Gregory A. Poland, Cleo Anastassopoulou |
| 1388 |
[GO] |
2021―Mrz―26 |
strategy to identify priority groups for covid-19 vaccination: a population based cohort STUDY |
Antonio Giampiero Russo, Adriano Decarli, Maria Grazia Valsecchi |
| 1389 |
[GO] |
2021―Mrz―26 |
The Development of COVID-19 Vaccines in the United States: Why and How So Fast? |
Barbara J. Kuter, Paul Offit, Gregory A. Poland |
| 1390 |
[GO] |
2021―Mrz―24 |
COVID-19 vaccination attitudes, values and intentions among United States adults prior to emergency use authorization |
Daniel A. Salmon, Matthew Z. Dudley, Janesse Brewer, Lilly Kan, Jennifer E. Gerber, Haley Budigan, Tina M. Proveaux, Roger Bernier, Rajiv Rimal, Benjamin Schwartz |
| 1391 |
[GO] |
2021―Mrz―23 |
Are vaccines against COVID-19 tailored to the most vulnerable people? |
Raffaele Antonelli Incalzi, Caterina Trevisan, Susanna Del Signore, Stefano Volpato, Stefano Fumagalli, Fabio Monzani, Giuseppe Bellelli, Pietro Gareri, Enrico Mossello, Alba Malara, Alessandra Coin, Gianluca Zia, Anette Hylen Ranhoff |
| 1392 |
[GO] |
2021―Mrz―23 |
COVID-19 Vaccine Safety Questions and Answers for Healthcare Providers (CONSIDER) |
Sonali Kochhar, Eve Dubé, Janice Graham, Youngmee Jee, Ziad A. Memish, Lisa Menning, Hanna Nohynek, Daniel Salmon, Karina A. Top, Noni E. MacDonald |
| 1393 |
[GO] |
2021―Mrz―23 |
Safeguarding evidence-based decision making in the FDA for COVID-19 vaccines |
Aris Angelis, Jonathan Darrow |
| 1394 |
[GO] |
2021―Mrz―23 |
The role of multiple SARS-CoV-2 viral antigens in a vaccine-induced integrated immune response |
Ying Zhang, Dandan Li, Heng Zhao, Lichun Wang, Yun Liao, Xueqi Li, Tangwei Mou, Qihan Li |
| 1395 |
[GO] |
2021―Mrz―23 |
Joining the Herd? U.S. Public Opinion and Vaccination Requirements Across Educational Settings During the COVID-19 Pandemic |
Simon F. Haeder |
| 1396 |
[GO] |
2021―Mrz―20 |
Projecting the impact of a two-dose COVID-19 vaccination campaign in Ontario, Canada |
Thomas N. Vilches, Kevin Zhang, Robert Van Exan, Joanne M. Langley, Seyed M. Moghadas |
| 1397 |
[GO] |
2021―Mrz―20 |
Safety monitoring of COVID-19 vaccines - Lessons learned from the 1976 national influenza immunization program about detecting rare vaccine-related severe adverse events in emergency mass-vaccination programs |
Alan Kendal |
| 1398 |
[GO] |
2021―Mrz―18 |
Media usage predicts intention to be vaccinated against SARS-CoV-2 in the US and the UK |
Daniel Allington, Siobhan McAndrew, Vivienne Louisa Moxham-Hall, Bobby Duffy |
| 1399 |
[GO] |
2021―Mrz―13 |
Developing standard safety outcomes for COVID-19 vaccines |
Jim P. Buttery |
| 1400 |
[GO] |
2021―Mrz―11 |
COVID-19 vaccination and critical care capacity: perilous months ahead |
Leslie A Reperant, Albert DME Osterhaus |
| 1401 |
[GO] |
2021―Mrz―11 |
COVID-19 vaccine intentions in the United States, a social-ecological framework |
Carl Latkin, Lauren Dayton, Grace Yi, Arianna Konstantopoulos, Ju Park, Catherine Maulsby, Xiangrong Kong |
| 1402 |
[GO] |
2021―Mrz―11 |
The social experience of participation in a COVID-19 vaccine trial: Subjects’ motivations, others’ concerns, and insights for vaccine promotion |
Emily Wentzell, Ana-Monica Racila |
| 1403 |
[GO] |
2021―Mrz―09 |
NIH funding for vaccine readiness before the COVID-19 pandemic |
Anthony E. Kiszewski, Ekaterina Galkina Cleary, Matthew J. Jackson, Fred D. Ledley |
| 1404 |
[GO] |
2021―Mrz―09 |
Importance of COVID-19 vaccine efficacy in older age groups |
Manish Sadarangani, Bahaa Abu Raya, Jessica M. Conway, Sarafa A. Iyaniwura, Rebeca Cardim Falcao, Caroline Colijn, Daniel Coombs, Soren Gantt |
| 1405 |
[GO] |
2021―Mrz―09 |
U.S. Public Support for COVID-19 Vaccine Donation to Low- and Middle-Income Countries during the COVID-19 Pandemic |
Jeanine P.D. Guidry, Paul B. Perrin, Linnea I. Laestadius, Emily K. Vraga, Carrie A. Miller, Bernard F. Fuemmeler, Candace W. Burton, Mark Ryan, Kellie E. Carlyle |
| 1406 |
[GO] |
2021―Mrz―07 |
The Critical Role Background Rates of Possible Adverse Events in the Assessment of COVID-19 Vaccine Safety |
Steven B Black, Barbara Law, Robert T. Chen, Cornelia L. Dekker, Miriam Sturkenboom, Wan-Ting Huang, Marc Gurwith, Greg Poland |
| 1407 |
[GO] |
2021―Mrz―07 |
Vaccine Hesitancy and Anti-Vaccination in the Time of COVID-19: a Google Trends Analysis |
Samuel Pullan, Mrinalini Dey |
| 1408 |
[GO] |
2021―Mrz―05 |
Influenza Vaccination in the Time of COVID-19: A National U.S. Survey of Adults |
Lynne Sturm, Monica L. Kasting, Katharine J. Head, Jane A. Hartsock, Gregory D. Zimet |
| 1409 |
[GO] |
2021―Mrz―05 |
Intranasal Administration of a Recombinant RBD Vaccine Induced Protective Immunity Against SARS-CoV-2 in Mouse |
Yingying Du, Yuhua Xu, Jin Feng, Longbo Hu, Yanan Zhang, Bo Zhang, Weili Guo, Runming Mai, Liyun Chen, Jianmin Fang, Hui Zhang, Tao Peng |
| 1410 |
[GO] |
2021―Mrz―05 |
Assessment of SARS-CoV-2 Specific CD4(+) and CD8 (+) T Cell Responses MHC Class I and II Tetramers |
Yuri Poluektov, Pirouz Daftarian, Marybeth George, Marc C. Delcommenne |
| 1411 |
[GO] |
2021―Mrz―02 |
Guidance for design and analysis of observational studies of fetal and newborn outcomes following COVID-19 vaccination during pregnancy |
Deshayne B. Fell, Michelle C. Dimitris, Jennifer A. Hutcheon, Justin R. Ortiz, Robert W. Platt, Annette K. Regan, David A. Savitz |
| 1412 |
[GO] |
2021―Feb―27 |
Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use |
Mingwang Shen, Jian Zu, Christopher K. Fairley, José A. Pagán, Li An, Zhanwei Du, Yuming Guo, Libin Rong, Yanni Xiao, Guihua Zhuang, Yan Li, Lei Zhang |
| 1413 |
[GO] |
2021―Feb―27 |
Willingness to Pay and Financing Preferences for COVID-19 Vaccination in China |
Jiahao Wang, Yun Lyu, Haijun Zhang, Rize Jing, Xiaozhen Lai, Huangyufei Feng, Maria Deloria Knoll, Hai Fang |
| 1414 |
[GO] |
2021―Feb―24 |
Building the global vaccine manufacturing capacity needed to respond to pandemics |
Tara Kirk Sell, Daniel Gastfriend, Matthew Watson, Crystal Watson, Lauren Richardson, Anita Cicero, Tom Inglesby, Nancy Connell |
| 1415 |
[GO] |
2021―Feb―21 |
The potential effects of deploying SARS-Cov-2 vaccines on cold storage capacity and immunization workload in countries of the WHO African Region |
Justin R. Ortiz, Joanie Robertson, Jui-Shan Hsu, Stephen L. Yu, Amanda J. Driscoll, Sarah R. Williams, Wilbur H. Chen, Meagan C. Fitzpatrick, Samba Sow, Robin J. Biellik, Kathleen M. Neuzil |
| 1416 |
[GO] |
2021―Feb―17 |
Perspectives on the Receipt of a COVID-19 Vaccine: A Survey of Employees in Two Large Hospitals in Philadelphia |
Barbara J. Kuter, Safa Browne, Florence M. Momplaisir, Kristen A. Feemster, Angela K. Shen, Judith Green-McKenzie, Walter Faig, Paul A. Offit |
| 1417 |
[GO] |
2021―Feb―10 |
Improving COVID-19 Vaccine Acceptance: Including Insights from Human Decision-Making Under Conditions of Uncertainty and Human-Centered Design |
Caroline M. Poland, Allison Matthews, Gregory A. Poland |
| 1418 |
[GO] |
2021―Feb―09 |
A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine |
Laurence Chu, Roderick McPhee, Wenmei Huang, Hamilton Bennett, Rolando Pajon, Biliana Nestorova, Brett Leav |
| 1419 |
[GO] |
2021―Feb―07 |
International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples |
Eric Robinson, Andrew Jones, India Lesser, Michael Daly |
| 1420 |
[GO] |
2021―Feb―03 |
Ethical tradeoffs in SARS-CoV-2 vaccine development: Assuring fair availability for low-income countries |
David Gurwitz |
| 1421 |
[GO] |
2021―Jan―31 |
Vaccines, masks, distancing and credibility: An urgent warning for pandemic management |
Paul H. Axelsen, Gregory A. Poland |
| 1422 |
[GO] |
2021―Jan―29 |
General Determination of Causation Between Covid-19 Vaccines and Possible Adverse Events |
Lee M. Hampton, Rakesh Aggarwal, Stephen J.W. Evans, Barbara Law |
| 1423 |
[GO] |
2021―Jan―22 |
The economics of global COVID vaccine administration during a pandemic - Why continue skin alcohol preparation as a costly but ineffective practice? |
Eric G. Poland, Darren K. McGuire, Tamar Ratishvili, Gregory A. Poland |
| 1424 |
[GO] |
2021―Jan―22 |
Variable seasonal influenza vaccine effectiveness across geographical regions, age groups and levels of vaccine antigenic similarity with circulating virus strains: A systematic review and meta-analysis of the evidence from test-negative design studies after the 2009/10 influenza pandemic |
G.N. Okoli, F. Racovitan, T. Abdulwahid, C.H. Righolt, S.M. Mahmud |
| 1425 |
[GO] |
2021―Jan―20 |
US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine |
Rafael Dal-Ré |
| 1426 |
[GO] |
2021―Jan―20 |
Recombinant SARS-CoV-2 RBD with a built in T helper epitope induces strong neutralization antibody response |
Qiu-dong Su, Ye-ning Zou, Yao Yi, Li-ping Shen, Xiang-zhong Ye, Yang Zhang, Hui Wang, Hong Ke, Jing-dong Song, Ke-ping Hu, Bo-lin Cheng, Feng Qiu, Peng-cheng Yu, Wen-ting Zhou, Ran Zhao, Lei Cao, Gao-feng Dong, Sheng-li Bi, Gui-zhen Wu, George Fu Gao, Jerry Zheng |
| 1427 |
[GO] |
2021―Jan―19 |
Immunoinformatics prediction of overlapping CD8+ T-cell, IFN-γ and IL-4 inducer CD4+ T-cell and linear B-cell epitopes based vaccines against COVID-19 (SARS-CoV-2) |
Abiodun J. Fatoba, Leah Maharaj, Victoria T. Adeleke, Moses Okpeku, Adebayo A Adeniyi, Matthew A. Adeleke |
| 1428 |
[GO] |
2021―Jan―13 |
The need for inclusion of pregnant women in COVID-19 vaccine trials |
Richard H. Beigi, Carleigh Krubiner, Denise J. Jamieson, Anne D. Lyerly, Brenna Hughes, Laura Riley, Ruth Faden, Ruth Karron |
| 1429 |
[GO] |
2021―Jan―13 |
Black-white disparities in 2009 H1N1 vaccination among adults in the United States: A cautionary tale for the COVID-19 pandemic |
Andrew E. Burger, Eric N. Reither, Svenn-Erik Mamelund, Sojung Lim |
| 1430 |
[GO] |
2021―Jan―11 |
Development of Vaccines for Influenza Disease: Opportunity Costs of the COVID-19 Pandemic |
Timothy L. Wiemken, Ana Santos Rutschman |
| 1431 |
[GO] |
2021―Jan―11 |
Immuno-informatics approach for B-cell and T-cell Epitope based peptide vaccine design against novel COVID-19 virus |
Jitender Singh, Deepti Malik, Ashvinder Raina |
| 1432 |
[GO] |
2021―Jan―11 |
Predictors of Intention to Vaccinate Against COVID-19: Results of a Nationwide Survey |
Jeanette B. Ruiz, Robert A. Bell |
| 1433 |
[GO] |
2021―Jan―08 |
Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020 |
Marit Middeldorp, Alies van Lier, Nicoline van der Maas, Irene Veldhuijzen, Wieke Freudenburg, Nina M van Sorge, Elisabeth A M Sanders, Mirjam J Knol, Hester E de Melker |
| 1434 |
[GO] |
2021―Jan―08 |
Acceptance of the COVID-19 vaccine based on the Health Belief Model: a population-based survey in Hong Kong |
Martin CS Wong, Eliza LY Wong, Junjie Huang, Annie WL Cheung, Kevin Law, Marc KC Chong, Rita WY Ng, Christopher KC Lai, Siaw S Boon, Joseph TF Lau, Zigui Chen, Paul KS Chan |
| 1435 |
[GO] |
2021―Jan―08 |
The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: use of cost-effectiveness modeling to inform vaccination prioritization |
Michele Kohli, Michael Maschio, Debbie Becker, Milton C. Weinstein |
| 1436 |
[GO] |
2021―Jan―08 |
Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines |
John M Kelso |
| 1437 |
[GO] |
2021―Jan―08 |
How should we conduct pandemic vaccination? |
Jane Williams, Chris Degeling, Jodie McVernon, Angus Dawson |
| 1438 |
[GO] |
2021―Jan―03 |
Constructing an ethical framework for priority allocation of pandemic vaccines |
J Fielding, S.G. Sullivan, F. Beard, K. Macartney, J. Williams, A. Dawson, G.L. Gilbert, P. Massey, K. Crooks, R. Moss, J.M. McCaw, J. McVernon |
| 1439 |
[GO] |
2020―Dez―26 |
Childhood vaccinations: hidden impact of COVID-19 on children in Singapore |
Youjia Zhong, Hannah Eleanor Clapham, Ramkumar Aishworiya, Ying Xian Chua, Jancy Mathews, Mabel Ong, Jingji Wang, Belinda Murugasu, Wen Chin Chiang, Bee Wah Lee, Hui-Lin Chin |
| 1440 |
[GO] |
2020―Dez―17 |
Timing of COVID-19 Vaccine Approval and Endorsement by Public Figures |
Scott E. Bokemper, Gregory A. Huber, Alan S. Gerber, Erin K. James, Saad B. Omer |
| 1441 |
[GO] |
2020―Dez―17 |
Preferences for a COVID-19 vaccine in Australia |
Antonio Borriello, Daniel Master, Andrea Pellegrini, John M Rose |
| 1442 |
[GO] |
2020―Dez―17 |
Global production capacity of seasonal and pandemic influenza vaccines in 2019 |
Erin Sparrow, James G Wood, Christopher Chadwick, Anthony T. Newall, Siranda Torvaldsen, Ann Moen, Guido Torelli |
| 1443 |
[GO] |
2020―Dez―16 |
Broad cross-national public support for accelerated COVID-19 vaccine trial designs |
David Broockman, Joshua Kalla, Alexander Guerrero, Mark Budolfson, Nir Eyal, Nicholas P. Jewell, Monica Magalhaes, Jasjeet S. Sekhon |
| 1444 |
[GO] |
2020―Dez―13 |
BCG vaccine: worrying proposal for COVID-19 |
Emanuel Sarinho, Ekaterini Goudouris, Dirceu Solé |
| 1445 |
[GO] |
2020―Dez―13 |
Priority allocation of pandemic influenza vaccines in Australia - Recommendations of 3 community juries |
C. Degeling, J. Williams, S.M. Carter, R. Moss, P. Massey, G.L. Gilbert, P. Shih, A. Braunack-Mayer, K. Crooks, D. Brown, J. McVernon |
| 1446 |
[GO] |
2020―Dez―11 |
Maintain and increase vaccination coverage in children, adolescents, adults and elderly people: Let's avoid adding epidemics to the pandemic |
P. Bonanni, I.F. Angelillo, A. Villani, P. Biasci, S. Scotti, R. Russo, T. Maio, G. Vitali Rosati, M. Barretta, E. Bozzola, P. Castiglia, G. Chiamenti, G. Conforti, M. Conversano, A. Ferro, F. Francia, P.G. Macrì, C. Azzari |
| 1447 |
[GO] |
2020―Dez―10 |
An Inventory-Location Optimization Model for Equitable Influenza Vaccine Distribution in Developing Countries During the COVID-19 Pandemic |
Mehdi Rastegar, Madjid Tavana, Afshin Meraj, Hassan Mina |
| 1448 |
[GO] |
2020―Dez―09 |
Potential impact of COVID-19 pandemic on vaccination coverage in children: A case study of measles-containing vaccine administration in the United States (US) |
Cristina Carias, Manjiri Pawaskar, Mawuli Nyaku, James H. Conway, Craig Roberts, Lyn Finelli, Ya-Ting Chen |
| 1449 |
[GO] |
2020―Dez―09 |
Critical Aspects of Packaging, Storage, Preparation, and Administration of mRNA and Adenovirus-vectored COVID-19 Vaccines for Optimal Efficacy |
Michelle Holm, Gregory Poland |
| 1450 |
[GO] |
2020―Dez―05 |
Epidemiology of COVID-19 infection in young children under five years: a systematic review and meta-analysis |
Mejbah Uddin Bhuiyan, Eunice Stiboy, Md. Zakiul Hassan, Mei Chan, Md. Saiful Islam, Najmul Haider, Adam Jaffe, Nusrat Homaira |
| 1451 |
[GO] |
2020―Dez―05 |
Individual Preferences for COVID-19 Vaccination in China |
Anli Leng, Elizabeth Maitland, Siyuan Wang, Stephen Nicholas, Rugang Liu, Jian Wang |
| 1452 |
[GO] |
2020―Dez―05 |
PIPDeploy: Development and implementation of a gamified table top simulation exercise to strengthen national pandemic vaccine preparedness and readiness |
Ioana Ghiga, Sol Richardson, Alba Maria Ropero Álvarez, Masaya Kato, Dhamari Naidoo, Satoko Otsu, Phuc Thi Nguyen, Phuong Nam Nguyen, Tim Nguyen |
| 1453 |
[GO] |
2020―Dez―04 |
Pregnant people deserve the protection offered by SARS-CoV-2 vaccines |
Melanie M. Maykin, Cara Heuser, Helen Feltovich |
| 1454 |
[GO] |
2020―Nov―24 |
A model for the incremental burden of invasive Haemophilus influenzae type b due to a decline of childhood vaccination during the COVID-19 outbreak: A dynamic transmission model in Japan |
Taito Kitano, Hirosato Aoki |
| 1455 |
[GO] |
2020―Nov―24 |
How to ensure we can track and trace the global use of COVID-19 vaccines? |
Robert H Vander Stichele, Christian Hay, Malin Fladvad, Miriam CJM Sturkenboom, Robert T Chen |
| 1456 |
[GO] |
2020―Nov―24 |
New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates |
Takehiro Ura, Akio Yamashita, Nobuhisa Mizuki, Kenji Okuda, Masaru Shimada |
| 1457 |
[GO] |
2020―Nov―08 |
Pandemic perspectives - The invisible hurricane |
Carly Muller |
| 1458 |
[GO] |
2020―Nov―07 |
The demand for a COVID-19 vaccine in Ecuador |
Oscar Sarasty, Carlos E. Carpio, Darren Hudson, Patricia A. Guerrero-Ochoa, Ivan Borja |
| 1459 |
[GO] |
2020―Nov―05 |
Influenza vaccination among infection control teams: A EUCIC survey prior to COVID-19 pandemic |
Şiran Keske, Nico T. Mutters, Constantinos Tsioutis, Önder Ergönül |
| 1460 |
[GO] |
2020―Nov―05 |
COVID-19: The Worst Date to the Senior Dance |
Luke Bothun |
| 1461 |
[GO] |
2020―Okt―30 |
The public’s role in COVID-19 vaccination: human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States |
Monica Schoch-Spana, Emily K. Brunson, Rex Long, Alexandra Ruth, Sanjana J. Ravi, Marc Trotochaud, Luciana Borio, Janesse Brewer, Joseph Buccina, Nancy Connell, Laura Lee Hall, Nancy Kass, Anna Kirkland, Lisa Koonin, Heidi Larson, Brooke Fisher Lu, Saad B. Omer, Walter A. Orenstein, Gregory A. Poland, Lois Privor-Dumm, Sandra Crouse Quinn, Daniel Salmon, Alexandre White |
| 1462 |
[GO] |
2020―Okt―28 |
Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group |
Euzebiusz Jamrozik, Katherine Littler, Susan Bull, Claudia Emerson, Gagandeep Kang, Melissa Kapulu, Elena Rey, Carla Saenz, Seema Shah, Peter G Smith, Ross Upshur, Charles Weijer, Michael J Selgelid |
| 1463 |
[GO] |
2020―Okt―26 |
“Cultivating” acceptance of a COVID-19 vaccination program: Lessons from Italy |
Guendalina Graffigna, Lorenzo Palamenghi, Serena Barello, Boccia Stefania |
| 1464 |
[GO] |
2020―Okt―26 |
Acceptance of a COVID-19 vaccine: A multifactorial consideration |
Leidy Y. García, Arcadio A. Cerda |
| 1465 |
[GO] |
2020―Okt―23 |
NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge |
Mimi Guebre-Xabier, Nita Patel, Jing-Hui Tian, Bin Zhou, Sonia Maciejewski, Kristal Lam, Alyse D. Portnoff, Michael J. Massare, Matthew B. Frieman, Pedro A. Piedra, Larry Ellingsworth, Gregory Glenn, Gale Smith |
| 1466 |
[GO] |
2020―Okt―21 |
“Expanding Global and National Influenza Vaccine Systems to match the COVID-19 Pandemic Response” |
Bruce A. Ruscio, Peter Hotez |
| 1467 |
[GO] |
2020―Okt―20 |
India’s cost-effective COVID-19 vaccine development initiatives |
Chiranjib Chakraborty, Govindasamy Agoramoorthy |
| 1468 |
[GO] |
2020―Okt―19 |
Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: a multi-methods study in England |
Sadie Bell, Richard Clarke, Sandra Mounier-Jack, Jemma L Walker, Pauline Paterson |
| 1469 |
[GO] |
2020―Okt―19 |
Identification of a dominant CD8+ CTL epitope in the SARS-associated coronavirus 2 spike protein |
Daisuke Muraoka, Deng Situo, Sawada Shin-ichi, Akiyoshi Kazunari, Naozumi Harada, Hiroaki Ikeda |
| 1470 |
[GO] |
2020―Okt―13 |
Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry |
L. Coudeville, G.B. Gomez, O. Jollivet, R.C. Harris, E. Thommes, S. Druelles, A. Chit, S.S. Chaves, C. Mahé |
| 1471 |
[GO] |
2020―Okt―10 |
Caregiver willingness to vaccinate their children against COVID-19: cross sectional survey |
Ran D. Goldman, Tyler D. Yan, Michelle Seiler, Cristina Parra Cotanda, Julie C. Brown, Eileen J. Klein, Julia Hoeffe, Renana Gelernter, Jeanine E. Hall, Adrienne L. Davis, Mark A. Griffiths, Ahmed Mater, Sergio Manzano, Gianluca Gualco, Naoki Shimizu, Thomas L. Hurt, Sara Ahmed, Matt Hansen, David Sheridan, Samina Ali, Graham C. Thompson, Nathalie Gaucher, Georg Staubli |
| 1472 |
[GO] |
2020―Okt―09 |
COVID-19 in Africa and collateral effects on health systems and their immunization programs |
Azucena Bardají, Quique Bassat, Graça Matsinhe, Teresa Aguado |
| 1473 |
[GO] |
2020―Okt―09 |
COVID-19 vaccine and boosted immunity: nothing ad interim to do? |
Luca Roncati, Maria Vadalà, Veronica Corazzari, Beniamino Palmieri |
| 1474 |
[GO] |
2020―Okt―09 |
COVID-19 vaccine trials: duty of care and standard of prevention considerations |
Jerome Amir Singh |
| 1475 |
[GO] |
2020―Okt―09 |
Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches |
Ashkan Safavi, Amirhosein Kefayat, Elham Mahdevar, Ardavan Abiri, Fatemeh Ghahremani |
| 1476 |
[GO] |
2020―Sep―22 |
Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1) Formulated with Aluminum Hydroxide Induces Protective Immunity and Reduces Immune Enhancement |
Wen-Hsiang Chen, Xinrong Tao, Anurodh Agrawal, Abdullah Algaissi, Bi-Hung Peng, Jeroen Pollet, Ulrich Strych, Maria Elena Bottazzi, Peter J. Hotez, Sara Lustigman, Lanying Du, Shibo Jiang, Chien-Te K. Tseng |
| 1477 |
[GO] |
2020―Sep―22 |
Enhanced Elicitation of Potent Neutralizing Antibodies by the SARS-CoV-2 Spike Receptor Binding Domain Fc Fusion Protein in Mice |
Xianglei Liu, Aleksandra Drelich, Wei Li, Chuan Chen, Zehua Sun, Megan Shi, Cynthia Adams, John W. Mellors, Chien-Te Tseng, Dimiter S. Dimitrov |
| 1478 |
[GO] |
2020―Sep―17 |
Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic |
Maëlle Detoc, Sébastien Bruel, Paul Frappe, Bernard Tardy, Elisabeth Botelho-Nevers, Amandine Gagneux-Brunon |
| 1479 |
[GO] |
2020―Sep―15 |
Ensemble forecast modeling for the design of COVID-19 vaccine efficacy trials |
Natalie E. Dean, Ana Pastore y Piontti, Zachary J. Madewell, Derek A.T Cummings, Matthew D.T. Hitchings, Keya Joshi, Rebecca Kahn, Alessandro Vespignani, M. Elizabeth Halloran, Ira M. Longini |
| 1480 |
[GO] |
2020―Sep―10 |
Intention of nurses to accept coronavirus disease 2019 vaccination and change of intention to accept seasonal influenza vaccination during the coronavirus disease 2019 pandemic: a cross-sectional survey |
Kailu WANG, Eliza Lai Yi WONG, Kin Fai HO, Annie Wai Ling CHEUNG, Emily Ying-yang CHAN, Eng Kiong YEOH, Samuel Yeung-shan WONG |
| 1481 |
[GO] |
2020―Aug―20 |
Acceptability of a COVID-19 Vaccine among Adults in the United States: How Many People Would Get Vaccinated? |
Paul L. Reiter, Michael L. Pennell, Mira L. Katz |
| 1482 |
[GO] |
2020―Aug―20 |
BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: in silico analyses and a hypothesis |
Yusuke Tomita, Ryo Sato, Tokunori Ikeda, Takuro Sakagami |
| 1483 |
[GO] |
2020―Aug―19 |
The impact of influenza vaccination on the COVID-19 pandemic? Evidence and lessons for public health policies |
John Paget, Saverio Caini, Ben Cowling, Susanna Esposito, Ann R. Falsey, Angela Gentile, Jan Kyncl, C. Raina McIntyre, Richard Pitman, Bruno Lina |
| 1484 |
[GO] |
2020―Aug―19 |
Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present α-gal epitopes |
Uri Galili |
| 1485 |
[GO] |
2020―Aug―15 |
Impact of COVID-19 pandemic response on uptake of routine immunizations in Sindh, Pakistan: an analysis of provincial electronic immunization registry |
Subhash Chandir, Danya Arif Siddiqi, Mariam Mehmood, Hamidreza Setayesh, Muhammad Siddique, Amna Mirza, Riswana Soundardjee, Vijay Kumar Dharma, Mubarak Taighoon Shah, Sara Abdullah, Mohammed Adil Akhter, Anokhi Khanum, Aamir Javed Khan |
| 1486 |
[GO] |
2020―Aug―10 |
The effect of Bacillus Calmette-Guérin (BCG) vaccination in preventing sever infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic |
Kiddus Yitbarek, Gelila Abraham, Tsinuel Girma, Tizta Tilahun, Mirkuzie Woldie |
| 1487 |
[GO] |
2020―Jul―31 |
Ensuring access and affordability through COVID-19 vaccine research and development investments: a proposal for the Options Market for Vaccines |
Rebecca Forman, Michael Anderson, Mark Jit, Elias Mossialos |
| 1488 |
[GO] |
2020―Jul―29 |
Influenza immunization and COVID-19 |
Helena C. Maltezou, Kalliopi Theodoridou, Gregory Poland |
| 1489 |
[GO] |
2020―Jul―12 |
Vaccines based on Virus-Like nano-Particles for use against Middle East Respiratory Syndrome (MERS) coronavirus |
Alireza Hashemzadeh, Amir Avan, Gordon A Ferns, Majid Khazaei |
| 1490 |
[GO] |
2020―Jul―10 |
Planning for COVID-19 Vaccines Safety surveillance |
Sonali Kochhar, Daniel A. Salmon |
| 1491 |
[GO] |
2020―Jul―03 |
A global agenda for older adult immunization in the COVID-19 era: A roadmap for action |
Lois A. Privor-Dumm, Gregory A. Poland, Jane Barratt, David N. Durrheim, Maria Deloria Knoll, Prarthana Vasudevan, Mark Jit, Pablo E. Bonvehí, Paolo Bonanni |
| 1492 |
[GO] |
2020―Jul―03 |
Bacillus Calmette-Guérin vaccine, antimalarial, age and gender relation to COVID-19 spread and mortality |
Ahmed Osama El-Gendy, Haitham Saeed, Ahmed M.A. Ali, Hossam M. Zawbaa, Dina Gomaa, Hadeer S. Harb, Yasmin M. Madney, Hasnaa Osama, Mona A. Abdelrahman, Mohamed E.A. Abdelrahim |
| 1493 |
[GO] |
2020―Jun―25 |
Contingent assessment of the COVID-19 vaccine |
Leidy Y. García, Arcadio A. Cerda |
| 1494 |
[GO] |
2020―Jun―25 |
Silver Lining of COVID-19: heightened global interest in pneumococcal and influenza vaccines, an infodemiology study |
Joseph Alexander Paguio, Jasper Seth Yao, Edward Christopher Dee |
| 1495 |
[GO] |
2020―Jun―24 |
Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates |
Wenlin Ren, Hunter Sun, George F. Gao, Jianxin Chen, Sean Sun, Rongqing Zhao, Guang Gao, Yalin Hu, Gan Zhao, Yuxin Chen, Xia Jin, Feng Fang, Jinggong Chen, Qi Wang, Sitao Gong, Wen Gao, Yufei Sun, Junchi Su, Ailiang He, Xin Cheng, Min Li, Chenxi Xia, Maohua Li, Le Sun |
| 1496 |
[GO] |
2020―Jun―23 |
Logistical challenges for potential SARS-CoV-2 vaccine and a call to research institutions, developers and manufacturers |
Umit H. Kartoglu, Kelly L. Moore, John S. Lloyd |
| 1497 |
[GO] |
2020―Jun―23 |
Allocation criteria for an initial shortage of a future SARS-CoV-2 vaccine and necessary measures for global immunity |
Wolfram Henn |
| 1498 |
[GO] |
2020―Jun―20 |
Exploring the role of mass immunisation in influenza pandemic preparedness: A modelling study for the UK context |
Luca Grieco, Jasmina Panovska-Griffiths, Edwin van Leeuwen, Peter Grove, Martin Utley |
| 1499 |
[GO] |
2020―Jun―19 |
Use of seasonal influenza and pneumococcal polysaccharide vaccines in older adults to reduce COVID-19 mortality |
Deus Thindwa, Maria Garcia Quesada, Yang Liu, Julia Bennett, Cheryl Cohen, Maria Deloria Knoll, Anne von Gottberg, Kyla Hayford, Stefan Flasche |
| 1500 |
[GO] |
2020―Jun―10 |
Vaccination Against Coronaviruses In Domestic Animals |
Ian R Tizard |
| 1501 |
[GO] |
2020―Jun―04 |
COVID-19 vaccine development: Time to consider SARS-CoV-2 challenge studies? |
G. Owen Schaefer, Clarence C. Tam, Julian Savulescu, Teck Chuan Voo |
| 1502 |
[GO] |
2020―Mai―25 |
Consensus Summary Report for CEPI/BC March 12-13, 2020 Meeting: Assessment of Risk of Disease Enhancement with COVID-19 Vaccines |
Paul-Henri Lambert, Donna M. Ambrosino, Svein R. Andersen, Ralph S. Baric, Steven B. Black, Robert T. Chen, Cornelia L. Dekker, Arnaud M. Didierlaurent, Barney S. Graham, Samantha D. Martin, Deborah C. Molrine, Stanley Perlman, Philip A. Picard-Fraser, Andrew J. Pollard, Chuan Qin, Kanta Subbarao, Jakob P. Cramer |
| 1503 |
[GO] |
2020―Mai―01 |
Tortoises, Hares, and Vaccines: A Cautionary Note for SARS-CoV-2 Vaccine Development |
Gregory A. Poland |
| 1504 |
[GO] |
2020―Apr―30 |
The biological characteristics of SARS-CoV-2 Spike protein Pro330-Leu650 |
Qiu-dong Su, Yao Yi, Ye-ning Zou, Zhi-yuan Jia, Feng Qiu, Feng Wang, Wen-jiao Yin, Wen-ting Zhou, Shuang Zhang, Peng-cheng Yu, Sheng-li Bi, Li-ping Shen, Gui-zhen Wu |
| 1505 |
[GO] |
2020―Apr―28 |
An Effective CTL Peptide Vaccine for Ebola Zaire Based on Survivors’ CD8+ Targeting of a Particular Nucleocapsid Protein Epitope with Potential Implications for COVID-19 Vaccine Design |
C.V. Herst, S. Burkholz, J. Sidney, A. Sette, P.E. Harris, S. Massey, T. Brasel, E. Cunha-Neto, D.S. Rosa, W.C.H. Chao, R. Carback, T. Hodge, L. Wang, S. Ciotlos, P. Lloyd, R. Rubsamen |
| 1506 |
[GO] |
2020―Apr―20 |
Enabling Emergency Mass Vaccination: Innovations in Manufacturing and Administration During a Pandemic |
Divya Hosangadi, Kelsey Lane Warmbrod, Elena K Martin, Amesh Adalja, Anita Cicero, Thomas Inglesby, Crystal Watson, Matthew Watson, Nancy Connell |
| 1507 |
[GO] |
2020―Mrz―12 |
Shaping meeting to explore the value of a coordinated work plan for epidemic and pandemic influenza vaccine preparedness |
Bruce Ruscio, Amanda Bolster, Joseph Bresee, Atika Abelin, Philippe Boutet, Hans Christiansen, Per Etholm, Samir Desai, Bruce Gellin, Josephine Golding, Mark Jit, Lawrence Kerr, Mark McKinlay, Samantha Kluglein, Fernando Lobos, Sophie Mathewson, Marie Mazur, Sonia Pagliusi, Pasi Penttinen, Dominique Richardson, Alba Maria Ropero Alvarez, Joseph R. Scovitch, Jennifer E. Seedorff, Louise Shaxson, John S. Tam, Beverly Taylor, Niteen Wairagkar, John Watson, Anonh Xeuatvongsa |
| 1508 |
[GO] |
2020―Feb―21 |
Another coronavirus, another epidemic, another warning |
Gregory A. Poland |
| 1509 |
[GO] |
2020―Feb―11 |
Recombinant infectious bronchitis coronavirus H120 with the spike protein S1 gene of the nephropathogenic IBYZ strain remains attenuated but induces protective immunity |
Yi Jiang, Xu Cheng, Xiumei Zhao, Yan Yu, Mingyan Gao, Sheng Zhou |
| 1510 |
[GO] |
2020―Jan―24 |
Pandemic influenza A(H1N1pdm09) vaccine induced high levels of influenza-specific IgG and IgM antibodies as analyzed by enzyme immunoassay and dual-mode multiplex microarray immunoassay methods |
Anna Kazakova, Laura Kakkola, Thedi Ziegler, Ritva Syrjänen, Henna Päkkilä, Matti Waris, Tero Soukka, Ilkka Julkunen |
| 1511 |
[GO] |
2019―Dez―12 |
Does having a seasonal influenza program facilitate pandemic preparedness? An analysis of vaccine deployment during the 2009 pandemic |
Rachael M. Porter, Shoshanna Goldin, Kathryn E. Lafond, Lisa Hedman, Mellissa Ungkuldee, Jordan Kurzum, Eduardo Azziz-Baumgartner, Claudia Nannei, Joseph S. Bresee, Ann Moen |
|
